
<html lang="en"     class="pb-page"  data-request-id="750bb3bd-8aed-44a9-8539-1e7918a0e905"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501350y;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-3"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease" /></meta><meta name="dc.Creator" content="Leticia M.  Toledo-Sherman" /></meta><meta name="dc.Creator" content="Michael E.  Prime" /></meta><meta name="dc.Creator" content="Ladislav  Mrzljak" /></meta><meta name="dc.Creator" content="Maria G.  Beconi" /></meta><meta name="dc.Creator" content="Alan  Beresford" /></meta><meta name="dc.Creator" content="Frederick A.  Brookfield" /></meta><meta name="dc.Creator" content="Christopher J.  Brown" /></meta><meta name="dc.Creator" content="Isabell  Cardaun" /></meta><meta name="dc.Creator" content="Stephen M.  Courtney" /></meta><meta name="dc.Creator" content="Ulrike  Dijkman" /></meta><meta name="dc.Creator" content="Estelle  Hamelin-Flegg" /></meta><meta name="dc.Creator" content="Peter D.  Johnson" /></meta><meta name="dc.Creator" content="Valerie  Kempf" /></meta><meta name="dc.Creator" content="Kathy  Lyons" /></meta><meta name="dc.Creator" content="Kimberly  Matthews" /></meta><meta name="dc.Creator" content="William L.  Mitchell" /></meta><meta name="dc.Creator" content="Catherine  O’Connell" /></meta><meta name="dc.Creator" content="Paula  Pena" /></meta><meta name="dc.Creator" content="Kendall  Powell" /></meta><meta name="dc.Creator" content="Arash  Rassoulpour" /></meta><meta name="dc.Creator" content="Laura  Reed" /></meta><meta name="dc.Creator" content="Wolfgang  Reindl" /></meta><meta name="dc.Creator" content="Suganathan  Selvaratnam" /></meta><meta name="dc.Creator" content="Weslyn Ward  Friley" /></meta><meta name="dc.Creator" content="Derek A.  Weddell" /></meta><meta name="dc.Creator" content="Naomi E.  Went" /></meta><meta name="dc.Creator" content="Patricia  Wheelan" /></meta><meta name="dc.Creator" content="Christin  Winkler" /></meta><meta name="dc.Creator" content="Dirk  Winkler" /></meta><meta name="dc.Creator" content="John  Wityak" /></meta><meta name="dc.Creator" content="Christopher J.  Yarnold" /></meta><meta name="dc.Creator" content="Dawn  Yates" /></meta><meta name="dc.Creator" content="Ignacio  Munoz-Sanjuan" /></meta><meta name="dc.Creator" content="Celia  Dominguez" /></meta><meta name="dc.Description" content="We report on the development of a series of pyrimidine carboxylic acids that are potent and selective inhibitors of kynurenine monooxygenase and competitive for kynurenine. We describe the SAR for ..." /></meta><meta name="Description" content="We report on the development of a series of pyrimidine carboxylic acids that are potent and selective inhibitors of kynurenine monooxygenase and competitive for kynurenine. We describe the SAR for ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 23, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501350y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501350y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501350y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501350y" /></link>
        
    
    

<title>Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501350y" /></meta><meta property="og:title" content="Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0028.jpeg" /></meta><meta property="og:description" content="We report on the development of a series of pyrimidine carboxylic acids that are potent and selective inhibitors of kynurenine monooxygenase and competitive for kynurenine. We describe the SAR for this novel series and report on their inhibition of KMO activity in biochemical and cellular assays and their selectivity against other kynurenine pathway enzymes. We describe the optimization process that led to the identification of a program lead compound with a suitable ADME/PK profile for therapeutic development. We demonstrate that systemic inhibition of KMO in vivo with this lead compound provides pharmacodynamic evidence for modulation of kynurenine pathway metabolites both in the periphery and in the central nervous system." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501350y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501350y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501350y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501350y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501350y&amp;href=/doi/10.1021/jm501350y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1159-1183</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501437v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501829f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leticia+M.++Toledo-Sherman">Leticia M. Toledo-Sherman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+E.++Prime">Michael E. Prime</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ladislav++Mrzljak">Ladislav Mrzljak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+G.++Beconi">Maria G. Beconi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Beresford">Alan Beresford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+A.++Brookfield">Frederick A. Brookfield</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Brown">Christopher J. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabell++Cardaun">Isabell Cardaun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+M.++Courtney">Stephen M. Courtney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ulrike++Dijkman">Ulrike Dijkman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Estelle++Hamelin-Flegg">Estelle Hamelin-Flegg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+D.++Johnson">Peter D. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valerie++Kempf">Valerie Kempf</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Lyons">Kathy Lyons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Matthews">Kimberly Matthews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+L.++Mitchell">William L. Mitchell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++O%E2%80%99Connell">Catherine O’Connell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paula++Pena">Paula Pena</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kendall++Powell">Kendall Powell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arash++Rassoulpour">Arash Rassoulpour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Reed">Laura Reed</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wolfgang++Reindl">Wolfgang Reindl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suganathan++Selvaratnam">Suganathan Selvaratnam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weslyn+Ward++Friley">Weslyn Ward Friley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek+A.++Weddell">Derek A. Weddell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naomi+E.++Went">Naomi E. Went</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Wheelan">Patricia Wheelan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christin++Winkler">Christin Winkler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Winkler">Dirk Winkler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Wityak">John Wityak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Yarnold">Christopher J. Yarnold</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dawn++Yates">Dawn Yates</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ignacio++Munoz-Sanjuan">Ignacio Munoz-Sanjuan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++Dominguez">Celia Dominguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 100, Los Angeles, California 90405, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Kathryn A. Lyons, P.O. Box 64, Holland, New York 14080, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Brains On-Line LLC, 7000 Shoreline Court, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Tandem Laboratories, 2202 Ellis Road, Durham, North Carolina 27703, United States</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">▽</span> <span class="aff-text">Charles River Laboratories, Chesterford Research Park, Saffron Walden, Essex, U.K.</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">¶</span> <span class="aff-text">CHDI Management/CHDI Foundation, 155 Village Boulevard, Suite 200, Princeton, New Jersey 08540, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#7f331a0b161c161e512b10131a1b10522c171a0d121e113f3c373b3639100a111b1e0b16101151100d18"><span class="__cf_email__" data-cfemail="531f36273a303a327d073c3f36373c7e003b36213e323d13101b171a153c263d3732273a3c3d7d3c2134">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501350y&amp;href=/doi/10.1021%2Fjm501350y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1159–1183</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 15, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 September 2014</li><li><span class="item_label"><b>Published</b> online</span>23 January 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 February 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501350y" title="DOI URL">https://doi.org/10.1021/jm501350y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1159%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLeticia%2BM.%2BToledo-Sherman%252C%2BMichael%2BE.%2BPrime%252C%2BLadislav%2BMrzljak%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D3%26contentID%3Djm501350y%26title%3DDevelopment%2Bof%2Ba%2BSeries%2Bof%2BAryl%2BPyrimidine%2BKynurenine%2BMonooxygenase%2BInhibitors%2Bas%2BPotential%2BTherapeutic%2BAgents%2Bfor%2Bthe%2BTreatment%2Bof%2BHuntington%25E2%2580%2599s%2BDisease%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1183%26publicationDate%3DFebruary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501350y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3557</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501350y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Leticia&quot;,&quot;last_name&quot;:&quot;M. Toledo-Sherman&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;E. Prime&quot;},{&quot;first_name&quot;:&quot;Ladislav&quot;,&quot;last_name&quot;:&quot;Mrzljak&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;G. Beconi&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Beresford&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;A. Brookfield&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Brown&quot;},{&quot;first_name&quot;:&quot;Isabell&quot;,&quot;last_name&quot;:&quot;Cardaun&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;M. Courtney&quot;},{&quot;first_name&quot;:&quot;Ulrike&quot;,&quot;last_name&quot;:&quot;Dijkman&quot;},{&quot;first_name&quot;:&quot;Estelle&quot;,&quot;last_name&quot;:&quot;Hamelin-Flegg&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;D. Johnson&quot;},{&quot;first_name&quot;:&quot;Valerie&quot;,&quot;last_name&quot;:&quot;Kempf&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Lyons&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Matthews&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;L. Mitchell&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;O’Connell&quot;},{&quot;first_name&quot;:&quot;Paula&quot;,&quot;last_name&quot;:&quot;Pena&quot;},{&quot;first_name&quot;:&quot;Kendall&quot;,&quot;last_name&quot;:&quot;Powell&quot;},{&quot;first_name&quot;:&quot;Arash&quot;,&quot;last_name&quot;:&quot;Rassoulpour&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Reed&quot;},{&quot;first_name&quot;:&quot;Wolfgang&quot;,&quot;last_name&quot;:&quot;Reindl&quot;},{&quot;first_name&quot;:&quot;Suganathan&quot;,&quot;last_name&quot;:&quot;Selvaratnam&quot;},{&quot;first_name&quot;:&quot;Weslyn&quot;,&quot;last_name&quot;:&quot;Ward Friley&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;A. Weddell&quot;},{&quot;first_name&quot;:&quot;Naomi&quot;,&quot;last_name&quot;:&quot;E. Went&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Wheelan&quot;},{&quot;first_name&quot;:&quot;Christin&quot;,&quot;last_name&quot;:&quot;Winkler&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Winkler&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Wityak&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Yarnold&quot;},{&quot;first_name&quot;:&quot;Dawn&quot;,&quot;last_name&quot;:&quot;Yates&quot;},{&quot;first_name&quot;:&quot;Ignacio&quot;,&quot;last_name&quot;:&quot;Munoz-Sanjuan&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;Dominguez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;1159-1183&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501350y&quot;},&quot;abstract&quot;:&quot;We report on the development of a series of pyrimidine carboxylic acids that are potent and selective inhibitors of kynurenine monooxygenase and competitive for kynurenine. We describe the SAR for this novel series and report on their inhibition of KMO activity in biochemical and cellular assays and their selectivity against other kynurenine pathway enzymes. We describe the optimization process that led to the identification of a program lead compound with a suitable ADME/PK profile for therapeutic development. We demonstrate that systemic inhibition of KMO in vivo with this lead compound provides pharmacodynamic evidence for modulation of kynurenine pathway metabolites both in the periphery and in the central nervous system.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501350y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501350y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501350y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501350y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501350y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501350y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501350y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501350y&amp;href=/doi/10.1021/jm501350y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501350y" /></input><a href="/doi/pdf/10.1021/jm501350y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501350y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501350y%26sid%3Dliteratum%253Aachs%26pmid%3D25590515%26genre%3Darticle%26aulast%3DToledo-Sherman%26date%3D2015%26atitle%3DDevelopment%2Bof%2Ba%2BSeries%2Bof%2BAryl%2BPyrimidine%2BKynurenine%2BMonooxygenase%2BInhibitors%2Bas%2BPotential%2BTherapeutic%2BAgents%2Bfor%2Bthe%2BTreatment%2Bof%2BHuntington%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D3%26spage%3D1159%26epage%3D1183%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jmcmar.2015.58.issue-3/20150212/jmcmar.2015.58.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report on the development of a series of pyrimidine carboxylic acids that are potent and selective inhibitors of kynurenine monooxygenase and competitive for kynurenine. We describe the SAR for this novel series and report on their inhibition of KMO activity in biochemical and cellular assays and their selectivity against other kynurenine pathway enzymes. We describe the optimization process that led to the identification of a program lead compound with a suitable ADME/PK profile for therapeutic development. We demonstrate that systemic inhibition of KMO in vivo with this lead compound provides pharmacodynamic evidence for modulation of kynurenine pathway metabolites both in the periphery and in the central nervous system.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Huntington’s disease (HD) is an autosomal dominant disease caused by a CAG repeat expansion in the <i>huntingtin</i> (<i>HTT</i>) gene that encodes an expanded polyglutamine tract in the mutant huntingtin (mHTT) protein. Clinical manifestations of this disease include motor and cognitive impairment and psychiatric disturbances, as well as metabolic abnormalities,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> with disease onset typically occurring between the ages of 30 and 50, and death within 15 to 20 years. While mHTT is ubiquitously expressed throughout the body, striatal medium spiny neurons display the highest susceptibility to cell death in HD<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and account for the manifestations of motor, cognitive, and psychiatric symptoms of this disease. There are currently no treatments for HD that modify disease progression, and few palliative treatments are available.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> The Kynurenine Pathway</h3><div class="NLM_p">The kynurenine pathway (KP) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is the major metabolic pathway in mammals to catabolize tryptophan leading to de novo synthesis of NAD<sup>+</sup>.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Tryptophan is catabolized to NAD<sup>+</sup> through a series of enzymatic reactions commencing with oxidative conversion to <i>N</i>-formyl kynurenine by indolamine dioxygenase, tryptophan dioxygenase, indolamine-pyrrole dioxygenase (IDO/TDO/INDOL1) dependent on tissue and cellular distribution, and each is regulated by different stimuli.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Hydrolysis of the aldehyde moiety by kynurenine formamidase forms the key intermediate metabolite L-kynurenine (KYN). KYN is a central substrate of three critical enzymes in the pathway, resulting in three different branches, kynurenine monooxygenase (KMO), kynureninase (KYNU), and kynurenine amino transferases (KATs). KMO hydroxylates kynurenine to 3-hydroxykynurenine (3-HK), followed by hydrolysis by kynureninase to yield 3-hydroxy anthranilic acid (3HAA). Additionally, KYNU hydrolyzes KYN to yield anthranilic acid (AA), which is in then oxidized to 3HAA by anthranilate 3-monooxygenase. Subsequently, 3HAA serves as a substrate for anthranilate 3-monooxygenase, which catalyzes an oxidative ring opening of the aryl group to form 2-amino-3-carboxymuconate semialdehyde, which then cyclizes to quinolinic acid (QA). QA is converted to nicotinic acid mononucleotide by the enzyme quinolinate phosphoribosyltransferase (QPRT) and further processed by several enzymatic steps beyond the KP to form NAD<sup>+</sup>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> An orthogonal branch of the pathway proceeds from KYN, leading to its transamination by kynurenine amino transferases (KATs) to yield kynurenic acid (KYNA).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Kynurenine pathway (KP) with neurotoxic metabolites colored red and neuroprotective metabolites colored green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Deregulation of the KP has been causally implicated in the pathophysiology of HD and other neurodegenerative diseases. While the exact mechanisms by which mHTT affects the normal functioning and regulation of the KP remain unclear, there is substantial evidence from human postmortem samples and animal models for deregulation of the pathway in the brain.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> For example, early grade HD patients show increased 3-HK/KYNA and QA/KYNA ratios in striatum and cortex compared to controls.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Elevation of 3-HK levels has also been reported in the brain of the R6/2 transgenic HD mouse model.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Other HD models have been shown to have elevated levels of 3-HK and QA. The full-length mHTT YAC128 mouse model, a much later-onset model of the disease, shows elevation of 3-HK in cortex, striatum, and cerebellum and elevation of QA in striatum and cortex at 8 and 12 months of age. Similarly, the HdhQ111 knock-in HD mouse model has elevations of 3-HK and QA at 15 months of age.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Evidence of KP deregulation in HD is not limited to the brain; HD patients have significantly higher plasma KYN levels and KYN/tryptophan ratios than healthy controls, suggesting deregulation or imbalance toward the QA-producing branches of the pathway in HD patients.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The collective evidence for the involvement of these metabolites in the pathophysiology of HD highlights the KP as an attractive therapeutic intervention point.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">From a therapeutic point of view, KMO is located at a critical branching point in the KP, its activity mediating opposite effects in the levels of 3-HK and QA versus KYNA. Inhibition of KMO should shunt the pathway away from the toxic metabolites 3-HK and QA and toward the formation of the protective metabolite KYNA. Evidence implicating KMO as a potential HD treatment has been provided by a functional genomics screen in yeast in which deletion of the yeast homologue of KMO, <i>BNA4</i>, resulted in suppression of mHTT-induced toxicity,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and by pharmacological and genetic inhibition of KMO in a fly model of HD that led to increased levels of KYNA and ameliorated neurodegeneration.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Pretreatment with UPF-648<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a 20 nM KMO inhibitor, protects KAT II-deficient mice against QA-induced lesions.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">It is important to note that not all branches and enzymes of the pathway are expressed in the same tissue and by the same cells; some degree of specialization occurs, and several kynurenines are released from cells and function as signaling molecules in addition to their role as metabolic precursors. In blood monocytes, for instance, the tryptophan catabolic pathway is fully expressed, and tryptophan can be catabolized to QA.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In the brain, KMO is mainly expressed by microglia,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> whereas KAT II is expressed predominantly in astrocytes and neurons.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, pathway metabolites such as 3-HK and KYNA are produced in different cells, as these branches of the pathway are segregated.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Furthermore, the interplay of the KP between the peripheral (blood and other tissues) and central compartments is not fully understood.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> While tryptophan, KYN, and 3-HK can cross the blood–brain barrier from the periphery via the large neutral amino acid transporter, acid-containing metabolites such as KYNA and QA have very limited brain penetration and are produced in situ in the brain.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The levels of KYNA in the brain can be influenced via influx of KYN into the brain from the periphery;<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> for example, systemic administration of 100 mg/kg of KYN to mice has been shown to significantly increase central levels of both KYN and KYNA.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> But systemic administration of KYN also leads to an elevation of the toxic metabolites 3-HK and QA in brains, limiting the potential beneficial effects of KYN administration for chronic indications. Similarly, in a variety of pro-inflammatory conditions, activation of IDO leads to an increase in KYN metabolites in the brain. Upstream activation of tryptophan catabolism toward KYN generation via systemic administration of IDO-activator interferon-γ increases KP metabolite levels in the brains of treated animals, including KYN and KYNA but also the neurotoxic metabolites 3-HK and QA.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The ability to modulate the KP peripherally, leading to a central elevation of KYN and KYNA, is essential to our therapeutic approach. Blocking KMO selectively would lead to an elevation of KYN and KYNA without affecting (or decreasing) the levels of 3-HK and QA in the brain, assuming that the KMO inhibitors modulate enzymatic activity centrally at sufficient levels to prevent 3-HK generation. Three metabolites of the pathway have been implicated in synaptic physiology or in the pathogenesis of HD; 3-HK and QA are thought to be neurotoxic, and KYNA is postulated to be neuroprotective.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> QA can act as an NMDA receptor agonist, with an EC<sub>50</sub> of 7–200 μM for NR2A- and NR2B-containing subunits of the NMDAR.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> When exogenously administered at high concentrations into the brain, QA can cause excitotoxic lesions in rodents and monkeys producing motor disturbances reminiscent of human HD due to widespread medium spiny neuron cell death.<a onclick="showRef(event, 'ref31 ref32 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref32 ref33">(31, 32, 32, 33)</a> 3-HK is a known reactive radical generator<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and can exacerbate QA-mediated lesions.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> KYNA, an antagonist of the NMDA receptor acting at the glycine coagonist site at micromolar concentrations,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> has been shown to protect against QA- and kainate-induced neurotoxicity.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Conversely, administration of dopaminergic drugs such as apomorphine (known to cause transient depression of KYNA extracellular levels in brain), increases the size of QA-induced lesions in rat brain.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Several KMO inhibitors based on the structure of the natural substrate KYN (<b>1</b>) have been described in the literature (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). One of the earliest published examples, <i>m</i>-Nitrobenzoylalanine (m-NBA, <b>2</b>), has an IC<sub>50</sub> of 0.9 μM against KMO; intraperitoneal administration (400 mg/kg) of this compound to mice decreases central levels of 3-HK while increasing the levels of KYNA in blood and brain.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Further structural manipulation of this compound produced FCE 28833A (<b>3</b>), a 0.2 μM inhibitor with improved efficiency at increasing the levels of KYNA in both blood and brain.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Removal of the amine and enantioselective conformational restriction, via incorporation of a cyclopropyl ring, led to the (1<i><i>S</i></i>,2<i><i>S</i></i>) isomer UPF-648 (<b>4</b>) with 20 nM potency.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Unlike <b>2</b> and <b>3</b>, compound <b>4</b> maintains excellent KMO inhibitory activity at the cellular level. Compound <b>4</b> has also been shown to be efficacious in protecting against striatal QA injections in mice lacking KAT II.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Recently this compound was found to increase KYNA levels and be neuroprotective in a fly model of HD.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A structurally unrelated compound, Ro-61-8048 (<b>5</b>), a 37 nM inhibitor in biochemical assays, has been widely used to study the effects of KMO inhibition in vivo.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This compound raises levels of KYNA in the brain and has shown protection in a variety of animal models of neurodegenerative diseases.<a onclick="showRef(event, 'ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46">(43-46)</a> Based on our previous work<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (Beconi et al., 2013, data not shown), <b>5</b> does not cross the blood-brain barrier and therefore peripheral KMO inhibition and subsequent increase of KYN and KYNA in the brain are thought to account for its neuroprotective effects.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of known KMO inhibitors and their potencies against KMO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While assessing the structures of the known KMO inhibitors, we designed a class of pyrimidine carboxylic acids with remarkably good potencies against KMO (such as compounds <b>6</b> and <b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The aryl pyrimidine was proposed since the pyrimidine N3 nitrogen would mimic the carbonyl oxygen of KYN and the KYN mimics m-NBA and FCE 28833A, while the nitrogen at the N1 position would mimic the amine nitrogen.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Example pyrimidine carboxylic acid KMO inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We report the structure–activity relationship of this novel series of selective KMO inhibitors and describe the chemical optimization of physicochemical properties, which led to excellent ADME/PK drug properties. PK/PD relationships have been established for several of our program compounds and are described. We also describe the ability of our lead KMO inhibitor to modulate in vivo peripheral and central levels of kynurenines in wild type rats. Work describing the biological effects of our lead molecule in mouse models of Huntington’s disease will be described elsewhere.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">General methods used for the synthesis of the pyrimidine KMO inhibitors are described in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Suitably substituted phenyl boronic acids or boronic esters were purchased commercially, or prepared using methods previously described by our group.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> Suzuki coupling with 4,6-dichloropyrimine led to the generation of a chloropyrimidine intermediate which was subsequently converted to the corresponding methyl ester via palladium-catalyzed carbonylation (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> The resulting esters were then   hydrolyzed with sodium hydroxide to give the desired carboxylic acids in good yields. </div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyrimidinecarboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KOAc, bis-pinacol borane, PdCl<sub>2</sub>(dppf)<sub>2</sub>, DMSO, 80 °C, 18 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 2 h; (c) CO (5 bar), MeOH, PdCl<sub>2</sub>(dppf)<sub>2</sub>, NEt<sub>3</sub>, 50 °C, 18 h; (d) 2 M NaOH, THF, 4 h.</p></p></figure><div class="NLM_p">Further manipulations to the left-hand side of the molecule were achieved using the chemistry described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. In this case, nucleophiles such as morpholine, 3,4-dichlorophenol, or 3,4-dichloroaniline underwent S<sub>N</sub>Ar displacement with 4,6-dichloropyrimidine in good yield, and the resulting chloropyrimidines <b>8</b>–<b>10</b> were subsequently converted to the corresponding methyl esters via palladium-catalyzed carbonylation.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Alternatively, palladium-catalyzed cross-coupling of methyl 6-chloropyrimidine-4-carboxylate with cyclohexyl zinc bromide gave intermediate <b>11</b>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Sodium hydroxide-mediated hydrolysis of the methyl esters then led to the isolation of the target carboxylic acids <b>12</b>–<b>15</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Modification via S<sub>N</sub>Ar Displacement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup>i</sup>PrOH, 80 °C, morpholine or 3,4-dichloroaniline, 12 h; (b) 3,4-dichlorophenol, <sup>t</sup>BuOK, <sup>t</sup>BuOH, 35 °C; (c) cyclohexyl zinc bromide, PdCl<sub>2</sub>(dppf)<sub>2</sub>, THF, 45 °C, 15 h; (d) CO (5 bar), MeOH, PdCl<sub>2</sub>(dppf)<sub>2</sub>, NEt<sub>3</sub>, 50 °C, 18 h; (e) 2 M NaOH, THF, 4 h.</p></p></figure><div class="NLM_p">Manipulations of the 3- and 5-positions of the pyrimidine ring are described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Suzuki coupling of 3,4-dichlorophenyl boronic acid with 4,6-dichloropyrimidine substituted at the 3- or 5-positions gave compounds <b>16</b>–<b>20</b> in good yields. Methyl derivative <b>20</b> was treated with NBS in the presence of AIBN and the resulting bromide treated with sodium methoxide to generate the methoxy methyl analogue <b>21</b>.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Palladium-catalyzed carbonylation of these analogues, followed by hydrolysis, gave the desired target compounds <b>22</b>–<b>27</b>. Methyl ether <b>27</b> was subsequently treated with lithium hydroxide to generate pyrimidinol <b>28</b>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Modification to the Core Pyrimidine Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>(dppf)<sub>2</sub>, DMF, 80 °C, 16 h; (b)NBS, AIBN, 1,2-DCE, 90 °C, 18 h; (c) NaOMe, MeOH, r.t., 20 h; (d) CO (5 bar), MeOH, PdCl<sub>2</sub>(dppf)<sub>2</sub>, NEt<sub>3</sub>, 50 °C, 18 h; (e) 2 M NaOH, THF, 4 h; (f) LiCl, DMF, 145 °C, 18 h.</p></p></figure><div class="NLM_p">Replacement of the carboxylic acid moiety required a more bespoke approach, and these are described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Conversion of chloropyrimidine <b>29</b> to the corresponding nitrile <b>30</b> could be achieved in good yield via palladium-catalyzed cross-coupling with zinc cyanide.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Reaction of nitrile <b>30</b> with sodium azide then generated tetrazole <b>31</b> which could be further derivatized to the 1- or 2-methyl tetrazoles (<b>32</b> or <b>33</b>) using sodium hydride and methyl iodide.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Alternatively, reaction of nitrile <b>30</b> with hydroxylamine led to the generation of intermediate <b>34</b> which could then be ring closed using either carbonyl diimidazole to give oxadiazolone <b>35</b>, or triethyl orthoformate to generate oxadiazole <b>36</b>.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a></div><div class="NLM_p">Amine <b>37</b> was generated by nucleophilic substitution of chloropyrimidine <b>29</b> with ammonia and, in turn, could be converted to sulfonamides <b>38</b> and <b>39</b>, or amides <b>40</b> and <b>41</b>, with sodium hydride and the corresponding sulfonyl chloride or acid chloride. Alternatively, heterocycles such as imidazole or pyrazole could be introduced directly following deprotonation of the heterocycle and microwave-promoted nucleophilic substitution of chloropyrimidine <b>30</b> to afford targets such as <b>42</b>, <b>43</b>, or <b>44</b>.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Example Carboxylic Acid Replacements<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 100 °C, 18 h; (b) TMS-N<sub>3</sub>, dibutyl(oxo)stannane, PhMe, 115 °C, 24 h; (c) NaH, MeI, DMF, 40 °C, 18 h; (d) H<sub>2</sub>N–OH, DIPEA, EtOH, 70 °C, 2 h; (e) CDI, DBU, dioxane, 110 °C, 1 h; (f) HC(OCH<sub>3</sub>)<sub>3</sub>, 100 °C, 3 h; (g) Sat. aq. NH<sub>3</sub>, 100 °C, 16 h; (h) R<sub>2</sub>Cl, NaH, dioxane, r.t., 18 h; (i) imidazole or pyrazole, EtOH, μwave, 140 °C, 20 min.; (j) imidazalone, NaH, DMF, μwave, 140 °C, 10 min; (k) NaH, MeI, DMF, 3 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We evaluated the compounds described in this report using biochemical and cellular KMO inhibition assays that utilized LC-MS/MS to monitor the effect of our compounds in inhibiting the conversion of kynurenine to 3-hydroxykynurenine by KMO (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). These assays have been previously described elsewhere but are briefly mentioned here.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> We developed biochemical assays using mitochondrial fractions derived from mice, rats (the two HD rodent species in which in vivo efficacy of compounds would be evaluated), and human liver tissues. The mass spectroscopy-based biochemical assays measure the conversion of exogenously added KYN (typically 100 μM) to 3HK.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Conversion of Kynurenine to 3-Hydroxykynurenine by KMO</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also established cellular assays in stably transfected CHO cell lines expressing human or rodent KMO enzymes, as well as in primary cells with endogenous levels of KMO, to provide a more relevant physiological context. These assays, which have been described previously,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> also monitor the direct conversion of exogenous KYN to 3HK by mass spectroscopy. We used freshly isolated neonatal rat microglial cultures and human peripheral blood mononuclear cells (PBMCs) stimulated to express KMO via a pro-inflammatory induction protocol, to provide relevant cellular contexts. These assays were employed routinely to evaluate compound effects on cellular KMO inhibition in a central (microglia) and a peripheral (blood cells) tissue population. Compound toxicity was evaluated using the ATPlite luminescence assay in the same mammalian CHO cell system to monitor potential confounding compound effects on cell proliferation and cytotoxicity.</div><div class="NLM_p">As mentioned previously, our initial design drew inspiration from the structures of KYN, m-NBA, and FCE 28833A. In our aryl pyrimidines, the pyrimidine N3 nitrogen was thought to mimic the carbonyl oxygen, while the nitrogen at the N1 position would mimic the amine nitrogen, although the hydrogen-bonding nature of these heteroatoms is different than in KYN and its mimics. Given the available SAR around the KYN mimics and UPF-648, our first compounds were the 3-chlorophenyl and 3,4-dichlorophenyl pyrimidine acids (<b>6</b> and <b>7</b>). These pyrimidine acids displayed excellent KMO inhibitory potency with IC<sub>50</sub> values of 0.5 nM and 0.6 nM, respectively, in the human KMO biochemical assay. While the potencies of these two compounds were almost identical at the biochemical level, the cellular activity of <b>7</b> was superior to that for analogue <b>6</b>, most likely due to enhanced cellular penetration. An overlap (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B) of aryl pyrimidines <b>6</b> and <b>7</b> with KYN (<b>3</b>) and UPF-648 (<b>4</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) shows the high fidelity of shape and a subset of pharmacophoric features shared between these compounds.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A. Structures of FCE 28833A (<b>3</b>), UPF-648 (<b>4</b>), and pyrimidine acid (<b>7</b>). B. Overlap of the pyrimidine acid (<b>7</b>) with FCE 28833A (<b>3</b>) and UPF-648 (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our SAR focused on three distinct areas: left hand side modifications, core pyrimidine modifications, and replacement of the carboxylic acid moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The subnanomolar KMO potencies of <b>6</b> and <b>7</b> focused our attention on this chemotype, and we set out to survey the SAR of this compound class. The first set of investigations we undertook involved modifications of the biaryl system, removal of the chlorines, replacement of the chlorophenyl ring with a saturated ring, introduction of large substituents, and replacement of the chlorophenyl with a heteroaryl ring. All modifications shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> resulted in detrimental effects on compound potency. While the SAR around <b>4</b> has not been published, we surmised a similar mode of binding and SAR around the dichlorophenyl for both chemotypes, and we therefore turned our attention to other areas of the series to further our understanding of SAR.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overview of SAR carried out on the pyrimidine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR around the Biaryl System<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0017.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0018.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">NT = not tested, SD = ±5–10%, IC<sub>50</sub> values are the average of triplicate tests.</p></div></div><div></div></div><div class="NLM_p">While the pyrimidine core resembles in shape the six-membered hydrogen bonded ring of benzoylalanine (<b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), the nature and positions of hydrogen bond donor and acceptor functionality and aromaticity of the pyrimidine core is different. We therefore turned our attention to the SAR around the pyrimidine group to understand the requirements for hydrogen binding of this core. In the limited SAR around the KYN mimics, it appears that the amino group, which in our structures is replaced by an aromatic nitrogen (N1 position), does not contribute much to the binding energy. This can be appreciated in the structure of <b>4</b> which lacks an amino functionality and is 10-fold more active than <b>3</b>. We were therefore curious to understand the importance of the pyrimidine nitrogen atoms and their correspondence to the hydrogen bonding groups in <b>3</b> and <b>4</b>. The 1-pyridyl analogue <b>49</b> had an IC<sub>50</sub> of 3.2 nM, while the 3-pyridyl analogue <b>50</b>, which maintains a hydrogen bond acceptor in a position equivalent to the ketone oxygen of <b>3</b> and <b>4</b>, showed a drop in activity with an IC<sub>50</sub> of 90 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This pointed to the requirement of a potential hydrogen bond acceptor atom at position 1 (N1) of the pyrimidine. Similarly, introduction of a methyl substituent at the 2 position of the pyrimidine core (<b>22</b>) resulted in a loss of activity of 20-fold over compound <b>7</b>, also reinforcing the potential role of the N1 pyrimidine as an acceptor atom, as the close proximity of a methyl group could pose steric hindrance on such hydrogen bonding interaction. Pyridine <b>49</b> displayed only a 5-fold drop of activity as compared to pyrimidine <b>7</b>; however, a 5-fold loss of cellular activity was also observed. Likewise, placement of a methyl at position 5 of the pyrimidine core (<b>25</b>) results in a loss of activity of greater than 17-fold relative to <b>7</b>, likely indicating a need for coplanarity of the biaryl ring systems, as a methyl at position 5 poses substantial strain on the biaryl ring torsions. We also investigated the incorporation of other small groups at the 5-position such as fluoro (<b>23</b>), hydroxyl (<b>28</b>), methoxy (<b>27</b>), and amino (<b>24</b>); while the loss of activity at the biochemical level varied from 10-fold for the 5-fluoro to >400-fold for the 5-amino, the cellular activity was in unacceptable ranges in all cases. This data indicate very little tolerance for substitution on the pyrimidine ring. It appears that maintaining coplanarity of the biaryl system is important. Likewise, substitutions adjacent to the nitrogen at position 1 of the pyrimidine were not tolerated, likely indicating a hydrogen bond acceptor function for this atom.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR around the Pyrimidine Core<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0019.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center" char=".">hKMO IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">hKMO CHO IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.0006</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.0032</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">SD = ±5–10%, IC<sub>50</sub> values are the average of triplicate tests.</p></div></div></div><div class="NLM_p">While it has been demonstrated that levels of KYNA in brain can be increased by peripheral inhibition of KMO with compounds that do not cross the blood–brain barrier,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> we wanted to obtain a brain-penetrable KMO inhibitor that may inhibit the catabolism of KYN into the presumed neurotoxic metabolites 3-HK and QA in the brain. One common feature of the benchmark compounds (<b>3</b> and <b>4</b>) and our pyrimidine inhibitors is the presence of a carboxylic acid. It is well-known that acids, which carry a negative charge at physiological pH, do not readily penetrate the brain. Furthermore, exploratory PK carried out on our pyrimidine acid (<b>6</b>, data not shown) confirmed the negligible brain exposure for this class of compounds in rodents. At the time this work was performed, the crystal structure of KMO was not available, but review of structural information and sequence alignment of KMO with a related enzyme class, the flavin-containing monooxygenases,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> indicated the presence of two critical arginine residues in the proximity of the putative binding site that we hypothesized would be involved in the binding of the KYN substrate and our inhibitors. We hypothesized that the critical carboxylate group in our compounds was likely engaged in an ionic salt bridge to a guanidinium moiety of one of the arginines, and that such interaction was critical for the binding of the KYN substrate to KMO. It has been estimated that the occurrence of such arginine guanidinium–carboxylate salt bridges account for about 40% of the pairs of ionic group interactions found in proteins.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The recent publication of the yeast KMO structure in complex with UPF-648<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A) confirms such critical interaction between the carboxylate group of UPF-648 and arginine residue Arg83 (yeast numbering).</div><div class="NLM_p">Given the realization that a carboxylate group is incompatible with good brain penetration, we investigated the SAR around acid isosteres or groups with attenuated acidity with the aim of discovering compounds with enhanced brain exposure. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes a subset of these efforts and clearly shows the requirement for an acidic group, as only acid replacements with low p<i>K</i><sub>a</sub> values were able to maintain inhibitory activity for KMO. The tetrazole carboxylic acid isostere can exist in two tautomeric states; the calculated p<i>K</i><sub>a</sub> values for these tautomeric forms in example <b>31</b> are 3.5 and 6.9, respectively. Similarly, oxadiazolone <b>35</b> has calculated p<i>K</i><sub>a</sub> values of 2.93 and 8.4, respectively. Both compounds retained KMO inhibitory activity with IC<sub>50</sub> values of 2 and 12 nM, respectively. Likewise, acidic acyl sulfonamide <b>51</b> (calculated p<i>K</i><sub>a</sub> = 3.9) had an IC<sub>50</sub> of 25 nM, but all other nonacidic replacements were either inactive or displayed weak KMO activity. Further investigations of compound <b>51</b> revealed instability issues, and this compound was not pursued further. Given the possibility of an equilibrium between acidic and nonacidic tautomeric states and the possibility that the nonacidic form may display brain penetration, we performed PK on tetrazole <b>31</b> and oxadiazolone <b>35</b> (data not shown), but neither compound displayed brain penetration.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Replacement of the Carboxylic Acid<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0020.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0021.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">N/A = not applicable, NT = not tested, SD = ±5–10%, IC<sub>50</sub> values are the average of triplicate tests.</p></div></div><div></div></div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A. Active site from crystal structure of UPF-648 complex with yeast KMO (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4j36">4j36</a>). B. Homology model of human KMO and proposed binding model of compound <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having confirmed that an acidic functionality was required for KMO inhibitory activity, and also having tried various pro-drug strategies (data not shown) unsuccessfully, we decided to continue to optimize the substitutions on the phenyl ring. We set to further optimize activity and permeability of the molecule, hoping to minimize the impact of the acid moiety on the blood–brain barrier and thus allow us to obtain adequate brain exposure. We continue to explore the effect of functionalities at the ortho, meta, and para positions and combinations thereof (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). While the introduction of fluorine in the ortho position was tolerated (see examples <b>57</b>, <b>59</b>, and <b>60</b>), introduction of a larger group such as trifluoromethyl (<b>64</b>) resulted in a loss of activity. A wide range of small functional groups were tolerated at the para and meta positions, but a clear preference was observed for combinations where the meta position was a halogen such as chloro or fluoro and the para position was either chloro, fluoro, methyl, trifluoromethyl, or small alkoxy. While the <i>m</i>-chloro and <i>m</i>-fluoro, in combinations as mentioned above, had equivalent effects at the biochemical level, cellular potency was best maintained with the <i>m</i>-chloro and small alkyl or alkoxy para substituents. Large substituents such as 4-(2-ethoxy)morpholine (<b>69</b>, <b>70</b>) at the para or meta position were less well tolerated at the biochemical levels and rendered the compounds inactive at the cellular level. The combinations of chloro at the meta position with small alkoxy groups at the para position consistently resulted in compounds with excellent KMO inhibitory activities and cellular potencies. In the crystal structure of UPF-648 with bacterial KMO,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> the 3,4-dichlorophenyl group of UPF-648 sits in a tight binding site surrounded by hydrophobic residues Pro321, Phe322, Phe246, Leu234, Ile232, Leu221, and Met230, while a water of crystallization hydrogen-bonded to Thr244 sits in close proximity to the 4-chloro atom. On the basis of this observation, we propose a similar binding mode for our compounds, where the 3-chloro-4-alkoxyphenyl group would be accommodated into a hydrophobic pocket made up by hydrophobic residues Pro305, Phe306, Phe232, Leu220, Ile218, Leu207, and Met216 and that the 4-alkoxy oxygen could hydrogen bond to the hydroxyl moiety of Thr230 (human numbering) also likely via a water molecule (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure–Activity Exploration of Phenyl Substitutions<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0022.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0023.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">NT = not tested, SD = ±5–10%, IC<sub>50</sub> values are the average of triplicate tests.</p></div></div><div></div></div><div class="NLM_p">On the basis of the favorable biochemical and cellular activity obtained with the 3-chloro-4-alkoxyphenyl group, we expanded the SAR around the alkoxy functionality (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Similar biochemical and cellular potencies were attained with methoxy (<b>73</b>), trifluoromethoxy (<b>72</b>), and isopropoxy (<b>74</b>). Exploration of cycloalkoxy groups at the para position produced a consistent drop in potency with increasing ring size from the cyclopropyl (<b>75</b>), to cyclobutyl (<b>78</b>), to cyclopentyl (<b>80</b>), and to cyclohexyl (<b>81</b>) rings. Interestingly, incorporation of a hydrogen-bond acceptor into the ring system restores some of the potency; for example, oxetane (<b>79</b>) displays a 5-fold increase in activity over cyclobutyl (<b>78</b>). Consistent with our model of the human protein, the oxetane oxygen would be within direct hydrogen bonding distance of Thr230. We were surprised to note the 12-fold difference in activity between the cyclopropyl (<b>75</b>) and isopropyl (<b>74</b>) analogues. We postulated that the more constrained cyclic groups could be better accommodated in the tight hydrophobic pocket. A potential π-stacking interaction with Phe232 is likely responsible for the 0.8 nM IC<sub>50</sub> of benzofuran (<b>77</b>). Extending out the cyclopropyl ring with the introduction of a methylene unit (<b>76</b>) results in a 98-fold drop in activity with respect to the cyclopropoxy analogue (<b>75</b>), consistent with the tightness of the pocket as observed in the bacterial KMO structure.</div><div class="NLM_p">Permeability in Caco-2 cells and stability in liver microsomes were evaluated for compounds with overall favorable biochemical and cellular potency profile. All compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were tested in human, rat, and mouse microsomes and were found to be stable (intrinsic clearance <0.02 μg/min/mg protein) and displayed high permeability in Caco-2 cells. We further evaluated our compounds potential to be substrates of the P-glycoprotein (PGP, MDR1) and the ATP-binding cassette subfamily G member 2 (BCRP) efflux pumps. These data are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> as effective efflux ratios (EER) of the permeability of compounds in cell lines overexpressing the respective efflux pump vs the permeability on the same cell lines without overexpression (EER MDCK-MDR1/MDCK-wt or EER MDCK-BCRP/MDCK-wt, methods provided as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The compounds evaluated were not PGP substrates but were found to be substrates of BCRP.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. 3-Chlorophenyl Pyrimidine Acids: Optimization of the Para Position<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0024.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0025.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">NT = not tested, SD = ±5–10%, IC<sub>50</sub> values are the average of triplicate tests.</p></div></div><div></div></div><div class="NLM_p">In addition to the human enzymatic assay, we profiled our compounds in assays for rat and mouse KMO (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) since there are Huntington’s disease models in these species. In addition, we determined that our compounds were selective for KMO over the other two kynurenine-processing enzymes in the pathway, the KATs and KYNU.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In agreement with the cellular KMO potency observed in the KMO-expressing CHO stably transfected cell lines, our compounds were very potent in primary rat microglia and in primary human PBMCs, which express endogenous levels of KMO (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). While our leading compounds were acids, their overall physicochemical and ADME properties were quite good; they had good cellular permeability in Caco-2 cells, were stable in microsomal cultures, and were not substrates of the PGP efflux pump. We prioritized compound <b>75</b> as a representative lead, based on its activity in the biochemical and cellular assays, its selectivity profile, and its in vitro ADME properties. Here we report the in vivo pharmacokinetic and pharmacodynamics effects of compound <b>75</b> in Sprague–Dawley rats.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. KMO Inhibition in Human, Mouse, and Rat Biochemical and Cellular Assays for a Set of Leading Inhibitors<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0026.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0027.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">NT = not tested, SD = ±5–10%, IC<sub>50</sub> values are the average of triplicate tests.</p></div></div><div></div></div><div class="NLM_p">PK studies were performed in nonfasted male Sprague–Dawley rats to support pharmacodynamic studies by both iv and po routes. Animals were dosed with a single iv dose of <b>75</b> at 6.2 mg equiv/kg formulated as a 1.24 mg equiv/mL solution in DMSO:PEG400:water (10:40:50 v/v/v) or orally at 12 mg equiv/kg as a 1.2 mg equiv/mL solution in 10% hydroxypropyl-β-cyclodextrin of <b>75</b>. This compound exhibited a relatively low clearance of 291 mL/h/kg, small to moderate <i>V</i><sub>dss</sub> of 0.32 L/kg, and a plasma half-life of 1.8 h (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Clearance rate is consistent with in vitro metabolism studies in hepatic fractions from cultures of various species, which indicated no or negligible metabolism for this compound (data not shown). Following oral administration, <b>75</b> was rapidly and well absorbed with <i>C</i><sub>max</sub> norm of 1.9 μM·kg/mg at 1 h, PO AUCN of 4.7 μM·hr·kg/mg, and good oral bioavailability of 64%.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Summary of Pharmacokinetic Parameters following a Single Acute iv (6.2 mg equiv/kg) or po (12 mg equiv/kg) Dose of <b>75</b> to Nonfasted Male Sprague–Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">plasma</th><th class="rowsep1 colsep0" colspan="2" align="center">brain</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameters</th><th class="colsep0 rowsep0" align="center">units</th><th class="colsep0 rowsep0" align="center">IV 6.2 mg equiv/kg</th><th class="colsep0 rowsep0" align="center">PO 12 mg equiv/kg</th><th class="colsep0 rowsep0" align="center">IV 6.2 mg equiv/kg</th><th class="colsep0 rowsep0" align="center">PO 12 mg equiv/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCN (0–infinity)</td><td class="colsep0 rowsep0" align="left">μM·h·kg/mg</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">0.230</td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left">%</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">observed <i>C</i><sub>max</sub>norm</td><td class="colsep0 rowsep0" align="left">μM·kg/mg</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">observed <i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">0.083</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL</td><td class="colsep0 rowsep0" align="left">mL/h/kg</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT</td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub></td><td class="colsep0 rowsep0" align="left">L/kg</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">half-life (<i>t</i><sub>1/2</sub>)</td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7afn1"><div class="footnote" id="t7afn1"><sup>a</sup><p class="last">N/A = not applicable due to matrix or route of administration.</p></div></div></div><div class="NLM_p">Plasma, liver, kidney, cortex, striatum, and CSF concentrations in nonfasted male Sprague–Dawley rats were measured from 0.25 to 12 h (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) after a single oral dose of 10 mg equiv/kg formulated as a 2 mg equiv/mL solution in 10% hydroxypropyl-β-cyclodextrin. Compound <b>75</b> exposure in liver and kidney, the primary organs of elimination, were higher than in plasma; particularly in kidney where dose normalized area under the curve (AUCN) was >13-fold higher (70 μM·h·kg/mg) vs plasma (5.3 μM·h·kg/mg). Consistent with the compounds acidic nature, its distribution to brain tissues (cortex and striatum) and CSF was limited. However, in microdialysis studies in brain tissues (shown below) and in CSF measurements, we could detect free-compound exposures near the EC<sub>50</sub> of compound <b>75</b> for rat KMO, as judged by its potency in the rat microglia KMO assay.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Summary of Pharmacokinetic Parameters in Plasma, Cortex Striatum, CSF, Kidney, and Liver following an Oral Dose (10 mg equiv/kg) of <b>75</b> to Fed Male Sprague–Dawley rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">dose regimen: 10 mg equiv/kg single po dose</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameters</th><th class="colsep0 rowsep0" align="center">units</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">CSF</th><th class="colsep0 rowsep0" align="center">cortex<a class="ref internalNav" href="#t7bfn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">striatum<a class="ref internalNav" href="#t7bfn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">kidney</th><th class="colsep0 rowsep0" align="center">liver</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCN (0–inf)</td><td class="colsep0 rowsep0" align="left">μM·h·kg/mg</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">0.014<a class="ref internalNav" href="#t7bfn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0.056</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub>Norm</td><td class="colsep0 rowsep0" align="left">μM·kg/mg</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">observed <i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">half-life (<i>t</i>1/2)</td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7bfn1"><div class="footnote" id="t7bfn1"><sup>a</sup><p class="last">From nonperfused brains.</p></div><div class="footnote" id="t7bfn2"><sup>b</sup><p class="last">AUCN value for CSF was from 0 to 8 h since half-life could not be determined (N/D) due to insufficient data points to define elimination phase.</p></div></div></div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concentration vs time profiles of compound <b>75</b> following a 10 mg equiv/kg oral dose to male Sprague–Dawley rats in plasma, kidney, liver, cortex, striatum, and CSF.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate whether compound <b>75</b> was being effluxed from the rodent blood–brain barrier (which could explain its low brain:plasma ratios), the compound was dosed to Bcrp(−/−), Mdr1a/b(−/−) and Mdr1a/b(−/−)/Bcrp(−/−) knock out (KO) and wild-type (WT) mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, methods provided as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In vivo, compound <b>75</b> did not appear to be a PGP substrate based on similar AUCN in WT vs Mdr1a/b(−/−) KO mice. A marginal increase of 2.5- to 3.5-fold in brain AUCN was observed in both Bcrp(−/−) and Mdr1a/b(−/−)/Bcrp(−/−)KO mice versus WT, respectively. These findings suggest that distribution of compound <b>75</b> to brain is partially dependent on BCRP, but not MDR1, expression, although the activity of BCRP is unlikely to account for the low level brain distribution of this series.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Summary of Pharmacokinetic Parameters for <b>75</b> following a Single iv (5 mg equiv/kg) Bolus Dose to Nonfasted Male Mice<a class="ref internalNav" href="#t7cfn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">mouse genotype</th><th class="colsep0 rowsep0" align="center">WT(FVB/N)</th><th class="colsep0 rowsep0" align="center">BCRP(−/−)</th><th class="colsep0 rowsep0" align="center">MDR1a(−/−)</th><th class="colsep0 rowsep0" align="center">BCRP(−/−) + MDR1a(−/−)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCN (0–infinity) μM·h·kg/mg</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">0.066</td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">0.073</td><td class="colsep0 rowsep0" align="left">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">plasma fold change over WT</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">brain fold change over WT</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">3.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7cfn1"><div class="footnote" id="t7cfn1"><sup>a</sup><p class="last">N/A: not applicable.</p></div></div></div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Brain concentration vs time profile of compound <b>75</b> following a single 5 mg equiv/kg iv dose to FVB (WT), Bcrp(−/−), Mdr1a/b(−/−), and Mdr1a/b(−/−)/Bcrp(−/−) male mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having determined that active efflux is likely not the main contributor to limited brain exposure of compound <b>75</b>, we determined the extent of plasma-protein binding of compound <b>75</b> in rat and mouse. Compound <b>75</b> was found to be moderately bound to plasma proteins with a 5.0% and 3.6% unbound fraction in rat and mouse, respectively. We believe that the limited brain exposure of compound <b>75</b> is likely a result of poor passive permeability at the blood-brain barrier due to the presence of the negatively charged acid moiety.</div><div class="NLM_p">Modulation of KP metabolite levels in plasma and in the CNS were followed as pharmacodynamics markers of target engagement. In support of our drug discovery program, we developed LC-MS/MS methods for the following KP metabolites: KYN, 3HK, KYNA, AA and QA (these methods are provided as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Typically, selected compounds from the program were evaluated in rats for their ability to modulate KYN and 3HK levels, as would be expected for a KMO inhibitor. In addition, and because of the importance in addressing pathway flux through other kynurenine-processing enzymes (both in plasma and in the brain), we simultaneously monitored the levels of KYNA and AA, which reflect flux through KATs and Kynureninase, respectively.</div><div class="NLM_p">In an initial experiment, we monitored the pharmacodynamic effects of compound <b>75</b> after a 10 mg/kg oral dose to freely moving Sprague–Dawley rats. We measured KP metabolites in plasma at multiple time points (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), and we monitored changes in the extracellular levels of kynurenines in the striatum, as assessed by microdialysis (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>; methods are provided as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Compound levels in both plasma and brain dialysates were measured to establish a PK/PD response. Consistent with previous observations of high compound exposure in plasma and peripheral tissues, we observed significant plasma elevations in KYN, KYNA and AA and a significant decrease in basal levels of 3-HK, as expected for a KMO inhibitor administered systemically (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Importantly, at this oral dose we observed a pharmacodynamic effect which lasted for 8–12 h, depending on the kynurenine metabolite in question.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Modulation of KP metabolites in plasma of Sprague–Dawley rats after administration of a 10 mg/kg po dose of compound <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our PK analysis indicated that compound <b>75</b> had limited distribution to brain tissues. However, given that in striatum we could detect dialysate levels of compound <b>75</b> reaching the EC<sub>50</sub> for microglial rat KMO (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>B), we wanted to test whether the compound could modulate CNS levels of kynurenine metabolites via a central mechanism. As previously reported, peripheral inhibition of KMO activity would lead to an influx of KYN from blood to the brain.<a onclick="showRef(event, 'ref24 ref25 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref66 ref67">(24, 25, 66, 67)</a> To evaluate the extent of brain extracellular levels of kynurenine metabolites, we measured compound <b>75</b> levels with quantitative microdialysis using a metaquant MQ probe,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and levels of kynurenines using a second probe implanted in the contralateral striatum. An AUC (0–240 min) of 66 nM*h for <b>75</b> in striatal extracellular fluid was determined. This represents the “free” level of <b>75</b>, confirming the limited brain penetration in the rat observed in the pharmacokinetics experiments, but also indicating compound <b>75</b> levels close to its EC<sub>50</sub> for KMO in rat microglia.</div><div class="NLM_p">Microdialysis experiments clearly indicate a profound elevation in extracellular levels of KYN, AA and KYNA centrally, as expected based on the peripheral modulation of KYN. Whether any extent of central inhibition of KMO by compound <b>75</b> contributed to these elevations is unclear. The microdialysis studies revealed that we can obtain a PD effect of 4 h or longer for KYN and KYNA after a single oral dose of 10 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). Statistical evaluation by 2-way ANOVA showed that there was a significant increase of KYN (F(12, 148) = 30.93, <i>p</i> < 0.001), AA over time from t = 40–240 min (F(12, 151) = 34.12, <i>p</i> < 0.001) and for KYNA from t = 60–240 min (F(12, 150) = 31.88, <i>p</i> < 0.001) in the striatal dialysate level, as compared with t = 0 min. In contrast, levels of 3-HK only rose 2-fold between t = 160–240 min (F(12, 139) = 9.98, <i>p</i> < 0.001) in the extracellular compartment (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). This minimal alteration in 3-HK levels in brain dialysate is suggestive that perhaps we can exert some degree of KMO inhibition centrally in rats. A complete lack of inhibition of central KMO would be expected to yield a large elevation of 3-HK levels in the brain, as the influx of peripheral KYN would presumably be catabolized by microglial KMO to produce 3-HK. Indeed, we have observed a large increase in extracellular 3-HK when KYN is directly administered to rats (data not shown). Attempts to measure central levels of QA, the other downstream metabolite of KMO, were unsuccessful as our QA detection methods were not sensitive enough given the small samples from the microdialysis probes. However, definitive experiments would require an assessment of compound <b>75</b> effects in the presence of exogenous administration of tryptophan or kynurenine to boost the low levels of 3HK detected centrally.</div><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0010.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Pharmacodynamic effects of compound <b>75</b> in rat kynurenines as measured by a microdialysis probe implanted in the striatum. A. Terminal plasma levels of <b>75</b> (<i>t</i> = 240 min post dose). B. Free drug unbound level of <b>75</b> in striatal extracellular fluid as measured by microdialysis. <b>C–F</b>. Modulation of KP metabolites in striatum brain microdialysate after administration of a 10 mg/kg po dose of compound <b>75</b> to wild-type rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the presumed neurotoxic role of 3HK and QA in the pathogenesis of HD, we conducted additional experiments to evaluate whether compound <b>75</b> could, dose-dependently, also modulate QA in vivo. In this study, we extended the initial observations in plasma by monitoring kynurenine levels in a multiple dose study (from 1 to 100 mg/kg po). The effects of compound <b>75</b> on KYN, KYNA, and AA levels in plasma are very robust and dose-dependent (see Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). In contrast, the modulation of 3-HK levels in plasma was found to be less dose-dependent. Due to the instability of the hydroxylated kynurenine and the sensitivity of the methods developed, the effects of KMO inhibition on 3HK are less profound (in many instances, levels of 3HK where at the limit of quantitation (LOQ) for the assay). In contrast to the observed effects on 3HK levels, compound <b>75</b> produced a significant dose-dependent decrease in QA levels in plasma. These results show the effects of compound <b>75</b> in blocking catabolism of kynurenine downstream of KMO activity. Altogether, these studies support the selective effect of compound <b>75</b> in modulating KMO activity in vivo. We have shown that the inhibition of KMO after oral dosing leads to a dose-dependently elevation of the “upstream” kynurenines (KYN, KYNA and AA) in plasma, and an inhibition of 3HK and QA levels (two metabolites “downstream” of KMO).</div><figure id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0011.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Pharmacodynamic effects of compound 75 in terminal plasma of Sprague–Dawley rats. Rats were dosed with various concentrations of compound <b>75</b> (from 3 to 100 mg/kg po), and terminal tissue/plasma levels of KYN (panel A), 3HK (panel B), KYNA (Panel C), and QA (Panels D) were analyzed at various time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36027" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36027" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have identified a series of pyrimidine carboxylic acids that are potent inhibitors of KMO both in vitro and in vivo. Through iterative medicinal chemistry our team has been able to optimize this series to produce compounds that potently inhibit KMO in both biochemical and cellular assays. We have shown that these compounds are selective for KMO over other KP enzymes that utilize KYN as a substrate, and demonstrate that systemic inhibition of KMO in vivo with compound <b>75</b> provides pharmacodynamic evidence for modulation of KP metabolites both in the periphery as well as in the central nervous system. Oral administration of compound <b>75</b> in rats produces the expected modulation of KP metabolites in plasma, that is, a dose-proportional increase in KYN, KYNA, and AA levels, and a decrease in 3-HK and QA levels. These effects are also observed in the tissues monitored (liver and kidney). As predicted from published studies, and given its ready transport into the brain, the increase of KYN in plasma after compound <b>75</b> administration leads to an increase of KYN levels in brain compartments (in tissues, in the extracellular fluid, and in CSF). We also observe an elevation of KYN catabolic products, KYNA and AA. As would be expected from the increase of brain KYN and the minimal compound exposure, we see an increase in 3-HK levels in brain. However, compared to the magnitude of increases in KYNA and AA, the 3-HK increase is minimal. Given that the free concentration of <b>75</b> in rat striatum intracellular space is close to the cellular EC<sub>50</sub> in rat microglia, there is likely a certain degree of KMO inhibition in the rat brain.</div><div class="NLM_p last">Compound <b>75</b> and several other program leads have suitable ADME/PK profiles for further development and will be evaluated as potential therapeutics for Huntington’s disease. The profile of this class of compounds (with poor brain exposure) allows us to test the hypothesis of whether modulating KMO activity systemically contributes to disease progression. Clearly, the lack of brain exposure of our lead molecule does not allow us to test the hypothesis of whether lowering 3HK and QA levels in situ in the brain is beneficial in the context of HD. However, compound <b>75</b> does modulate the pathway beautifully in the periphery in rodents and therefore allows us to test whether a systemic, peripheral modulation of the pathway affects disease progression, as has been claimed previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In addition, we clearly show that we can elevate KYN, KYNA, and AA levels in brain. We believe that the central elevation of KYN and KYNA is beneficial in the context of the synaptic alterations observed in HD models. The dose-dependency of the reponse in plasma reflects the existence of a clear PK/PD response, which will be useful in clinical development for this class of modecules, in the context of HD or other indications where deregulation of KMO activity has been implicated.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Synthetic Procedures</h3><div class="NLM_p">Commercially available reagents and solvents (HPLC grade) were used without further purification. <sup><b>1</b></sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker DRX 500 MHz spectrometer or Bruker DPX 250 MHz spectrometer in deuterated solvents. Chemical shifts (δ) are in parts per million. Thin-layer chromatography (TLC) analysis was performed with Kieselgel 60 F<sub>254</sub> (Merck) plates and visualized using UV light.</div><div class="NLM_p">Analytical HPLC-MS was performed on Shimadzu LCMS-2010EV systems using reverse phase Atlantis dC18 columns (3 μm, 2.1 × 50 mm), gradient 5–100% B (A = water/0.1% formic acid, B = acetonitrile/0.1% formic acid) over 3 min, injection volume 3 μL, flow = 1.0 mL/min. UV spectra were recorded at 215 nm using a Waters 2788 dual wavelength UV detector. Mass spectra were obtained over the range <i>m</i>/<i>z</i> 150 to 850 at a sampling rate of two scans per second using Waters LCT or analytical HPLC-MS on Shimadzu LCMS-2010EV systems using reverse phase Water Atlantis dC18 columns (3 μm, 2.1 × 100 mm), gradient 5–100% B (A = water/0.1% formic acid, B = acetonitrile/0.1% formic acid) over 7 min, injection volume 3 μL, flow = 0.6 mL/min. UV spectra were recorded at 215 nm using a Waters 2996 photodiode array. Data were integrated and reported using Shimadzu psiport software. All compounds display purity of >95% as determined by this method, unless stated otherwise. Accurate mass measurements were carried out using a Waters Micromass LCT Premier orthogonal acceleration time-of-flight mass spectrometer 4 GHz TDC with LockSpray enable.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Procedure A</h4><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 6-(3,4-Dichlorophenyl)pyrimidine-4-carboxylic Acid (<b>7</b>)</h5><div class="NLM_p">Potassium carbonate (2 M solution, 40.0 mL, 94.3 mmol) was added in one portion to a stirred solution of 3,4-dichlorophenyl boronic acid (4.5 g, 23.6 mmol) and 4,6-dichloropyrimidine (5.0 g, 37.0 mmol) in dioxane (80 mL). The mixture was degassed with nitrogen for 5 min, after which time Pd(PPh<sub>3</sub>)<sub>4</sub> (1.1 g, 0.9 mmol) was added in one portion, and the mixture was then heated to 90 °C and stirred at this temperature for 2 h under a nitrogen atmosphere. After this time, the reaction mixture was cooled to room temperature and concentrated. The resulting residue was suspended in DCM (300 mL) and washed sequentially with water (200 mL) and brine (300 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated, and the resulting brown solid was purified by flash column chromatography (elution: 5% EtOAc, 95% heptane) to give 4-chloro-6-(3,4-dichlorophenyl)pyrimidine (3.6 g, 58% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 261.</div><div class="NLM_p">Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (0.46 g, 0.56 mmol) was added in one portion to a stirred solution of 4-chloro-6-(3,4-dichlorophenyl)pyrimidine (2.9 g, 11.2 mmol) and triethylamine (3.1 mL, 22.4 mmol) in methanol (150 mL) within an autoclave. The autoclave was purged with nitrogen (×2) before being sealed and charged with carbon monoxide (5 bar pressure), and the reaction mixture was then heated to 50 °C and stirred at this temperature and pressure for 18 h. After this time, the reaction mixture was cooled to room temperature and concentrated. The resulting residue was suspended in EtOAc (300 mL) and washed sequentially with water (200 mL) and brine (300 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated, and the resulting brown solid was purified by flash column chromatography (elution: 40% EtOAc, 60% heptane) to give methyl 6-(3,4-dichlorophenyl)pyrimidine-4-carboxylate (2.2 g, 70% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 284.</div><div class="NLM_p last">NaOH (2 M solution, 5.0 mL, 10.0 mmol) was added in one portion to a stirred solution of methyl 6-(3,4-dichlorophenyl)pyrimidine-4-carboxylate (0.95 g, 3.4 mmol) in THF (10 mL), and the mixture was stirred at room temperature for 16 h. After this time, the resulting precipitate was collected by filtration and washed with water (1 mL) and DCM (20 mL) before being dried under vacuum to give the sodium salt of <b>7</b> (0.64 g, 66% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 269/271; <sup>1</sup>H NMR (500 MHz, DMSO) 9.09–9.23 (m, 1H), 8.18–8.23 (m, 1H), 8.13–8.17 (m, 1H), 7.85–7.92 (m, 1H), 7.60–7.70 (m, 1H). <sup>13</sup>C NMR (126 MHz, CD<sub>3</sub>CO<sub>2</sub>D) 167.16, 165.74, 159.76, 156.68, 137.05, 136.82, 134.44, 132.27, 130.58, 128.12, 117.72. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 268.9877 (268.9885 Calcd for C<sub>11</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 6-(3-Chlorophenyl)pyrimidine-4-carboxylic Acid (<b>6</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 235/237; <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) 9.06 (s, 1H), 8.07 (s, 1H), 7.86 (s, 1H), 7.79 (d, <i>J</i> = 7.72 Hz, 1H), 7.37–7.47 (m, 2H). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O) 170.82, 164.73, 161.79, 157.80, 137.55, 134.49, 131.15, 130.56, 127.27, 125.78, 116.61. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 235.0255 (235.0274 Calcd for C<sub>11</sub>H<sub>7</sub>ClN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 6-Phenylpyrimidine-4-carboxylic Acid (<b>46</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 201; <sup>1</sup>H NMR (500 MHz, DMSO) 9.04–9.17 (m, 1H), 8.07–8.26 (m, 3H), 7.43–7.64 (m, 3H). <sup>13</sup>C NMR (63 MHz, CD<sub>3</sub>CO<sub>2</sub>D) 168.22, 167.41, 159.32, 156.46, 136.42, 133.05, 130.18, 128.78, 117.73. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 201.0656 (201.0664 Calcd for C<sub>11</sub>H<sub>8</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 6-(Pyridin-3-yl)pyrimidine-4-carboxylic Acid (<b>47</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 202; <sup>1</sup>H NMR (500 MHz, DMSO) 9.33 (d, <i>J</i> = 1.80 Hz, 1H), 9.14 (d, <i>J</i> = 1.25 Hz, 1H), 8.71 (dd, <i>J</i> = 1.54, 4.75 Hz, 1H), 8.53 (dt, <i>J</i> = 1.94, 7.99 Hz, 1H), 8.23 (d, <i>J</i> = 1.12 Hz, 1H), 7.56 (dd, <i>J</i> = 4.87, 7.91 Hz, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 202.0607 (202.0617 Calcd for C<sub>10</sub>H<sub>7</sub>N<sub>3</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 6-(3-Phenylphenyl)pyrimidine-4-carboxylic Acid (<b>48</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 277; <sup>1</sup>H NMR (500 MHz, DMSO) 13.79 (br s, 1H), 9.43 (d, <i>J</i> = 1.10 Hz, 1H), 8.63 (d, <i>J</i> = 1.10 Hz, 1H), 8.52 (s, 1H), 8.28 (d, <i>J</i> = 7.88 Hz, 1H), 7.90 (d, <i>J</i> = 7.88 Hz, 1H), 7.76–7.86 (m, 2H), 7.68 (t, <i>J</i> = 7.80 Hz, 1H), 7.52 (t, <i>J</i> = 7.65 Hz, 2H), 7.37–7.46 (m, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 277.0979 (277.0977 Calcd for C<sub>17</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 6-(4-Chlorophenyl)pyrimidine-4-carboxylic Acid (<b>52</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 235/237; <sup>1</sup>H NMR (500 MHz, DMSO) 9.34–9.46 (m, 1H), 8.45–8.56 (m, 1H), 8.25–8.38 (m, 2H), 7.57–7.71 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.43, 163.71, 159.06, 156.89, 136.65, 134.31, 129.28, 129.18, 116.19. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 235.0269 (235.0274 Calcd for C<sub>11</sub>H<sub>7</sub>ClN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 6-(3,5-Dichlorophenyl)pyrimidine-4-carboxylic Acid (<b>53</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 269/271; <sup>1</sup>H NMR (500 MHz, DMSO) 9.44 (s, 1H), 8.63 (s, 1H), 8.33 (s, 2H), 7.86 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.29, 162.17, 159.00, 157.37, 138.99, 135.11, 130.86, 126.03, 117.01. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 268.9887 (268.9885 Calcd for C<sub>11</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 6-(3-Fluorophenyl)pyrimidine-4-carboxylic Acid (<b>54</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 219; <sup>1</sup>H NMR (500 MHz, DMSO) 14.01 (br s, 1H), 9.42 (s, 1H), 8.54 (s, 1H), 8.23–8.00 (m, 2H), 7.71–7.56 (m, 1H), 7.53–7.37 (m, 1H). <sup>13</sup>C NMR (63 MHz, <i>d</i><sub>4</sub>-AcOH) 167.42 (d, <i>J</i> = 2.70 Hz), 167.34, 164.98 (d, <i>J</i> = 245.53 Hz), 160.25, 156.45, 139.43 (d, <i>J</i> = 7.78 Hz), 132.59 (d, <i>J</i> = 8.14 Hz), 125.14 (d, <i>J</i> = 2.91 Hz), 120.38 (d, <i>J</i> = 21.52 Hz), 118.42, 116.04 (d, <i>J</i> = 23.62 Hz). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 219.0579 (219.057 Calcd for C<sub>11</sub>H<sub>7</sub>FN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 6-(3-Chloro-4-fluorophenyl)pyrimidine-4-carboxylic Acid (<b>55</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 253; <sup>1</sup>H NMR (500 MHz, DMSO) 9.31–9.36 (m, 1H), 8.53–8.57 (m, 1H), 8.40–8.46 (m, 1H), 8.21–8.27 (m, 1H), 7.44 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 163.4, 162.6, 159.28 (d, <i>J</i> = 252 Hz), 159.0, 157.1, 133.32 (d, <i>J</i> = 3 Hz), 129.7, 128.43 (d, <i>J</i> = 8 Hz, H), 120.71 (d, <i>J</i> = 18 Hz), 117.73 (d, <i>J</i> = 21 Hz), 116.4. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 253.0196 (253.0180 Calcd for C<sub>11</sub>H<sub>6</sub>ClFN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 6-(4-Chloro-3-fluorophenyl)pyrimidine-4-carboxylic Acid (<b>56</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 253; <sup>1</sup>H NMR (500 MHz, DMSO) 9.41 (d, <i>J</i> = 1.00 Hz, 1H), 8.60–8.52 (m, 1H), 8.31 (dd, <i>J</i> = 1.84, 10.65 Hz, 1H), 8.17 (dd, <i>J</i> = 1.54, 8.45 Hz, 1H), 7.78 (t, <i>J</i> = 8.06 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.34, 162.64, 159.03, 157.73 (d, <i>J</i> = 247 Hz) 157.21, 136.62 (d, <i>J</i> = 7.0 Hz), 131.47, 124.53 (d, <i>J</i> = 3.4 Hz), 123.01 (d, <i>J</i> = 17.6 Hz), 116.53, 115.54 (d, <i>J</i> = 22.8 Hz). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 253.0197 (253.018 Calcd for C<sub>11</sub>H<sub>6</sub>ClFN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 6-(3-Chloro-2-fluorophenyl)pyrimidine-4-carboxylic Acid (<b>57</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 253; <sup>1</sup>H NMR (500 MHz, MeOD) 9.35–9.40 (m, 1H), 8.44–8.49 (m, 1H), 8.05–8.12 (m, 1H), 7.65–7.73 (m, 1H), 7.33–7.41 (m, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 253.0176 (253.018 Calcd for C<sub>11</sub>H<sub>6</sub>ClFN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 6-(3,4-Difluorophenyl)pyrimidine-4-carboxylic Acid (<b>58</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 236; <sup>1</sup>H NMR (500 MHz, DMSO) 9.10 (s, 1H), 8.22–8.28 (m, 1H), 8.19 (s, 1H), 8.06–8.11 (m, 1H), 7.54–7.65 (m, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 237.0469 (237.0476 Calcd for C<sub>11</sub>H<sub>6</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 6-(2,4-Difluorophenyl)pyrimidine-4-carboxylic Acid (<b>59</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 237; <sup>1</sup>H NMR (500 MHz, MeOD) 9.48 (s, 1H), 8.51 (s, 1H), 8.34–8.26 (m, 1H), 7.23–7.16 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.2, 164.1 (dd, <i>J</i> = 13, 252 Hz), 161.3 (dd, <i>J</i> = 13, 255 Hz), 160.7 (d, <i>J</i> = 3 Hz), 159.1, 156.5, 132.4 (dd, <i>J</i> = 4, 10 Hz), 120.6 (dd, <i>J</i> = 3.53, 10.39 Hz), 119.7 (d, <i>J</i> = 11 Hz), 112.8 (dd, <i>J</i> = 3, 22 Hz), 105.3 (t, <i>J</i> = 27 Hz). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 237.0472 (237.0476 Calcd for C<sub>11</sub>H<sub>6</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 6-(4-Chloro-2-fluorophenyl)pyrimidine-4-carboxylic Acid (<b>60</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 253/255; <sup>1</sup>H NMR (500 MHz, MeOD) 9.38 (br. s, 1H), 8.26 (br. s, 1H.), 8.18 (t, <i>J</i> = 8.54 Hz, 1H), 7.70 (dd, <i>J</i> = 11.44, 1.83 Hz, 1H), 7.52 (dd, <i>J</i> = 8.47, 1.75 Hz, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 253.0179 (253.018 Calcd for C<sub>11</sub>H<sub>6</sub>ClFN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 6-[3-Chloro-4-(trifluoromethyl)phenyl]pyrimidine-4-carboxylic Acid (<b>61</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 303; <sup>1</sup>H NMR (250 MHz, DMSO) 9.43–9.52 (m, 1H), 8.63–8.69 (m, 1H), 8.58 (s, 1H), 8.39–8.47 (m, 1H), 7.99–8.08 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.3, 162.1, 159.1, 157.4, 141.0, 131.8, 130.1, 128.8–128.7 (m), 128.6, 126.6, 122.7 (q, <i>J</i> = 273 Hz). 117.3. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 303.0129 (303.0148 Calcd for C<sub>12</sub>H<sub>6</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 6-[3-(Trifluoromethyl)phenyl]pyrimidine-4-carboxylic Acid (<b>62</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 269; <sup>1</sup>H NMR (500 MHz, DMSO) 9.45 (s, 1H), 8.57–8.68 (m, 3H), 7.94–8.00 (m, 1H), 7.80–7.86 (m, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 269.0529 (269.0538 Calcd for C<sub>12</sub>H<sub>7</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 6-[2-(Trifluoromethyl)phenyl]pyrimidine-4-carboxylic Acid (<b>63</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 269; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 9.47 (s, 1H), 8.28 (s, 1H), 7.89–7.82 (m, 1H), 7.72–7.66 (m, 2H), 7.56–7.53 (1H, m). <sup>13</sup>C NMR (126 MHz, DMSO) 166.76, 165.23, 158.39, 156.60, 136.57–136.55 (m), 132.80, 131.58, 130.34, 126.89–126.72 (m), 126.77 (q, <i>J</i> = 30.88 Hz), 123.90 (q, <i>J</i> = 273.73 Hz), 120.13. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 269.0537 (269.0538 Calcd for C<sub>12</sub>H<sub>7</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 6-(3-Methylphenyl)pyrimidine-4-carboxylic Acid (<b>64</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 215; <sup>1</sup>H NMR (500 MHz, DMSO) 13.88 (br. s, 1H), 9.37 (d, <i>J</i> = 1.06 Hz, 1H), 8.46 (d, <i>J</i> = 1.05 Hz, 1H), 8.16–7.83 (m, 2H), 7.51–7.19 (m, 2H), 2.41 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.52, 164.97, 159.00, 156.70, 138.60, 135.40, 132.40, 129.14, 127.79, 124.45, 116.10, 21.00. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 215.0806 (215.0821 Calcd for C<sub>12</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 6-[4-Fluoro-3-(trifluoromethyl)phenyl]pyrimidine-4-carboxylic Acid (<b>65</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 287; <sup>1</sup>H NMR (500 MHz, DMSO) 14.04 (br. s, 1H), 9.42 (s, 1H), 8.79–8.42 (m, 3H), 7.71 (t, <i>J</i> = 9.61 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.4, 162.4, 160.79 (d, <i>J</i> = 258.91 Hz, H), 159.0, 157.2, 134.48 (d, <i>J</i> = 9.62 Hz, H), 132.6, 126.4, 122.43 (q, <i>J</i> = 271.93 Hz, H), 118.27 (d, <i>J</i> = 20.96 Hz, H), 117.45 (dd, <i>J</i> = 12.80, 32.66 Hz, H), 116.6. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 287.044 (287.0444 Calcd for C<sub>12</sub>H<sub>6</sub>F<sub>4</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 6-(3-Chloro-4-methylphenyl)pyrimidine-4-carboxylic Acid (<b>66</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 249; <sup>1</sup>H NMR (500 MHz, DMSO) 9.39 (d, <i>J</i> = 1.37 Hz, 1H), 8.52 (d, <i>J</i> = 1.22 Hz, 1H), 8.32 (d, <i>J</i> = 1.83 Hz, 1H), 8.17 (dd, <i>J</i> = 1.83, 7.93 Hz, 1H), 7.56 (d, <i>J</i> = 8.09 Hz, 1H), 2.42 (s, 3H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 249.0442 (249.0431 Calcd for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 6-(3-Fluoro-4-methylphenyl)pyrimidine-4-carboxylic Acid (<b>67</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 232; <sup>1</sup>H NMR (500 MHz, DMSO) 9.38 (s, 1H) 8.49 (s, 1H) 7.94–8.11 (m, 2H) 7.39–7.57 (m, 1H) 2.32 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.46, 163.59, 161.14 (d, <i>J</i> = 243.39 Hz), 158.99, 156.89, 135.33 (d, <i>J</i> = 7.76 Hz), 132.44 (d, <i>J</i> = 5.18 Hz), 128.45 (d, <i>J</i> = 17.24 Hz), 123.15 (d, <i>J</i> = 3.01 Hz), 116.09, 113.49 (d, <i>J</i> = 24.08 Hz), 14.31 (d, <i>J</i> = 2.98 Hz). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 233.0744 (233.0726 Calcd for C<sub>12</sub>H<sub>9</sub>FN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 6-(4-Chloro-3-methoxyphenyl)pyrimidine-4-carboxylic Acid (<b>68</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 265/267; <sup>1</sup>H NMR (500 MHz, DMSO) 14.01 (br s, 1H), 9.41 (d, <i>J</i> = 1.26 Hz, 1H), 8.58 (d, <i>J</i> = 1.10 Hz, 1H), 7.97 (d, <i>J</i> = 1.89 Hz, 1H), 7.90 (dd, <i>J</i> = 2.05, 8.35 Hz, 1H), 7.63 (d, <i>J</i> = 8.35 Hz, 1H), 4.00 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.51, 163.83, 158.95, 156.93, 155.05, 135.71, 130.55, 124.77, 120.45, 116.36, 111.01, 56.38. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 265.0381 (265.038 Calcd for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 6-(3-Chloro-4-methoxyphenyl)pyrimidine-4-carboxylic Acid (<b>73</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 265; <sup>1</sup>H NMR (500 MHz, DMSO) 13.92 (br s, 1H), 9.27–9.36 (m, 1H), 8.47 (d, <i>J</i> = 1.22 Hz, 1H), 8.35 (d, <i>J</i> = 2.14 Hz, 1H), 8.27 (dd, <i>J</i> = 2.29, 8.70 Hz, 1H), 7.21–7.36 (m, 1H), 3.96 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.54, 163.26, 158.92, 157.26, 156.67, 128.63 (2 peaks), 127.85, 122.01, 115.60, 113.16, 56.55. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 265.0389 (265.038 Calcd for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 6-[3-Chloro-4-(propan-2-yloxy)phenyl]pyrimidine-4-carboxylic Acid (<b>74</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 293/295; <sup>1</sup>H NMR (500 MHz, DMSO) 9.33 (s, 1H), 8.47 (s, 1H), 8.36 (d, <i>J</i> = 1.94 Hz, 1H), 8.24 (dd, <i>J</i> = 1.89, 8.72 Hz, 1H), 7.34 (d, <i>J</i> = 8.80 Hz, 1H), 4.84 (p, <i>J</i> = 5.98 Hz, 1H), 1.34 (d, <i>J</i> = 6.00 Hz, 5H). <sup>13</sup>C NMR (63 MHz, DMSO) 166.43, 165.79, 161.58, 158.21, 155.15, 129.43, 128.46, 127.12, 122.90, 115.22, 114.17, 71.36, 21.81. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 293.0679 (293.0693 Calcd for C<sub>14</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 6-(3,4-Dichlorophenyl)-2-methylpyrimidine-4-carboxylic Acid (<b>22</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 283; <sup>1</sup>H NMR (500 MHz, DMSO) 8.49 (d, <i>J</i> = 1.98 Hz, 1H), 8.37 (s, 1H), 8.25 (dd, <i>J</i> = 8.53, 2.13 Hz, 1H), 7.81 (d, <i>J</i> = 8.38 Hz, 1H), 2.76 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) 168.22, 165.56, 162.52, 157.64, 136.28, 134.22, 132.16, 131.34, 129.04, 127.42, 113.52, 25.80. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 283.0038 (283.0041 Calcd for C<sub>12</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 6-(3,4-Dichlorophenyl)-5-fluoropyrimidine-4-carboxylic Acid (<b>23</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 287; <sup>1</sup>H NMR (500 MHz, DMSO) 9.20 (d, <i>J</i> = 2.29 Hz, 1H), 8.24 (d, <i>J</i> = 1.83 Hz, 1H), 7.98–8.05 (m, 1H), 7.88 (d, <i>J</i> = 8.39 Hz, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 286.9794 (286.979 Calcd for C<sub>11</sub>H<sub>5</sub>Cl<sub>2</sub>FN<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 6-(3,4-Dichlorophenyl)-5-methoxypyrimidine-4-carboxylic Acid (<b>27</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 299/301; <sup>1</sup>H NMR (500 MHz, DMSO) 8.73 (s, 1H) 8.21 (d, <i>J</i> = 1.89 Hz, 1H) 8.02 (dd, <i>J</i> = 8.51, 2.05 Hz, 1H) 7.78 (d, <i>J</i> = 8.51 Hz, 1H) 3.64–3.83 (m, 3H). <sup>13</sup>C NMR (63 MHz, DMSO) 167.65, 163.65, 152.59, 152.46, 146.33, 136.26, 132.45, 131.20, 130.74, 130.55, 129.13, 60.72. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 298.9988 (298.999 Calcd for C<sub>12</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 6-(3,4-Dichlorophenyl)-5-methylpyrimidine-4-carboxylic Acid (<b>25</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 283/285; <sup>1</sup>H NMR (500 MHz, DMSO) 14.13 (br s, 1H) 9.16 (s, 1H) 7.94 (d, <i>J</i> = 2.05 Hz, 1H) 7.81 (d, <i>J</i> = 8.35 Hz, 1H) 7.67 (dd, <i>J</i> = 8.35, 2.05 Hz, 1H) 2.37 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO) 166.98, 164.37, 158.94, 155.55, 137.93, 132.52, 131.31, 131.08, 130.64, 129.45, 125.40, 15.22. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 283.0052 (283.0041 Calcd for C<sub>12</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 5-Amino-6-(3,4-dichlorophenyl)pyrimidine-4-carboxylic Acid (<b>24</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure A as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 284/286; <sup>1</sup>H NMR (500 MHz, DMSO) 8.36 (s, 1H) 7.92 (d, <i>J</i> = 1.58 Hz, 1H) 7.68–7.78 (m, 2H) 6.87 (br s, 2H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 283.9976 (283.9994 Calcd for C<sub>11</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> M + H).</div></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Method B</h4><div id="sec5_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 6-(3-Chloro-4-cyclopropoxyphenyl)pyrimidine-4-carboxylic Acid (<b>75</b>)</h5><div class="NLM_p">Bromocyclopropane (87.5 g, 0.723 mol) was added portionwise over 10 min to a stirred solution of 4-bromo-2-chlorophenol (30.0 g, 0.145 mol) and cesium dicarbonate (118 g, 0.362 mol) in dimethylacetamide (450 mL). The mixture was heated to 150 °C and stirred at this temperature for 16 h. After this time, the reaction was cooled to room temperature, poured onto ice–water (600 mL), and extracted with TBME (3 × 400 mL). The organic layers were combined and washed with water (2 × 200 mL) before being dried (MgSO<sub>4</sub>), filtered, and concentrated to give 4-bromo-2-chloro-1-cyclopropoxybenzene (31.2 g, 72% yield) as a pale orange oil which was used directly without purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 7.51–7.45 (m, 1H), 7.34 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.21–7.13 (m, 1H), 3.84–3.74 (m, 1H) 0.93–0.77 (m, 4H).</div><div class="NLM_p">Potassium acetate (37.1 g, 0.378 mol) was added portionwise over 10 min to a stirred solution of 4-bromo-2-chloro-1-cyclopropoxybenzene (31.2 g, 0.126 mol) and bis(pinacolato)diboron (38.4 g, 0.151 mol) in DMSO (340 mL). The mixture was degassed with nitrogen for 15 min, after which time Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (4.60 g, 6.28 mmol) was added in one portion, and the mixture was then heated to 80 °C and stirred at this temperature for 16 h under a nitrogen atmosphere. After this time, the reaction mixture was cooled to room temperature and partitioned between ethyl acetate (300 mL) and water (300 mL). The organic layer was removed and washed sequentially with water (1.50 L) and then brine (500 mL) before being dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was dry-loaded onto silica gel (90.0 g) and purified by dry flash column chromatography (elution: 100% heptane to 92% heptane, 8% EtOAc) to give 2-(3-chloro-4-cyclopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (27.0 g, 62% yield) as a pale yellow oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 7.79 (d, <i>J</i> = 1.3 Hz, 1 H) 7.67 (dd, <i>J</i> = 8.2, 1.4 Hz, 1 H) 7.32–7.25 (m, 1 H) 3.90–3.77 (m, 1 H) 1.42–1.30 (m, 12 H) 0.95–0.77 (m, 4 H).</div><div class="NLM_p last">2-(3-Chloro-4-cyclopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was then taken forward as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="general procedure A">general procedure A</a> above to give compound <b>75</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 291/293; <sup>1</sup>H NMR (500 MHz, DMSO) 9.10–9.05 (m, 1H), 8.28–8.17 (m, 3H), 7.60–7.54 (m, 1H), 4.11–4.02 (m, 1H) 0.92–0.71 (m, 4H). <sup>13</sup>C NMR (300 MHz, DMSO) 166.7, 166.4, 161.8, 158.5, 156.6, 130.5, 128.6, 127.5, 122.1, 115.3, 114.5, 52.5, 6.4.</div></div><div id="sec5_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 6-(3-Chloro-4-cyclobutoxyphenyl)pyrimidine-4-carboxylic Acid (<b>78</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 305/307; <sup>1</sup>H NMR (500 MHz, MeOD) 9.20–9.29 (m, 1H) 8.40–8.49 (m, 1H) 8.25–8.34 (m, 1H) 8.07–8.18 (m, 1H) 7.04–7.11 (m, 1H) 2.48–2.62 (m, 2H) 2.16–2.28 (m, 2H) 1.87–1.96 (m, 1H) 1.73–1.83 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.52, 163.27, 158.90, 156.64, 155.22, 128.83, 128.61, 127.75, 122.19, 115.56, 114.38, 72.07, 29.97, 12.72. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 305.0697 (305.0693 Calcd for C<sub>15</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 6-[3-Chloro-4-(oxetan-3-yloxy)phenyl]pyrimidine-4-carboxylic Acid (<b>79</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 307/309; δ<sub>H</sub> (500 MHz, DMSO) 9.12 (s, 1H), 8.32 (d, <i>J</i> = 2.05 Hz, 1H), 8.27 (s, 1H), 8.13 (dd, <i>J</i> = 2.05, 8.67 Hz, 1H), 6.94 (d, <i>J</i> = 8.67 Hz, 1H), 5.48 (quin, <i>J</i> = 5.40 Hz, 1H), 5.00 (t, <i>J</i> = 6.78 Hz, 2H), 4.62 (dd, <i>J</i> = 4.89, 7.41 Hz, 2H). <sup>13</sup>C NMR (63 MHz, <i>d</i><sub>4</sub>-AcOH) 167.72, 167.00, 159.85, 157.02, 156.69, 131.60, 131.13, 129.54, 125.33, 117.64, 114.94, 79.21, 72.88. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 307.0492 (307.0486 Calcd for C<sub>14</sub>H<sub>11</sub>ClN<sub>2</sub>O<sub>4</sub> M + H).</div></div><div id="sec5_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 6-[3-Chloro-4-(cyclopentyloxy)phenyl]pyrimidine-4-carboxylic Acid (<b>80</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 319; <sup>1</sup>H NMR (500 MHz, DMSO) 9.33 (s, 1H), 8.47 (s, 1H), 8.37–8.29 (m, 1H), 8.29–8.17 (m, 1H), 7.31 (d, <i>J</i> = 8.77 Hz, 1H), 5.05 (s, 1H), 2.10–1.87 (m, 2H), 1.84–1.53 (m, 7H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.58, 163.26, 158.90, 156.81, 155.81, 128.79, 128.30, 127.58, 122.90, 115.50, 115.05, 80.60, 32.29, 23.61. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 319.0852 (319.0849 Calcd for C<sub>16</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 6-[3-Chloro-4-(cyclohexyloxy)phenyl]pyrimidine-4-carboxylic Acid (<b>81</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 333/335; <sup>1</sup>H NMR (500 MHz, DMSO) 9.04 (s, 1H), 8.23 (d, <i>J</i> = 2.18 Hz, 1H), 8.15–8.07 (m, 2H), 7.33 (d, <i>J</i> = 8.84 Hz, 1H), 4.60 (dt, <i>J</i> = 4.35, 8.15 Hz, 1H), 1.96–1.88 (m, 2H), 1.79–1.69 (m, 2H), 1.61–1.48 (m, 3H), 1.47–1.28 (m, 3H). <sup>13</sup>C NMR (63 MHz, <i>d</i><sub>4</sub>-AcOH) 168.14, 167.36, 159.54, 158.40, 157.09, 131.43, 129.77, 129.40, 126.12, 117.51, 116.39, 78.07, 32.74, 26.93, 24.60. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 333.1006 (333.1006 Calcd for C<sub>17</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 6-{3-Chloro-4-[2-(morpholin-4-yl)ethoxy]phenyl}pyrimidine-4-carboxylic Acid (<b>69</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 364/366; <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O) 8.90–9.04 (m, 1H), 7.93–8.02 (m, 1H), 7.80–7.89 (m, 1H), 7.69–7.78 (m, 1H), 6.92–7.06 (m, 1H), 4.10–4.25 (m, 2H), 3.55–3.78 (m, 4H), 2.78–2.90 (m, 2H), 2.55–2.74 (m, 4H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 364.1081 (364.1064 Calcd for C<sub>17</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub> M + H).</div></div><div id="sec5_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 6-{4-Chloro-3-[2-(morpholin-4-yl)ethoxy]phenyl}pyrimidine-4-carboxylic Acid (<b>70</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 364/366; <sup>1</sup>H NMR (500 MHz, DMSO) 9.41 (d, <i>J</i> = 0.96 Hz, 1H), 8.63–8.40 (m, 1H), 8.11–7.83 (m, 2H), 7.66 (d, <i>J</i> = 8.32 Hz, 1H), 4.89–4.47 (m, 2H), 3.91 (s, 4H), 3.65–3.53 (m, 2H), 3.39 (s, 4H). <sup>13</sup>C NMR (126 MHz, DMSO) 165.49, 163.63, 158.98, 157.07, 153.54, 135.78, 130.75, 125.03, 121.27, 116.42, 112.15, 64.18, 63.39, 54.84, 51.99. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 364.1063 (364.1064 Calcd for C<sub>17</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub> M + H).</div></div><div id="sec5_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 6-[3-Chloro-4-(cyclopropylmethoxy)phenyl]pyrimidine-4-carboxylic Acid (<b>76</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure B as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 303/305. <sup>1</sup>H NMR (500 MHz, DMSO) 9.04 (s, 1 H) 8.25 (d, J=2.21 Hz, 1 H) 8.06–8.16 (m, 2 H) 7.27 (d, <i>J</i> = 8.67 Hz, 1 H) 4.02 (d, <i>J</i> = 7.09 Hz, 2 H) 1.24–1.37 (m, 1 H) 0.34–0.67 (m, 4 H). <sup>13</sup>C NMR (63 MHz, <i>d</i><sub>4</sub>-AcOH) 167.86, 167.36, 159.56, 159.50, 156.69, 131.18, 129.86, 129.52, 125.20, 117.49, 115.00, 75.26, 11.34, 4.22. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 305.0701 (305.0693 Calcd for C<sub>15</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> General Method C</h4><div id="sec5_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 6-[3-Chloro-4-(trifluoromethoxy)phenyl]pyrimidine-4-carboxylic Acid (<b>72</b>)</h5><div class="NLM_p">A solution of sodium nitrite (2.31 g, 33.4 mmol) in water (15 mL) was slowly added over 30 min to a suspension of [3-chloro-4-(trifluoromethoxy)phenyl]amine (2.95 g, 13.9 mmol) in 20 mL of 15% HCl at −5 °C. The solid material was removed by filtration, and a solution of sodium tetrafluoroborate (2.45 g, 22.3 mmol) in water (5 mL) was mixed with the filtrate. The resulting solid was collected by filtration, washed with water (5 mL), and dried on a sinter funnel under vacuum for 1 h. It was then dried in the vacuum oven at 40 °C until constant weight to give 3-chloro-4-(trifluoromethoxy)benzene-1-diazonium tetrafluoroboranide (2.93 g, 68% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 223/225.</div><div class="NLM_p last">Bis(pinacolato) diboron (2.51 g, 9.8 mmol) was added in one portion to a cooled (0 °C), stirred suspension of 3-chloro-4-(trifluoromethoxy)benzene-1-diazonium tetrafluoroboranide (2.92 g, 9.41 mmol) in methanol (20 mL). The mixture was degassed with nitrogen for 10 min before PdCl<sub>2</sub>(dppf)<sub>2</sub> (0.19 g, 0.23 mmol) was added, and the mixture was stirred at room temperature for 18 h. After this time, the reaction was evaporated to dryness, redissolved in DCM, dry loaded onto silica, and purified by dry flash chromatography (elution: 100% heptane to 20% EtOAc, 80% heptane) to give 2-[3-chloro-4-(trifluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.11 g, 37% yield) as a brown oil which was taken on directly as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="general procedure A">general procedure A</a> above to give compound <b>72</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 319/321; <sup>1</sup>H NMR (500 MHz, DMSO) 9.45 (s, 1H), 8.58–8.65 (m, 2H), 8.37–8.44 (m, 1H), 7.74–7.81 (m, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 319.0091 (319.0097 Calcd for C<sub>12</sub>H<sub>6</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 6-[3-Chloro-4-(pyrrolidin-1-yl)phenyl]pyrimidine-4-carboxylic Acid (<b>71</b>)</h5><div class="NLM_p last">4-Bromo-2-chloroaniline (2.0 g, 9.69 mmol), 1,4-dibromobutane (2.31 mL, 19.4 mmol), potassium carbonate (2.68 g, 19.4 mmol), water (25 mL), and dioxane (10 mL) were heated to 100 °C overnight with vigorous stirring. The reaction mixture was allowed to cool and then extracted with EtOAc (2 × 25 mL). The combined organics were washed with brine (15 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by flash column chromatography (elution: 100% heptane to 20% EtOAc, 80% heptane) to give 1-(4-bromo-2-chlorophenyl)pyrrolidine (1.16 g, 45% yield) as a yellow oil. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 260/262. <sup>1</sup>H NMR (500 MHz, DMSO) 7.48 (d, <i>J</i> = 2.36 Hz, 1H), 7.33 (dd, <i>J</i> = 2.36, 8.83 Hz, 1H), 6.87 (d, <i>J</i> = 8.83 Hz, 1H), 3.29–3.33 (m, 4H), 1.87 (td, <i>J</i> = 3.43, 6.38 Hz, 4H). This material was then taken on as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="general procedure A">general procedure A</a> above to give the title compound <b>71</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 304/306; <sup>1</sup>H NMR (500 MHz, DMSO) 9.25 (s, 1H), 8.37 (s, 1H), 8.24 (s, 1H), 8.10 (s,1H), 6.98 (d, <i>J</i> = 8.9 Hz, 1H), 3.52 (t, <i>J</i> = 6.4 Hz, 5H), 1.92 (t, <i>J</i> = 6.5 Hz, 4H). <sup>13</sup>C NMR (63 MHz, DMSO) 165.85, 163.20, 158.78, 157.19, 148.60, 130.12, 126.78, 125.32, 119.75, 116.57, 114.52, 50.82, 25.27. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 304.0855 (304.0853 Calcd for C<sub>15</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 6-(3,4-Dichlorophenyl)-5-(methoxymethyl)pyrimidine-4-carboxylic Acid (<b>26</b>)</h5><div class="NLM_p">Methyl 6-(3,4-dichlorophenyl)-5-methylpyrimidine-4-carboxylate, <i>N</i>-bromosuccinimide (0.66 g, 4.0 mmol), and AIBN (0.05 g, 0.34 mmol) were dissolved in 1,2-dichloroethane, heated to 90 °C under a nitrogen atmosphere, and stirred at this temperature for 18 h. After this time, the reaction was cooled to room temperature, saturated aqueous sodium bicarbonate solution (20 mL) was added, and the organic layer was separated. The organic layer was diluted with DCM (20 mL) and then washed with a further 20 mL of saturated aqueous sodium bicarbonate solution, followed by water (100 mL) and brine (50 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by flash column chromatography (elution: 5% methanol, 95% DCM) to give methyl 5-(bromomethyl)-6-(3,4-dichlorophenyl)pyrimidine-4-carboxylate (0.46 g, 36% yield) as a yellow oil which solidified on standing. <sup>1</sup>H NMR (500 MHz, DMSO) 9.33 (s, 1H) 7.95–8.01 (m, 1H) 7.85–7.91 (m, 1H) 7.69 (dd, <i>J</i> = 8.20, 2.05 Hz, 1H) 4.72–4.80 (m, 1H) 3.97–4.01 (m, 3H).</div><div class="NLM_p">Sodium methoxide (0.03g, 0.53 mmol) was added in one portion to a stirred solution of methyl 5-(bromomethyl)-6-(3,4-dichlorophenyl)pyrimidine-4-carboxylate (0.1 g, 0.26 mmol) in methanol (5 mL), and the mixture was stirred at room temperature under a nitrogen atmosphere for 20 h. After this time, the mixture was concentrated, and the resulting residue taken up in DCM (10 mL). The solution was washed consecutively with water (2 × 50 mL) and brine (2 × 50 mL), before being separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by flash column chromatography (elution: 100% DCM to 99% DCM: 1% methanol) to give methyl 6-(3,4-dichlorophenyl)-5-(methoxymethyl)pyrimidine-4-carboxylate (0.02g, 20% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 327/329.</div><div class="NLM_p last">Sodium hydroxide (0.05 mL, 0.1 mmol) was added in one portion to a stirred solution of methyl 6-(3,4-dichlorophenyl)-5-(methoxymethyl)pyrimidine-4-carboxylate (0.1 g, 0.26 mmol) in THF (5 mL), and the mixture was stirred at room temperature under a nitrogen atmosphere for 20 h. After this time, the resulting precipitate was collected by filtration, washed with water (1 mL), and dried under vacuum to give the title compound <b>26</b> (0.004 g, 15% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 313/315; <sup>1</sup>H NMR (500 MHz, DMSO) 8.95 (s, 1H) 7.99 (d, <i>J</i> = 1.73 Hz, 1H) 7.76–7.83 (m, 1H) 7.70–7.76 (m, 1H) 4.39 (s, 2H) 3.22 (s, 3H).</div></div><div id="sec5_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 6-(3,4-Dichlorophenyl)-5-hydroxypyrimidine-4-carboxylic Acid (<b>28</b>)</h5><div class="NLM_p last">Lithium chloride (0.19 g, 5.0 mmol) was added in one portion to a stirred solution of methyl 6-(3,4-dichlorophenyl)-5-hydroxypyrimidine-4-carboxylate (0.47 g, 2.0 mmol) in DMF (5 mL) and the mixture was heated to 145 °C and stirred at this temperature under a nitrogen atmosphere for 18 h. After this time, the mixture was cooled to room temperature and partitioned between ethyl acetate (50 mL) and 1 M HCl solution (25 mL). The organic layer was separated and washed consecutively with 1 M HCl solution (50 mL), water (50 mL), and brine (50 mL) before being dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by prep HPLC to give the title compound <b>28</b> (0.02 g, 4% yield) as a yellow solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 285/287; <sup>1</sup>H NMR (500 MHz, DMSO) 8.66–8.75 (m, 1H) 8.48–8.56 (m, 1H) 8.40–8.46 (m, 1H) 7.70–7.80 (m, 1H).</div></div><div id="sec5_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 6-(Morpholin-4-yl)pyrimidine-4-carboxylic Acid (<b>12</b>)</h5><div class="NLM_p last">Morpholine (1.23 mL, 14.1 mmol) was added in one portion to a suspension of 4,6-dichloropyrimidine in isopropanol (10 mL) in a pressure tube. The tube was sealed, heated to 80 °C, and stirred at this temperature for 2 h. After this time, the tube was cooled to room temperature and the reaction mixture was concentrated. The resulting solid was suspended in saturated sodium bicarbonate solution (5 mL) before being collected by filtration and dried under vacuum to give 4-(6-chloropyrimidin-4-yl)morpholine (1.04 g, 78% yield) as a pale brown solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 200/202. This material was then taken on as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="general procedure A">general procedure A</a> above to give the title compound <b>12</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 210; <sup>1</sup>H NMR (500 MHz, DMSO) <sup>1</sup>H NMR (500 MHz, DMSO-d6) δ 8.75 (s, 1H), 7.53 (s, 1H), 3.90 (s, 4H), 3.75 (dt, <i>J</i> = 4.72, 33.27 Hz, 4H). <sup>13</sup>C NMR (126 MHz, DMSO) 161.79, 161.72, 153.15, 145.70, 103.95, 65.73, 45.38. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 210.0869 (210.0879 Calcd for C<sub>9</sub>H<sub>11</sub>N<sub>3</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 6-[(3,4-Dichlorophenyl)amino]pyrimidine-4-carboxylic Acid (<b>14</b>)</h5><div class="NLM_p last">3,4-Dichloroaniline (1.2 g, 7.8 mmol) was added in one portion to a suspension of 4,6-dichloropyrimidine in isopropanol (7 mL) in a pressure tube. The tube was sealed, heated to 80 °C, and stirred at this temperature for 2 h. After this time, the tube was cooled to room temperature and the resulting solid was collected by filtration and dried under vacuum to give 6-chloro-<i>N</i>-(3,4-dichlorophenyl)pyrimidin-4-amine (0.8 g, 44% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 275. This material was then taken on as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="general procedure A">general procedure A</a> above to give the title compound <b>14</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 284; <sup>1</sup>H NMR (500 MHz, DMSO) 11.17 (br s, 1H), 8.85 (s, 1H), 8.26 (br s, 1H), 7.72 (d, 1H), 7.49–7.65 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) 163.67, 161.40, 156.54, 150.07, 139.04, 131.02, 130.72, 125.03, 121.42, 120.41, 108.72. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 283.999 (283.9994 Calcd for C<sub>11</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 6-(3,4-Dichlorophenoxy)pyrimidine-4-carboxylic Acid (<b>13</b>)</h5><div class="NLM_p last">Potassium <i>tert</i>-butoxide (0.51 g, 3.0 mmol) in <i>tert</i>-butanol (5 mL) was added dropwise over 5 min to a stirred solution of 3,4-dichlorophenol (5 mL) in <i>tert</i>-butanol (5 mL). After 5 min, 4,6-dichloropyrimidine (0.5 g, 3.0 mmol) was added in one portion and the resulting reaction mixture was stirred at 35 °C for 2 h. After this time, the reaction was quenched by the addition of water (20 mL) and the resulting mixture extracted with diethyl ether (2 × 25 mL). The combined organic extracts were dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was triturated with heptane (5 mL) to give 4-chloro-6-(3,4-dichlorophenoxy)pyrimidine (0.32 g, 37% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 274/276. This material was then taken on as described in <a class="ref internalNav" href="#sec5_1_1" aria-label="general procedure A">general procedure A</a> above to give the title compound <b>13</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 285; <sup>1</sup>H NMR (500 MHz, DMSO) 14.04 (br s, 1H), 8.91 (s, 1H), 7.70–7.81 (m, 2H), 7.61 (s, 1H), 7.31–7.39 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 169.81, 164.75, 158.56, 158.09, 151.10, 131.84, 131.50, 128.52, 124.39, 122.63, 108.75. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 284.9821 (284.9834 Calcd for C<sub>11</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> M + H).</div></div><div id="sec5_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 6-Cyclohexylpyrimidine-4-carboxylic Acid (<b>15</b>)</h5><div class="NLM_p">Cyclohexylzinc bromide (0.66 g, 2.9 mmol) was added in one portion to a stirred solution of methyl 6-chloropyrimidine-4-carboxylate (0.5 g, 2.9 mmol) and PdCl<sub>2</sub>(dppf)<sub>2</sub> (0.12 g, 0.14 mmol) in THF (5 mL). The mixture was degassed with nitrogen for 15 min before being heated to reflux and stirred for 15 h. After this time, the reaction mixture was cooled to room temperature and treated with aqueous saturated ammonium chloride (25 mL), before being extracted with ethyl acetate (3 × 25 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified on a Biotage machine (100 g column), eluting with ethyl acetate–heptane (7:93–3CV, 7:93 to 60:40–10 CV, 40:60–2CV) to give methyl 6-cyclohexylpyrimidine-4-carboxylate (0.13 g, 21% yield) as a pale yellow oil. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 221.</div><div class="NLM_p last">Sodium hydroxide solution (1.5 mL, 3.1 mmol, 2 M) was added in one portion to a stirred solution of methyl 6-cyclohexylpyrimidine-4-carboxylate (0.13 g, 0.61 mmol) in THF (3 mL), and the mixture was stirred at room temperature under a nitrogen atmosphere for 2 h. After this time, the resulting precipitate was collected by filtration, washed with water (1 mL), and dried under vacuum to give the title compound <b>15</b> (0.045 g, 35% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 207; <sup>1</sup>H NMR (500 MHz, DMSO) 13.86 (br s, 1H) 9.23 (s, 1H) 7.87 (s, 1H) 2.70–2.88 (m, 1H) 1.12–1.97 (m, 10H). <sup>13</sup>C NMR (126 MHz, DMSO) 176.30, 165.55, 158.47, 155.62, 118.26, 44.98, 31.37, 25.65, 25.40. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 207.1123 (207.1134 Calcd for C<sub>11</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 6-(3,4-Dichlorophenyl)pyrimidine-4-carbonitrile (<b>30</b>)</h5><div class="NLM_p last">A mixture of 4-chloro-6-(3,4-dichlorophenyl)pyrimidine (4.0 g, 15.4 mmol), zinc cyanide (1.8 g, 15.3 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.89 g, 0.77 mmol), and DMF (80 mL) was stirred at 100 °C under nitrogen for 19 h. After this time, the reaction mixture was cooled and then shaken with brine (100 mL), water (20 mL), and ethyl acetate (100 mL). The mixture was filtered and the separated organic layer dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by flash column chromatography (elution: 6% EtOAc, 94% heptane) to give the title compound (1.73 g, 45% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 250/252; <sup>1</sup>H NMR (500 MHz, DMSO) 9.45 (d, <i>J</i> = 1.19 Hz, 1H), 8.89 (d, <i>J</i> = 1.22 Hz, 1H), 8.50 (d, <i>J</i> = 2.08 Hz, 1H), 8.25 (dd, <i>J</i> = 2.11, 8.49 Hz, 1H), 7.86 (d, <i>J</i> = 8.48 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 162.52, 159.46, 141.48, 135.21, 134.99, 132.36, 131.55, 129.28, 127.45, 121.43, 116.03. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 249.9929 (249.9939 Calcd for C<sub>11</sub>H<sub>5</sub>Cl<sub>2</sub>N<sub>3</sub> M + H).</div></div><div id="sec5_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 3-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]-4,5-dihydro-1,2,4-oxadiazol-5-one (<b>35</b>)</h5><div class="NLM_p">A solution of <b>30</b> (2.6 g, 7.9 mmol), hydroxylamine hydrochloride (0.58 g, 8.3 mmol), ethanol (50 mL), and diisopropylethylamine (1.45 mL, 8.33 mmol) was stirred at 70 °C under a nitrogen atmosphere for 2.5 h. After this time, the mixture was concentrated and the resulting residue was washed with water (15 mL) and ether (7 mL), before being air-dried for 30 min, and then dried in vacuo to give 6-(3,4-dichlorophenyl)-<i>N</i>′-hydroxypyrimidine-4-carboximidamide (2.1 g, 75% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 283.</div><div class="NLM_p last">A mixture of 6-(3,4-dichlorophenyl)-<i>N</i>′-hydroxypyrimidine-4-carboximidamide (0.71 g, 2.5 mmol), CDI (0.6 g, 3.7 mmol), DBU (0.48 mL, 3.2 mmol), and 1,4-dioxane (12 mL) was stirred at 105 °C under a nitrogen atmopshere for 4 h. After this time, the reaction mixture was concentrated and treated with water (100 mL) and 6 M hydrochloric acid (50 mL) before being extracted with ethyl acetate (2 × 150 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by preparative HPLC to give the title compound (0.12 g, 13% yield) as a white powder. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 309; <sup>1</sup>H NMR (500 MHz, DMSO) 13.64 (br s, 1H), 9.44–9.52 (m, 1H), 8.60–8.67 (m, 1H), 8.53–8.59 (m, 1H), 8.25–8.35 (m, 1H), 7.84–7.92 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 162.18, 159.58, 159.15, 156.77, 151.34, 135.64, 134.74, 132.29, 131.47, 129.14, 127.41, 113.77. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 308.9935 (308.9946 Calcd for C<sub>12</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub> M + H).</div></div><div id="sec5_1_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 4-(3,4-Dichlorophenyl)-6-(1,2,4-oxadiazol-3-yl)pyrimidine (<b>36</b>)</h5><div class="NLM_p last">A mixture of 6-(3,4-dichlorophenyl)-<i>N</i>′-hydroxypyrimidine-4-carboximidamide (0.12 g, 0.42 mmol), trimethyl orthoformate (3 mL), and concentrated HCl (3 drops) was stirred at 100 °C for 1 h. After this time, the reaction mixture was cooled to room temperature and the resulting precipitate was collected by filtration and washed with heptane (5 mL) before being dried under vacuum to give the title compound (0.09 g, 74% yield) as a pale pink solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 293; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 9.44–9.51 (m, 1H), 8.94–9.00 (m, 1H), 8.46–8.52 (m, 1H), 8.36 (m, 1H), 8.02–8.10 (m, 1H), 7.62–7.68 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 168.54, 166.03, 162.45, 159.44, 153.97, 135.96, 134.58, 132.26, 131.45, 129.22, 127.53, 115.80. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 293.0011 (292.9997 Calcd for C<sub>12</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>4</sub>O M + H).</div></div><div id="sec5_1_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 4-(3,4-Dichlorophenyl)-6-(1<i>H</i>-1,2,3,4-tetrazol-5-yl)pyrimidine (<b>31</b>)</h5><div class="NLM_p last">To a stirred solution of <b>30</b> (1.0 g, 4.0 mmol) in toluene (50 mL) were added azido(trimethyl)silane (1.1 mL, 8.0 mmol) and dibutyl(oxo)stannane (0.1 g, 0.4 mmol) sequentially. The mixture was heated to 115 °C and stirred at this temperature for 24 h under a nitrogen atmosphere. After this time, the mixture was cooled to room temperature and the mixture was concentrated. The resulting residue was partitioned between ethyl acetate (200 mL) and saturated sodium bicarbonate (200 mL). The aqueous layer was removed and acidifed to pH 2 with HCl (6 M solution), and the resulting precipitate was collected by filtration and washed with water (10 mL) before being dried in a vacuum over overnight. The crude solid was then purified by prep HPLC to give the title compound (0.33 g, 28% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 293/295; <sup>1</sup>H NMR (500 MHz, DMSO) 9.47 (s, 1H), 8.80 (s, 1H), 8.55 (d, <i>J</i> = 1.95 Hz, 1H), 8.30 (dd, <i>J</i> = 1.99, 8.47 Hz, 1H), 7.83 (d, <i>J</i> = 8.46 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 162.40, 159.29, 154.35, 152.27, 135.87, 134.62, 132.27, 131.43, 129.17, 127.47, 114.78. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 293.0093 (293.0109 Calcd for C<sub>11</sub>H<sub>6</sub>Cl<sub>2</sub>N<sub>6</sub> M + H).</div></div><div id="sec5_1_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 4-(3,4-Dichlorophenyl)-6-(1-methyl-1<i>H</i>-1,2,3,4-tetrazol-5-yl)pyrimidine (<b>32</b>) and 4-(3,4-Dichlorophenyl)-6-(2-methyl-2<i>H</i>-1,2,3,4-tetrazol-5-yl)pyrimidine (<b>33</b>)</h5><div class="NLM_p last">Sodium hydride (60%, 0.03 g, 0.7 mmol) was added in one portion to a cooled (0 °C), stirred solution of <b>31</b> (0.2 g, 0.7 mmol) in DMF, and the reaction mixture was stirred under a nitrogen atmosphere for 15 min. After this time, methyl iodide (0.08 mL, 1.4 mmol) was added in one portion, the mixture was allowed to warm to room temperature, and stirring was continued for a further 15 h. After this time, the reaction was quenched by the addition of water (10 mL) before being extracted with ethyl acetate (3 × 25 mL). The combined organic extracts were dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was then purified by flash column chromatography (elution: 50% EtOAc, 50% heptane) to give <b>32</b> (0.048 g, 22% yield) as a beige powder MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 307/309; <sup>1</sup>H NMR (250 MHz, DMSO) 9.53 (d, <i>J</i> = 1.34 Hz, 1H), 8.87 (d, <i>J</i> = 1.36 Hz, 1H), 8.60 (d, <i>J</i> = 2.10 Hz, 1H), 8.34 (dd, <i>J</i> = 2.16, 8.50 Hz, 1H), 7.87 (d, <i>J</i> = 8.49 Hz, 1H), 4.48 (s, 3H); <sup>13</sup>C NMR (63 MHz, DMSO) 162.32, 158.93, 152.86, 150.98, 135.83, 134.69, 132.32, 131.50, 129.24, 127.53, 116.16, 36.98; HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 307.0261 (307.0266 Calcd for C<sub>12</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>6</sub> M + H) and <b>33</b> (0.048 g, 22% yield) as a beige solid MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 307/309; <sup>1</sup>H NMR (250 MHz, DMSO) 9.45 (d, <i>J</i> = 1.34 Hz, 1H), 8.75 (d, <i>J</i> = 1.35 Hz, 1H), 8.58 (d, <i>J</i> = 2.10 Hz, 1H), 8.33 (dd, <i>J</i> = 2.16, 8.49 Hz, 1H), 7.86 (d, <i>J</i> = 8.48 Hz, 1H), 4.53 (s, 3H). <sup>13</sup>C NMR (63 MHz, DMSO) 162.61, 162.07, 159.47, 156.87, 154.51, 136.15, 134.42, 132.24, 131.43, 129.19, 127.49, 114.72; HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 307.0251 (307.0266 Calcd for C<sub>12</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>6</sub> M + H).</div></div><div id="sec5_1_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 6-(3,4-Dichlorophenyl)pyrimidin-4-amine (<b>37</b>)</h5><div class="NLM_p last"><b>29</b> (0.58 g, 2.6 mmol) was suspended in saturated aqueous ammonia solution (5 mL) in a pressure tube. The tube was sealed and heated to 100 °C for 18 h. After this time, the tube was cooled to room temperature and the mixture was poured onto water (15 mL). The resulting solid precipitate was collected by filtration and dried under vacuum to give the title compound (0.4 g, 76% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 240; <sup>1</sup>H NMR (500 MHz, DMSO) 8.45 (s, 1H), 8.20 (d, <i>J</i> = 2.05 Hz, 1H), 7.94 (dd, <i>J</i> = 8.43, 1.97 Hz, 1H), 7.76 (d, <i>J</i> = 8.35 Hz, 1H), 7.02 (br s, 2H), 6.94 (s, 1H). <sup>13</sup>C NMR (63 MHz, DMSO) 164.48, 158.75, 158.23, 137.90, 132.61, 131.72, 131.07, 128.16, 126.38, 100.25. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 240.0087 (240.0095 Calcd for C<sub>10</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>3</sub> M + H).</div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> General Method D</h4><div id="sec5_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> <i>N</i>-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]benzenesulfonamide (<b>38</b>)</h5><div class="NLM_p last">Sodium hydride (0.3 g, 8.0 mmol) was added portionwise to a stirred solution of <b>37</b> (0.61 g, 3.0 mmol) in dioxane (10 mL), and the mixture was stirred at room temperature under a nitrogen atmosphere for 1 h. After this time, benzenesulfonyl chloride (0.49 g, 3.0 mmol) was added dropwise and stirring was continued for 5 h. After this time, the mixture was partitioned between ethyl acetate (20 mL) and water (5 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was triturated with diethyl ether, and the solid precipitate was collected by filtration, washed with ether, and dried under vacuum to give the title compound (0.17 g, 18% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 380; <sup>1</sup>H NMR (500 MHz, DMSO) 12.26 (br s, 1H), 8.75 (br s, 1H), 8.19 (d, <i>J</i> = 1.73 Hz, 1H), 8.00 (d, <i>J</i> = 7.57 Hz, 2H), 7.94 (dd, <i>J</i> = 8.51, 1.89 Hz, 1H), 7.82 (d, <i>J</i> = 8.51 Hz, 1H), 7.63–7.71 (m, 1H), 7.57–7.63 (m, 2H), 7.49 (br s, 1H). <sup>13</sup>C NMR (63 MHz, DMSO) 166.32, 158.32, 157.03, 146.16, 138.77, 131.98, 131.58, 130.97, 129.81, 127.91, 126.48, 126.16, 106.33. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 380.0009 (380.0027 Calcd for C<sub>16</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>S M + H).</div></div><div id="sec5_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> <i>N</i>-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]methanesulfonamide (<b>39</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure D as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 318/320; <sup>1</sup>H NMR (250 MHz, DMSO) 11.6 (br s, 1H), 8.89 (s, 1H), 8.25 (d, <i>J</i> = 1.63 Hz, 1H), 7.99 (dd, <i>J</i> = 1.85, 8.42 Hz, 1H), 7.82 (d, <i>J</i> = 8.43 Hz, 1H), 7.41 (s, 1H), 3.40 (s, 3H). <sup>13</sup>C NMR (63 MHz, DMSO) 160.64, 159.01, 136.66, 133.79, 132.03, 131.40, 128.63, 126.94, 103.88, 41.81. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 317.9863 (317.9871 Calcd for C<sub>11</sub>H<sub>9</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>S M + H).</div></div><div id="sec5_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> <i>N</i>-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]acetamide (<b>40</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure D as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 282/284; <sup>1</sup>H NMR (500 MHz, DMSO) 11.08 (s, 1H), 8.96 (d, <i>J</i> = 1.10 Hz, 1H), 8.55 (d, <i>J</i> = 0.95 Hz, 1H), 8.26 (d, <i>J</i> = 2.05 Hz, 1H), 8.01 (dd, <i>J</i> = 8.43, 2.13 Hz, 1H), 7.83 (d, <i>J</i> = 8.51 Hz, 1H), 2.18 (s, 3H). <sup>13</sup>C NMR (63 MHz, DMSO) 170.98, 161.40, 159.06, 158.55, 137.08, 133.67, 132.04, 131.42, 128.53, 126.88, 104.96, 24.27. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 282.0213 (282.0201 Calcd for C<sub>12</sub>H<sub>9</sub>Cl<sub>2</sub>N<sub>3</sub>O M + H).</div></div><div id="sec5_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> <i>N</i>-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]benzamide (<b>41</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure D as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 343/345; <sup>1</sup>H NMR (500 MHz, DMSO) 11.41 (s, 1H), 9.20–8.89 (m, 1H), 8.82–8.63 (m, 1H), 8.29 (d, <i>J</i> = 2.00 Hz, 1H), 8.14–7.89 (m, 3H), 7.82 (d, <i>J</i> = 8.43 Hz, 1H), 7.64 (t, <i>J</i> = 7.38 Hz, 1H), 7.54 (t, <i>J</i> = 7.68 Hz, 2H). <sup>13</sup>C NMR (63 MHz, DMSO) 167.32, 161.48, 159.64, 158.51, 137.08, 133.73, 133.28, 132.65, 132.07, 131.42, 128.61, 128.52, 128.35, 126.98, 106.15. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 344.0347 (344.0357 Calcd for C<sub>17</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>3</sub>O M + H).</div></div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> General Method E</h4><div id="sec5_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 4-(3,4-Dichlorophenyl)-6-(1<i>H</i>-imidazol-1-yl)pyrimidine (<b>42</b>)</h5><div class="NLM_p last">Imidazole (0.16 g, 2.3 mmol) was added in one portion to a solution of <b>29</b> (0.15 g, 0.58 mmol) in ethanol (2 mL) in a microwave pressure vessel. The vessel was sealed and heated to 140 °C for 1 h in a microwave. After this time, the reaction was cooled to room temperature, the reaction mixture was concentrated, and the resulting residue was triturated with 1:1 acetonitrile/water (5 mL). The solid precipitate was collected by filtration and dried under vacuum to give the title compound (0.04 g, 25% yield) as a white powder. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 291; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 9.03–9.07 (m, 1H), 8.48 (s, 1H), 8.17–8.21 (m, 1H), 7.87–7.92 (m, 1H), 7.67–7.71 (m, 1H), 7.53–7.59 (m, 2H), 7.21 (s, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 291.0195 (291.0204 Calcd for C<sub>13</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>4</sub> M + H).</div></div><div id="sec5_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 4-(3,4-Dichlorophenyl)-6-(1<i>H</i>-pyrazol-1-yl)pyrimidine (<b>43</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure E as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 291; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 9.06 (s, 1H), 8.63–8.68 (m, 1H), 8.30–8.36 (m, 2H), 8.01–8.06 (m, 1H), 7.85 (s, 1H), 7.59–7.64 (m, 1H), 6.57 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 162.67, 158.69, 157.63, 144.28, 136.26, 134.21, 132.12, 131.30, 128.99, 128.21, 127.33, 109.83, 104.09. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 291.0203 (291.0204 Calcd for C<sub>13</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>4</sub> M + H).</div></div><div id="sec5_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 1-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]-2,3-dihydro-1<i>H</i>-imidazol-2-one (<b>44</b>)</h5><div class="NLM_p last">Sodium hydride (60%, 0.05 g, 1.2 mmol) was added in one portion to a stirred solution of <b>29</b> (0.15 g, 0.58 mmol) in DMF (3 mL) in a microwave pressure vessel, and stirring was continued for 5 min. After this time, 1-methylimidazol-2-one (0.08 g, 0.87 mmol) was added in one portion, the vessel was sealed and heated to 85 °C for 5 min in a microwave. After this time, the reaction was cooled to room temperature and partitioned between DCM (10 mL) and saturated sodium bicarbonate (10 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by flash column chromatography (elution: 50% EtOAc, 50% heptane) to give the title compound (0.1 g, 59% yield) as a light brown solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 307/308; <sup>1</sup>H NMR (500 MHz, DMSO) 10.75 (br s, 1H), 9.09 (s, 1H), 8.90 (s, 1H), 8.29 (d, <i>J</i> = 1.98 Hz, 1H), 8.05 (dd, <i>J</i> = 1.98, 8.54 Hz, 1H), 7.86 (d, <i>J</i> = 8.54 Hz, 1H), 7.31 (d, <i>J</i> = 3.05 Hz, 1H), 6.77 (d, <i>J</i> = 3.20 Hz, 1H). HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 307.0146 (307.0153 Calcd for C<sub>13</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>4</sub>O M + H).</div></div><div id="sec5_1_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 1-[6-(3,4-Dichlorophenyl)pyrimidin-4-yl]-3-methyl-2,3-dihydro-1<i>H</i>-imidazol-2-one (<b>45</b>)</h5><div class="NLM_p last">Sodium hydride (60%, 0.02 g, 0.8 mmol) was added portionwise to a stirred solution of 1-[6-(3,4-dichlorophenyl)pyrimidin-4-yl]-2,3-dihydro-1<i>H</i>-imidazol-2-one (0.1 g, 0.33 mmol) in DMF (3 mL), and the mixture was stirred at room temperature under a nitrogen atmosphere for 15 min. After this time, methyl iodide (0.04 mL, 0.65 mmol) was added in one portion and stirring was continued for 15 h. After this time, the mixture was partitioned between ethyl acetate (20 mL) and water (5 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified by flash column chromatography (elution: 30% EtOAc, 70% heptane) to give the title compound (0.07 g, 72% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 321/323; <sup>1</sup>H NMR (500 MHz, DMSO) 9.09 (d, <i>J</i> = 0.92 Hz, 1H), 8.88 (d, <i>J</i> = 0.92 Hz, 1H), 8.28 (d, <i>J</i> = 2.14 Hz, 1H), 8.05 (dd, <i>J</i> = 2.14, 8.39 Hz, 1H), 7.86 (d, <i>J</i> = 8.54 Hz, 1H), 7.36 (d, <i>J</i> = 3.36 Hz, 1H), 6.89 (d, <i>J</i> = 3.20 Hz, 1H), 3.24 (s, 3H). <sup>13</sup>C NMR (63 MHz, DMSO) 161.80, 158.61, 156.03, 151.40, 136.70, 134.00, 132.13, 131.53, 128.57, 126.95, 115.93, 105.71, 104.11, 29.98. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 321.0291 (321.031 Calcd for C<sub>14</sub>H<sub>10</sub>Cl<sub>2</sub>N<sub>4</sub>O M + H).</div></div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> General Method F</h4><div id="sec5_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 4-(3,4-Dichlorophenyl)pyridine-2-carboxylic Acid (<b>50</b>)</h5><div class="NLM_p">Tripotassium phosphate (2.45 g, 12.0 mmol) was added in one portion to a stirred solution of 3,4-dichlorophenyl boronic acid (1.47 g, 8.0 mmol) and methyl 4-bromopyridine-2-carboxylate (2.0 g, 9.0 mmol) in DMF (30 mL). The mixture was degassed with nitrogen for 5 min, after which time Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (0.31 g, 0.38 mmol) was added in one portion, and the mixture was then heated to 60 °C and stirred at this temperature for 16 h under a nitrogen atmosphere. After this time, the reaction mixture was cooled to room temperature and partitioned between ethyl acetate (200 mL) and water (100 mL). The organic layer was separated and washed sequentially with water (100 mL) and then brine (100 mL) before being dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting brown solid was purified by flash column chromatography (elution: 50% EtOAc, 50% heptane) to give 4-(3,4-dichlorophenyl)pyridine-2-carboxylic acid methyl ester (1.41g, 65% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 282, 284. <sup>1</sup>H NMR (500 MHz, DMSO) 8.77–8.83 (1 H, m), 8.33–8.39 (1 H, m), 8.18–8.22 (1 H, m), 8.02–8.09 (1 H, m), 7.86–7.93 (1 H, m), 7.78–7.83 (1 H, m), 3.92 (3 H, s).</div><div class="NLM_p last">NaOH (2 M solution, 3.1 mL, 6.0 mmol) was added in one portion to a stirred solution of 4-(3,4-dichlorophenyl)pyridine-2-carboxylic acid methyl ester (0.87 g, 3.0 mmol) in THF (50 mL), and the mixture was stirred at room temperature for 16 h. After this time, the resulting precipitate was collected by filtration and washed with water (1 mL) and DCM (20 mL) before being dried under vacuum. This solid was then suspended in HCl (2 M solution, 60 mL) and acetonitrile (60 mL), heated to 80 °C until complete dissolution, and then cooled to room temperature. The acetonitrile was removed under reduced pressure, and the solid precipitate was collected by filtration and washed with water (10 mL) before being dried in a vacuum over overnight to give the hydrochloride salt of compound <b>50</b> (0.54 g, 57% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 268, 270. <sup>1</sup>H NMR (500 MHz, DMSO) 8.78 (d, <i>J</i> = 5.04 Hz, 1H), 8.31 (d, <i>J</i> = 1.10 Hz, 1H), 8.17 (d, <i>J</i> = 2.21 Hz, 1H), 8.00 (dd, <i>J</i> = 5.04, 1.73 Hz, 1H), 7.87 (m, <i>J</i> = 8.35, 2.21 Hz, 1H) 7.77–7.81 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 166.07, 154.53, 150.83, 139.75, 138.45, 132.27, 131.90, 131.13, 128.50, 126.84, 122.40, 119.51. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 267.9932 (267.9938 Calcd for C<sub>12</sub>H<sub>7</sub>Cl<sub>2</sub>NO<sub>2</sub> M + H).</div></div><div id="sec5_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 2-(3,4-Dichlorophenyl)pyridine-4-carboxylic Acid (<b>49</b>)</h5><div class="NLM_p last">This material was synthesized according to general procedure F as described above. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 268, 270; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 13.85 (br s, 1H), 8.87 (d, <i>J</i> = 5.04 Hz, 1H), 8.33–8.44 (m, 2H), 8.14 (dd, <i>J</i> = 8.51, 1.89 Hz, 1H), 7.83 (d, <i>J</i> = 4.89 Hz, 1H), 7.77 (d, <i>J</i> = 8.35 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO) 166.00, 154.46, 150.75, 139.74, 138.40, 132.19, 131.82, 131.06, 128.43, 126.78, 122.32, 119.44. HRMS (ES<sup>+</sup>) 267.9933 (267.9932 Calcd for C<sub>12</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> M + H).</div></div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> General Method G</h4><div id="sec5_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 6-(7-Chlorobenzofuran-5-yl)pyrimidine-4-carboxylic Acid (<b>77</b>)</h5><div class="NLM_p">Potassium carbonate (13.3 g, 96.4 mmol) was added portionwise to a stirred solution of 4-bromo-2-chlorophenol (10.0 g, 48.2 mmol) and bromoacetaldehyde diethyl acetal (8.91 mL, 57.8 mmol) in DMF (60 mL), and the mixture was heated to 140 °C and heated at this temperature under a nitrogen atmosphere for 3 h. After this time, the reaction mixture was cooled to room temperature and concentrated. The resulting residue was partitioned between ethyl acetate (200 mL) and water (50 mL), and the organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified using a Biotage Isolera (340 g silica column eluting with a gradient from 0% DCM to 60% DCM/40% heptane) to give 4-bromo-2-chloro-1-(2,2-diethoxyethoxy)benzene (14.8 g, 90% yield) as a colorless oil. <i>t</i><sub>R</sub> = 2.42 min <i>m</i>/<i>z</i> (ES<sup>+</sup>) (M + Na<sup>+</sup>) 347.</div><div class="NLM_p">4-Bromo-2-chloro-1-(2,2-diethoxyethoxy)benzene (8.47 g, 26.2 mmol) was added portionwise as a solution in toluene (36 mL) to polyphosphonic acid (17.0 g, 207.3 mmol) at 0 °C. The resulting suspension was allowed to warm to room temperature before being heated to reflux and stirred for 1 h. After this time, the mixture was cooled to room temperature and partitioned between water (100 mL) and ethyl acetate (300 mL). The resulting residue was partitioned between ethyl acetate (300 mL) and water (50 mL), and the organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified using a Biotage Isolera (340 g silica column eluting with 100% heptane) to give 5-bromo-7-chlorobenzofuran (1.63 g, 26% yield) as a white solid. <i>t</i><sub>R</sub> = 2.29 min <i>m</i>/<i>z</i> (ES<sup>+</sup>) (M + Na<sup>+</sup>) 254.</div><div class="NLM_p">Potassium acetate (1.97 g, 31.5 mmol) was added in one portion to a stirred solution of 5-bromo-7-chlorobenzofuran (2.43 g, 10.5 mmol) and bis-pinacol borane (2.93 g, 11.5 mmol) in DMF (30 mL). The mixture was degassed with nitrogen for 5 min, after which time Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (0.26 g, 0.31 mmol) was added in one portion, and the mixture was then heated to 80 °C and stirred at this temperature for 18 h under a nitrogen atmosphere. After this time, the reaction mixture was cooled to room temperature and partitioned between ethyl acetate (200 mL) and water (100 mL). The biphasic suspension was filtered through glass fiber filter paper, and the organic layer was separated and washed sequentially with water (3 × 100 mL) before being dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified purified using a Biotage Isolera (100g silica column eluting with 100% heptane to 50% DCM/50% heptane) to give <b>7-</b>chloro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzofuran (2.23 g, 73% yield) as a white solid. <i>t</i><sub>R</sub> = 2.53 min <i>m</i>/<i>z</i> (ES<sup>+</sup>) (M + H<sup>+</sup>) 279.</div><div class="NLM_p">Tripotassium phosphate (2.76 g, 12.0 mmol) was added in one portion to a stirred solution of 7-chloro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzofuran (2.23 g, 8.0 mmol) and methyl 6-chloropyrimidine-4-carboxylate (1.7 g, 9.6 mmol) in DMF (35 mL). The mixture was degassed with nitrogen for 5 min, after which time Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (0.33 g, 0.4 mmol) was added in one portion, the mixture was then heated to 60 °C and stirred at this temperature for 16 h under a nitrogen atmosphere. After this time, the reaction mixture was cooled to room temperature and partitioned between ethyl acetate (200 mL) and water (100 mL). The organic layer was separated and washed sequentially with water (100 mL) and then brine (100 mL) before being dried (MgSO<sub>4</sub>), filtered, and concentrated. The resulting residue was purified purified using a Biotage Isolera (50 g silica column eluting with 100% heptane to 20% ethyl acetate/50% heptane) to give 6-(7-chlorobenzofuran-5-yl)pyrimidine-4-carboxylic acid methyl ester (0.37 g, 16% yield) as a white solid. <i>t</i><sub>R</sub> = 2.01 min <i>m</i>/<i>z</i> (ES<sup>+</sup>) (M + H<sup>+</sup>) 289, 291.</div><div class="NLM_p last">NaOH (2 M solution, 3.2 mL, 2.3 mmol) was added in one portion to a stirred solution of 6-(7-chlorobenzofuran-5-yl)pyrimidine-4-carboxylic acid methyl ester (0.37 g, 1.3 mmol) in THF (8 mL), and the mixture was stirred at room temperature for 16 h. After this time, the resulting precipitate was collected by filtration, washed with water (1 mL), and dried under vacuum to give compound <b>77</b> (0.06 g, 16% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 275/277. <sup>1</sup>H NMR (500 MHz, DMSO) 14.02 (br s, 1 H) 9.40 (s, 1 H) 8.65 (d, <i>J</i> = 1.26 Hz, 1 H) 8.60 (s, 1 H) 8.37 (d, <i>J</i> = 1.26 Hz, 1 H) 8.24 (d, <i>J</i> = 2.05 Hz, 1H) 7.21 (d, <i>J</i> = 2.05 Hz, 1 H). <sup>13</sup>C NMR (63 MHz, <i>d</i><sub>4</sub>-AcOH) 168.55, 167.72, 159.93, 157.85, 154.35, 149.27, 133.64, 131.62, 125.62, 121.78, 119.33, 118.30, 109.56. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 275.0229 (275.0223 Calcd for C<sub>13</sub>H<sub>7</sub>ClN<sub>2</sub>O<sub>3</sub> M + H).</div></div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> General Method H</h4><div id="sec5_1_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> <i>N</i>-(Benzenesulfonyl)-6-(3,4-dichlorophenyl)pyrimidine-4-carboxamide (<b>51</b>)</h5><div class="NLM_p last">Oxalyl chloride (0.34 mL, 4.23 mmol) was added dropwise to a stirred solution of <b>7</b> (0.38 g, 1.41 mmol) in DCM (15 mL) containing 1 drop of DMF, and the reaction mixture was stirred at room temperature for 30 min. After this time, benzenesulfonamide (0.33 g, 2.1 mmol) was added followed by triethylamine (0.58 mL, 4.23 mmol) and the resulting solution was stirred at room temperature for a further 1 h. The resulting mixture was concentrated, diluted with DCM (30 mL), and washed consecutively with water (20 mL), saturated sodium bicarbonate (20 mL), citric acid (20 mL, 2 M solution), and brine (20 mL). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The resulting residue was triturated with 1:1 MeCN/H<sub>2</sub>O and the solid precipitate collected by filtration before being further purified by flash column chromatography (elution: 10% ethyl acetate, 90% heptane) to give compound <b>51</b> (0.06g, 10% yield) as a white solid. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> (M + 1) 408. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) 10.32 (br s, 1H), 9.30 (s, 1H), 8.39 (s, 1H), 8.29 (s, 1H), 8.24–8.18 (m, 2H), 7.99–7.77 (m, 1H), 7.67–7.72 (m, 1H), 7.57–7.63 (m, 3H). <sup>13</sup>C NMR (63 MHz, DMSO) 163.99, 162.46, 158.53, 140.45, 136.05, 134.46, 133.19, 132.21, 131.40, 129.17, 128.91, 127.65, 127.46, 115.40. HRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 407.9971 (407.9976 Calcd for C<sub>17</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>S M + H).</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Pharmacokinetics</h3><div class="NLM_p last">The pharmacokinetics of <b>75</b> were determined following a single iv dose of 6.2 mg equiv/kg or oral gavage at 12 mg equiv/kg administration to nonfasted male Sprague–Dawley rats (body weight 300–370 g, Hilltop Laboratories, Scottsdale, PA). Compound was formulation for iv administration as a 1.24 mg equiv/mL solution in DMSO:PEG 400: Water (10:40:50 v/v/v) and dosed via the tail vein. A 1.20 mg equiv/mL solution in 10% hydroxypropyl-β-cyclodextrin in water was dosed orally by gavage. Doses were administered to each animal on a volumetric basis, calculated from the animal’s nonfasting weight. Animals were anesthetized using isoflurance inhalation and terminally bled (<i>N</i> = 3) via abdominal aorta or cardiac puncture at 0.083, 0.25, 0.5, 1, 2, 4, 8, and 24 h. Blood was treated with sodium heparin and plasma prepared by centrifugation. Tissues were harvested, rinsed with saline, and snap-frozen in liquid nitrogen. All samples were frozen at −70 °C until analyzed by LC-MS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94"><a href="/doi/suppl/10.1021/jm501350y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Methods for permeability and efflux studies; methods for in vivo studies in efflux transporter knock out mouse model; methods for sample preparation and LC-MS/MS analysis conditions; methods for plasma extraction; methods for tissue homogenate preparation; methods for LC-MS/MS methodology; methods for pharmacokinetic analysis; methods for pharmacodynamic in vivo studies; methods for terminal PK/PD studies; methods for tissue distribution study; methods for analysis of KYN, KYNA, 3-HK, and AA; methods for analysis of QA; methods for microdialysis studies; methods for quantification of KP metabolites in plasma and microdialysate samples; methods for quantification of compound <b>75</b> in plasma and microdialysate samples. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501350y/suppl_file/jm501350y_si_001.pdf">jm501350y_si_001.pdf (191.71 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501350y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leticia M. Toledo-Sherman</span> - <span class="hlFld-Affiliation affiliation">CHDI Management/CHDI
Foundation, 6080 Center Drive, Suite
100, Los Angeles, California 90405, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91ddf4e5f8f2f8f0bfc5fefdf4f5febcc2f9f4e3fcf0ffd1d2d9d5d8d7fee4fff5f0e5f8feffbffee3f6"><span class="__cf_email__" data-cfemail="501c3524393339317e043f3c35343f7d033835223d313e1013181419163f253e343124393f3e7e3f2237">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael E. Prime</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ladislav Mrzljak</span> - <span class="hlFld-Affiliation affiliation">CHDI Management/CHDI
Foundation, 155 Village Boulevard,
Suite 200, Princeton, New
Jersey 08540, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria G. Beconi</span> - <span class="hlFld-Affiliation affiliation">CHDI Management/CHDI
Foundation, 6080 Center Drive, Suite
100, Los Angeles, California 90405, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Beresford</span> - <span class="hlFld-Affiliation affiliation">Charles River
Laboratories, Chesterford Research
Park, Saffron Walden, Essex, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick A. Brookfield</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Brown</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabell Cardaun</span> - <span class="hlFld-Affiliation affiliation">Evotec AG, Manfred
Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen M. Courtney</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrike Dijkman</span> - <span class="hlFld-Affiliation affiliation">Brains On-Line
LLC, 7000 Shoreline Court, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Estelle Hamelin-Flegg</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter D. Johnson</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerie Kempf</span> - <span class="hlFld-Affiliation affiliation">Tandem Laboratories, 2202 Ellis Road, Durham, North Carolina 27703, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Lyons</span> - <span class="hlFld-Affiliation affiliation">Kathryn A. Lyons, P.O.
Box 64, Holland, New York 14080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Matthews</span> - <span class="hlFld-Affiliation affiliation">Charles River
Laboratories, Chesterford Research
Park, Saffron Walden, Essex, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William L. Mitchell</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine O’Connell</span> - <span class="hlFld-Affiliation affiliation">Charles River
Laboratories, Chesterford Research
Park, Saffron Walden, Essex, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paula Pena</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kendall Powell</span> - <span class="hlFld-Affiliation affiliation">Tandem Laboratories, 2202 Ellis Road, Durham, North Carolina 27703, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arash Rassoulpour</span> - <span class="hlFld-Affiliation affiliation">Brains On-Line
LLC, 7000 Shoreline Court, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Reed</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolfgang Reindl</span> - <span class="hlFld-Affiliation affiliation">Evotec AG, Manfred
Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suganathan Selvaratnam</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weslyn Ward Friley</span> - <span class="hlFld-Affiliation affiliation">Tandem Laboratories, 2202 Ellis Road, Durham, North Carolina 27703, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek A. Weddell</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naomi E. Went</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Wheelan</span> - <span class="hlFld-Affiliation affiliation">Tandem Laboratories, 2202 Ellis Road, Durham, North Carolina 27703, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christin Winkler</span> - <span class="hlFld-Affiliation affiliation">Evotec AG, Manfred
Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Winkler</span> - <span class="hlFld-Affiliation affiliation">Evotec AG, Manfred
Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Wityak</span> - <span class="hlFld-Affiliation affiliation">CHDI Management/CHDI
Foundation, 6080 Center Drive, Suite
100, Los Angeles, California 90405, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Yarnold</span> - <span class="hlFld-Affiliation affiliation">Evotec (U.K.)
Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dawn Yates</span> - <span class="hlFld-Affiliation affiliation">Charles River
Laboratories, Chesterford Research
Park, Saffron Walden, Essex, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ignacio Munoz-Sanjuan</span> - <span class="hlFld-Affiliation affiliation">CHDI Management/CHDI
Foundation, 6080 Center Drive, Suite
100, Los Angeles, California 90405, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia Dominguez</span> - <span class="hlFld-Affiliation affiliation">CHDI Management/CHDI
Foundation, 6080 Center Drive, Suite
100, Los Angeles, California 90405, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d902e6799-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Teri Buchanan and Tod Wehrman of Xenometrics for help on the in-life portion of the PK study with compound <b>75</b>. We also thank Helen Birch and Tania Mead, of BioFocus DPI Ltd., who contributed to the bioanaltyical work for the PK study on Bcrp(−/−), Mdr1a/b(−/−), and Mdr1a/b(−/−)/Bcrp(−/−) mice.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i97" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i97"> Abbreviations Used</h2><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption distribution metabolism excretion</p></td></tr><tr><td class="NLM_term">NAD</td><td class="NLM_def"><p class="first last">nicotinamide adenine nucleotide</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">AIBN</td><td class="NLM_def"><p class="first last">azobis(isobutyronitrile)</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">AUCN</td><td class="NLM_def"><p class="first last">area under the curve normalized</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">EER</td><td class="NLM_def"><p class="first last">effective efflux ratio</p></td></tr><tr><td class="NLM_term">KYN</td><td class="NLM_def"><p class="first last">kynurenine</p></td></tr><tr><td class="NLM_term">KYNA</td><td class="NLM_def"><p class="first last">kynurenic acid</p></td></tr><tr><td class="NLM_term">3-HK</td><td class="NLM_def"><p class="first last">3-hydroxykynurenice acid</p></td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">anthranilic acid</p></td></tr><tr><td class="NLM_term">QA</td><td class="NLM_def"><p class="first last">quinolinic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Reiner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragatsis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, P.</span><span> </span><span class="NLM_article-title">Genetics and neuropathology of Huntington’s disease</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2FB978-0-12-381328-2.00014-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=21907094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2011&pages=325-372&author=A.+Reinerauthor=I.+Dragatsisauthor=P.+Dietrich&title=Genetics+and+neuropathology+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics and neuropathology of Huntington's disease</span></div><div class="casAuthors">Reiner, Anton; Dragatsis, Ioannis; Dietrich, Paula</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia</span>),
    <span class="NLM_cas:pages">325-372</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder that prominently affects the basal ganglia, leading to affective, cognitive, behavioral and motor decline.  The basis of HD is a CAG repeat expansion to >35 CAG in a gene that codes for a ubiquitous protein known as huntingtin, resulting in an expanded N-terminal polyglutamine tract.  The size of the expansion is correlated with disease severity, with increasing CAG accelerating the age of onset.  A variety of possibilities have been proposed as to the mechanism by which the mutation causes preferential injury to the basal ganglia.  The present chapter provides a basic overview of the genetics and pathol. of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwSNKvotkgBLVg90H21EOLACvtfcHk0ljphvsSfnOkRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsL3O&md5=8858c4c983907fa228e230dadfe8d823</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381328-2.00014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-381328-2.00014-6%26sid%3Dliteratum%253Aachs%26aulast%3DReiner%26aufirst%3DA.%26aulast%3DDragatsis%26aufirst%3DI.%26aulast%3DDietrich%26aufirst%3DP.%26atitle%3DGenetics%2520and%2520neuropathology%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2011%26volume%3D98%26spage%3D325%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Delmaire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Bogaard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valabregue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jauffret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craufurd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehéricy, S.</span><span> </span><span class="NLM_article-title">The structural correlates of functional deficits in early Huntington’s Disease</span> <span class="citation_source-journal">Hum. Brain Mapping</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2141</span><span class="NLM_x">–</span> <span class="NLM_lpage">2153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1002%2Fhbm.22055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22438242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A280%3ADC%252BC38vosFGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2141-2153&issue=9&author=C.+Delmaireauthor=E.+M.+Dumasauthor=M.+A.+Sharmanauthor=S.+J.+van+den+Bogaardauthor=R.+Valabregueauthor=C.+Jauffretauthor=D.+Justoauthor=R.+Reilmannauthor=J.+C.+Stoutauthor=D.+Craufurdauthor=S.+J.+Tabriziauthor=R.+A.+Roosauthor=A.+Durrauthor=S.+Leh%C3%A9ricy&title=The+structural+correlates+of+functional+deficits+in+early+Huntington%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The structural correlates of functional deficits in early huntington's disease</span></div><div class="casAuthors">Delmaire Christine; Dumas Eve M; Sharman Michael A; van den Bogaard Simon J A; Valabregue Romain; Jauffret Celine; Justo Damian; Reilmann Ralf; Stout Julie C; Craufurd David; Tabrizi Sarah J; Roos Raymund A C; Durr Alexandra; Lehericy Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Human brain mapping</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2141-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathological studies in Huntington disease (HD) have demonstrated neuronal loss in the striatum, as well as in other brain regions including the cortex.  With diffusion tensor MRI we evaluated the hypothesis that the clinical dysfunction in HD is related to regionally specific lesions of circuit-specific cortico-basal ganglia networks rather than to the striatum only.  We included 27 HD and 24 controls from the TRACK-HD Paris cohort.  The following assessments were used: self-paced tapping tasks, trail B making test (TMT), University of Pennsylvania smell identification test (UPSIT), and apathy scores from the problem behaviors assessment.  Group comparisons of fractional anisotropy and mean diffusivity and correlations were performed using voxel-based analysis.  In the cortex, HD patients showed significant correlations between: (i) self paced tapping and mean diffusivity in the parietal lobe at 1.8 Hz and prefrontal areas at 3 Hz, (ii) UPSIT and mean diffusivity in the parietal, and median temporal lobes, the cingulum and the insula, and fractional anisotropy in the insula and the external capsule, (iii) TMT B and mean diffusivity in the white matter of the superior frontal, orbital, temporal, superior parietal and post central areas, and (iv) apathy and fractional anisotropy in the white matter of the rectus gyrus.  In the basal ganglia, we found correlations between the self paced tapping, UPSIT, TMT tests, and mean diffusivity in the anterior part of the putamen and the caudate nucleus.  In conclusion, disruption of motor, associative and limbic cortico-striatal circuits differentially contribute to the clinical signs of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTredyCevNYgvupmecNw_lfW6udTcc2eYHxCJwUhZ-brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vosFGltA%253D%253D&md5=b4b76a518825edfdefd3ebbd0002e4a8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fhbm.22055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhbm.22055%26sid%3Dliteratum%253Aachs%26aulast%3DDelmaire%26aufirst%3DC.%26aulast%3DDumas%26aufirst%3DE.%2BM.%26aulast%3DSharman%26aufirst%3DM.%2BA.%26aulast%3Dvan%2Bden%2BBogaard%26aufirst%3DS.%2BJ.%26aulast%3DValabregue%26aufirst%3DR.%26aulast%3DJauffret%26aufirst%3DC.%26aulast%3DJusto%26aufirst%3DD.%26aulast%3DReilmann%26aufirst%3DR.%26aulast%3DStout%26aufirst%3DJ.%2BC.%26aulast%3DCraufurd%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DS.%2BJ.%26aulast%3DRoos%26aufirst%3DR.%2BA.%26aulast%3DDurr%26aufirst%3DA.%26aulast%3DLeh%25C3%25A9ricy%26aufirst%3DS.%26atitle%3DThe%2520structural%2520correlates%2520of%2520functional%2520deficits%2520in%2520early%2520Huntington%25E2%2580%2599s%2520Disease%26jtitle%3DHum.%2520Brain%2520Mapping%26date%3D2013%26volume%3D34%26issue%3D9%26spage%3D2141%26epage%3D2153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Poon, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. J.</span><span> </span><span class="NLM_article-title">Role of tetrabenazine for Huntington’s disease-associated chorea</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1080</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=1080-1089&issue=6&author=L.+H.+Poonauthor=G.+A.+Kangauthor=A.+J.+Lee&title=Role+of+tetrabenazine+for+Huntington%E2%80%99s+disease-associated+chorea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoon%26aufirst%3DL.%2BH.%26aulast%3DKang%26aufirst%3DG.%2BA.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26atitle%3DRole%2520of%2520tetrabenazine%2520for%2520Huntington%25E2%2580%2599s%2520disease-associated%2520chorea%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2010%26volume%3D44%26issue%3D6%26spage%3D1080%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.-Q.</span><span> </span><span class="NLM_article-title">Kynurenines in the mammalian brain: When physiology meets pathology</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fnrn3257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22678511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=465-477&issue=7&author=R.+Schwarczauthor=J.+P.+Brunoauthor=J.+P.+Muchowskiauthor=H.-Q.+Wu&title=Kynurenines+in+the+mammalian+brain%3A+When+physiology+meets+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines in the mammalian brain: when physiology meets pathology</span></div><div class="casAuthors">Schwarcz, Robert; Bruno, John P.; Muchowski, Paul J.; Wu, Hui-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compds., including kynurenic acid, 3-hydroxykynurenine and quinolinic acid.  The synthesis of these metabolites is regulated by an enzymic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system.  Dysregulation of this pathway, resulting in hyper- or hypofunction of active metabolites, is assocd. with neurodegenerative and other neurol. disorders, as well as with psychiatric diseases such as depression and schizophrenia.  With recently developed pharmacol. agents, it is now possible to restore metabolic equil. and envisage novel therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7vLdWHblurVg90H21EOLACvtfcHk0lghpevY4BYK8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D&md5=b30a985543d32947138d98e6de82b9ea</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrn3257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3257%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26aulast%3DMuchowski%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DH.-Q.%26atitle%3DKynurenines%2520in%2520the%2520mammalian%2520brain%253A%2520When%2520physiology%2520meets%2520pathology%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26issue%3D7%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Vécsei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalárdy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toldi, J.</span><span> </span><span class="NLM_article-title">Kynurenines in the CNS: Recent advances and new questions</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=64-82&issue=1&author=L.+V%C3%A9cseiauthor=L.+Szal%C3%A1rdyauthor=F.+F%C3%BCl%C3%B6pauthor=J.+Toldi&title=Kynurenines+in+the+CNS%3A+Recent+advances+and+new+questions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A9csei%26aufirst%3DL.%26aulast%3DSzal%25C3%25A1rdy%26aufirst%3DL.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DF.%26aulast%3DToldi%26aufirst%3DJ.%26atitle%3DKynurenines%2520in%2520the%2520CNS%253A%2520Recent%2520advances%2520and%2520new%2520questions%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D1%26spage%3D64%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mandi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecsei, L.</span><span> </span><span class="NLM_article-title">The kynurenine systems and immunoregulation</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=197-209&issue=2&author=Y.+Mandiauthor=L.+Vecsei&title=The+kynurenine+systems+and+immunoregulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandi%26aufirst%3DY.%26aulast%3DVecsei%26aufirst%3DL.%26atitle%3DThe%2520kynurenine%2520systems%2520and%2520immunoregulation%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2012%26volume%3D119%26issue%3D2%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Belenky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">NAD<sup>+</sup> metabolism in health and disease</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=12-19&issue=1&author=P.+Belenkyauthor=K.+L.+Boganauthor=C.+Brenner&title=NAD%2B+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelenky%26aufirst%3DP.%26aulast%3DBogan%26aufirst%3DK.%2BL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DNAD%252B%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2006%26volume%3D32%26issue%3D1%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemin, G. J.</span><span> </span><span class="NLM_article-title">Kynurenine Pathway Metabolites in Humans: Disease and Healthy States</span> <span class="citation_source-journal">Int. J. Tryptophan Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.4137%2FIJTR.S2097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22084578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslCht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-19&author=Y.+Chenauthor=G.+J.+Guillemin&title=Kynurenine+Pathway+Metabolites+in+Humans%3A+Disease+and+Healthy+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine pathway metabolites in humans: disease and healthy states</span></div><div class="casAuthors">Chen, Yiquan; Guillemin, Gilles J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Tryptophan Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">IJTRBS</span>;
        ISSN:<span class="NLM_cas:issn">1178-6469</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica</span>)
        </div><div class="casAbstract">A review.  Tryptophan is an essential amino acid that can be metabolised through different pathways, a major route being the kynurenine pathway.  The first enzyme of the pathway, indoleamine-2,3-dioxygenase, is strongly stimulated by inflammatory mols., particularly interferon gamma.  Thus, the kynurenine pathway is often systematically up-regulated when the immune response is activated.  The biol. significance is that 1) the depletion of tryptophan and generation of kynurenines play a key modulatory role in the immune response; and 2) some of the kynurenines, such as quinolinic acid, 3-hydroxykynurenine and kynurenic acid, are neuroactive.  The kynurenine pathway has been demonstrated to be involved in many diseases and disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, AIDS dementia complex, malaria, cancer, depression and schizophrenia, where imbalances in tryptophan and kynurenines have been found.  This review compiles most of these studies and provides an overview of how the kynurenine pathway might be contributing to disease development, and the concns. of tryptophan and kynurenines in the serum, cerebrospinal fluid and brain tissues in control and patient subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV4vsr8Fs4k7Vg90H21EOLACvtfcHk0lghpevY4BYK8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslCht7c%253D&md5=5d16678f21d5c2f40630ba6b6152d1c9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4137%2FIJTR.S2097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4137%252FIJTR.S2097%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26atitle%3DKynurenine%2520Pathway%2520Metabolites%2520in%2520Humans%253A%2520Disease%2520and%2520Healthy%2520States%26jtitle%3DInt.%2520J.%2520Tryptophan%2520Res.%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyasaikumar, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span> </span><span class="NLM_article-title">Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.pneurobio.2009.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=19394403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=230-245&author=R.+Schwarczauthor=P.+Guidettiauthor=K.+P.+Sathyasaikumarauthor=P.+J.+Muchowski&title=Of+mice%2C+rats+and+men%3A+Revisiting+the+quinolinic+acid+hypothesis+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease</span></div><div class="casAuthors">Schwarcz, Robert; Guidetti, Paolo; Sathyasaikumar, Korrapati V.; Muchowski, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">230-245</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The neurodegenerative disease Huntington's disease (HD) is caused by an expanded polyglutamine (polyQ) tract in the protein huntingtin (htt).  Although the gene encoding htt was identified and cloned more than 15 years ago, and in spite of impressive efforts to unravel the mechanism(s) by which mutant htt induces nerve cell death, these studies have so far not led to a good understanding of pathophysiol. or an effective therapy.  Set against a historical background, we review data supporting the idea that metabolites of the kynurenine pathway (KP) of tryptophan degrdn. provide a crit. link between mutant htt and the pathophysiol. of HD.  New studies in HD brain and genetic model organisms suggest that the disease may in fact be causally related to early abnormalities in KP metab., favoring the formation of two neurotoxic metabolites, 3-hydroxykynurenine and quinolinic acid, over the related neuroprotective agent kynurenic acid.  These findings not only link the excitotoxic hypothesis of HD pathol. to an impairment of the KP but also define new drug targets and therefore have direct therapeutic implications.  Thus, pharmacol. normalization of the imbalance in brain KP metab. may provide clin. benefits, which could be esp. effective in early stages of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpizeHxnPo5LVg90H21EOLACvtfcHk0ljh5NcOXI1_PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOmu7w%253D&md5=edec2f985cd7e574ce3001b61672b5ea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2009.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2009.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DSathyasaikumar%26aufirst%3DK.%2BP.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26atitle%3DOf%2520mice%252C%2520rats%2520and%2520men%253A%2520Revisiting%2520the%2520quinolinic%2520acid%2520hypothesis%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2010%26volume%3D90%26spage%3D230%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthi-Carter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augood, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Neostriatal and cortical quinolinate levels are increased in early grade Huntington’s disease</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.nbd.2004.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15571981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVansbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=455-461&author=P.+Guidettiauthor=R.+E.+Luthi-Carterauthor=S.+J.+Augoodauthor=R.+Schwarcz&title=Neostriatal+and+cortical+quinolinate+levels+are+increased+in+early+grade+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease</span></div><div class="casAuthors">Guidetti, Paolo; Luthi-Carter, Ruth E.; Augood, Sarah J.; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Huntington's disease (HD), an inherited neurodegenerative disorder, is caused by an abnormal polyglutamine expansion in the huntingtin protein.  This genetic defect may result in heightened neuronal susceptibility to excitotoxic injury, a mechanism that has been postulated to play a crit. role in HD.  Quinolinate (QUIN) and kynurenate (KYNA), two endogenous neuroactive metabolites of the kynurenine pathway of tryptophan degrdn., have been proposed to modulate excitotoxic neuronal death in HD.  A third kynurenine pathway metabolite, the free radical generator 3-hydroxykynurenine (3-HK), has also been hypothesized to play a causal role in the pathogenesis of HD.  The authors show here that the brain levels of both 3-HK and QUIN are increased 3 to 4-fold in low-grade (grade 0/1) HD brain.  These changes were seen in the neocortex and in the neostriatum, but not in the cerebellum.  In contrast, brain 3-HK and QUIN levels were either unchanged or tended to decrease in grade 2 and advanced grade (grades 3-4) HD brain.  Brain kynurenine and KYNA levels fluctuated only modestly as the illness progressed.  These results support a possible involvement of 3-HK and QUIN in the early phases of HD pathophysiol. and indicate novel therapeutic strategies against the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_yEwFAF0v17Vg90H21EOLACvtfcHk0ljh5NcOXI1_PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVansbjP&md5=abcb6bd75492573c111228aeadf021b2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2004.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2004.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DLuthi-Carter%26aufirst%3DR.%2BE.%26aulast%3DAugood%26aufirst%3DS.%2BJ.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DNeostriatal%2520and%2520cortical%2520quinolinate%2520levels%2520are%2520increased%2520in%2520early%2520grade%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2004%26volume%3D17%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slow, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.nbd.2006.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=16697652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFyqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=190-197&issue=1&author=P.+Guidettiauthor=G.+P.+Batesauthor=R.+K.+Grahamauthor=M.+R.+Haydenauthor=B.+R.+Leavittauthor=M.+E.+MacDonaldauthor=E.+J.+Slowauthor=V.+C.+Wheelerauthor=B.+Woodmanauthor=R.+Schwarcz&title=Elevated+brain+3-hydroxykynurenine+and+quinolinate+levels+in+Huntington+disease+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice</span></div><div class="casAuthors">Guidetti, Paolo; Bates, Gillian P.; Graham, Rona K.; Hayden, Michael R.; Leavitt, Blair R.; MacDonald, Marcy E.; Slow, Elizabeth J.; Wheeler, Vanessa C.; Woodman, Ben; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-197</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The brain levels of the endogenous excitotoxin quinolinic acid (QUIN) and its bioprecursor, the free radical generator 3-hydroxykynurenine (3-HK), are elevated in early stage Huntington disease (HD).  We now examd. the status of these metabolites in three mouse models of HD.  In R6/2 mice, 3-HK levels were significantly and selectively elevated in the striatum, cortex and cerebellum starting at 4 wk of age.  In contrast, both 3-HK and QUIN levels were increased in the striatum and cortex of the full-length HD models, beginning at 8 mo (YAC128) and 15 mo (Hdh Q92 and Hdh Q111), resp.  No changes were seen in 13-mo-old shortstop mice, which show no signs of motor or cognitive dysfunction or selective neuropathol.  These results demonstrate both important parallels and intriguing differences in the progressive neurochem. changes in these HD mouse models and support the hypothesis that QUIN may play a role in the striatal and cortical neurodegeneration of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNZRDsP7kxrVg90H21EOLACvtfcHk0ljh5NcOXI1_PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFyqtrY%253D&md5=3831ba1712e90d17ec9f025f96e5875e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DGraham%26aufirst%3DR.%2BK.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DMacDonald%26aufirst%3DM.%2BE.%26aulast%3DSlow%26aufirst%3DE.%2BJ.%26aulast%3DWheeler%26aufirst%3DV.%2BC.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DElevated%2520brain%25203-hydroxykynurenine%2520and%2520quinolinate%2520levels%2520in%2520Huntington%2520disease%2520mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D23%26issue%3D1%26spage%3D190%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Forrest, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiden, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, L. G.</span><span> </span><span class="NLM_article-title">Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1111%2Fj.1471-4159.2009.06442.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=19845828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1GhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2010&pages=112-122&author=C.+M.+Forrestauthor=G.+M.+Mackayauthor=N.+Stoyauthor=S.+L.+Spidenauthor=R.+Taylorauthor=T.+W.+Stoneauthor=L.+G.+Darlington&title=Blood+levels+of+kynurenines%2C+interleukin-23+and+soluble+human+leucocyte+antigen-G+at+different+stages+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease</span></div><div class="casAuthors">Forrest, Caroline M.; MacKay, Gillian M.; Stoy, Nicholas; Spiden, Sarah L.; Taylor, Rohan; Stone, Trevor W.; Darlington, L. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">There is substantial evidence that abnormal concns. of oxidized tryptophan metabolites, produced via the kynurenine pathway, contribute to progressive neurodegeneration in Huntington's disease.  The authors have now examd. the blood levels of these metabolites in patients at different stages of Huntington's disease, assessed both in terms of clin. disease severity and nos. of CAG repeats.  Close relatives of the patients were included in the study as well as unrelated healthy controls.  Levels of lipid peroxidn. products, the proinflammatory cytokine interleukin (IL)-23 and the sol. human leukocyte antigen-G (sHLA-G) were also measured.  There were lower levels of tryptophan and a higher kynurenine: tryptophan ratio, indicating activation of indoleamine-2,3-dioxygenase, in the most severely affected group of patients, with increased levels of IL-23 and sHLA-G.  Marked correlations were noted between IL-23 and the patient severity group, anthranilic acid levels and the no. of CAG repeats, and between anthranilic acid and IL-23, supporting previous evidence of a relation between anthranilic acid and inflammatory status.  Tryptophan was neg. correlated with symptom severity and no. of CAG repeats, and pos. correlated with sHLA-G.  The results support the proposal that tryptophan metab. along the kynurenine pathway in Huntington's disease is related to the degree of genetic abnormality, to clin. disease severity and to aspects of immunopathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTdA_toqmgJ7Vg90H21EOLACvtfcHk0ljTw3AZTGUM3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1GhsQ%253D%253D&md5=f8d4a6c51dc69bc717d47ec88a8639da</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06442.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06442.x%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DC.%2BM.%26aulast%3DMackay%26aufirst%3DG.%2BM.%26aulast%3DStoy%26aufirst%3DN.%26aulast%3DSpiden%26aufirst%3DS.%2BL.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DStone%26aufirst%3DT.%2BW.%26aulast%3DDarlington%26aufirst%3DL.%2BG.%26atitle%3DBlood%2520levels%2520of%2520kynurenines%252C%2520interleukin-23%2520and%2520soluble%2520human%2520leucocyte%2520antigen-G%2520at%2520different%2520stages%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D112%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Thevandavakkam, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span> </span><span class="NLM_article-title">Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington’s disease</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.2174%2F187152710793237430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=20942784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFarsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=791-800&author=M.+A.+Thevandavakkamauthor=R.+Schwarczauthor=P.+J.+Muchowskiauthor=F.+Giorgini&title=Targeting+kynurenine+3-monooxygenase+%28KMO%29%3A+implications+for+therapy+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease</span></div><div class="casAuthors">Thevandavakkam, Mathuravani A.; Schwarcz, Robert; Muchowski, Paul J.; Giorgini, Flaviano</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">791-800</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Huntington's dfisease (HD) is an adult onset neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein.  Recent work has shown that perturbation of kynurenine pathway (KP) metab. is a hallmark of HD pathol., and that changes in brain levels of KP metabolites may play a causative role in this disease.  The KP contains three neuroactive metabolites, the neurotoxins 3-hydroxykynurenine (3-HK) and quinolinic acid (QUIN), and the neuroprotectant kynurenic acid (KYNA).  In model systems in vitro and in vivo, 3-HK and QUIN have been shown to cause neurodegeneration via a combination of excitotoxic mechanisms and oxidative stress.  Recent studies with HD patient samples and in HD model systems have supported the idea that a shift away from the synthesis of KYNA and towards the formation of 3-HK and QUIN may trigger the neuropathol. features obsd. in HD.  The enzyme kynurenine 3-monooxygenase (KMO) is located at a crit. branching point in the KP such that inhibition of this enzyme by either pharmacol. or genetic means shifts the flux in the pathway towards the formation of KYNA.  This intervention ameliorates disease-relevant phenotypes in HD models.  Here we review the work implicating the KP in HD pathol. and discuss the potential of KMO as a therapeutic target for this disorder.  As several neurodegenerative diseases exhibit alterations in KP metab., this concept has broader implications for the treatment of brain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0i82T8y6mbLVg90H21EOLACvtfcHk0ljTw3AZTGUM3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFarsbrL&md5=917ad7a46c22e93a2034923651fdab08</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F187152710793237430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710793237430%26sid%3Dliteratum%253Aachs%26aulast%3DThevandavakkam%26aufirst%3DM.%2BA.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DGiorgini%26aufirst%3DF.%26atitle%3DTargeting%2520kynurenine%25203-monooxygenase%2520%2528KMO%2529%253A%2520implications%2520for%2520therapy%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D791%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Giorgini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span> </span><span class="NLM_article-title">A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fng1542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15806102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsF2ksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=526-531&issue=5&author=F.+Giorginiauthor=P.+Guidettiauthor=Q.+Nguyenauthor=S.+C.+Bennettauthor=P.+J.+Muchowski&title=A+genomic+screen+in+yeast+implicates+kynurenine+3-monooxygenase+as+a+therapeutic+target+for+Huntington+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease</span></div><div class="casAuthors">Giorgini, Flaviano; Guidetti, Paolo; Nguyen, QuangVu; Bennett, Simone C.; Muchowski, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">526-531</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington disease is a fatal neurodegenerative disorder caused by expansion of a polyglutamine tract in the protein huntingtin (Htt), which leads to its aggregation in nuclear and cytoplasmic inclusion bodies.  We recently identified 52 loss-of-function mutations in yeast genes that enhance the toxicity of a mutant Htt fragment.  Here we report the results from a genome-wide loss-of-function suppressor screen in which we identified 28 gene deletions that suppress toxicity of a mutant Htt fragment.  The suppressors are known or predicted to have roles in vesicle transport, vacuolar degrdn., transcription and prion-like aggregation.  Among the most potent suppressors was Bna4 (kynurenine 3-monooxygenase), an enzyme in the kynurenine pathway of tryptophan degrdn. that has been linked directly to the pathophysiol. of Huntington disease in humans by a mechanism that may involve reactive oxygen species.  This finding is suggestive of a conserved mechanism of polyglutamine toxicity from yeast to humans and identifies new candidate therapeutic targets for the treatment of Huntington disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0BkWdAqP-TLVg90H21EOLACvtfcHk0ljTw3AZTGUM3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsF2ksrs%253D&md5=9a56f8aa79eb9a0d9ec2eaea849182dd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fng1542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1542%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgini%26aufirst%3DF.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DQ.%26aulast%3DBennett%26aufirst%3DS.%2BC.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26atitle%3DA%2520genomic%2520screen%2520in%2520yeast%2520implicates%2520kynurenine%25203-monooxygenase%2520as%2520a%2520therapeutic%2520target%2520for%2520Huntington%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2005%26volume%3D37%26issue%3D5%26spage%3D526%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Campesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyasaikumar, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyriacou, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span> </span><span class="NLM_article-title">The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington’s disease</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.cub.2011.04.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=21636279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=961-966&issue=11&author=S.+Campesanauthor=E.+W.+Greenauthor=C.+Bredaauthor=K.+V.+Sathyasaikumarauthor=P.+J.+Muchowskiauthor=R.+Schwarczauthor=C.+P.+Kyriacouauthor=F.+Giorgini&title=The+kynurenine+pathway+modulates+neurodegeneration+in+a+Drosophila+model+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease</span></div><div class="casAuthors">Campesan, Susanna; Green, Edward W.; Breda, Carlo; Sathyasaikumar, Korrapati V.; Muchowski, Paul J.; Schwarcz, Robert; Kyriacou, Charalambos P.; Giorgini, Flaviano</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">961-966</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degrdn. have been implicated in the pathophysiol. of neurodegenerative disorders, including Huntington's disease (HD) [].  A central hallmark of HD is neurodegeneration caused by a polyglutamine expansion in the huntingtin (htt) protein [].  Here we exploit a transgenic Drosophila melanogaster model of HD to interrogate the therapeutic potential of KP manipulation.  We observe that genetic and pharmacol. inhibition of kynurenine 3-monooxygenase (KMO) increases levels of the neuroprotective metabolite kynurenic acid (KYNA) relative to the neurotoxic metabolite 3-hydroxykynurenine (3-HK) and ameliorates neurodegeneration.  We also find that genetic inhibition of tryptophan 2,3-dioxygenase (TDO), the first and rate-limiting step in the pathway, leads to a similar neuroprotective shift toward KYNA synthesis.  Importantly, we demonstrate that the feeding of KYNA and 3-HK to HD model flies directly modulates neurodegeneration, underscoring the causative nature of these metabolites.  This study provides the first genetic evidence that inhibition of KMO and TDO activity protects against neurodegenerative disease in an animal model, indicating that strategies targeted at two key points within the KP may have therapeutic relevance in HD, and possibly other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVd3ZDuYatabVg90H21EOLACvtfcHk0lhNOs6aA3QlmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKmtr8%253D&md5=15ae2d2478db87ec6748d74af31ea322</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2011.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2011.04.028%26sid%3Dliteratum%253Aachs%26aulast%3DCampesan%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DE.%2BW.%26aulast%3DBreda%26aufirst%3DC.%26aulast%3DSathyasaikumar%26aufirst%3DK.%2BV.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DKyriacou%26aufirst%3DC.%2BP.%26aulast%3DGiorgini%26aufirst%3DF.%26atitle%3DThe%2520kynurenine%2520pathway%2520modulates%2520neurodegeneration%2520in%2520a%2520Drosophila%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Biol.%26date%3D2011%26volume%3D21%26issue%3D11%26spage%3D961%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speciale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span> </span><span class="NLM_article-title">Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=2003&pages=621-628&author=R.+Pellicciariauthor=L.+Amoriauthor=G.+Costantinoauthor=A.+Giordaniauthor=A.+Macchiaruloauthor=L.+Mattoliauthor=P.+Pevarelloauthor=C.+Specialeauthor=M.+Varasi&title=Modulation+of+the+kynurine+pathway+of+tryptophan+metabolism+in+search+for+neuroprotective+agents.+Focus+on+kynurenine-3-hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DAmori%26aufirst%3DL.%26aulast%3DCostantino%26aufirst%3DG.%26aulast%3DGiordani%26aufirst%3DA.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DMattoli%26aufirst%3DL.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DSpeciale%26aufirst%3DC.%26aulast%3DVarasi%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520kynurine%2520pathway%2520of%2520tryptophan%2520metabolism%2520in%2520search%2520for%2520neuroprotective%2520agents.%2520Focus%2520on%2520kynurenine-3-hydroxylase%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2003%26volume%3D527%26spage%3D621%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Amori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1111%2Fj.1471-4159.2009.05893.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=19226371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=316-325&issue=2&author=L.+Amoriauthor=P.+Guidettiauthor=R.+Pellicciariauthor=Y.+Kajiiauthor=R.+Schwarcz&title=On+the+relationship+between+the+two+branches+of+the+kynurenine+pathway+in+the+rat+brain+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo</span></div><div class="casAuthors">Amori, Laura; Guidetti, Paolo; Pellicciari, Roberto; Kajii, Yasushi; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-325</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In the mammalian brain, kynurenine aminotransferase II (KAT II) and kynurenine 3-monooxygenase (KMO), key enzymes of the kynurenine pathway (KP) of tryptophan degrdn., form the neuroactive metabolites kynurenic acid (KYNA) and 3-hydroxykynurenine (3-HK), resp.  Although phys. segregated, both enzymes use the pivotal KP metabolite L-kynurenine as a substrate.  We studied the functional consequences of this cellular compartmentalization in vivo using two specific tools, the KAT II inhibitor BFF 122 and the KMO inhibitor UPF 648.  The acute effects of selective KAT II or KMO inhibition were studied using a radiotracing method in which the de novo synthesis of KYNA, and of 3-HK and its downstream metabolite quinolinic acid (QUIN), is monitored following an intrastriatal injection of 3H-kynurenine.  In naive rats, intrastriatal BFF 122 decreased newly formed KYNA by 66%, without influencing 3-HK or QUIN prodn.  Conversely, UPF 648 reduced 3-HK synthesis (by 64%) without affecting KYNA formation.  Similar, selective effects of KAT II and KMO inhibition were obsd. when the inhibitors were applied acutely together with the excitotoxin QUIN, which impairs local KP metab.  Somewhat different effects of KMO (but not KAT II) inhibition were obtained in rats that had received an intrastriatal QUIN injection 7 days earlier.  In these neuron-depleted striata, UPF 648 not only decreased both 3-HK and QUIN prodn. (by 77% and 66%, resp.) but also moderately raised KYNA synthesis (by 27%).  These results indicate a remarkable functional segregation of the two pathway branches in the brain, boding well for the development of selective KAT II or KMO inhibitors for cognitive enhancement and neuroprotection, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd9pXuKi1ZgrVg90H21EOLACvtfcHk0lhNOs6aA3QlmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKgtbg%253D&md5=8cf09ef8d475d1d2771ab6e1326c336d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.05893.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.05893.x%26sid%3Dliteratum%253Aachs%26aulast%3DAmori%26aufirst%3DL.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DKajii%26aufirst%3DY.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DOn%2520the%2520relationship%2520between%2520the%2520two%2520branches%2520of%2520the%2520kynurenine%2520pathway%2520in%2520the%2520rat%2520brain%2520in%2520vivo%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D109%26issue%3D2%26spage%3D316%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Heyes, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span> </span><span class="NLM_article-title">Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1997&pages=351-356&issue=2&author=M.+P.+Heyesauthor=C.+Y.+Chenauthor=E.+O.+Majorauthor=K.+Saito&title=Different+kynurenine+pathway+enzymes+limit+quinolinic+acid+formation+by+various+human+cell+types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeyes%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DMajor%26aufirst%3DE.%2BO.%26aulast%3DSaito%26aufirst%3DK.%26atitle%3DDifferent%2520kynurenine%2520pathway%2520enzymes%2520limit%2520quinolinic%2520acid%2520formation%2520by%2520various%2520human%2520cell%2520types%26jtitle%3DBiochem.%2520J.%26date%3D1997%26volume%3D326%26issue%3D2%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Guillemin, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smythe, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armati, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brew, B. J.</span><span> </span><span class="NLM_article-title">Expression of the kynurenine pathway enzymes in human microglia and macrophages</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=2003&pages=105-112&author=G.+J.+Guilleminauthor=D.+G.+Smithauthor=G.+A.+Smytheauthor=P.+J.+Armatiauthor=B.+J.+Brew&title=Expression+of+the+kynurenine+pathway+enzymes+in+human+microglia+and+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DSmythe%26aufirst%3DG.%2BA.%26aulast%3DArmati%26aufirst%3DP.%2BJ.%26aulast%3DBrew%26aufirst%3DB.%2BJ.%26atitle%3DExpression%2520of%2520the%2520kynurenine%2520pathway%2520enzymes%2520in%2520human%2520microglia%2520and%2520macrophages%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2003%26volume%3D527%26spage%3D105%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rzeski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wejksza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdzisińska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandefer-Szerszeń, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turski, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J.</span><span> </span><span class="NLM_article-title">Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1002%2Fjnr.20505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15880762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFagtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=677-682&issue=5&author=W.+Rzeskiauthor=T.+Kockiauthor=A.+Dybelauthor=K.+Wejkszaauthor=B.+Zdzisi%C5%84skaauthor=M.+Kandefer-Szersze%C5%84author=W.+A.+Turskiauthor=E.+Okunoauthor=J.+Albrecht&title=Demonstration+of+kynurenine+aminotransferases+I+and+II+and+characterization+of+kynurenic+acid+synthesis+in+cultured+cerebral+cortical+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons</span></div><div class="casAuthors">Rzeski, Wojciech; Kocki, Tomasz; Dybel, Anna; Wejksza, Katarzyna; Zdzisinska, Barbara; Kandefer-Szerszen, Martyna; Turski, Waldemar A.; Okuno, Etsuo; Albrecht, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">677-682</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The present study characterizes the synthesis of kynurenic acid (KYNA) from exogenously added kynurenine and its regulation by extrinsic factors, in cultured cerebral cortical neurons and, for comparison, in astrocytes incubated under identical conditions.  The neuronal culture showed pos. immunostaining for both kynurenic acid aminotransferase (KAT) isoforms I and II.  Neurons synthesized KYNA at a rate about 2.3 times higher than astrocytes.  Neuronal, but not astrocytic, KYNA synthesis was lowered ∼30% by ionotropic glutamate receptor agonists [(R,S)-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA; 100 μM) and N-methyl-D-aspartic acid (NMDA; 100 μM)] and depolarizing agents [KCl (50 mM) and 4-aminopyridine (4-AP; 10 μM)].  Neuronal and astrocytic synthesis alike were vulnerable to inhibition exerted by the aminotransferase inhibitor aminooxyacetic acid (AOAA), glutamate (IC50: 31 and 85 μM, resp.), substrates of the L-amino transport system [leucine (Leu); IC50: 19 and 42 μM, resp.] and 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid (BCH; IC50: 19 and 28 μM, resp.).  Glutamine (Gln), which is a metabolic precursor of glutamate in astrocytes and L-system substrate in both cell types, inhibited KYNA synthesis both in neurons and in astrocytes (IC50: 268 and 318 μM, resp.).  α-Ketoisocaproic acid (KIC), a Leu transamination product that is produced mainly in astrocytes and shuttled to neurons to modulate intraneuronal concn. of glutamate, stimulated KYNA synthesis in neurons but did not affect the synthesis in astrocytes.  In conclusion, this study is the first to demonstrate active, regulation-prone KYNA synthesis in neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCYn81xHIdcLVg90H21EOLACvtfcHk0lgoCGzC3mjxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFagtbg%253D&md5=d4388e49de0c0046d9a9d112ad636d02</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20505%26sid%3Dliteratum%253Aachs%26aulast%3DRzeski%26aufirst%3DW.%26aulast%3DKocki%26aufirst%3DT.%26aulast%3DDybel%26aufirst%3DA.%26aulast%3DWejksza%26aufirst%3DK.%26aulast%3DZdzisi%25C5%2584ska%26aufirst%3DB.%26aulast%3DKandefer-Szersze%25C5%2584%26aufirst%3DM.%26aulast%3DTurski%26aufirst%3DW.%2BA.%26aulast%3DOkuno%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DJ.%26atitle%3DDemonstration%2520of%2520kynurenine%2520aminotransferases%2520I%2520and%2520II%2520and%2520characterization%2520of%2520kynurenic%2520acid%2520synthesis%2520in%2520cultured%2520cerebral%2520cortical%2520neurons%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2005%26volume%3D80%26issue%3D5%26spage%3D677%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span> </span><span class="NLM_article-title">Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1124%2Fjpet.102.034439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=12235226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1-10&author=R.+Schwarczauthor=R.+Pellicciari&title=Manipulation+of+brain+kynurenines%3A+glial+targets%2C+neuronal+effects%2C+and+clinical+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities</span></div><div class="casAuthors">Schwarcz, Robert; Pellicciari, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Degrdn. of the essential amino acid tryptophan along the kynurenine pathway (KP) yields several neuroactive intermediates, including the free radical generator 3-hydroxykynurenine, the excitotoxic N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid, and the NMDA and α7 nicotinic acetylcholine receptor antagonist kynurenic acid.  The ambient levels of these compds. are detd. by several KP enzymes, which in the brain are preferentially localized in astrocytes and microglial cells.  Normal fluctuations in the brain levels of neuroactive KP intermediates might modulate several neurotransmitter systems.  Impairment of KP metab. is functionally significant and occurs in a variety of diseases that affect the brain.  Pharmacol. agents targeting specific KP enzymes are now available to manipulate the concn. of neuroactive KP intermediates in the brain.  These compds. can be used to normalize KP defects, show remarkable efficacy in animal models of central nervous system disorders, and offer novel therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVe45AXh3TXrVg90H21EOLACvtfcHk0lgoCGzC3mjxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2ru7k%253D&md5=3b1c0ecc1601b35d1b335f386c18ecd5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.034439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.034439%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DPellicciari%26aufirst%3DR.%26atitle%3DManipulation%2520of%2520brain%2520kynurenines%253A%2520glial%2520targets%252C%2520neuronal%2520effects%252C%2520and%2520clinical%2520opportunities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Guillemin, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smythe, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brew, B. J.</span><span> </span><span class="NLM_article-title">Characterization of the kynurenine pathway in human neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">12884</span><span class="NLM_x">–</span> <span class="NLM_lpage">12892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1523%2FJNEUROSCI.4101-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=18032661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=12884-12892&author=G.+J.+Guilleminauthor=K.+M.+Cullenauthor=C.+K.+Limauthor=G.+A.+Smytheauthor=B.+Garnerauthor=V.+Kapoorauthor=O.+Takikawaauthor=B.+J.+Brew&title=Characterization+of+the+kynurenine+pathway+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Kynurenine pathway in human neurons</span></div><div class="casAuthors">Guillemin, Gilles J.; Cullen, Karen M.; Lim, Chai K.; Smythe, George A.; Garner, Brett; Kapoor, Vimal; Takikawa, Osamu; Brew, Bruce J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12884-12892</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The kynurenine pathway is a major route of L-tryptophan catabolism producing neuroactive metabolites implicated in neurodegeneration and immune tolerance.  We characterized the kynurenine pathway in human neurons and the human SK-N-SH neuroblastoma cell line and found that the kynurenine pathway enzymes were variably expressed.  Picolinic carboxylase was expressed only in primary and some adult neurons but not in SK-N-SH cells.  Because of this difference, SK-N-SH cells were able to produce the excitotoxin quinolinic acid, whereas human neurons produced the neuroprotectant picolinic acid.  The net result of kynurenine pathway induction in human neurons is therefore predicted to result in neuroprotection, immune regulation, and tumor inhibition, whereas in SK-N-SH cells, it may result in neurotoxicity, immune tolerance, and tumor promotion.  This study represents the first comprehensive characterization of the kynurenine pathway in neurons and the first description of the involvement of the kynurenine pathway as a mechanism for controlling both tumor cell neurotoxicity and persistence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgz7ShgU7irVg90H21EOLACvtfcHk0lgoCGzC3mjxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsr3F&md5=55e63fe7ac90b71e50cc1bb3c49a9141</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4101-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4101-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26aulast%3DCullen%26aufirst%3DK.%2BM.%26aulast%3DLim%26aufirst%3DC.%2BK.%26aulast%3DSmythe%26aufirst%3DG.%2BA.%26aulast%3DGarner%26aufirst%3DB.%26aulast%3DKapoor%26aufirst%3DV.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DBrew%26aufirst%3DB.%2BJ.%26atitle%3DCharacterization%2520of%2520the%2520kynurenine%2520pathway%2520in%2520human%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D12884%26epage%3D12892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span> </span><span class="NLM_article-title">Kynurenines in the mammalian brain: When physiology meets pathology</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fnrn3257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22678511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=465-477&author=R.+Schwarczauthor=J.+P.+Brunoauthor=P.+J.+Muchowskiauthor=H.+Q.+Wu&title=Kynurenines+in+the+mammalian+brain%3A+When+physiology+meets+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines in the mammalian brain: when physiology meets pathology</span></div><div class="casAuthors">Schwarcz, Robert; Bruno, John P.; Muchowski, Paul J.; Wu, Hui-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compds., including kynurenic acid, 3-hydroxykynurenine and quinolinic acid.  The synthesis of these metabolites is regulated by an enzymic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system.  Dysregulation of this pathway, resulting in hyper- or hypofunction of active metabolites, is assocd. with neurodegenerative and other neurol. disorders, as well as with psychiatric diseases such as depression and schizophrenia.  With recently developed pharmacol. agents, it is now possible to restore metabolic equil. and envisage novel therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7vLdWHblurVg90H21EOLACvtfcHk0lieSekIhgzuhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D&md5=b30a985543d32947138d98e6de82b9ea</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrn3257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3257%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26atitle%3DKynurenines%2520in%2520the%2520mammalian%2520brain%253A%2520When%2520physiology%2520meets%2520pathology%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fukui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Blood-Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2017</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1111%2Fj.1471-4159.1991.tb03460.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=1827495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK3MXktVGltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=2007-2017&issue=6&author=S.+Fukuiauthor=R.+Schwarczauthor=S.+I.+Rapoportauthor=Y.+Takadaauthor=Q.+R.+Smith&title=Blood-Brain+Barrier+Transport+of+Kynurenines%3A+Implications+for+Brain+Synthesis+and+Metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier transport of kynurenines:  implications for brain synthesis and metabolism</span></div><div class="casAuthors">Fukui, Shinsuke; Schwarcz, Robert; Rapoport, Stanley I.; Takada, Yoshiaki; Smith, Quentin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2007-17</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To evaluate the potential contribution of circulating kynurenines to brain kynurenine pools, the rates of cerebral uptake and mechanisms of blood-brain barrier transport were detd. for several kynurenine metabolites of tryptophan, including L-kynurenine (L-KYN), 3-hydroxykynurenine (3-HKYN), 3-hydroxyanthranilic acid (3-HANA), anthranilic acid (ANA), kynurenic acid (KYNA), and quinolinic acid (QUIN), in pentobarbital-anesthetized rats using an in situ brain perfusion technique.  L-KYN was taken up into brain at a significant rate [permeability-surface area product (PA) = 2-3 × 10-3 mL/s/g] by the large neutral amino acid carrier (L-system) of the blood-brain barrier.  Best-fit ests. of the Vmax and Km of saturable L-KYN transfer equaled 4.5 × 10-4 μmol/s/g and 0.16 μmol/mL, resp.  The same carrier may also mediate the brain uptake of 3-HKYN as D,L-3-HKYN competitively inhibited the brain transfer of the large neutral amino acid L-leucine.  For the other metabolites, uptake appeared mediated by passive diffusion.  This occurred at a significant rate for ANA (PA, 0.7-1.6 × 10-3 mL/s/g), and at far lower rates (PA, 2-7 × 10-5 mL/s/g) for 3-HANA, KYNA, and QUIN.  Transfer for KYNA, 3-HANA, and ANA also appeared to be limited by plasma protein binding.  The results demonstrate the saturable transfer of L-KYN across the blood-brain barrier and suggest that circulating L-KYN, 3-HKYN, and ANA may each contribute significantly to resp. cerebral pools.  In contrast, QUIN, KYNA, and 3-HANA cross the blood-brain barrier poorly, and therefore are not expected to contribute significantly to brain pools under normal conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrAlsvOTFGLVg90H21EOLACvtfcHk0lieSekIhgzuhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVGltLY%253D&md5=b97956c6ef4e07edad4d30a809286536</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1991.tb03460.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1991.tb03460.x%26sid%3Dliteratum%253Aachs%26aulast%3DFukui%26aufirst%3DS.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DRapoport%26aufirst%3DS.%2BI.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DBlood-Brain%2520Barrier%2520Transport%2520of%2520Kynurenines%253A%2520Implications%2520for%2520Brain%2520Synthesis%2520and%2520Metabolism%26jtitle%3DJ.%2520Neurochem.%26date%3D1991%26volume%3D56%26issue%3D6%26spage%3D2007%26epage%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zwilling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyasaikumar, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews-Zwilling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassoulpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span> </span><span class="NLM_article-title">Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration</span> <span class="citation_source-journal">Cell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=863-874&issue=6&author=D.+Zwillingauthor=S.+Y.+Huangauthor=K.+V.+Sathyasaikumarauthor=F.+M.+Notarangeloauthor=P.+Guidettiauthor=H.+Q.+Wuauthor=J.+Leeauthor=J.+Truongauthor=Y.+Andrews-Zwillingauthor=E.+W.+Hsiehauthor=J.+Y.+Louieauthor=T.+Wuauthor=K.+Scearce-Levieauthor=C.+Patrickauthor=A.+Adameauthor=F.+Giorginiauthor=S.+Moussaouiauthor=G.+Laueauthor=A.+Rassoulpourauthor=G.+Flikauthor=Y.+Huangauthor=J.+M.+Muchowskiauthor=E.+Masliahauthor=R.+Schwarczauthor=P.+J.+Muchowski&title=Kynurenine+3-monooxygenase+inhibition+in+blood+ameliorates+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwilling%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DS.%2BY.%26aulast%3DSathyasaikumar%26aufirst%3DK.%2BV.%26aulast%3DNotarangelo%26aufirst%3DF.%2BM.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTruong%26aufirst%3DJ.%26aulast%3DAndrews-Zwilling%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DE.%2BW.%26aulast%3DLouie%26aufirst%3DJ.%2BY.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DPatrick%26aufirst%3DC.%26aulast%3DAdame%26aufirst%3DA.%26aulast%3DGiorgini%26aufirst%3DF.%26aulast%3DMoussaoui%26aufirst%3DS.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DRassoulpour%26aufirst%3DA.%26aulast%3DFlik%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMuchowski%26aufirst%3DJ.%2BM.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26atitle%3DKynurenine%25203-monooxygenase%2520inhibition%2520in%2520blood%2520ameliorates%2520neurodegeneration%26jtitle%3DCell.%26date%3D2011%26volume%3D145%26issue%3D6%26spage%3D863%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chiarugi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Kynurenine Disposition in Blood and Brain of Mice: Effects of Selective Inhibitors of Kynurenine Hydroxylase and of Kynureninase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=8764597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=692-698&issue=2&author=A.+Chiarugiauthor=R.+Carpenedoauthor=F.+Moroni&title=Kynurenine+Disposition+in+Blood+and+Brain+of+Mice%3A+Effects+of+Selective+Inhibitors+of+Kynurenine+Hydroxylase+and+of+Kynureninase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase</span></div><div class="casAuthors">Chiarugi A; Carpenedo R; Moroni F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">692-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To study the regulation of the synthesis of quinolinic and kynurenic acids in vivo, we evaluated (a) the metabolism of administered kynurenine by measuring the content of its main metabolites 3-hydroxykynurenine, anthranilic acid, and 3-hydroxyanthranilic acid in blood and brain of mice; (b) the effects of (m-nitrobenzoyl)alanine, a selective inhibitor of kynurenine hydroxylase and of (o-methoxybenzoyl) alanine, a selective inhibitor of kynureninase, on this metabolism; and (c) the effects of (o-methoxybenzoyl)alanine on liver kynureninase and 3-hydroxykynureninase activity.  The conclusions drawn from these experiments are (a) the disposition of administered kynurenine preferentially occurs through hydroxylation in brain and through hydrolysis in peripheral tissues; (b) (m-nitrobenzoyl)alanine, the inhibitor of kynurenine hydroxylase, causes the expected changes in brain kynurenine metabolism, such as a decrease of 3-hydroxykynurenine, and an increase of kynurenic acid; and (c) (o-methoxybenzoyl)alanine, the kynureninase inhibitor, increases brain concentration of the cytotoxic compound 3-hydroxykynurenine, and unexpectedly does not reduce brain concentration of 3-hydroxyanthranilic acid, the direct precursor of quinolinic acid.  Taken together, the experiments suggest that the systemic administration of a kynurenine hydroxylase inhibitor is a rational approach to increase the brain content of kynurenate and to decrease that of cytotoxic kynurenine metabolites, such as 3-hydroxykynurenine and quinolinic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-MKFVxCBo-Ny3lHz94U-GfW6udTcc2eaSWUjV67icP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D&md5=b9843554a48282aa2660283eab76c8df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiarugi%26aufirst%3DA.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DKynurenine%2520Disposition%2520in%2520Blood%2520and%2520Brain%2520of%2520Mice%253A%2520Effects%2520of%2520Selective%2520Inhibitors%2520of%2520Kynurenine%2520Hydroxylase%2520and%2520of%2520Kynureninase%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26issue%3D2%26spage%3D692%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markey, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, M. P.</span><span> </span><span class="NLM_article-title">Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=25-39&author=K.+Saitoauthor=S.+P.+Markeyauthor=M.+P.+Heyes&title=Effects+of+immune+activation+on+quinolinic+acid+and+neuroactive+kynurenines+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DMarkey%26aufirst%3DS.%2BP.%26aulast%3DHeyes%26aufirst%3DM.%2BP.%26atitle%3DEffects%2520of%2520immune%2520activation%2520on%2520quinolinic%2520acid%2520and%2520neuroactive%2520kynurenines%2520in%2520the%2520mouse%26jtitle%3DNeuroscience%26date%3D1992%26volume%3D51%26spage%3D25%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patte-Mensah, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taleb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bihel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah-Nyagan, A. G.</span><span> </span><span class="NLM_article-title">The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=254-260&author=C.+Kleinauthor=C.+Patte-Mensahauthor=O.+Talebauthor=J.-J.+Bourguignonauthor=M.+Schmittauthor=F.+Bihelauthor=M.+Maitreauthor=A.+G.+Mensah-Nyagan&title=The+neuroprotector+kynurenic+acid+increases+neuronal+cell+survival+through+neprilysin+induction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DPatte-Mensah%26aufirst%3DC.%26aulast%3DTaleb%26aufirst%3DO.%26aulast%3DBourguignon%26aufirst%3DJ.-J.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DBihel%26aufirst%3DF.%26aulast%3DMaitre%26aufirst%3DM.%26aulast%3DMensah-Nyagan%26aufirst%3DA.%2BG.%26atitle%3DThe%2520neuroprotector%2520kynurenic%2520acid%2520increases%2520neuronal%2520cell%2520survival%2520through%2520neprilysin%2520induction%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D254%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Stone, T. W.</span><span> </span><span class="NLM_article-title">Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=149-154&issue=4&author=T.+W.+Stone&title=Development+and+therapeutic+potential+of+kynurenic+acid+and+kynurenine+derivatives+for+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BW.%26atitle%3DDevelopment%2520and%2520therapeutic%2520potential%2520of%2520kynurenic%2520acid%2520and%2520kynurenine%2520derivatives%2520for%2520neuroprotection%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2000%26volume%3D21%26issue%3D4%26spage%3D149%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Stone, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, L. G.</span><span> </span><span class="NLM_article-title">Endogenous kynurenines as targets for drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fnrd870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=12402501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslGqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=609-620&issue=8&author=T.+W.+Stoneauthor=L.+G.+Darlington&title=Endogenous+kynurenines+as+targets+for+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous kynurenines as targets for drug discovery and development</span></div><div class="casAuthors">Stone, Trevor W.; Darlington, L. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">609-620</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The kynurenine pathway is the main pathway for tryptophan metab.  It generates compds. that can modulate activity at glutamate receptors and possibly nicotinic receptors, in addn. to some as-yet-unidentified sites.  The pathway is in a unique position to regulate other aspects of the metab. of tryptophan to neuroactive compds., and also seems to be a key factor in the communication between the nervous and immune systems.  It also has potentially important roles in the regulation of cell proliferation and tissue function in the periphery.  As a result, the pathway presents a multitude of potential sites for drug discovery in neuroscience, oncol. and visceral pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Wxl-a-7RF7Vg90H21EOLACvtfcHk0lgip2InvDVSVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslGqtr4%253D&md5=079072419577259ddc6df3c7ff151dcd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd870%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BW.%26aulast%3DDarlington%26aufirst%3DL.%2BG.%26atitle%3DEndogenous%2520kynurenines%2520as%2520targets%2520for%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discovery%26date%3D2002%26volume%3D1%26issue%3D8%26spage%3D609%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Storey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipolloni, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Movement disorder following excitotoxin lesions in primates</span> <span class="citation_source-journal">Neuroreport.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=1259-1261&issue=10&author=E.+Storeyauthor=P.+B.+Cipolloniauthor=R.+J.+Ferranteauthor=N.+W.+Kowallauthor=M.+F.+Beal&title=Movement+disorder+following+excitotoxin+lesions+in+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStorey%26aufirst%3DE.%26aulast%3DCipolloni%26aufirst%3DP.%2BB.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMovement%2520disorder%2520following%2520excitotoxin%2520lesions%2520in%2520primates%26jtitle%3DNeuroreport.%26date%3D1994%26volume%3D5%26issue%3D10%26spage%3D1259%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whetsell, W. O.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, R. M.</span><span> </span><span class="NLM_article-title">Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x"> (</span><span class="NLM_issue">4582</span><span class="NLM_x">) </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1983&pages=316-318&issue=4582&author=R.+Schwarczauthor=W.+O.+Whetsellauthor=R.+M.+Mangano&title=Quinolinic+acid%3A+An+endogenous+metabolite+that+produces+axon-sparing+lesions+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DWhetsell%26aufirst%3DW.%2BO.%26aulast%3DMangano%26aufirst%3DR.%2BM.%26atitle%3DQuinolinic%2520acid%253A%2520An%2520endogenous%2520metabolite%2520that%2520produces%2520axon-sparing%2520lesions%2520in%2520rat%2520brain%26jtitle%3DScience%26date%3D1983%26volume%3D219%26issue%3D4582%26spage%3D316%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span> </span><span class="NLM_article-title">Chronic quinolinic acid lesions in rats closely resemble Huntington’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=1710657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=1649-1659&issue=6&author=M.+F.+Bealauthor=R.+J.+Ferranteauthor=K.+J.+Swartzauthor=N.+W.+Kowall&title=Chronic+quinolinic+acid+lesions+in+rats+closely+resemble+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic quinolinic acid lesions in rats closely resemble Huntington's disease</span></div><div class="casAuthors">Beal, M. Flint; Ferrante, Robert J.; Swartz, Kenton J.; Kowall, Neil W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1649-59</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">The authors previously found a relative sparing of somatostatin and neuropeptide Y neurons 1 wk after producing striatal lesions with NMDA receptor agonists.  These results are similar to postmortem findings in Huntington's disease (HD), though in this illness there are two- to threefold increases in striatal somatostatin and neuropeptide Y concns., which may be due to striatal atrophy.  The present study examd. the effects of striatal excitotoxin lesions at 6 mo and 1 yr, because these lesions exhibit striatal shrinkage and atrophy similar to that occurring in HD striatum.  At 6 mo and 1 yr, lesions with the NMDA receptor agonist quinolinic acid (QA) resulted in increases (up to twofold) in concns. of somatostatin and neuropeptide Y immunoreactivity, while concns. of GABA, substance P immunoreactivity, and ChAT activity were reduced.  In contrast, somatostatin and neuropeptide Y concns. did not increase 6 mo after kainic acid (KA) or α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) lesions.  At both 6 mo and 1 yr, QA lesions showed striking sparing of NADPH-diaphorase neurons as compared with both AMPA and KA lesions, neither of which showed preferential sparing of these neurons.  Long-term QA lesions also resulted in increases in concns. of both 5-HT and 5-hydroxyindoleacetic acid (HIAA), similar to findings in HD.  Chronic QA lesions therefore closely resemble the neurochem. features of HD, because they result in increases in somatostatin and neuropeptide Y and in 5-HT and HIAA.  These findings strengthen the possibility that an NMDA receptor-mediated excitotoxic process could play a role in the pathogenesis of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4R2paUdLIwbVg90H21EOLACvtfcHk0lgip2InvDVSVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFKgtLo%253D&md5=6d7ded31592dd7548de2f0fc5a1f724c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DSwartz%26aufirst%3DK.%2BJ.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26atitle%3DChronic%2520quinolinic%2520acid%2520lesions%2520in%2520rats%2520closely%2520resemble%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D1991%26volume%3D11%26issue%3D6%26spage%3D1649%26epage%3D1659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Okuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, H.</span><span> </span><span class="NLM_article-title">Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">12553</span><span class="NLM_x">–</span> <span class="NLM_lpage">12558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=12553-12558&author=S.+Okudaauthor=N.+Nishiyamaauthor=H.+Saitoauthor=H.+Katsuki&title=Hydrogen+peroxide-mediated+neuronal+cell+death+induced+by+an+endogenous+neurotoxin%2C+3-hydroxykynurenine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DNishiyama%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DKatsuki%26aufirst%3DH.%26atitle%3DHydrogen%2520peroxide-mediated%2520neuronal%2520cell%2520death%2520induced%2520by%2520an%2520endogenous%2520neurotoxin%252C%25203-hydroxykynurenine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D12553%26epage%3D12558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Stone, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catherine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, L. G.</span><span> </span><span class="NLM_article-title">Tryptophan Metabolites and Brain Disorders</span> <span class="citation_source-journal">Clin. Chem. Lab. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1515%2FCCLM.2003.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=12940508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtlymu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2003&pages=852-859&issue=7&author=T.+W.+Stoneauthor=G.+M.+Mackayauthor=C.+M.+Forrestauthor=J.+Catherineauthor=C.+J.+Clarkauthor=L.+G.+Darlington&title=Tryptophan+Metabolites+and+Brain+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Tryptophan metabolites and brain disorders</span></div><div class="casAuthors">Stone, Trevor W.; Mackay, Gillian M.; Forrest, Caroline M.; Clark, Catherine J.; Darlington, L. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry and Laboratory Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">852-859</span>CODEN:
                <span class="NLM_cas:coden">CCLMFW</span>;
        ISSN:<span class="NLM_cas:issn">1434-6621</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Tryptophan is metabolized primarily along the kynurenine pathway, of which two components are now known to have marked effects on neurons in the central nervous system.  Quinolinic acid is an agonist at the population of glutamate receptors which are sensitive to N-methyl-D-aspartate (NMDA), and kynurenic acid is an antagonist at several glutamate receptors.  Consequently quinolinic acid can act as a neurotoxin while kynurenic acid is neuroprotectant.  A third kynurenine, 3-hydroxykynurenine, can generate free radicals and contribute to, or exacerbate, neuronal damage.  Changes in the abs. or relative concns. of these kynurenines have been implicated in a variety of central nervous system disorders such as the AIDS-dementia complex and Huntington's disease, raising the possibility that interference with their actions or synthesis could lead to new forms of pharmacotherapy for these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8J5HeG3vGbVg90H21EOLACvtfcHk0linDSeZpGRPyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtlymu74%253D&md5=2ee1eeb87c079f6dff75979e7a1e65d5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1515%2FCCLM.2003.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FCCLM.2003.129%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BW.%26aulast%3DMackay%26aufirst%3DG.%2BM.%26aulast%3DForrest%26aufirst%3DC.%2BM.%26aulast%3DCatherine%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DC.%2BJ.%26aulast%3DDarlington%26aufirst%3DL.%2BG.%26atitle%3DTryptophan%2520Metabolites%2520and%2520Brain%2520Disorders%26jtitle%3DClin.%2520Chem.%2520Lab.%2520Med.%26date%3D2003%26volume%3D41%26issue%3D7%26spage%3D852%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Majláth, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vécsei, L.</span><span> </span><span class="NLM_article-title">Kynurenines and other novel therapeutic strategies in the treatment of dementia</span> <span class="citation_source-journal">Ther. Adv. Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1177%2F1756285613494989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OktrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=386-397&issue=6&author=Z.+Majl%C3%A1thauthor=J.+Tajtiauthor=L.+V%C3%A9csei&title=Kynurenines+and+other+novel+therapeutic+strategies+in+the+treatment+of+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines and other novel therapeutic strategies in the treatment of dementia</span></div><div class="casAuthors">Majlath, Zsofia; Tajti, Janos; Vecsei, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Neurological Disorders</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">386-397, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">TANDCF</span>;
        ISSN:<span class="NLM_cas:issn">1756-2856</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Dementia is a common neuropsychol. disorder with an increasing incidence.  The most prevalent type of dementia is Alzheimer's disease.  The underlying pathophysiol. features of the cognitive decline are neurodegenerative processes, a cerebrovascular dysfunction and immunol. alterations.  The therapeutic approaches are still limited, although intensive research is being conducted with the aim of finding neuroprotective strategies.  The widely accepted cholinesterase inhibitors and glutamate antagonists did not meet expectations of preventing disease progression, and research is therefore currently focusing on novel targets.  Nonsteroidal anti-inflammatory drugs, secretase inhibitors and statins are promising drug candidates for the prevention and management of different forms of dementia.  The kynurenine pathway has been assocd. with various neurodegenerative disorders and cerebrovascular diseases.  This pathway is also closely related to neuroinflammatory processes and it has been implicated in the pathomechanisms of certain kinds of dementia.  Targeting the kynurenine system may be of therapeutic value in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFMJvLjV_RG7Vg90H21EOLACvtfcHk0linDSeZpGRPyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OktrbN&md5=25d0ce73219bd6b1f0ca675ae98b7f47</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1177%2F1756285613494989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1756285613494989%26sid%3Dliteratum%253Aachs%26aulast%3DMajl%25C3%25A1th%26aufirst%3DZ.%26aulast%3DTajti%26aufirst%3DJ.%26aulast%3DV%25C3%25A9csei%26aufirst%3DL.%26atitle%3DKynurenines%2520and%2520other%2520novel%2520therapeutic%2520strategies%2520in%2520the%2520treatment%2520of%2520dementia%26jtitle%3DTher.%2520Adv.%2520Neurol.%2520Disord.%26date%3D2013%26volume%3D6%26issue%3D6%26spage%3D386%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Parsons, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danysz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollenburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przegalinski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzascik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chizh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headley, P. M.</span><span> </span><span class="NLM_article-title">Novel systemically active antagonists of the glycine site of the N-methyl-d-aspartate receptor: Electrophysiological, biochemical and behavioral characterization</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=9400002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK1cXis1Gitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1264-1275&author=C.+G.+Parsonsauthor=W.+Danyszauthor=G.+Quackauthor=S.+Hartmannauthor=B.+Lorenzauthor=C.+Wollenburgauthor=L.+Baranauthor=E.+Przegalinskiauthor=W.+Kostowskiauthor=P.+Krzascikauthor=B.+Chizhauthor=P.+M.+Headley&title=Novel+systemically+active+antagonists+of+the+glycine+site+of+the+N-methyl-d-aspartate+receptor%3A+Electrophysiological%2C+biochemical+and+behavioral+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization</span></div><div class="casAuthors">Parsons, Chris G.; Danysz, Wojciech; Quack, Gunter; Hartmann, Sabine; Lorenz, Bianke; Wollenburg, Christine; Baran, Leokadia; Przegalinski, Edmund; Kostowski, Wojciech; Krzascik, Pawel; Chizh, Boris; Headley, P. Max.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1264-1275</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A series of novel tricyclic pyrido-phthalazine-dione derivs. was tested for antagonistic effects at the strychnine-insensitive modulatory site of the N-methyl-D-aspartate (NMDA) receptor (glycineB).  All compds. displaced [3H]MDL-105,519 binding to rat cortical membranes with IC50 values of between 90 nM and 3.6 μM.  In patch-clamp expts., steady-state inward current responses of cultured hippocampal neurons to NMDA (200 μM, glycine 1 μM) were antagonized by these same compds. with IC50 values of 0.14 to 13.8 μM.  The antagonism obsd. was typical for glycineB antagonists, i.e., they induced desensitization and their effects were not use or voltage dependent.  Moreover, increasing concns. of glycine were able to decrease their apparent potency.  Much higher concns. (>100 μM) were required to antagonize α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced currents.  They were potent, systemically active NMDA receptor antagonists in vivo against responses of single neurons in the rat spinal cord to microelectrophoretic application of NMDA with ID50 values in the low milligram per kg i.v. range.  They also inhibited pentylenetetrazol-, NMDA- and maximal electroshock-induced convulsions in mice with ED50 values ranging from 8 to 100 mg/kg i.p.  The duration of anticonvulsive action was rather short but was prolonged by the org. acid transport inhibitor probenecid (200 mg/kg).  The agents tested represent a novel class of systemically active glycineB antagonists with greatly improved bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1EQUFAPvrZbVg90H21EOLACvtfcHk0linDSeZpGRPyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1Gitg%253D%253D&md5=d0d894db997e1d9a2b33c619185a1ce0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DC.%2BG.%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DQuack%26aufirst%3DG.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DLorenz%26aufirst%3DB.%26aulast%3DWollenburg%26aufirst%3DC.%26aulast%3DBaran%26aufirst%3DL.%26aulast%3DPrzegalinski%26aufirst%3DE.%26aulast%3DKostowski%26aufirst%3DW.%26aulast%3DKrzascik%26aufirst%3DP.%26aulast%3DChizh%26aufirst%3DB.%26aulast%3DHeadley%26aufirst%3DP.%2BM.%26atitle%3DNovel%2520systemically%2520active%2520antagonists%2520of%2520the%2520glycine%2520site%2520of%2520the%2520N-methyl-d-aspartate%2520receptor%253A%2520Electrophysiological%252C%2520biochemical%2520and%2520behavioral%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1264%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sapko, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagle, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington’s disease</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.expneurol.2005.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=16099455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2006&pages=31-40&issue=1&author=M.+T.+Sapkoauthor=P.+Guidettiauthor=P.+Yuauthor=D.+A.+Tagleauthor=R.+Pellicciariauthor=R.+Schwarcz&title=Endogenous+kynurenate+controls+the+vulnerability+of+striatal+neurons+to+quinolinate%3A+Implications+for+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease</span></div><div class="casAuthors">Sapko, Michael T.; Guidetti, Paolo; Yu, Ping; Tagle, Danilo A.; Pellicciari, Roberto; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Excessive activation of NMDA receptors results in excitotoxic nerve cell loss, which is believed to play a crit. role in the pathophysiol. of Huntington's disease (HD) and several other catastrophic neurodegenerative diseases.  Kynurenic acid (KYNA), a neuroinhibitory tryptophan metabolite, has neuroprotective properties and may serve as an endogenous anti-excitotoxic agent.  This hypothesis was tested in the striatum, using mice with a targeted deletion of kynurenine aminotransferase II (KAT II), a major biosynthetic enzyme of KYNA in the mammalian brain.  On post-natal day (PND) 14, the striatum of mkat-2-/- mice showed a redn. in KYNA levels but contained normal concns. of the metabolically related neurotoxins 3-hydroxykynurenine and quinolinic acid (QUIN).  Intrastriatal injections of QUIN, a NMDA receptor agonist, caused significantly larger lesions in these immature mutant mice than in age-matched wild-type animals.  This lesion enlargement was not obsd. when mkat-2-/- mice were acutely pre-treated with the kynurenine 3-hydroxylase inhibitor UPF 648, which counteracted the striatal KYNA deficit.  Moreover, no increased vulnerability to QUIN was obsd. in 2-mo-old mkat-2-/- mice, which present with normal brain KYNA levels.  Intrastriatal injections of the non-NMDA receptor agonist kainate caused similar lesion sizes in both genotypes regardless of age.  These results indicate that endogenous KYNA preferentially controls the vulnerability of striatal neurons to QUIN.  Our data suggest that timely pharmacol. interventions resulting in an up-regulation of brain KYNA levels may benefit patients suffering from HD or other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5WclI6mnY7Vg90H21EOLACvtfcHk0lijYhYi3LZKzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL&md5=76a890b6b0bfa21fac83fdf9235d1bf5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2005.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2005.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSapko%26aufirst%3DM.%2BT.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DTagle%26aufirst%3DD.%2BA.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DEndogenous%2520kynurenate%2520controls%2520the%2520vulnerability%2520of%2520striatal%2520neurons%2520to%2520quinolinate%253A%2520Implications%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Neurol.%26date%3D2006%26volume%3D197%26issue%3D1%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Poeggeler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassoulpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=188-197&issue=1&author=B.+Poeggelerauthor=A.+Rassoulpourauthor=H.+Q.+Wuauthor=P.+Guidettiauthor=R.+C.+Robertsauthor=R.+Schwarcz&title=Dopamine+receptor+activation+reveals+a+novel%2C+kynurenate-sensitive+component+of+striatal+N-methyl-D-aspartate+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoeggeler%26aufirst%3DB.%26aulast%3DRassoulpour%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DR.%2BC.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DDopamine%2520receptor%2520activation%2520reveals%2520a%2520novel%252C%2520kynurenate-sensitive%2520component%2520of%2520striatal%2520N-methyl-D-aspartate%2520neurotoxicity%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D148%26issue%3D1%26spage%3D188%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Chiarugi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Kynurenine disposition in blood and brain of mice: Effects of selective inhibitors of kynurenine hydroxylase and of kynureninase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=8764597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=692-698&issue=2&author=A.+Chiarugiauthor=R.+Carpenedoauthor=F.+Moroni&title=Kynurenine+disposition+in+blood+and+brain+of+mice%3A+Effects+of+selective+inhibitors+of+kynurenine+hydroxylase+and+of+kynureninase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase</span></div><div class="casAuthors">Chiarugi A; Carpenedo R; Moroni F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">692-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To study the regulation of the synthesis of quinolinic and kynurenic acids in vivo, we evaluated (a) the metabolism of administered kynurenine by measuring the content of its main metabolites 3-hydroxykynurenine, anthranilic acid, and 3-hydroxyanthranilic acid in blood and brain of mice; (b) the effects of (m-nitrobenzoyl)alanine, a selective inhibitor of kynurenine hydroxylase and of (o-methoxybenzoyl) alanine, a selective inhibitor of kynureninase, on this metabolism; and (c) the effects of (o-methoxybenzoyl)alanine on liver kynureninase and 3-hydroxykynureninase activity.  The conclusions drawn from these experiments are (a) the disposition of administered kynurenine preferentially occurs through hydroxylation in brain and through hydrolysis in peripheral tissues; (b) (m-nitrobenzoyl)alanine, the inhibitor of kynurenine hydroxylase, causes the expected changes in brain kynurenine metabolism, such as a decrease of 3-hydroxykynurenine, and an increase of kynurenic acid; and (c) (o-methoxybenzoyl)alanine, the kynureninase inhibitor, increases brain concentration of the cytotoxic compound 3-hydroxykynurenine, and unexpectedly does not reduce brain concentration of 3-hydroxyanthranilic acid, the direct precursor of quinolinic acid.  Taken together, the experiments suggest that the systemic administration of a kynurenine hydroxylase inhibitor is a rational approach to increase the brain content of kynurenate and to decrease that of cytotoxic kynurenine metabolites, such as 3-hydroxykynurenine and quinolinic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-MKFVxCBo-Ny3lHz94U-GfW6udTcc2eaKEf5kCI7NArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D&md5=b9843554a48282aa2660283eab76c8df</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiarugi%26aufirst%3DA.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DKynurenine%2520disposition%2520in%2520blood%2520and%2520brain%2520of%2520mice%253A%2520Effects%2520of%2520selective%2520inhibitors%2520of%2520kynurenine%2520hydroxylase%2520and%2520of%2520kynureninase%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26issue%3D2%26spage%3D692%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Speciale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2FS0014-2999%2896%2900613-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=8982663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK28XntFajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=1996&pages=263-267&issue=3&author=C.+Specialeauthor=H.+Q.+Wuauthor=M.+Ciniauthor=M.+Marconiauthor=M.+Varasiauthor=R.+Schwarcz&title=%28R%2CS%29-3%2C4-dichlorobenzoylalanine+%28FCE+28833A%29+causes+a+large+and+persistent+increase+in+brain+kynurenic+acid+levels+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats</span></div><div class="casAuthors">Speciale, Carmela; Wu, Hui-Qiu; Cini, Massimo; Marconi, Marina; Varasi, Mario; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-267</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Kynurenic acid is an endogenous excitatory amino-acid receptor antagonist with neuroprotective and anticonvulsant properties.  We demonstrate here that systemic administration of the new and potent kynurenine 3-hydroxylase inhibitor (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a dose-dependent elevation in endogenous kynurenine and kynurenic acid levels in rat brain tissue.  In hippocampal microdialyzates, peak increases of 10- and 80-fold above basal kynurenic acid concns., resp., were obtained after a single oral or i.p. administration of 400 mg/kg FCE 28833A.  After i.p. treatment with FCE 28833A, extracellular brain kynurenic acid levels remained significantly elevated for at least 22 h, rendering this compd. a far more effective enhancer of kynurenic acid levels than the previously described kynurenine 3-hydroxylase blocker m-nitrobenzoylalanine.  FCE 28833A and similar mols. may have therapeutic value in diseases which are linked to a hyperfunction of excitatory amino-acid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA8SDjJSJ-WrVg90H21EOLACvtfcHk0lijYhYi3LZKzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFajs7g%253D&md5=57728270fcd997712d2c8f597837a6ae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900613-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900613-9%26sid%3Dliteratum%253Aachs%26aulast%3DSpeciale%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DCini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DM.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3D%2528R%252CS%2529-3%252C4-dichlorobenzoylalanine%2520%2528FCE%252028833A%2529%2520causes%2520a%2520large%2520and%2520persistent%2520increase%2520in%2520brain%2520kynurenic%2520acid%2520levels%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D315%26issue%3D3%26spage%3D263%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Sapko, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagle, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington’s disease</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.expneurol.2005.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=16099455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2006&pages=31-40&author=M.+T.+Sapkoauthor=P.+Guidettiauthor=P.+Yuauthor=D.+A.+Tagleauthor=R.+Pellicciariauthor=R.+Schwarcz&title=Endogenous+kynurenate+controls+the+vulnerability+of+striatal+neurons+to+quinolinate%3A+Implications+for+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease</span></div><div class="casAuthors">Sapko, Michael T.; Guidetti, Paolo; Yu, Ping; Tagle, Danilo A.; Pellicciari, Roberto; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Excessive activation of NMDA receptors results in excitotoxic nerve cell loss, which is believed to play a crit. role in the pathophysiol. of Huntington's disease (HD) and several other catastrophic neurodegenerative diseases.  Kynurenic acid (KYNA), a neuroinhibitory tryptophan metabolite, has neuroprotective properties and may serve as an endogenous anti-excitotoxic agent.  This hypothesis was tested in the striatum, using mice with a targeted deletion of kynurenine aminotransferase II (KAT II), a major biosynthetic enzyme of KYNA in the mammalian brain.  On post-natal day (PND) 14, the striatum of mkat-2-/- mice showed a redn. in KYNA levels but contained normal concns. of the metabolically related neurotoxins 3-hydroxykynurenine and quinolinic acid (QUIN).  Intrastriatal injections of QUIN, a NMDA receptor agonist, caused significantly larger lesions in these immature mutant mice than in age-matched wild-type animals.  This lesion enlargement was not obsd. when mkat-2-/- mice were acutely pre-treated with the kynurenine 3-hydroxylase inhibitor UPF 648, which counteracted the striatal KYNA deficit.  Moreover, no increased vulnerability to QUIN was obsd. in 2-mo-old mkat-2-/- mice, which present with normal brain KYNA levels.  Intrastriatal injections of the non-NMDA receptor agonist kainate caused similar lesion sizes in both genotypes regardless of age.  These results indicate that endogenous KYNA preferentially controls the vulnerability of striatal neurons to QUIN.  Our data suggest that timely pharmacol. interventions resulting in an up-regulation of brain KYNA levels may benefit patients suffering from HD or other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5WclI6mnY7Vg90H21EOLACvtfcHk0lhNhuNMTvZ0HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL&md5=76a890b6b0bfa21fac83fdf9235d1bf5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2005.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2005.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSapko%26aufirst%3DM.%2BT.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DTagle%26aufirst%3DD.%2BA.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DEndogenous%2520kynurenate%2520controls%2520the%2520vulnerability%2520of%2520striatal%2520neurons%2520to%2520quinolinate%253A%2520Implications%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Neurol.%26date%3D2006%26volume%3D197%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Röver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huguenin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szente, A.</span><span> </span><span class="NLM_article-title">Synthesis and Biochemical Evaluation of <i>N</i>-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4378</span><span class="NLM_x">–</span> <span class="NLM_lpage">4385</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970467t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4378-4385&author=S.+R%C3%B6verauthor=A.+M.+Cesuraauthor=P.+Hugueninauthor=R.+Kettlerauthor=A.+Szente&title=Synthesis+and+Biochemical+Evaluation+of+N-%284-Phenylthiazol-2-yl%29benzenesulfonamides+as+High-Affinity+Inhibitors+of+Kynurenine+3-Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm970467t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970467t%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6ver%26aufirst%3DS.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DHuguenin%26aufirst%3DP.%26aulast%3DKettler%26aufirst%3DR.%26aulast%3DSzente%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Biochemical%2520Evaluation%2520of%2520N-%25284-Phenylthiazol-2-yl%2529benzenesulfonamides%2520as%2520High-Affinity%2520Inhibitors%2520of%2520Kynurenine%25203-Hydroxylase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4378%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Moroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruginelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini-Giampietro, D. E.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=1999&pages=199-206&author=F.+Moroniauthor=A.+Cozziauthor=F.+Peruginelliauthor=R.+Carpenedoauthor=D.+E.+Pellegrini-Giampietro&title=Neuroprotective+effects+of+kynurenine-3-hydroxylase+inhibitors+in+models+of+brain+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoroni%26aufirst%3DF.%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DPeruginelli%26aufirst%3DF.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DPellegrini-Giampietro%26aufirst%3DD.%2BE.%26atitle%3DNeuroprotective%2520effects%2520of%2520kynurenine-3-hydroxylase%2520inhibitors%2520in%2520models%2520of%2520brain%2520ischemia%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1999%26volume%3D467%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Cozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Kynurenine hydroxylase inhibitors reduce ischemic brain damage: Studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1097%2F00004647-199907000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=10413032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVCqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=771-777&issue=7&author=A.+Cozziauthor=R.+Carpenedoauthor=F.+Moroni&title=Kynurenine+hydroxylase+inhibitors+reduce+ischemic+brain+damage%3A+Studies+with+%28m-nitrobenzoyl%29-alanine+%28mNBA%29+and+3%2C4-dimethoxy-%5BN-4-%28nitrophenyl%29thiazol-2yl%5D-benzenesulfonamide+%28Ro+61-8048%29+in+models+of+focal+or+global+brain+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2YL]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia</span></div><div class="casAuthors">Cozzi, A.; Carpenedo, R.; Moroni, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Two kynurenine hydroxylase inhibitors, (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048), have been tested as neuroprotective agents on brain lesions induced by bilateral carotid occlusion in gerbils or by middle cerebral artery occlusion in rats.  The percentage of lesioned pyramidal neurons found in the hippocampal CA 1 region of gerbils subjected to bilateral carotid occlusion for 5 min decreased from 92±10% in vehicle-treated animals to 7±6% after mNBA (400 mg/kg i.p., three times at 1, 30, and 180 min after occlusion) or to 10±11% after Ro 61-8048 (40 mg/kg i.p., three times).  A significant redn. in infarct vols. also was found when the kynurenine hydroxylase inhibitors were given to rats after permanent middle cerebral artery occlusion (from 207±111 mm3 in vehicle-treated rats to 82±18 and to 62±57 mm3 in rats treated with mNBA, 400 mg/kg i.p., or with Ro 61-8048, 40 mg/kg i.p., resp.).  The administration of mNBA (400 mg/kg i.p.) or Ro 61-8048 (40 mg/kg i.p.) to gerbils with a dialysis probe in their dorsal hippocampus or to rats with a dialysis probe in their parietal cortex significantly increased kynurenic acid concn. in the dialyzates.  The data suggest that inhibition of kynurenine hydroxylase could be a new avenue to reduce neuronal loss in brain ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvjv2QFdoiC7Vg90H21EOLACvtfcHk0lhNhuNMTvZ0HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVCqsbk%253D&md5=ff003fd2c888b9c7e97afd193fe6fbd0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1097%2F00004647-199907000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-199907000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DKynurenine%2520hydroxylase%2520inhibitors%2520reduce%2520ischemic%2520brain%2520damage%253A%2520Studies%2520with%2520%2528m-nitrobenzoyl%2529-alanine%2520%2528mNBA%2529%2520and%25203%252C4-dimethoxy-%255BN-4-%2528nitrophenyl%2529thiazol-2yl%255D-benzenesulfonamide%2520%2528Ro%252061-8048%2529%2520in%2520models%2520of%2520focal%2520or%2520global%2520brain%2520ischemia%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1999%26volume%3D19%26issue%3D7%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Samadi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grégoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassoulpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bédard, P. J.</span><span> </span><span class="NLM_article-title">Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=792-802&issue=7&author=P.+Samadiauthor=L.+Gr%C3%A9goireauthor=A.+Rassoulpourauthor=P.+Guidettiauthor=E.+Izzoauthor=R.+Schwarczauthor=P.+J.+B%C3%A9dard&title=Effect+of+kynurenine+3-hydroxylase+inhibition+on+the+dyskinetic+and+antiparkinsonian+responses+to+levodopa+in+Parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamadi%26aufirst%3DP.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DL.%26aulast%3DRassoulpour%26aufirst%3DA.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DIzzo%26aufirst%3DE.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DB%25C3%25A9dard%26aufirst%3DP.%2BJ.%26atitle%3DEffect%2520of%2520kynurenine%25203-hydroxylase%2520inhibition%2520on%2520the%2520dyskinetic%2520and%2520antiparkinsonian%2520responses%2520to%2520levodopa%2520in%2520Parkinsonian%2520monkeys%26jtitle%3DMov.%2520Disord.%26date%3D2005%26volume%3D20%26issue%3D7%26spage%3D792%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Beconi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael Prime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo-Sherman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Sanjuan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2297-2306&issue=12&author=M.+G.+Beconiauthor=D.+Yatesauthor=K.+Lyonsauthor=K.+Matthewsauthor=S.+Cliftonauthor=T.+Meadauthor=M.+Michael+Primeauthor=D.+Winklerauthor=C.+O%E2%80%99Connellauthor=D.+Walterauthor=L.+M.+Toledo-Shermanauthor=I.+Munoz-Sanjuanauthor=C.+Dominguez&title=Metabolism+and+Pharmacokinetics+of+JM6+in+Mice%3A+JM6+Is+Not+a+Prodrug+for+Ro-61-8048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DYates%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DK.%26aulast%3DClifton%26aufirst%3DS.%26aulast%3DMead%26aufirst%3DT.%26aulast%3DMichael%2BPrime%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DC.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DToledo-Sherman%26aufirst%3DL.%2BM.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMetabolism%2520and%2520Pharmacokinetics%2520of%2520JM6%2520in%2520Mice%253A%2520JM6%2520Is%2520Not%2520a%2520Prodrug%2520for%2520Ro-61-8048%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2297%26epage%3D2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Courtney, S. M.; Prime, M.; Mitchell, W.; Brown, C. J.; De Aguiar Pena, P. C.; Johnson, P.; Dominguez, C.; Toledo-Sherman, L. M.; Munoz, I.</span><span> </span><span class="NLM_article-title">Kynurenine-3-Monooxygenase Inhibitors, Pharmaceutical Compositions and Methods of use Thereof</span>. International Patent WO2013/033085, Mar 7,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+M.+Courtney&author=M.+Prime&author=W.+Mitchell&author=C.+J.+Brown&author=P.+C.+De+Aguiar+Pena&author=P.+Johnson&author=C.+Dominguez&author=L.+M.+Toledo-Sherman&author=I.+Munoz&title=Kynurenine-3-Monooxygenase+Inhibitors%2C+Pharmaceutical+Compositions+and+Methods+of+use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26atitle%3DKynurenine-3-Monooxygenase%2520Inhibitors%252C%2520Pharmaceutical%2520Compositions%2520and%2520Methods%2520of%2520use%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Dominguez, C.; Toledo-Sherman, L. M.; Courtney, S. M.; Prime, M.; Mitchell, W.; Brown, C. J.; De Aguiar Pena, P. C.; Johnson, P.</span><span> </span><span class="NLM_article-title">Certain Kynurenine-3-Monooxygenase Inhibitors, Pharmaceutical Compositions and Methods of use Thereof</span>. International Patent WO2013/016488, Jan 31,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Dominguez&author=L.+M.+Toledo-Sherman&author=S.+M.+Courtney&author=M.+Prime&author=W.+Mitchell&author=C.+J.+Brown&author=P.+C.+De+Aguiar+Pena&author=P.+Johnson&title=Certain+Kynurenine-3-Monooxygenase+Inhibitors%2C+Pharmaceutical+Compositions+and+Methods+of+use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DCertain%2520Kynurenine-3-Monooxygenase%2520Inhibitors%252C%2520Pharmaceutical%2520Compositions%2520and%2520Methods%2520of%2520use%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&issue=7&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lg5icO7guKoug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26issue%3D7%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Albaneze-Walker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazaral, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormer, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, J. A.</span><span> </span><span class="NLM_article-title">Improved Carbonylation of Heterocyclic Chlorides and Electronically Challenging Aryl Bromides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2097</span><span class="NLM_x">–</span> <span class="NLM_lpage">2100</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0498287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=2097-2100&issue=13&author=J.+Albaneze-Walkerauthor=C.+Bazaralauthor=T.+Leaveyauthor=P.+G.+Dormerauthor=J.+A.+Murry&title=Improved+Carbonylation+of+Heterocyclic+Chlorides+and+Electronically+Challenging+Aryl+Bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol0498287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0498287%26sid%3Dliteratum%253Aachs%26aulast%3DAlbaneze-Walker%26aufirst%3DJ.%26aulast%3DBazaral%26aufirst%3DC.%26aulast%3DLeavey%26aufirst%3DT.%26aulast%3DDormer%26aufirst%3DP.%2BG.%26aulast%3DMurry%26aufirst%3DJ.%2BA.%26atitle%3DImproved%2520Carbonylation%2520of%2520Heterocyclic%2520Chlorides%2520and%2520Electronically%2520Challenging%2520Aryl%2520Bromides%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26issue%3D13%26spage%3D2097%26epage%3D2100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">van der Westhuyzen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, C. J.</span><span> </span><span class="NLM_article-title">Effect of Substituent Structure on Pyrimidine Electrophilic Substitution</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">5394</span><span class="NLM_x">–</span> <span class="NLM_lpage">5405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=5394-5405&issue=25&author=C.+W.+van+der+Westhuyzenauthor=A.+L.+Rousseauauthor=C.+J.+Parkinson&title=Effect+of+Substituent+Structure+on+Pyrimidine+Electrophilic+Substitution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuyzen%26aufirst%3DC.%2BW.%26aulast%3DRousseau%26aufirst%3DA.%2BL.%26aulast%3DParkinson%26aufirst%3DC.%2BJ.%26atitle%3DEffect%2520of%2520Substituent%2520Structure%2520on%2520Pyrimidine%2520Electrophilic%2520Substitution%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26issue%3D25%26spage%3D5394%26epage%3D5405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, T.</span><span> </span><span class="NLM_article-title">Dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II): An effective catalyst for cross-coupling of secondary and primary alkyl Grignard and alkylzinc reagents with organic halides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00313a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1984&pages=158-163&issue=1&author=T.+Hayashiauthor=M.+Konishiauthor=Y.+Koboriauthor=M.+Kumadaauthor=T.+Higuchi&title=Dichloro%5B1%2C1%E2%80%B2-bis%28diphenylphosphino%29ferrocene%5Dpalladium%28II%29%3A+An+effective+catalyst+for+cross-coupling+of+secondary+and+primary+alkyl+Grignard+and+alkylzinc+reagents+with+organic+halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja00313a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00313a032%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DKobori%26aufirst%3DY.%26aulast%3DKumada%26aufirst%3DM.%26aulast%3DHiguchi%26aufirst%3DT.%26atitle%3DDichloro%255B1%252C1%25E2%2580%25B2-bis%2528diphenylphosphino%2529ferrocene%255Dpalladium%2528II%2529%253A%2520An%2520effective%2520catalyst%2520for%2520cross-coupling%2520of%2520secondary%2520and%2520primary%2520alkyl%2520Grignard%2520and%2520alkylzinc%2520reagents%2520with%2520organic%2520halides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1984%26volume%3D106%26issue%3D1%26spage%3D158%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Pearson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">The Mechanism of Benzylic Bromination with <i>N</i>-Bromosuccinimide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00886a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=354-355&issue=3&author=R.+E.+Pearsonauthor=J.+C.+Martin&title=The+Mechanism+of+Benzylic+Bromination+with+N-Bromosuccinimide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja00886a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00886a029%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DR.%2BE.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Mechanism%2520of%2520Benzylic%2520Bromination%2520with%2520N-Bromosuccinimide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26issue%3D3%26spage%3D354%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Bernard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiani, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piras, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivoldini, A.</span><span> </span><span class="NLM_article-title">Dealkylation of Activated Alkyl Aryl Ethers Using Lithium Chloride in Dimethylformamide</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1055%2Fs-1989-27225" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1989&pages=287-289&author=A.+M.+Bernardauthor=M.+R.+Ghianiauthor=P.+P.+Pirasauthor=A.+Rivoldini&title=Dealkylation+of+Activated+Alkyl+Aryl+Ethers+Using+Lithium+Chloride+in+Dimethylformamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1055%2Fs-1989-27225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1989-27225%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DA.%2BM.%26aulast%3DGhiani%26aufirst%3DM.%2BR.%26aulast%3DPiras%26aufirst%3DP.%2BP.%26aulast%3DRivoldini%26aufirst%3DA.%26atitle%3DDealkylation%2520of%2520Activated%2520Alkyl%2520Aryl%2520Ethers%2520Using%2520Lithium%2520Chloride%2520in%2520Dimethylformamide%26jtitle%3DSynthesis%26date%3D1989%26volume%3D4%26spage%3D287%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Doláková, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masojídková, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holy, A.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of Pyrimidinecarbonitriles and Their Derivatives</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1107-1115&issue=5&author=P.+Dol%C3%A1kov%C3%A1author=M.+Masoj%C3%ADdkov%C3%A1author=A.+Holy&title=Efficient+Synthesis+of+Pyrimidinecarbonitriles+and+Their+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDol%25C3%25A1kov%25C3%25A1%26aufirst%3DP.%26aulast%3DMasoj%25C3%25ADdkov%25C3%25A1%26aufirst%3DM.%26aulast%3DHoly%26aufirst%3DA.%26atitle%3DEfficient%2520Synthesis%2520of%2520Pyrimidinecarbonitriles%2520and%2520Their%2520Derivatives%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D71%26issue%3D5%26spage%3D1107%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Finnegan, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofquist, R.</span><span> </span><span class="NLM_article-title">An Improved Synthesis of 5-Substituted Tetrazoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">3908</span><span class="NLM_x">–</span> <span class="NLM_lpage">3911</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01548a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaG1MXhtFOqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=3908-3911&author=W.+G.+Finneganauthor=R.+A.+Henryauthor=R.+Lofquist&title=An+Improved+Synthesis+of+5-Substituted+Tetrazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">An improved synthesis of 5-substituted tetrazoles</span></div><div class="casAuthors">Finnegan, William G.; Henry, Ronald A.; Lofquist, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3908-11</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">5-Substituted tetrazoles (I) are readily obtained from alkyl-or arylnitriles and inorg. azides in HCONMe2 (II) or Et2SO.  C7F15CN, b705 100-2°, was prepd. in 52% yield from the acid by the method of Gilman and Jones (C.A. 37, 56961).  The appropriate nitrile (0.2 mole), 14.3 g. NaN3, LiCl, the appropriate ammonium chloride or catalyst in the desired molar ratio, and 100 cc. solvent heated with stirring, the solvent evapd. in vacuo on the steam bath, and the residue (if H2O-insol.) dissolved in 100 cc. H2O, acidified with concd. HCl to pH 2, cooled to 5°, and filtered gave the corresponding I (method A).  The crude residue (if sol. or partially sol. in H2O) dissolved in 100 cc. H2O, basified with 50% aq. NaOH, and evapd. to dryness in vacuo on the steam bath, the residue dissolved in 100 cc. H2O, acidified to pH 2 with concd. HCl, and evapd. to dryness on the steam bath, and the residue extd. with EtOH or MeOH yielded the corresponding I (method B).  The finally acidified soln. in method B concd., cooled to room temp., adjusted to pH 5 with base, treated with 0.1 mole aq. Cu(OAc)2, and filtered, the residue washed with H2O, suspended in 100-200 cc. H2O, heated with stirring to 50°, bubbled with H2S, and filtered, and the filtrate evapd. to dryness in vacuo gave the corresponding I (method C).  In this manner were prepd. the following I (5-substituent, m.p., % yield, azide used, reaction temp., reaction time in hrs., reaction medium used, and method used given): H, 147-51° (decompn.) (EtOAc), 69.2, Me3NHN3, 105-10°, 22, II, B;  Pr, 63-4° (iso-Pr2O), 73.5, NH4N3 (III), 120-5°, 24, II, C; HOCH2CH2, 83-4° (EtCOMe), 93.3°, III, 120-5°, 24, II, B;  MeO(CH2)2, 66-7° (EtOAc), 100, III, 120°, 18, II, B;  EtO2CCH2, 128-30° (iso-PrOH), 81, III, 95°, 8, II, A;  NaOSO2(CH2)2, 208-9° (decompn.) (95% EtOH), -, III, 120-5°, 7, II, B;  PhCH2, 123-5° [(CH2Cl)2], 84.1, III, 120-5°, 7, II, A; MeS, 150-1° (decompn.) (H2O), 91.5, III, 95°, 6, II, A; PhCH2S, 137.5-8.5° (30% EtOH), 22, III, 95°, 5, II, A; C7F15, -, 100, III, 95°, 4, II, A; Ph (IV), 213-15° (decompn.) (H2O), 100, III, 125°, 7, II, A; IV, -, 90.6, Me3NHN3, 100°, 3, II, A; IV, -, 90, III, 100°, 96°, Ethyl Cellosolve, A; IV,  -, 51.3, NaN3, reflux, 20.5, II, A; IV, -, 43.9, NaN3, 120-5°, 24, Me2SO, A (the Na salt was pptd. with CH2Cl2 and treated in H2O with concd. HCl to yield IV); IV, -, 19.4, NaN3, 126°, 24, Methyl Cellosolve, A; p-H2NC6H4, 268-70° (aq. II), -, -, -, -, -, -; p-NCC6H4, above 300° (decompn.) (H2O), -, -, -, -, -, -; bis(5-tetrazolyl)methane, 215-19° (decompn.) (MeCN), 100, III, 95°, 16, II, A; 1,4-bis(5-tetrazolyl)butane, 204-5° (decompn.) (95% EtOH), 26, III, 100°, 96, Ethyl Cellosolve, A; 1,4-bis(5-tetrazolyl)- benzene (V), above 300° (decompn.) (95% EtOH), 100, III, 125°, 7, II, A.  A series of runs was performed for the prepn. of IV by treating 0.2 mole PhCN, 100 cc. HCONMe2, and 0.22 mole NaN3 during 7 hrs. at 123-7° in the presence of various added salts or catalyst (added material, mole-%, and % yield of IV given): none, -, 24.9; NH4Cl, 10, 59.6 (54.1); Bu2NH.HCl, 5, 51.6; PhNH2.HCl, 5.8, 57.2; PhNH2.HCl, 10, 73.8; EtSO4H, 4, 51.3; EtSO3H (in 100 cc. MeOCH2CH2OH), 8, 16.3; Et2O-BF3, 10, 55.6; Me4NCl, 100, 40.4; LiCl, 100, 48.6; H2O, - (5 cc.), 5.8.  The appropriate substituted benzonitrile (0.2 mole), 0.22 mole III, and 100 cc. HCONMe2 yielded during 3 hrs. at 100° varying yields of I depending on the substituent (5- substituent of I and % yield given): p-NH2, 10.4, p-MeO 43.2, p-Me 63.8, H, 75.6, p-NO2 96.9, m-NO2 99.5, p-CN 90.5 (and a small amt. of V).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5x4qHLA-D-rVg90H21EOLACvtfcHk0ljOatCjEs_gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXhtFOqtg%253D%253D&md5=c02810dd38cce62bfdfe9c398136201d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja01548a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01548a028%26sid%3Dliteratum%253Aachs%26aulast%3DFinnegan%26aufirst%3DW.%2BG.%26aulast%3DHenry%26aufirst%3DR.%2BA.%26aulast%3DLofquist%26aufirst%3DR.%26atitle%3DAn%2520Improved%2520Synthesis%2520of%25205-Substituted%2520Tetrazoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D3908%26epage%3D3911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tailleux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Novel non-carboxylic acid retinoids: 1,2,4-Oxadiazol-5-one derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=489-492&issue=2&author=J.+Chartonauthor=R.+Deprez-Poulainauthor=N.+Hennuyerauthor=A.+Tailleuxauthor=B.+Staelsauthor=B.+Deprez&title=Novel+non-carboxylic+acid+retinoids%3A+1%2C2%2C4-Oxadiazol-5-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DTailleux%26aufirst%3DA.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DNovel%2520non-carboxylic%2520acid%2520retinoids%253A%25201%252C2%252C4-Oxadiazol-5-one%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D2%26spage%3D489%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Santilli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. L.</span><span> </span><span class="NLM_article-title">Synthesis of 3-Arylsulfonylmethyl-1,2-4-oxadiazole-5-carboxylic Acid Derivatives</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=1197-1200&issue=6&author=A.+Santilliauthor=R.+L.+Morris&title=Synthesis+of+3-Arylsulfonylmethyl-1%2C2-4-oxadiazole-5-carboxylic+Acid+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantilli%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DR.%2BL.%26atitle%3DSynthesis%2520of%25203-Arylsulfonylmethyl-1%252C2-4-oxadiazole-5-carboxylic%2520Acid%2520Derivatives%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26issue%3D6%26spage%3D1197%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Manley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balitza, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodman, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1673-1677&issue=10&author=P.+J.+Manleyauthor=A.+E.+Balitzaauthor=M.+T.+Bilodeauauthor=K.+E.+Collauthor=R.+C.+Hartmanauthor=K.+W.+McFallauthor=L.+D.+Rodmanauthor=K.+A.+Thomas&title=2%2C4-Disubstituted+pyrimidines%3A+A+novel+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DBalitza%26aufirst%3DA.%2BE.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DHartman%26aufirst%3DR.%2BC.%26aulast%3DMcFall%26aufirst%3DK.%2BW.%26aulast%3DRodman%26aufirst%3DL.%2BD.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3D2%252C4-Disubstituted%2520pyrimidines%253A%2520A%2520novel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D10%26spage%3D1673%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo-Sherman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebneth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Sanjuan, I.</span><span> </span><span class="NLM_article-title">Development of LC/MS/MS, High-Throughput Enzymatic and Cellular Assays for the Characterization of Compounds That Inhibit Kynurenine Monooxygenase (KMO)</span> <span class="citation_source-journal">J. Biol. Screening.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1177%2F1087057113489731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=23690293" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=879-889&issue=8&author=D.+Winklerauthor=M.+Beconiauthor=L.+M.+Toledo-Shermanauthor=M.+Primeauthor=A.+Ebnethauthor=C.+Dominguezauthor=I.+Mu%C3%B1oz-Sanjuan&title=Development+of+LC%2FMS%2FMS%2C+High-Throughput+Enzymatic+and+Cellular+Assays+for+the+Characterization+of+Compounds+That+Inhibit+Kynurenine+Monooxygenase+%28KMO%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1177%2F1087057113489731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113489731%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DToledo-Sherman%26aufirst%3DL.%2BM.%26aulast%3DPrime%26aufirst%3DM.%26aulast%3DEbneth%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DMu%25C3%25B1oz-Sanjuan%26aufirst%3DI.%26atitle%3DDevelopment%2520of%2520LC%252FMS%252FMS%252C%2520High-Throughput%2520Enzymatic%2520and%2520Cellular%2520Assays%2520for%2520the%2520Characterization%2520of%2520Compounds%2520That%2520Inhibit%2520Kynurenine%2520Monooxygenase%2520%2528KMO%2529%26jtitle%3DJ.%2520Biol.%2520Screening.%26date%3D2013%26volume%3D18%26issue%3D8%26spage%3D879%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Krueger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. E.</span><span> </span><span class="NLM_article-title">Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.pharmthera.2005.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15922018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1SltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=357-387&author=S.+K.+Kruegerauthor=D.+E.+Williams&title=Mammalian+flavin-containing+monooxygenases%3A+structure%2Ffunction%2C+genetic+polymorphisms+and+role+in+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism</span></div><div class="casAuthors">Krueger, Sharon K.; Williams, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-387</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Flavin-contg. monooxygenase (FMO) oxygenates drugs and xenobiotics contg. a "soft nucleophile", usually N or S.  FMO, like cytochrome P 450 (CYP), is a monooxygenase, utilizing the reducing equiv. of NADPH to reduce 1 atom of O2 to H2O, while the other atom is used to oxidize the substrate.  FMO and CYP also exhibit similar tissue and cellular location, mol. wt., substrate specificity, and exist as multiple enzymes under developmental control.  The human FMO functional gene family is much smaller (5 families each with a single member) than CYP.  FMO does not require a reductase to transfer electrons from NADPH and the catalytic cycle of the 2 monooxygenases is strikingly different.  Another distinction is the lack of induction of FMOs by xenobiotics.  In general, CYP is the major contributor to oxidative xenobiotic metab.  However, FMO activity may be of significance in a no. of cases and should not be overlooked.  FMO and CYP have overlapping substrate specificities, but often yield distinct metabolites with potentially significant toxicol./pharmacol. consequences.  The physiol. function(s) of FMOs are poorly understood.  Three of the 5 expressed human FMO genes, FMO1, FMO2, and FMO3, exhibit genetic polymorphisms.  The most studied of these is FMO3 (adult human liver) in which mutant alleles contribute to the disease known as trimethylaminuria.  The consequences of these FMO genetic polymorphisms in drug metab. and human health are areas of research requiring further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfwDBzxhgaYbVg90H21EOLACvtfcHk0ljwBKe9K_6xlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1SltLc%253D&md5=2f0b76495aa8a53069bacc9b4ae8de43</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2005.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2005.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DKrueger%26aufirst%3DS.%2BK.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26atitle%3DMammalian%2520flavin-containing%2520monooxygenases%253A%2520structure%252Ffunction%252C%2520genetic%2520polymorphisms%2520and%2520role%2520in%2520drug%2520metabolism%26jtitle%3DPharmacol.%2520Ther.%26date%3D2005%26volume%3D106%26spage%3D357%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Melo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floriano, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, J. A. N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leao, J. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalhães, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nascimento, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, N.</span><span> </span><span class="NLM_article-title">Theoretical study of arginine–carboxylate interactions</span> <span class="citation_source-journal">J. Mol. Struct.: THEOCHEM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2FS0166-1280%2898%2900396-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK1MXit12itLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=1999&pages=81-90&issue=1&author=A.+Meloauthor=M.+J.+Ramosauthor=W.+B.+Florianoauthor=J.+A.+N.+F.+Gomesauthor=J.+F.+R.+Leaoauthor=A.+L.+Magalh%C3%A3esauthor=B.+Maigretauthor=M.+C.+Nascimentoauthor=N.+Reuter&title=Theoretical+study+of+arginine%E2%80%93carboxylate+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical study of arginine-carboxylate interactions</span></div><div class="casAuthors">Melo, A.; Ramos, M. J.; Floriano, W. B.; Gomes, J. A. N. F.; Leao, J. F. R.; Magalhaes, A. L.; Maigret, B.; Nascimento, M. C.; Reuter, N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure: THEOCHEM</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">81-90</span>CODEN:
                <span class="NLM_cas:coden">THEODJ</span>;
        ISSN:<span class="NLM_cas:issn">0166-1280</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The importance of the guanidinium-carboxylate interactions has sprung from the obsd. salt bridges often present in biol. systems involving the arginine-glutamate or arginine-aspartate side chains.  The strength of these interactions has been explained on the basis of a great coulombic energy gain, due to the closeness of two charges of opposite sign and the occurrence of H-bond interactions.  However, in some environments proton transfer, from guanidinium to carboxylate, can occur with the consequent annihilation of charge.  In this work, both ab-initio (6-31G** and MP2/6-31G**) and semi-empirical (AM1) calcns. were performed in vacuo on appropriate models, methylguanidinium-acetate and methylguanidine-acetic acid to simulate the zwitterionic and the neutral forms, resp.  The results obtained indicate that, in solvent-free hydrophobic environments, the neutral form should be more stable than the zwitterionic one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVeW2ZpN-T-7Vg90H21EOLACvtfcHk0ljwBKe9K_6xlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit12itLY%253D&md5=36b8a16151fe18fcc1709759e671b3b6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0166-1280%2898%2900396-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-1280%252898%252900396-0%26sid%3Dliteratum%253Aachs%26aulast%3DMelo%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26aulast%3DFloriano%26aufirst%3DW.%2BB.%26aulast%3DGomes%26aufirst%3DJ.%2BA.%2BN.%2BF.%26aulast%3DLeao%26aufirst%3DJ.%2BF.%2BR.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DA.%2BL.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DNascimento%26aufirst%3DM.%2BC.%26aulast%3DReuter%26aufirst%3DN.%26atitle%3DTheoretical%2520study%2520of%2520arginine%25E2%2580%2593carboxylate%2520interactions%26jtitle%3DJ.%2520Mol.%2520Struct.%253A%2520THEOCHEM%26date%3D1999%26volume%3D463%26issue%3D1%26spage%3D81%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Amaral, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafite, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrutton, N. S.</span><span> </span><span class="NLM_article-title">Structural basis of kynurenine 3-monooxygenase inhibition</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">496</span><span class="NLM_x"> (</span><span class="NLM_issue">7445</span><span class="NLM_x">) </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=382-385&issue=7445&author=M.+Amaralauthor=C.+Levyauthor=D.+J.+Heyesauthor=P.+Lafiteauthor=T.+F.+Outeiroauthor=F.+Giorginiauthor=D.+Leysauthor=N.+S.+Scrutton&title=Structural+basis+of+kynurenine+3-monooxygenase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmaral%26aufirst%3DM.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DHeyes%26aufirst%3DD.%2BJ.%26aulast%3DLafite%26aufirst%3DP.%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DGiorgini%26aufirst%3DF.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DScrutton%26aufirst%3DN.%2BS.%26atitle%3DStructural%2520basis%2520of%2520kynurenine%25203-monooxygenase%2520inhibition%26jtitle%3DNature%26date%3D2013%26volume%3D496%26issue%3D7445%26spage%3D382%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Krajcsi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tóth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beéry, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sziráki, I.</span><span> </span><span class="NLM_article-title">Efflux transporters in the blood-brain interfaces-in vitro and in vivo methods and correlations</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1517%2F17425255.2012.668184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22394316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=419-431&issue=4&author=P.+Krajcsiauthor=M.+Janiauthor=B.+T%C3%B3thauthor=F.+Erdoauthor=E.+Kisauthor=E.+Be%C3%A9ryauthor=I.+Szir%C3%A1ki&title=Efflux+transporters+in+the+blood-brain+interfaces-in+vitro+and+in+vivo+methods+and+correlations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Efflux transporters in the blood-brain interfaces - in vitro and in vivo methods and correlations</span></div><div class="casAuthors">Krajcsi, Peter; Jani, Marton; Toth, Beata; Erdoo, Franciska; Kis, Emese; Beery, Erzsebet; Sziraki, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Sufficient brain exposure is crucial to the success of CNS drugs.  The twofold greater attrition rate in clin. development of CNS drugs over the resp. attrition rate of non-CNS drugs is due to lack of efficacy.  It is generally thought that poor brain exposure is at least partly responsible for this, as the concn.-time profile at the brain target site is crit. for efficacy.  Efflux transporters in the blood-brain interfaces play a crucial role in modulation of permeability of drugs across these interfaces.  Validation of preclin. tools to correctly predict brain exposure in humans is essential.Areas covered: This review summarizes in vitro and in vivo tools to detect and characterize interactions of drugs with efflux transporters relevant to blood-brain interfaces.  Furthermore, the article discusses the strengths and weaknesses of these methods and the limitations of their application, in addn. to covering in vitro - in vivo correlations.Expert opinion: A more detailed validation of in vitro efflux transporter assays employing primary brain endothelial cultures is needed.  This should go along with mapping uptake transporters expressed in the blood-brain interfaces.  With the availability of specific inhibitors, utilization of in vivo methods such as brain microdialysis is increasing.  Once transporter-humanized mice are available, we may witness a further increase in applications of in vivo methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-t2mdNe-CKbVg90H21EOLACvtfcHk0lhpDHT7d5jqVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOrsL0%253D&md5=deca903466a82d5d026bf8ca08bbecbf</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.668184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.668184%26sid%3Dliteratum%253Aachs%26aulast%3DKrajcsi%26aufirst%3DP.%26aulast%3DJani%26aufirst%3DM.%26aulast%3DT%25C3%25B3th%26aufirst%3DB.%26aulast%3DErdo%26aufirst%3DF.%26aulast%3DKis%26aufirst%3DE.%26aulast%3DBe%25C3%25A9ry%26aufirst%3DE.%26aulast%3DSzir%25C3%25A1ki%26aufirst%3DI.%26atitle%3DEfflux%2520transporters%2520in%2520the%2520blood-brain%2520interfaces-in%2520vitro%2520and%2520in%2520vivo%2520methods%2520and%2520correlations%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D8%26issue%3D4%26spage%3D419%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Jauch, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethy, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weick, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Intravenous administration of L-kynurenine to rhesus monkeys: Effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=467-472&issue=5&author=D.+A.+Jauchauthor=V.+H.+Sethyauthor=B.+G.+Weickauthor=T.+N.+Chaseauthor=R.+Schwarcz&title=Intravenous+administration+of+L-kynurenine+to+rhesus+monkeys%3A+Effect+on+quinolinate+and+kynurenate+levels+in+serum+and+cerebrospinal+fluid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DD.%2BA.%26aulast%3DSethy%26aufirst%3DV.%2BH.%26aulast%3DWeick%26aufirst%3DB.%2BG.%26aulast%3DChase%26aufirst%3DT.%2BN.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DIntravenous%2520administration%2520of%2520L-kynurenine%2520to%2520rhesus%2520monkeys%253A%2520Effect%2520on%2520quinolinate%2520and%2520kynurenate%2520levels%2520in%2520serum%2520and%2520cerebrospinal%2520fluid%26jtitle%3DNeuropharmacology%26date%3D1993%26volume%3D32%26issue%3D5%26spage%3D467%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Alexander, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span> </span><span class="NLM_article-title">Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2012&pages=627-637&issue=3&author=K.+S.+Alexanderauthor=H.+Q.+Wuauthor=R.+Schwarczauthor=J.+P.+Bruno&title=Acute+elevations+of+brain+kynurenic+acid+impair+cognitive+flexibility%3A+normalization+by+the+alpha7+positive+modulator+galantamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26atitle%3DAcute%2520elevations%2520of%2520brain%2520kynurenic%2520acid%2520impair%2520cognitive%2520flexibility%253A%2520normalization%2520by%2520the%2520alpha7%2520positive%2520modulator%2520galantamine%26jtitle%3DPsychopharmacology%26date%3D2012%26volume%3D220%26issue%3D3%26spage%3D627%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Westerink, B. H. C.; Cremers, T. I. F. H.</span>, Eds.  <span class="citation_source-book">Handbook of Microdialyis – Methods, Applications and Clinical Aspects</span>; <span class="NLM_publisher-name">Academic Press, Elsevier</span>: <span class="NLM_publisher-loc">London, UK</span>.<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+H.+C.+Westerink&author=T.+I.+F.+H.+Cremers&title=Handbook+of+Microdialyis+%E2%80%93+Methods%2C+Applications+and+Clinical+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWesterink%26aufirst%3DB.%2BH.%2BC.%26btitle%3DHandbook%2520of%2520Microdialyis%2520%25E2%2580%2593%2520Methods%252C%2520Applications%2520and%2520Clinical%2520Aspects%26pub%3DAcademic%2520Press%252C%2520Elsevier%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tsz Ying Yuen, Christopher J. Brown, Yaw Sing Tan, <span class="NLM_string-name hlFld-ContribAuthor">Charles W. Johannes</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Chiral Alkenyl Cyclopropane Amino Acids for Incorporation into Stapled Peptides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (3)
                                     , 1556-1566. <a href="https://doi.org/10.1021/acs.joc.9b02659" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02659%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BChiral%252BAlkenyl%252BCyclopropane%252BAmino%252BAcids%252Bfor%252BIncorporation%252Binto%252BStapled%252BPeptides%26aulast%3DYuen%26aufirst%3DTsz%2BYing%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D01102019%26date%3D26122019%26date%3D11122019%26volume%3D85%26issue%3D3%26spage%3D1556%26epage%3D1566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annalise Di Marco, Odalys Gonzalez Paz, Ivan Fini, Domenico Vignone, Antonella Cellucci, Maria Rosaria Battista, Giulio Auciello, Laura Orsatti, Matteo Zini, Edith Monteagudo, Vinod Khetarpal, Mark Rose, Celia Dominguez, Todd Herbst, Leticia Toledo-Sherman, Vincenzo Summa, <span class="NLM_string-name hlFld-ContribAuthor">Ignacio Muñoz-Sanjuán</span>. </span><span class="cited-content_cbyCitation_article-title">Application of an in Vitro Blood–Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , 2069-2082. <a href="https://doi.org/10.1021/acs.molpharmaceut.9b00042" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.9b00042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.9b00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.9b00042%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DApplication%252Bof%252Ban%252Bin%252BVitro%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BModel%252Bin%252Bthe%252BSelection%252Bof%252BExperimental%252BDrug%252BCandidates%252Bfor%252Bthe%252BTreatment%252Bof%252BHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DDi%2BMarco%26aufirst%3DAnnalise%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10012019%26date%3D27032019%26date%3D06032019%26date%3D04042019%26date%3D27032019%26volume%3D16%26issue%3D5%26spage%3D2069%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joseph Derosa, Miriam L. O’Duill, Matthew Holcomb, Mark N. Boulous, Ryan L. Patman, Fen Wang, Michelle Tran-Dubé, Indrawan McAlpine, <span class="NLM_string-name hlFld-ContribAuthor">Keary M. Engle</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Chan–Lam Cyclopropylation of Phenols and Azaheterocycles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (7)
                                     , 3417-3425. <a href="https://doi.org/10.1021/acs.joc.7b03100" title="DOI URL">https://doi.org/10.1021/acs.joc.7b03100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b03100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b03100%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BChan%2525E2%252580%252593Lam%252BCyclopropylation%252Bof%252BPhenols%252Band%252BAzaheterocycles%26aulast%3DDerosa%26aufirst%3DJoseph%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D07122017%26date%3D13032018%26date%3D02032018%26volume%3D83%26issue%3D7%26spage%3D3417%26epage%3D3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Pellicciari</span>, <span class="hlFld-ContribAuthor ">Paride  Liscio</span>, <span class="hlFld-ContribAuthor ">Nicola  Giacchè</span>, <span class="hlFld-ContribAuthor ">Francesca  De Franco</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Janet  Robertson</span>, <span class="hlFld-ContribAuthor ">Lucia  Cialabrini</span>, <span class="hlFld-ContribAuthor ">Elena  Katsyuba</span>, <span class="hlFld-ContribAuthor ">Nadia  Raffaelli</span>, and <span class="hlFld-ContribAuthor ">Johan  Auwerx</span>  . </span><span class="cited-content_cbyCitation_article-title">α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 745-759. <a href="https://doi.org/10.1021/acs.jmedchem.7b01254" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01254%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B1-Amino-%2525CE%2525B2-carboxymuconate-%2525CE%2525B5-semialdehyde%252BDecarboxylase%252B%252528ACMSD%252529%252BInhibitors%252Bas%252BNovel%252BModulators%252Bof%252BDe%252BNovo%252BNicotinamide%252BAdenine%252BDinucleotide%252B%252528NAD%25252B%252529%252BBiosynthesis%26aulast%3DPellicciari%26aufirst%3DRoberto%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D23082017%26date%3D26012018%26date%3D08022018%26date%3D18012018%26volume%3D61%26issue%3D3%26spage%3D745%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ann L.  Walker</span>, <span class="hlFld-ContribAuthor ">Nicolas  Ancellin</span>, <span class="hlFld-ContribAuthor ">Benjamin  Beaufils</span>, <span class="hlFld-ContribAuthor ">Marylise  Bergeal</span>, <span class="hlFld-ContribAuthor ">Margaret  Binnie</span>, <span class="hlFld-ContribAuthor ">Anne  Bouillot</span>, <span class="hlFld-ContribAuthor ">David  Clapham</span>, <span class="hlFld-ContribAuthor ">Alexis  Denis</span>, <span class="hlFld-ContribAuthor ">Carl P.  Haslam</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Jonathan P.  Hutchinson</span>, <span class="hlFld-ContribAuthor ">John  Liddle</span>, <span class="hlFld-ContribAuthor ">Andrew  McBride</span>, <span class="hlFld-ContribAuthor ">Olivier  Mirguet</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Mowat</span>, <span class="hlFld-ContribAuthor ">Paul  Rowland</span>, <span class="hlFld-ContribAuthor ">Nathalie  Tiberghien</span>, <span class="hlFld-ContribAuthor ">Lionel  Trottet</span>, <span class="hlFld-ContribAuthor ">Iain  Uings</span>, <span class="hlFld-ContribAuthor ">Scott P.  Webster</span>, <span class="hlFld-ContribAuthor ">Xiaozhong  Zheng</span>, and <span class="hlFld-ContribAuthor ">Damian J.  Mole</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (8)
                                     , 3383-3404. <a href="https://doi.org/10.1021/acs.jmedchem.7b00055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BSeries%252Bof%252BKynurenine%252B3-Monooxygenase%252BInhibitors%252BLeading%252Bto%252Ba%252BClinical%252BCandidate%252Bfor%252Bthe%252BTreatment%252Bof%252BAcute%252BPancreatitis%26aulast%3DWalker%26aufirst%3DAnn%2BL.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D31012017%26date%3D11042017%26date%3D27042017%26date%3D28032017%26volume%3D60%26issue%3D8%26spage%3D3383%26epage%3D3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinya  Mimasu</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Yamagishi</span>, <span class="hlFld-ContribAuthor ">Satoshi  Kubo</span>, <span class="hlFld-ContribAuthor ">Mie  Kiyohara</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Matsuda</span>, <span class="hlFld-ContribAuthor ">Toshiko  Yahata</span>, <span class="hlFld-ContribAuthor ">Heather A.  Thomson</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Hupp</span>, <span class="hlFld-ContribAuthor ">Julie  Liu</span>, <span class="hlFld-ContribAuthor ">Takao  Okuda</span>, <span class="hlFld-ContribAuthor ">Kenichi  Kakefuda</span>. </span><span class="cited-content_cbyCitation_article-title">Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-021-01666-5" title="DOI URL">https://doi.org/10.1038/s42003-021-01666-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-021-01666-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-021-01666-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DFull-length%252Bin%252Bmeso%252Bstructure%252Band%252Bmechanism%252Bof%252Brat%252Bkynurenine%252B3-monooxygenase%252Binhibition%26aulast%3DMimasu%26aufirst%3DShinya%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Marszalek-Grabska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Walczak</span>, <span class="hlFld-ContribAuthor ">Kinga  Gawel</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Wicha-Komsta</span>, <span class="hlFld-ContribAuthor ">Sylwia  Wnorowska</span>, <span class="hlFld-ContribAuthor ">Artur  Wnorowski</span>, <span class="hlFld-ContribAuthor ">Waldemar A.  Turski</span>. </span><span class="cited-content_cbyCitation_article-title">Kynurenine emerges from the shadows – Current knowledge on its fate and function. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>225 </em>, 107845. <a href="https://doi.org/10.1016/j.pharmthera.2021.107845" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107845%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DKynurenine%252Bemerges%252Bfrom%252Bthe%252Bshadows%252B%2525E2%252580%252593%252BCurrent%252Bknowledge%252Bon%252Bits%252Bfate%252Band%252Bfunction%26aulast%3DMarszalek-Grabska%26aufirst%3DMarta%26date%3D2021%26volume%3D225%26spage%3D107845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian  Mor</span>, <span class="hlFld-ContribAuthor ">Anna  Tankiewicz-Kwedlo</span>, <span class="hlFld-ContribAuthor ">Anna  Krupa</span>, <span class="hlFld-ContribAuthor ">Dariusz  Pawlak</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 1603. <a href="https://doi.org/10.3390/cells10071603" title="DOI URL">https://doi.org/10.3390/cells10071603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10071603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10071603%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DRole%252Bof%252BKynurenine%252BPathway%252Bin%252BOxidative%252BStress%252Bduring%252BNeurodegenerative%252BDisorders%26aulast%3DMor%26aufirst%3DAdrian%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lizaveta  Gotina</span>, <span class="hlFld-ContribAuthor ">Seon Hee  Seo</span>, <span class="hlFld-ContribAuthor ">Chae Won  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Min  Lim</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3314. <a href="https://doi.org/10.3390/molecules26113314" title="DOI URL">https://doi.org/10.3390/molecules26113314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113314%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPharmacophore-Based%252BVirtual%252BScreening%252Bof%252BNovel%252BCompetitive%252BInhibitors%252Bof%252Bthe%252BNeurodegenerative%252BDisease%252BTarget%252BKynurenine-3-Monooxygenase%26aulast%3DGotina%26aufirst%3DLizaveta%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary EW  Collier</span>, <span class="hlFld-ContribAuthor ">Shaowei  Zhang</span>, <span class="hlFld-ContribAuthor ">Nigel S  Scrutton</span>, <span class="hlFld-ContribAuthor ">Flaviano  Giorgini</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1473-1481. <a href="https://doi.org/10.1016/j.drudis.2021.02.009" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DInflammation%252Bcontrol%252Band%252Bimprovement%252Bof%252Bcognitive%252Bfunction%252Bin%252BCOVID-19%252Binfections%25253A%252Bis%252Bthere%252Ba%252Brole%252Bfor%252Bkynurenine%252B3-monooxygenase%252Binhibition%25253F%26aulast%3DCollier%26aufirst%3DMary%2BEW%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1473%26epage%3D1481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaowei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mary E.W.  Collier</span>, <span class="hlFld-ContribAuthor ">Derren J.  Heyes</span>, <span class="hlFld-ContribAuthor ">Flaviano  Giorgini</span>, <span class="hlFld-ContribAuthor ">Nigel S.  Scrutton</span>. </span><span class="cited-content_cbyCitation_article-title">Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2021,</strong> <em>697 </em>, 108702. <a href="https://doi.org/10.1016/j.abb.2020.108702" title="DOI URL">https://doi.org/10.1016/j.abb.2020.108702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2020.108702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2020.108702%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DAdvantages%252Bof%252Bbrain%252Bpenetrating%252Binhibitors%252Bof%252Bkynurenine-3-monooxygenase%252Bfor%252Btreatment%252Bof%252Bneurodegenerative%252Bdiseases%26aulast%3DZhang%26aufirst%3DShaowei%26date%3D2021%26volume%3D697%26spage%3D108702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgane  Modoux</span>, <span class="hlFld-ContribAuthor ">Nathalie  Rolhion</span>, <span class="hlFld-ContribAuthor ">Sridhar  Mani</span>, <span class="hlFld-ContribAuthor ">Harry  Sokol</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptophan Metabolism as a Pharmacological Target. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (1)
                                     , 60-73. <a href="https://doi.org/10.1016/j.tips.2020.11.006" title="DOI URL">https://doi.org/10.1016/j.tips.2020.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTryptophan%252BMetabolism%252Bas%252Ba%252BPharmacological%252BTarget%26aulast%3DModoux%26aufirst%3DMorgane%26date%3D2021%26volume%3D42%26issue%3D1%26spage%3D60%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yılmaz  Özkılıç</span>, <span class="hlFld-ContribAuthor ">Nurcan Ş  Tüzün</span>. </span><span class="cited-content_cbyCitation_article-title">In silico methods predict new blood-brain barrier permeable structure for the inhibition of kynurenine 3-monooxygenase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>100 </em>, 107701. <a href="https://doi.org/10.1016/j.jmgm.2020.107701" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107701%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DIn%252Bsilico%252Bmethods%252Bpredict%252Bnew%252Bblood-brain%252Bbarrier%252Bpermeable%252Bstructure%252Bfor%252Bthe%252Binhibition%252Bof%252Bkynurenine%252B3-monooxygenase%26aulast%3D%25C3%2596zk%25C4%25B1l%25C4%25B1%25C3%25A7%26aufirst%3DY%25C4%25B1lmaz%26date%3D2020%26volume%3D100%26spage%3D107701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annalise  Di Marco</span>, <span class="hlFld-ContribAuthor ">Domenico  Vignone</span>, <span class="hlFld-ContribAuthor ">Odalys  Gonzalez Paz</span>, <span class="hlFld-ContribAuthor ">Ivan  Fini</span>, <span class="hlFld-ContribAuthor ">Maria Rosaria  Battista</span>, <span class="hlFld-ContribAuthor ">Antonella  Cellucci</span>, <span class="hlFld-ContribAuthor ">Elena  Bracacel</span>, <span class="hlFld-ContribAuthor ">Giulio  Auciello</span>, <span class="hlFld-ContribAuthor ">Maria  Veneziano</span>, <span class="hlFld-ContribAuthor ">Vinod  Khetarpal</span>, <span class="hlFld-ContribAuthor ">Mark  Rose</span>, <span class="hlFld-ContribAuthor ">Alessandro  Rosa</span>, <span class="hlFld-ContribAuthor ">Isabelle  Gloaguen</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Todd  Herbst</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Ignacio  Muñoz-Sanjuán</span>. </span><span class="cited-content_cbyCitation_article-title">Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (4)
                                     , 994. <a href="https://doi.org/10.3390/cells9040994" title="DOI URL">https://doi.org/10.3390/cells9040994</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9040994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9040994%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DEstablishment%252Bof%252Ban%252Bin%252BVitro%252BHuman%252BBlood-Brain%252BBarrier%252BModel%252BDerived%252Bfrom%252BInduced%252BPluripotent%252BStem%252BCells%252Band%252BComparison%252Bto%252Ba%252BPorcine%252BCell-Based%252BSystem%26aulast%3DDi%2BMarco%26aufirst%3DAnnalise%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3D994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanislav S.  Shcherbakov</span>, <span class="hlFld-ContribAuthor ">Artyom Yu.  Magometov</span>, <span class="hlFld-ContribAuthor ">Viktoriia Yu.  Shcherbakova</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Aksenov</span>, <span class="hlFld-ContribAuthor ">Dmitriy A.  Domenyuk</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Zelensky</span>, <span class="hlFld-ContribAuthor ">Michael  Rubin</span>. </span><span class="cited-content_cbyCitation_article-title">Electrophilic alkylation of arenes with 5-bromopyrimidine en route to 4-aryl-5-alkynylpyrimidines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (17)
                                     , 10315-10321. <a href="https://doi.org/10.1039/D0RA01335H" title="DOI URL">https://doi.org/10.1039/D0RA01335H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA01335H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA01335H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DElectrophilic%252Balkylation%252Bof%252Barenes%252Bwith%252B5-bromopyrimidine%252Ben%252Broute%252Bto%252B4-aryl-5-alkynylpyrimidines%26aulast%3DShcherbakov%26aufirst%3DStanislav%2BS.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D17%26spage%3D10315%26epage%3D10321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaowei  Zhang</span>, <span class="hlFld-ContribAuthor ">Michiyo  Sakuma</span>, <span class="hlFld-ContribAuthor ">Girdhar S.  Deora</span>, <span class="hlFld-ContribAuthor ">Colin W.  Levy</span>, <span class="hlFld-ContribAuthor ">Alex  Klausing</span>, <span class="hlFld-ContribAuthor ">Carlo  Breda</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Read</span>, <span class="hlFld-ContribAuthor ">Chris D.  Edlin</span>, <span class="hlFld-ContribAuthor ">Benjamin P.  Ross</span>, <span class="hlFld-ContribAuthor ">Marina  Wright Muelas</span>, <span class="hlFld-ContribAuthor ">Philip J.  Day</span>, <span class="hlFld-ContribAuthor ">Stephen  O’Hagan</span>, <span class="hlFld-ContribAuthor ">Douglas B.  Kell</span>, <span class="hlFld-ContribAuthor ">Robert  Schwarcz</span>, <span class="hlFld-ContribAuthor ">David  Leys</span>, <span class="hlFld-ContribAuthor ">Derren J.  Heyes</span>, <span class="hlFld-ContribAuthor ">Flaviano  Giorgini</span>, <span class="hlFld-ContribAuthor ">Nigel S.  Scrutton</span>. </span><span class="cited-content_cbyCitation_article-title">A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-019-0520-5" title="DOI URL">https://doi.org/10.1038/s42003-019-0520-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-019-0520-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-019-0520-5%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DA%252Bbrain-permeable%252Binhibitor%252Bof%252Bthe%252Bneurodegenerative%252Bdisease%252Btarget%252Bkynurenine%252B3-monooxygenase%252Bprevents%252Baccumulation%252Bof%252Bneurotoxic%252Bmetabolites%26aulast%3DZhang%26aufirst%3DShaowei%26date%3D2019%26date%3D2019%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley  Jarvis</span>, <span class="hlFld-ContribAuthor ">Gilles  Ouvry</span>. </span><span class="cited-content_cbyCitation_article-title">Essential ingredients for rational drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126674. <a href="https://doi.org/10.1016/j.bmcl.2019.126674" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126674%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEssential%252Bingredients%252Bfor%252Brational%252Bdrug%252Bdesign%26aulast%3DJarvis%26aufirst%3DAshley%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Louise A.  Swainson</span>, <span class="hlFld-ContribAuthor ">Haelee  Ahn</span>, <span class="hlFld-ContribAuthor ">Priya  Pajanirassa</span>, <span class="hlFld-ContribAuthor ">Vinod  Khetarpal</span>, <span class="hlFld-ContribAuthor ">Claire  Deleage</span>, <span class="hlFld-ContribAuthor ">Jacob D.  Estes</span>, <span class="hlFld-ContribAuthor ">Peter W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Ignacio  Munoz-Sanjuan</span>, <span class="hlFld-ContribAuthor ">Joseph M.  McCune</span>. </span><span class="cited-content_cbyCitation_article-title">Kynurenine 3-Monooxygenase Inhibition during Acute Simian Immunodeficiency Virus Infection Lowers PD-1 Expression and Improves Post–Combination Antiretroviral Therapy CD4
              +
              T Cell Counts and Body Weight. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2019,</strong> <em>203 </em>
                                    (4)
                                     , 899-910. <a href="https://doi.org/10.4049/jimmunol.1801649" title="DOI URL">https://doi.org/10.4049/jimmunol.1801649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.1801649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.1801649%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DKynurenine%252B3-Monooxygenase%252BInhibition%252Bduring%252BAcute%252BSimian%252BImmunodeficiency%252BVirus%252BInfection%252BLowers%252BPD-1%252BExpression%252Band%252BImproves%252BPost%2525E2%252580%252593Combination%252BAntiretroviral%252BTherapy%252BCD4%252B%25252B%252BT%252BCell%252BCounts%252Band%252BBody%252BWeight%26aulast%3DSwainson%26aufirst%3DLouise%2BA.%26date%3D2019%26date%3D2019%26volume%3D203%26issue%3D4%26spage%3D899%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenxi  Sun</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Zhigang  Yao</span>, <span class="hlFld-ContribAuthor ">Fan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective synthesis of α-dicarbonyl cyclopropanes
              via
              a lanthanide amide-catalysed reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (27)
                                     , 6620-6628. <a href="https://doi.org/10.1039/C9OB00732F" title="DOI URL">https://doi.org/10.1039/C9OB00732F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00732F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00732F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDiastereoselective%252Bsynthesis%252Bof%252B%2525CE%2525B1-dicarbonyl%252Bcyclopropanes%252Bvia%252Ba%252Blanthanide%252Bamide-catalysed%252Breaction%26aulast%3DSun%26aufirst%3DWenxi%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D27%26spage%3D6620%26epage%3D6628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khushwant  Singh</span>, <span class="hlFld-ContribAuthor ">Achintya  Jana</span>, <span class="hlFld-ContribAuthor ">Petra  Lippmann</span>, <span class="hlFld-ContribAuthor ">Ingo  Ott</span>, <span class="hlFld-ContribAuthor ">Neeladri  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidine Derivatives with Terminal Pyridyl Heterocycles: Facile Synthesis and Their Antiproliferative Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (6)
                                     , 1866-1872. <a href="https://doi.org/10.1002/jhet.3547" title="DOI URL">https://doi.org/10.1002/jhet.3547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3547%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DPyrimidine%252BDerivatives%252Bwith%252BTerminal%252BPyridyl%252BHeterocycles%25253A%252BFacile%252BSynthesis%252Band%252BTheir%252BAntiproliferative%252BActivities%26aulast%3DSingh%26aufirst%3DKhushwant%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D6%26spage%3D1866%26epage%3D1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Platten</span>, <span class="hlFld-ContribAuthor ">Ellen A. A.  Nollen</span>, <span class="hlFld-ContribAuthor ">Ute F.  Röhrig</span>, <span class="hlFld-ContribAuthor ">Francesca  Fallarino</span>, <span class="hlFld-ContribAuthor ">Christiane A.  Opitz</span>. </span><span class="cited-content_cbyCitation_article-title">Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (5)
                                     , 379-401. <a href="https://doi.org/10.1038/s41573-019-0016-5" title="DOI URL">https://doi.org/10.1038/s41573-019-0016-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0016-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTryptophan%252Bmetabolism%252Bas%252Ba%252Bcommon%252Btherapeutic%252Btarget%252Bin%252Bcancer%25252C%252Bneurodegeneration%252Band%252Bbeyond%26aulast%3DPlatten%26aufirst%3DMichael%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D5%26spage%3D379%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascal  Barone</span>. </span><span class="cited-content_cbyCitation_article-title">The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Pharmacology</span><span> <strong>2019,</strong> <em>30 </em>
                                    (2 and 3)
                                     , 163-186. <a href="https://doi.org/10.1097/FBP.0000000000000477" title="DOI URL">https://doi.org/10.1097/FBP.0000000000000477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FBP.0000000000000477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFBP.0000000000000477%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Pharmacology%26atitle%3DThe%252B%2525E2%252580%252598Yin%2525E2%252580%252599%252Band%252Bthe%252B%2525E2%252580%252598Yang%2525E2%252580%252599%252Bof%252Bthe%252Bkynurenine%252Bpathway%25253A%252Bexcitotoxicity%252Band%252Bneuroprotection%252Bimbalance%252Bin%252Bstress-induced%252Bdisorders%26aulast%3DBarone%26aufirst%3DPascal%26date%3D2019%26volume%3D30%26issue%3D2%2520and%25203%26spage%3D163%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert S.  Phillips</span>, <span class="hlFld-ContribAuthor ">Emma Carine  Iradukunda</span>, <span class="hlFld-ContribAuthor ">Tamera  Hughes</span>, <span class="hlFld-ContribAuthor ">J. Phillip  Bowen</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2019,</strong> <em>6 </em><a href="https://doi.org/10.3389/fmolb.2019.00003" title="DOI URL">https://doi.org/10.3389/fmolb.2019.00003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2019.00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2019.00003%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DModulation%252Bof%252BEnzyme%252BActivity%252Bin%252Bthe%252BKynurenine%252BPathway%252Bby%252BKynurenine%252BMonooxygenase%252BInhibition%26aulast%3DPhillips%26aufirst%3DRobert%2BS.%26date%3D2019%26date%3D2019%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fanni A.  Boros</span>, <span class="hlFld-ContribAuthor ">Péter  Klivényi</span>, <span class="hlFld-ContribAuthor ">József  Toldi</span>, <span class="hlFld-ContribAuthor ">László  Vécsei</span>. </span><span class="cited-content_cbyCitation_article-title">Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (1)
                                     , 39-51. <a href="https://doi.org/10.1080/14728222.2019.1549231" title="DOI URL">https://doi.org/10.1080/14728222.2019.1549231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1549231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1549231%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DIndoleamine%252B2%25252C3-dioxygenase%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bfor%252BHuntington%2525E2%252580%252599s%252Bdisease%26aulast%3DBoros%26aufirst%3DFanni%2BA.%26date%3D2019%26date%3D2018%26volume%3D23%26issue%3D1%26spage%3D39%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvie  Vancassel</span>, <span class="hlFld-ContribAuthor ">Lucile  Capuron</span>, <span class="hlFld-ContribAuthor ">Nathalie  Castanon</span>. </span><span class="cited-content_cbyCitation_article-title">Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2018,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnins.2018.00499" title="DOI URL">https://doi.org/10.3389/fnins.2018.00499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2018.00499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2018.00499%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DBrain%252BKynurenine%252Band%252BBH4%252BPathways%25253A%252BRelevance%252Bto%252Bthe%252BPathophysiology%252Band%252BTreatment%252Bof%252BInflammation-Driven%252BDepressive%252BSymptoms%26aulast%3DVancassel%26aufirst%3DSylvie%26date%3D2018%26date%3D2018%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Korrapati V.  Sathyasaikumar</span>, <span class="hlFld-ContribAuthor ">Carlo  Breda</span>, <span class="hlFld-ContribAuthor ">Robert  Schwarcz</span>, <span class="hlFld-ContribAuthor ">Flaviano  Giorgini</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing and Modulating Kynurenine Pathway Dynamics in Huntington’s Disease: Focus on Kynurenine 3-Monooxygenase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 397-413. <a href="https://doi.org/10.1007/978-1-4939-7825-0_18" title="DOI URL">https://doi.org/10.1007/978-1-4939-7825-0_18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7825-0_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7825-0_18%26sid%3Dliteratum%253Aachs%26atitle%3DAssessing%252Band%252BModulating%252BKynurenine%252BPathway%252BDynamics%252Bin%252BHuntington%2525E2%252580%252599s%252BDisease%25253A%252BFocus%252Bon%252BKynurenine%252B3-Monooxygenase%26aulast%3DSathyasaikumar%26aufirst%3DKorrapati%2BV.%26date%3D2018%26date%3D2018%26spage%3D397%26epage%3D413%26pub%3DSpringer%2520New%2520York%26atitle%3DHuntington%2525E2%252580%252599s%252BDisease%26aulast%3DPrecious%26aufirst%3DSophie%2BV.%26date%3D2018%26volume%3D1780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen J.  Chawner</span>, <span class="hlFld-ContribAuthor ">Manuel J.  Cases-Thomas</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent Synthesis of Cyclopropane-Containing Lead-Like Compounds, Fragments and Building Blocks through a Cobalt Catalyzed Cyclopropanation of Phenyl Vinyl Sulfide. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (34)
                                     , 5015-5024. <a href="https://doi.org/10.1002/ejoc.201701030" title="DOI URL">https://doi.org/10.1002/ejoc.201701030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDivergent%252BSynthesis%252Bof%252BCyclopropane-Containing%252BLead-Like%252BCompounds%25252C%252BFragments%252Band%252BBuilding%252BBlocks%252Bthrough%252Ba%252BCobalt%252BCatalyzed%252BCyclopropanation%252Bof%252BPhenyl%252BVinyl%252BSulfide%26aulast%3DChawner%26aufirst%3DStephen%2BJ.%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D34%26spage%3D5015%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Liddle</span>, <span class="hlFld-ContribAuthor ">Benjamin  Beaufils</span>, <span class="hlFld-ContribAuthor ">Margaret  Binnie</span>, <span class="hlFld-ContribAuthor ">Anne  Bouillot</span>, <span class="hlFld-ContribAuthor ">Alexis A.  Denis</span>, <span class="hlFld-ContribAuthor ">Michael M.  Hann</span>, <span class="hlFld-ContribAuthor ">Carl P.  Haslam</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Jon P.  Hutchinson</span>, <span class="hlFld-ContribAuthor ">Michael  Kranz</span>, <span class="hlFld-ContribAuthor ">Andrew  McBride</span>, <span class="hlFld-ContribAuthor ">Olivier  Mirguet</span>, <span class="hlFld-ContribAuthor ">Damian J.  Mole</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Mowat</span>, <span class="hlFld-ContribAuthor ">Sandeep  Pal</span>, <span class="hlFld-ContribAuthor ">Paul  Rowland</span>, <span class="hlFld-ContribAuthor ">Lionel  Trottet</span>, <span class="hlFld-ContribAuthor ">Iain J.  Uings</span>, <span class="hlFld-ContribAuthor ">Ann L.  Walker</span>, <span class="hlFld-ContribAuthor ">Scott P.  Webster</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (9)
                                     , 2023-2028. <a href="https://doi.org/10.1016/j.bmcl.2017.02.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bpotent%252Band%252Bselective%252Bkynurenine%252B3-monooxygenase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bacute%252Bpancreatitis%26aulast%3DLiddle%26aufirst%3DJohn%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D2023%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert S.  Phillips</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Anderson</span>, <span class="hlFld-ContribAuthor ">Harvey G.  Gentry</span>, <span class="hlFld-ContribAuthor ">Osman F.  Güner</span>, <span class="hlFld-ContribAuthor ">J. Phillip  Bowen</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (8)
                                     , 1705-1708. <a href="https://doi.org/10.1016/j.bmcl.2017.02.080" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstrate%252Band%252Binhibitor%252Bspecificity%252Bof%252Bkynurenine%252Bmonooxygenase%252Bfrom%252BCytophaga%252Bhutchinsonii%26aulast%3DPhillips%26aufirst%3DRobert%2BS.%26date%3D2017%26volume%3D27%26issue%3D8%26spage%3D1705%26epage%3D1708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Yamanushkin</span>, <span class="hlFld-ContribAuthor ">Michael  Lu-Diaz</span>, <span class="hlFld-ContribAuthor ">Andrew  Edwards</span>, <span class="hlFld-ContribAuthor ">Nicolai A.  Aksenov</span>, <span class="hlFld-ContribAuthor ">Marina  Rubina</span>, <span class="hlFld-ContribAuthor ">Michael  Rubin</span>. </span><span class="cited-content_cbyCitation_article-title">Directed nucleophilic addition of phenoxides to cyclopropenes. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (38)
                                     , 8153-8165. <a href="https://doi.org/10.1039/C7OB01785E" title="DOI URL">https://doi.org/10.1039/C7OB01785E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01785E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01785E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDirected%252Bnucleophilic%252Baddition%252Bof%252Bphenoxides%252Bto%252Bcyclopropenes%26aulast%3DYamanushkin%26aufirst%3DPavel%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D38%26spage%3D8153%26epage%3D8165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>, <span class="hlFld-ContribAuthor ">Shovanlal  Gayen</span>. </span><span class="cited-content_cbyCitation_article-title">First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington’s disease: A proposal to chemists!. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5712-5718. <a href="https://doi.org/10.1016/j.bmcl.2016.10.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFirst%252Bmolecular%252Bmodeling%252Breport%252Bon%252Bnovel%252Barylpyrimidine%252Bkynurenine%252Bmonooxygenase%252Binhibitors%252Bthrough%252Bmulti-QSAR%252Banalysis%252Bagainst%252BHuntington%2525E2%252580%252599s%252Bdisease%25253A%252BA%252Bproposal%252Bto%252Bchemists%252521%26aulast%3DAmin%26aufirst%3DSk.%2BAbdul%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5712%26epage%3D5718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer L.  Remus</span>, <span class="hlFld-ContribAuthor ">Robert  Dantzer</span>. </span><span class="cited-content_cbyCitation_article-title">Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2016,</strong> <em>19 </em>
                                    (9)
                                     , pyw028. <a href="https://doi.org/10.1093/ijnp/pyw028" title="DOI URL">https://doi.org/10.1093/ijnp/pyw028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ijnp/pyw028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fijnp%2Fpyw028%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DInflammation%252BModels%252Bof%252BDepression%252Bin%252BRodents%25253A%252BRelevance%252Bto%252BPsychotropic%252BDrug%252BDiscovery%26aulast%3DRemus%26aufirst%3DJennifer%2BL.%26date%3D2016%26date%3D2016%26volume%3D19%26issue%3D9%26spage%3Dpyw028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vahri  Beaumont</span>, <span class="hlFld-ContribAuthor ">Ladislav  Mrzljak</span>, <span class="hlFld-ContribAuthor ">Ulrike  Dijkman</span>, <span class="hlFld-ContribAuthor ">Robert  Freije</span>, <span class="hlFld-ContribAuthor ">Mariette  Heins</span>, <span class="hlFld-ContribAuthor ">Arash  Rassoulpour</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Tombaugh</span>, <span class="hlFld-ContribAuthor ">Simon  Gelman</span>, <span class="hlFld-ContribAuthor ">Amyaouch  Bradaia</span>, <span class="hlFld-ContribAuthor ">Esther  Steidl</span>, <span class="hlFld-ContribAuthor ">Melanie  Gleyzes</span>, <span class="hlFld-ContribAuthor ">Taneli  Heikkinen</span>, <span class="hlFld-ContribAuthor ">Kimmo  Lehtimäki</span>, <span class="hlFld-ContribAuthor ">Jukka  Puoliväli</span>, <span class="hlFld-ContribAuthor ">Outi  Kontkanen</span>, <span class="hlFld-ContribAuthor ">Robyn M.  Javier</span>, <span class="hlFld-ContribAuthor ">Ioana  Neagoe</span>, <span class="hlFld-ContribAuthor ">Heike  Deisemann</span>, <span class="hlFld-ContribAuthor ">Dirk  Winkler</span>, <span class="hlFld-ContribAuthor ">Andreas  Ebneth</span>, <span class="hlFld-ContribAuthor ">Vinod  Khetarpal</span>, <span class="hlFld-ContribAuthor ">Leticia  Toledo-Sherman</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Larry C.  Park</span>, <span class="hlFld-ContribAuthor ">Ignacio  Munoz-Sanjuan</span>. </span><span class="cited-content_cbyCitation_article-title">The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2016,</strong> <em>282 </em>, 99-118. <a href="https://doi.org/10.1016/j.expneurol.2016.05.005" title="DOI URL">https://doi.org/10.1016/j.expneurol.2016.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2016.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2016.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DThe%252Bnovel%252BKMO%252Binhibitor%252BCHDI-340246%252Bleads%252Bto%252Ba%252Brestoration%252Bof%252Belectrophysiological%252Balterations%252Bin%252Bmouse%252Bmodels%252Bof%252BHuntington%252527s%252Bdisease%26aulast%3DBeaumont%26aufirst%3DVahri%26date%3D2016%26volume%3D282%26spage%3D99%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dénes  Zádori</span>, <span class="hlFld-ContribAuthor ">Gábor  Veres</span>, <span class="hlFld-ContribAuthor ">Levente  Szalárdy</span>, <span class="hlFld-ContribAuthor ">Péter  Klivényi</span>, <span class="hlFld-ContribAuthor ">Ferenc  Fülöp</span>, <span class="hlFld-ContribAuthor ">József  Toldi</span>, <span class="hlFld-ContribAuthor ">László  Vécsei</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012–2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (7)
                                     , 815-832. <a href="https://doi.org/10.1080/13543776.2016.1189531" title="DOI URL">https://doi.org/10.1080/13543776.2016.1189531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2016.1189531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2016.1189531%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252Bthe%252Bkynurenine%252Bpathway%252Bas%252Bneurotherapeutics%25253A%252Ba%252Bpatent%252Breview%252B%2525282012%2525E2%252580%2525932015%252529%26aulast%3DZ%25C3%25A1dori%26aufirst%3DD%25C3%25A9nes%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D7%26spage%3D815%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel S.  Woodling</span>, <span class="hlFld-ContribAuthor ">Damien  Colas</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Paras  Minhas</span>, <span class="hlFld-ContribAuthor ">Maharshi  Panchal</span>, <span class="hlFld-ContribAuthor ">Xibin  Liang</span>, <span class="hlFld-ContribAuthor ">Siddhita D.  Mhatre</span>, <span class="hlFld-ContribAuthor ">Holden  Brown</span>, <span class="hlFld-ContribAuthor ">Novie  Ko</span>, <span class="hlFld-ContribAuthor ">Irene  Zagol-Ikapitte</span>, <span class="hlFld-ContribAuthor ">Marieke  van der Hart</span>, <span class="hlFld-ContribAuthor ">Taline V.  Khroyan</span>, <span class="hlFld-ContribAuthor ">Bayarsaikhan  Chuluun</span>, <span class="hlFld-ContribAuthor ">Prachi G.  Priyam</span>, <span class="hlFld-ContribAuthor ">Ginger L.  Milne</span>, <span class="hlFld-ContribAuthor ">Arash  Rassoulpour</span>, <span class="hlFld-ContribAuthor ">Olivier  Boutaud</span>, <span class="hlFld-ContribAuthor ">Amy B.  Manning-Boğ</span>, <span class="hlFld-ContribAuthor ">H. Craig  Heller</span>, <span class="hlFld-ContribAuthor ">Katrin I.  Andreasson</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice. </span><span class="cited-content_cbyCitation_journal-name">Brain</span><span> <strong>2016,</strong> <em>139 </em>
                                    (7)
                                     , 2063-2081. <a href="https://doi.org/10.1093/brain/aww117" title="DOI URL">https://doi.org/10.1093/brain/aww117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/brain/aww117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbrain%2Faww117%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%26atitle%3DCyclooxygenase%252Binhibition%252Btargets%252Bneurons%252Bto%252Bprevent%252Bearly%252Bbehavioural%252Bdecline%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bmodel%252Bmice%26aulast%3DWoodling%26aufirst%3DNathaniel%2BS.%26date%3D2016%26date%3D2016%26volume%3D139%26issue%3D7%26spage%3D2063%26epage%3D2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason R.  Smith</span>, <span class="hlFld-ContribAuthor ">Joanne F.  Jamie</span>, <span class="hlFld-ContribAuthor ">Gilles J.  Guillemin</span>. </span><span class="cited-content_cbyCitation_article-title">Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (2)
                                     , 315-324. <a href="https://doi.org/10.1016/j.drudis.2015.11.001" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DKynurenine-3-monooxygenase%25253A%252Ba%252Breview%252Bof%252Bstructure%25252C%252Bmechanism%25252C%252Band%252Binhibitors%26aulast%3DSmith%26aufirst%3DJason%2BR.%26date%3D2016%26volume%3D21%26issue%3D2%26spage%3D315%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. Alison  Rinderspacher</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 439-492. <a href="https://doi.org/10.1016/B978-0-08-100755-6.00013-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-100755-6.00013-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100755-6.00013-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100755-6.00013-2%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DRinderspacher%26aufirst%3DK.%2BAlison%26date%3D2016%26spage%3D439%26epage%3D492%26pub%3DElsevier%26date%3D2016%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer M.  Parrott</span>, <span class="hlFld-ContribAuthor ">Jason C.  O’Connor</span>. </span><span class="cited-content_cbyCitation_article-title">Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2015,</strong> <em>6 </em><a href="https://doi.org/10.3389/fpsyt.2015.00116" title="DOI URL">https://doi.org/10.3389/fpsyt.2015.00116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2015.00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2015.00116%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DKynurenine%252B3-Monooxygenase%25253A%252BAn%252BInfluential%252BMediator%252Bof%252BNeuropathology%26aulast%3DParrott%26aufirst%3DJennifer%2BM.%26date%3D2015%26date%3D2015%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel C.  Maddison</span>, <span class="hlFld-ContribAuthor ">Flaviano  Giorgini</span>. </span><span class="cited-content_cbyCitation_article-title">The kynurenine pathway and neurodegenerative disease. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2015,</strong> <em>40 </em>, 134-141. <a href="https://doi.org/10.1016/j.semcdb.2015.03.002" title="DOI URL">https://doi.org/10.1016/j.semcdb.2015.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2015.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2015.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DThe%252Bkynurenine%252Bpathway%252Band%252Bneurodegenerative%252Bdisease%26aulast%3DMaddison%26aufirst%3DDaniel%2BC.%26date%3D2015%26volume%3D40%26spage%3D134%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Kynurenine pathway (KP) with neurotoxic metabolites colored red and neuroprotective metabolites colored green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of known KMO inhibitors and their potencies against KMO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Example pyrimidine carboxylic acid KMO inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyrimidinecarboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KOAc, bis-pinacol borane, PdCl<sub>2</sub>(dppf)<sub>2</sub>, DMSO, 80 °C, 18 h; (b) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C, 2 h; (c) CO (5 bar), MeOH, PdCl<sub>2</sub>(dppf)<sub>2</sub>, NEt<sub>3</sub>, 50 °C, 18 h; (d) 2 M NaOH, THF, 4 h.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Modification via S<sub>N</sub>Ar Displacement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup>i</sup>PrOH, 80 °C, morpholine or 3,4-dichloroaniline, 12 h; (b) 3,4-dichlorophenol, <sup>t</sup>BuOK, <sup>t</sup>BuOH, 35 °C; (c) cyclohexyl zinc bromide, PdCl<sub>2</sub>(dppf)<sub>2</sub>, THF, 45 °C, 15 h; (d) CO (5 bar), MeOH, PdCl<sub>2</sub>(dppf)<sub>2</sub>, NEt<sub>3</sub>, 50 °C, 18 h; (e) 2 M NaOH, THF, 4 h.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Modification to the Core Pyrimidine Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>(dppf)<sub>2</sub>, DMF, 80 °C, 16 h; (b)NBS, AIBN, 1,2-DCE, 90 °C, 18 h; (c) NaOMe, MeOH, r.t., 20 h; (d) CO (5 bar), MeOH, PdCl<sub>2</sub>(dppf)<sub>2</sub>, NEt<sub>3</sub>, 50 °C, 18 h; (e) 2 M NaOH, THF, 4 h; (f) LiCl, DMF, 145 °C, 18 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Example Carboxylic Acid Replacements<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 100 °C, 18 h; (b) TMS-N<sub>3</sub>, dibutyl(oxo)stannane, PhMe, 115 °C, 24 h; (c) NaH, MeI, DMF, 40 °C, 18 h; (d) H<sub>2</sub>N–OH, DIPEA, EtOH, 70 °C, 2 h; (e) CDI, DBU, dioxane, 110 °C, 1 h; (f) HC(OCH<sub>3</sub>)<sub>3</sub>, 100 °C, 3 h; (g) Sat. aq. NH<sub>3</sub>, 100 °C, 16 h; (h) R<sub>2</sub>Cl, NaH, dioxane, r.t., 18 h; (i) imidazole or pyrazole, EtOH, μwave, 140 °C, 20 min.; (j) imidazalone, NaH, DMF, μwave, 140 °C, 10 min; (k) NaH, MeI, DMF, 3 h.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Conversion of Kynurenine to 3-Hydroxykynurenine by KMO</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. A. Structures of FCE 28833A (<b>3</b>), UPF-648 (<b>4</b>), and pyrimidine acid (<b>7</b>). B. Overlap of the pyrimidine acid (<b>7</b>) with FCE 28833A (<b>3</b>) and UPF-648 (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overview of SAR carried out on the pyrimidine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. A. Active site from crystal structure of UPF-648 complex with yeast KMO (pdb code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4j36">4j36</a>). B. Homology model of human KMO and proposed binding model of compound <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concentration vs time profiles of compound <b>75</b> following a 10 mg equiv/kg oral dose to male Sprague–Dawley rats in plasma, kidney, liver, cortex, striatum, and CSF.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Brain concentration vs time profile of compound <b>75</b> following a single 5 mg equiv/kg iv dose to FVB (WT), Bcrp(−/−), Mdr1a/b(−/−), and Mdr1a/b(−/−)/Bcrp(−/−) male mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Modulation of KP metabolites in plasma of Sprague–Dawley rats after administration of a 10 mg/kg po dose of compound <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0010.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Pharmacodynamic effects of compound <b>75</b> in rat kynurenines as measured by a microdialysis probe implanted in the striatum. A. Terminal plasma levels of <b>75</b> (<i>t</i> = 240 min post dose). B. Free drug unbound level of <b>75</b> in striatal extracellular fluid as measured by microdialysis. <b>C–F</b>. Modulation of KP metabolites in striatum brain microdialysate after administration of a 10 mg/kg po dose of compound <b>75</b> to wild-type rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/medium/jm-2014-01350y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0011.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Pharmacodynamic effects of compound 75 in terminal plasma of Sprague–Dawley rats. Rats were dosed with various concentrations of compound <b>75</b> (from 3 to 100 mg/kg po), and terminal tissue/plasma levels of KYN (panel A), 3HK (panel B), KYNA (Panel C), and QA (Panels D) were analyzed at various time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501350y/20150206/images/large/jm-2014-01350y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501350y&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Reiner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragatsis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, P.</span><span> </span><span class="NLM_article-title">Genetics and neuropathology of Huntington’s disease</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2FB978-0-12-381328-2.00014-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=21907094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2011&pages=325-372&author=A.+Reinerauthor=I.+Dragatsisauthor=P.+Dietrich&title=Genetics+and+neuropathology+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics and neuropathology of Huntington's disease</span></div><div class="casAuthors">Reiner, Anton; Dragatsis, Ioannis; Dietrich, Paula</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia</span>),
    <span class="NLM_cas:pages">325-372</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder that prominently affects the basal ganglia, leading to affective, cognitive, behavioral and motor decline.  The basis of HD is a CAG repeat expansion to >35 CAG in a gene that codes for a ubiquitous protein known as huntingtin, resulting in an expanded N-terminal polyglutamine tract.  The size of the expansion is correlated with disease severity, with increasing CAG accelerating the age of onset.  A variety of possibilities have been proposed as to the mechanism by which the mutation causes preferential injury to the basal ganglia.  The present chapter provides a basic overview of the genetics and pathol. of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwSNKvotkgBLVg90H21EOLACvtfcHk0lgthgskLbOGtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWhsL3O&md5=8858c4c983907fa228e230dadfe8d823</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381328-2.00014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-381328-2.00014-6%26sid%3Dliteratum%253Aachs%26aulast%3DReiner%26aufirst%3DA.%26aulast%3DDragatsis%26aufirst%3DI.%26aulast%3DDietrich%26aufirst%3DP.%26atitle%3DGenetics%2520and%2520neuropathology%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2011%26volume%3D98%26spage%3D325%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Delmaire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Bogaard, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valabregue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jauffret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craufurd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehéricy, S.</span><span> </span><span class="NLM_article-title">The structural correlates of functional deficits in early Huntington’s Disease</span> <span class="citation_source-journal">Hum. Brain Mapping</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2141</span><span class="NLM_x">–</span> <span class="NLM_lpage">2153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1002%2Fhbm.22055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22438242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A280%3ADC%252BC38vosFGltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=2141-2153&issue=9&author=C.+Delmaireauthor=E.+M.+Dumasauthor=M.+A.+Sharmanauthor=S.+J.+van+den+Bogaardauthor=R.+Valabregueauthor=C.+Jauffretauthor=D.+Justoauthor=R.+Reilmannauthor=J.+C.+Stoutauthor=D.+Craufurdauthor=S.+J.+Tabriziauthor=R.+A.+Roosauthor=A.+Durrauthor=S.+Leh%C3%A9ricy&title=The+structural+correlates+of+functional+deficits+in+early+Huntington%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The structural correlates of functional deficits in early huntington's disease</span></div><div class="casAuthors">Delmaire Christine; Dumas Eve M; Sharman Michael A; van den Bogaard Simon J A; Valabregue Romain; Jauffret Celine; Justo Damian; Reilmann Ralf; Stout Julie C; Craufurd David; Tabrizi Sarah J; Roos Raymund A C; Durr Alexandra; Lehericy Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Human brain mapping</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2141-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neuropathological studies in Huntington disease (HD) have demonstrated neuronal loss in the striatum, as well as in other brain regions including the cortex.  With diffusion tensor MRI we evaluated the hypothesis that the clinical dysfunction in HD is related to regionally specific lesions of circuit-specific cortico-basal ganglia networks rather than to the striatum only.  We included 27 HD and 24 controls from the TRACK-HD Paris cohort.  The following assessments were used: self-paced tapping tasks, trail B making test (TMT), University of Pennsylvania smell identification test (UPSIT), and apathy scores from the problem behaviors assessment.  Group comparisons of fractional anisotropy and mean diffusivity and correlations were performed using voxel-based analysis.  In the cortex, HD patients showed significant correlations between: (i) self paced tapping and mean diffusivity in the parietal lobe at 1.8 Hz and prefrontal areas at 3 Hz, (ii) UPSIT and mean diffusivity in the parietal, and median temporal lobes, the cingulum and the insula, and fractional anisotropy in the insula and the external capsule, (iii) TMT B and mean diffusivity in the white matter of the superior frontal, orbital, temporal, superior parietal and post central areas, and (iv) apathy and fractional anisotropy in the white matter of the rectus gyrus.  In the basal ganglia, we found correlations between the self paced tapping, UPSIT, TMT tests, and mean diffusivity in the anterior part of the putamen and the caudate nucleus.  In conclusion, disruption of motor, associative and limbic cortico-striatal circuits differentially contribute to the clinical signs of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTredyCevNYgvupmecNw_lfW6udTcc2eb9xi7-Q2kuBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vosFGltA%253D%253D&md5=b4b76a518825edfdefd3ebbd0002e4a8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fhbm.22055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhbm.22055%26sid%3Dliteratum%253Aachs%26aulast%3DDelmaire%26aufirst%3DC.%26aulast%3DDumas%26aufirst%3DE.%2BM.%26aulast%3DSharman%26aufirst%3DM.%2BA.%26aulast%3Dvan%2Bden%2BBogaard%26aufirst%3DS.%2BJ.%26aulast%3DValabregue%26aufirst%3DR.%26aulast%3DJauffret%26aufirst%3DC.%26aulast%3DJusto%26aufirst%3DD.%26aulast%3DReilmann%26aufirst%3DR.%26aulast%3DStout%26aufirst%3DJ.%2BC.%26aulast%3DCraufurd%26aufirst%3DD.%26aulast%3DTabrizi%26aufirst%3DS.%2BJ.%26aulast%3DRoos%26aufirst%3DR.%2BA.%26aulast%3DDurr%26aufirst%3DA.%26aulast%3DLeh%25C3%25A9ricy%26aufirst%3DS.%26atitle%3DThe%2520structural%2520correlates%2520of%2520functional%2520deficits%2520in%2520early%2520Huntington%25E2%2580%2599s%2520Disease%26jtitle%3DHum.%2520Brain%2520Mapping%26date%3D2013%26volume%3D34%26issue%3D9%26spage%3D2141%26epage%3D2153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Poon, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. J.</span><span> </span><span class="NLM_article-title">Role of tetrabenazine for Huntington’s disease-associated chorea</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1080</span><span class="NLM_x">–</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=1080-1089&issue=6&author=L.+H.+Poonauthor=G.+A.+Kangauthor=A.+J.+Lee&title=Role+of+tetrabenazine+for+Huntington%E2%80%99s+disease-associated+chorea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoon%26aufirst%3DL.%2BH.%26aulast%3DKang%26aufirst%3DG.%2BA.%26aulast%3DLee%26aufirst%3DA.%2BJ.%26atitle%3DRole%2520of%2520tetrabenazine%2520for%2520Huntington%25E2%2580%2599s%2520disease-associated%2520chorea%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2010%26volume%3D44%26issue%3D6%26spage%3D1080%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.-Q.</span><span> </span><span class="NLM_article-title">Kynurenines in the mammalian brain: When physiology meets pathology</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fnrn3257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22678511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=465-477&issue=7&author=R.+Schwarczauthor=J.+P.+Brunoauthor=J.+P.+Muchowskiauthor=H.-Q.+Wu&title=Kynurenines+in+the+mammalian+brain%3A+When+physiology+meets+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines in the mammalian brain: when physiology meets pathology</span></div><div class="casAuthors">Schwarcz, Robert; Bruno, John P.; Muchowski, Paul J.; Wu, Hui-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compds., including kynurenic acid, 3-hydroxykynurenine and quinolinic acid.  The synthesis of these metabolites is regulated by an enzymic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system.  Dysregulation of this pathway, resulting in hyper- or hypofunction of active metabolites, is assocd. with neurodegenerative and other neurol. disorders, as well as with psychiatric diseases such as depression and schizophrenia.  With recently developed pharmacol. agents, it is now possible to restore metabolic equil. and envisage novel therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7vLdWHblurVg90H21EOLACvtfcHk0lhRn1zpjg7b_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D&md5=b30a985543d32947138d98e6de82b9ea</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrn3257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3257%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26aulast%3DMuchowski%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DH.-Q.%26atitle%3DKynurenines%2520in%2520the%2520mammalian%2520brain%253A%2520When%2520physiology%2520meets%2520pathology%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26issue%3D7%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Vécsei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalárdy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toldi, J.</span><span> </span><span class="NLM_article-title">Kynurenines in the CNS: Recent advances and new questions</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=64-82&issue=1&author=L.+V%C3%A9cseiauthor=L.+Szal%C3%A1rdyauthor=F.+F%C3%BCl%C3%B6pauthor=J.+Toldi&title=Kynurenines+in+the+CNS%3A+Recent+advances+and+new+questions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A9csei%26aufirst%3DL.%26aulast%3DSzal%25C3%25A1rdy%26aufirst%3DL.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DF.%26aulast%3DToldi%26aufirst%3DJ.%26atitle%3DKynurenines%2520in%2520the%2520CNS%253A%2520Recent%2520advances%2520and%2520new%2520questions%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D1%26spage%3D64%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mandi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecsei, L.</span><span> </span><span class="NLM_article-title">The kynurenine systems and immunoregulation</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=197-209&issue=2&author=Y.+Mandiauthor=L.+Vecsei&title=The+kynurenine+systems+and+immunoregulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandi%26aufirst%3DY.%26aulast%3DVecsei%26aufirst%3DL.%26atitle%3DThe%2520kynurenine%2520systems%2520and%2520immunoregulation%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2012%26volume%3D119%26issue%3D2%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Belenky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">NAD<sup>+</sup> metabolism in health and disease</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=12-19&issue=1&author=P.+Belenkyauthor=K.+L.+Boganauthor=C.+Brenner&title=NAD%2B+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelenky%26aufirst%3DP.%26aulast%3DBogan%26aufirst%3DK.%2BL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DNAD%252B%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2006%26volume%3D32%26issue%3D1%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemin, G. J.</span><span> </span><span class="NLM_article-title">Kynurenine Pathway Metabolites in Humans: Disease and Healthy States</span> <span class="citation_source-journal">Int. J. Tryptophan Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.4137%2FIJTR.S2097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22084578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslCht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-19&author=Y.+Chenauthor=G.+J.+Guillemin&title=Kynurenine+Pathway+Metabolites+in+Humans%3A+Disease+and+Healthy+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine pathway metabolites in humans: disease and healthy states</span></div><div class="casAuthors">Chen, Yiquan; Guillemin, Gilles J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Tryptophan Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">IJTRBS</span>;
        ISSN:<span class="NLM_cas:issn">1178-6469</span>.
    
            (<span class="NLM_cas:orgname">Libertas Academica</span>)
        </div><div class="casAbstract">A review.  Tryptophan is an essential amino acid that can be metabolised through different pathways, a major route being the kynurenine pathway.  The first enzyme of the pathway, indoleamine-2,3-dioxygenase, is strongly stimulated by inflammatory mols., particularly interferon gamma.  Thus, the kynurenine pathway is often systematically up-regulated when the immune response is activated.  The biol. significance is that 1) the depletion of tryptophan and generation of kynurenines play a key modulatory role in the immune response; and 2) some of the kynurenines, such as quinolinic acid, 3-hydroxykynurenine and kynurenic acid, are neuroactive.  The kynurenine pathway has been demonstrated to be involved in many diseases and disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, AIDS dementia complex, malaria, cancer, depression and schizophrenia, where imbalances in tryptophan and kynurenines have been found.  This review compiles most of these studies and provides an overview of how the kynurenine pathway might be contributing to disease development, and the concns. of tryptophan and kynurenines in the serum, cerebrospinal fluid and brain tissues in control and patient subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV4vsr8Fs4k7Vg90H21EOLACvtfcHk0lj09TMDuMP2cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslCht7c%253D&md5=5d16678f21d5c2f40630ba6b6152d1c9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4137%2FIJTR.S2097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4137%252FIJTR.S2097%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26atitle%3DKynurenine%2520Pathway%2520Metabolites%2520in%2520Humans%253A%2520Disease%2520and%2520Healthy%2520States%26jtitle%3DInt.%2520J.%2520Tryptophan%2520Res.%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyasaikumar, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span> </span><span class="NLM_article-title">Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.pneurobio.2009.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=19394403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=230-245&author=R.+Schwarczauthor=P.+Guidettiauthor=K.+P.+Sathyasaikumarauthor=P.+J.+Muchowski&title=Of+mice%2C+rats+and+men%3A+Revisiting+the+quinolinic+acid+hypothesis+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease</span></div><div class="casAuthors">Schwarcz, Robert; Guidetti, Paolo; Sathyasaikumar, Korrapati V.; Muchowski, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">230-245</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The neurodegenerative disease Huntington's disease (HD) is caused by an expanded polyglutamine (polyQ) tract in the protein huntingtin (htt).  Although the gene encoding htt was identified and cloned more than 15 years ago, and in spite of impressive efforts to unravel the mechanism(s) by which mutant htt induces nerve cell death, these studies have so far not led to a good understanding of pathophysiol. or an effective therapy.  Set against a historical background, we review data supporting the idea that metabolites of the kynurenine pathway (KP) of tryptophan degrdn. provide a crit. link between mutant htt and the pathophysiol. of HD.  New studies in HD brain and genetic model organisms suggest that the disease may in fact be causally related to early abnormalities in KP metab., favoring the formation of two neurotoxic metabolites, 3-hydroxykynurenine and quinolinic acid, over the related neuroprotective agent kynurenic acid.  These findings not only link the excitotoxic hypothesis of HD pathol. to an impairment of the KP but also define new drug targets and therefore have direct therapeutic implications.  Thus, pharmacol. normalization of the imbalance in brain KP metab. may provide clin. benefits, which could be esp. effective in early stages of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpizeHxnPo5LVg90H21EOLACvtfcHk0lj09TMDuMP2cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOmu7w%253D&md5=edec2f985cd7e574ce3001b61672b5ea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2009.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2009.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DSathyasaikumar%26aufirst%3DK.%2BP.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26atitle%3DOf%2520mice%252C%2520rats%2520and%2520men%253A%2520Revisiting%2520the%2520quinolinic%2520acid%2520hypothesis%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2010%26volume%3D90%26spage%3D230%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthi-Carter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augood, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Neostriatal and cortical quinolinate levels are increased in early grade Huntington’s disease</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.nbd.2004.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15571981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVansbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=455-461&author=P.+Guidettiauthor=R.+E.+Luthi-Carterauthor=S.+J.+Augoodauthor=R.+Schwarcz&title=Neostriatal+and+cortical+quinolinate+levels+are+increased+in+early+grade+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease</span></div><div class="casAuthors">Guidetti, Paolo; Luthi-Carter, Ruth E.; Augood, Sarah J.; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Huntington's disease (HD), an inherited neurodegenerative disorder, is caused by an abnormal polyglutamine expansion in the huntingtin protein.  This genetic defect may result in heightened neuronal susceptibility to excitotoxic injury, a mechanism that has been postulated to play a crit. role in HD.  Quinolinate (QUIN) and kynurenate (KYNA), two endogenous neuroactive metabolites of the kynurenine pathway of tryptophan degrdn., have been proposed to modulate excitotoxic neuronal death in HD.  A third kynurenine pathway metabolite, the free radical generator 3-hydroxykynurenine (3-HK), has also been hypothesized to play a causal role in the pathogenesis of HD.  The authors show here that the brain levels of both 3-HK and QUIN are increased 3 to 4-fold in low-grade (grade 0/1) HD brain.  These changes were seen in the neocortex and in the neostriatum, but not in the cerebellum.  In contrast, brain 3-HK and QUIN levels were either unchanged or tended to decrease in grade 2 and advanced grade (grades 3-4) HD brain.  Brain kynurenine and KYNA levels fluctuated only modestly as the illness progressed.  These results support a possible involvement of 3-HK and QUIN in the early phases of HD pathophysiol. and indicate novel therapeutic strategies against the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_yEwFAF0v17Vg90H21EOLACvtfcHk0lj09TMDuMP2cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVansbjP&md5=abcb6bd75492573c111228aeadf021b2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2004.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2004.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DLuthi-Carter%26aufirst%3DR.%2BE.%26aulast%3DAugood%26aufirst%3DS.%2BJ.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DNeostriatal%2520and%2520cortical%2520quinolinate%2520levels%2520are%2520increased%2520in%2520early%2520grade%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2004%26volume%3D17%26spage%3D455%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slow, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.nbd.2006.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=16697652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFyqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=190-197&issue=1&author=P.+Guidettiauthor=G.+P.+Batesauthor=R.+K.+Grahamauthor=M.+R.+Haydenauthor=B.+R.+Leavittauthor=M.+E.+MacDonaldauthor=E.+J.+Slowauthor=V.+C.+Wheelerauthor=B.+Woodmanauthor=R.+Schwarcz&title=Elevated+brain+3-hydroxykynurenine+and+quinolinate+levels+in+Huntington+disease+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice</span></div><div class="casAuthors">Guidetti, Paolo; Bates, Gillian P.; Graham, Rona K.; Hayden, Michael R.; Leavitt, Blair R.; MacDonald, Marcy E.; Slow, Elizabeth J.; Wheeler, Vanessa C.; Woodman, Ben; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-197</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The brain levels of the endogenous excitotoxin quinolinic acid (QUIN) and its bioprecursor, the free radical generator 3-hydroxykynurenine (3-HK), are elevated in early stage Huntington disease (HD).  We now examd. the status of these metabolites in three mouse models of HD.  In R6/2 mice, 3-HK levels were significantly and selectively elevated in the striatum, cortex and cerebellum starting at 4 wk of age.  In contrast, both 3-HK and QUIN levels were increased in the striatum and cortex of the full-length HD models, beginning at 8 mo (YAC128) and 15 mo (Hdh Q92 and Hdh Q111), resp.  No changes were seen in 13-mo-old shortstop mice, which show no signs of motor or cognitive dysfunction or selective neuropathol.  These results demonstrate both important parallels and intriguing differences in the progressive neurochem. changes in these HD mouse models and support the hypothesis that QUIN may play a role in the striatal and cortical neurodegeneration of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGNZRDsP7kxrVg90H21EOLACvtfcHk0ljy4t3-70P8LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFyqtrY%253D&md5=3831ba1712e90d17ec9f025f96e5875e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DG.%2BP.%26aulast%3DGraham%26aufirst%3DR.%2BK.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DMacDonald%26aufirst%3DM.%2BE.%26aulast%3DSlow%26aufirst%3DE.%2BJ.%26aulast%3DWheeler%26aufirst%3DV.%2BC.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DElevated%2520brain%25203-hydroxykynurenine%2520and%2520quinolinate%2520levels%2520in%2520Huntington%2520disease%2520mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D23%26issue%3D1%26spage%3D190%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Forrest, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiden, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, L. G.</span><span> </span><span class="NLM_article-title">Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1111%2Fj.1471-4159.2009.06442.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=19845828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1GhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2010&pages=112-122&author=C.+M.+Forrestauthor=G.+M.+Mackayauthor=N.+Stoyauthor=S.+L.+Spidenauthor=R.+Taylorauthor=T.+W.+Stoneauthor=L.+G.+Darlington&title=Blood+levels+of+kynurenines%2C+interleukin-23+and+soluble+human+leucocyte+antigen-G+at+different+stages+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease</span></div><div class="casAuthors">Forrest, Caroline M.; MacKay, Gillian M.; Stoy, Nicholas; Spiden, Sarah L.; Taylor, Rohan; Stone, Trevor W.; Darlington, L. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">There is substantial evidence that abnormal concns. of oxidized tryptophan metabolites, produced via the kynurenine pathway, contribute to progressive neurodegeneration in Huntington's disease.  The authors have now examd. the blood levels of these metabolites in patients at different stages of Huntington's disease, assessed both in terms of clin. disease severity and nos. of CAG repeats.  Close relatives of the patients were included in the study as well as unrelated healthy controls.  Levels of lipid peroxidn. products, the proinflammatory cytokine interleukin (IL)-23 and the sol. human leukocyte antigen-G (sHLA-G) were also measured.  There were lower levels of tryptophan and a higher kynurenine: tryptophan ratio, indicating activation of indoleamine-2,3-dioxygenase, in the most severely affected group of patients, with increased levels of IL-23 and sHLA-G.  Marked correlations were noted between IL-23 and the patient severity group, anthranilic acid levels and the no. of CAG repeats, and between anthranilic acid and IL-23, supporting previous evidence of a relation between anthranilic acid and inflammatory status.  Tryptophan was neg. correlated with symptom severity and no. of CAG repeats, and pos. correlated with sHLA-G.  The results support the proposal that tryptophan metab. along the kynurenine pathway in Huntington's disease is related to the degree of genetic abnormality, to clin. disease severity and to aspects of immunopathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTdA_toqmgJ7Vg90H21EOLACvtfcHk0ljy4t3-70P8LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1GhsQ%253D%253D&md5=f8d4a6c51dc69bc717d47ec88a8639da</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06442.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06442.x%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DC.%2BM.%26aulast%3DMackay%26aufirst%3DG.%2BM.%26aulast%3DStoy%26aufirst%3DN.%26aulast%3DSpiden%26aufirst%3DS.%2BL.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DStone%26aufirst%3DT.%2BW.%26aulast%3DDarlington%26aufirst%3DL.%2BG.%26atitle%3DBlood%2520levels%2520of%2520kynurenines%252C%2520interleukin-23%2520and%2520soluble%2520human%2520leucocyte%2520antigen-G%2520at%2520different%2520stages%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D112%26spage%3D112%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Thevandavakkam, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span> </span><span class="NLM_article-title">Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington’s disease</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.2174%2F187152710793237430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=20942784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFarsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=791-800&author=M.+A.+Thevandavakkamauthor=R.+Schwarczauthor=P.+J.+Muchowskiauthor=F.+Giorgini&title=Targeting+kynurenine+3-monooxygenase+%28KMO%29%3A+implications+for+therapy+in+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease</span></div><div class="casAuthors">Thevandavakkam, Mathuravani A.; Schwarcz, Robert; Muchowski, Paul J.; Giorgini, Flaviano</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">791-800</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Huntington's dfisease (HD) is an adult onset neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein.  Recent work has shown that perturbation of kynurenine pathway (KP) metab. is a hallmark of HD pathol., and that changes in brain levels of KP metabolites may play a causative role in this disease.  The KP contains three neuroactive metabolites, the neurotoxins 3-hydroxykynurenine (3-HK) and quinolinic acid (QUIN), and the neuroprotectant kynurenic acid (KYNA).  In model systems in vitro and in vivo, 3-HK and QUIN have been shown to cause neurodegeneration via a combination of excitotoxic mechanisms and oxidative stress.  Recent studies with HD patient samples and in HD model systems have supported the idea that a shift away from the synthesis of KYNA and towards the formation of 3-HK and QUIN may trigger the neuropathol. features obsd. in HD.  The enzyme kynurenine 3-monooxygenase (KMO) is located at a crit. branching point in the KP such that inhibition of this enzyme by either pharmacol. or genetic means shifts the flux in the pathway towards the formation of KYNA.  This intervention ameliorates disease-relevant phenotypes in HD models.  Here we review the work implicating the KP in HD pathol. and discuss the potential of KMO as a therapeutic target for this disorder.  As several neurodegenerative diseases exhibit alterations in KP metab., this concept has broader implications for the treatment of brain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0i82T8y6mbLVg90H21EOLACvtfcHk0ljy4t3-70P8LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFarsbrL&md5=917ad7a46c22e93a2034923651fdab08</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F187152710793237430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710793237430%26sid%3Dliteratum%253Aachs%26aulast%3DThevandavakkam%26aufirst%3DM.%2BA.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DGiorgini%26aufirst%3DF.%26atitle%3DTargeting%2520kynurenine%25203-monooxygenase%2520%2528KMO%2529%253A%2520implications%2520for%2520therapy%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D791%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Giorgini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span> </span><span class="NLM_article-title">A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fng1542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15806102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsF2ksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=526-531&issue=5&author=F.+Giorginiauthor=P.+Guidettiauthor=Q.+Nguyenauthor=S.+C.+Bennettauthor=P.+J.+Muchowski&title=A+genomic+screen+in+yeast+implicates+kynurenine+3-monooxygenase+as+a+therapeutic+target+for+Huntington+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease</span></div><div class="casAuthors">Giorgini, Flaviano; Guidetti, Paolo; Nguyen, QuangVu; Bennett, Simone C.; Muchowski, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">526-531</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington disease is a fatal neurodegenerative disorder caused by expansion of a polyglutamine tract in the protein huntingtin (Htt), which leads to its aggregation in nuclear and cytoplasmic inclusion bodies.  We recently identified 52 loss-of-function mutations in yeast genes that enhance the toxicity of a mutant Htt fragment.  Here we report the results from a genome-wide loss-of-function suppressor screen in which we identified 28 gene deletions that suppress toxicity of a mutant Htt fragment.  The suppressors are known or predicted to have roles in vesicle transport, vacuolar degrdn., transcription and prion-like aggregation.  Among the most potent suppressors was Bna4 (kynurenine 3-monooxygenase), an enzyme in the kynurenine pathway of tryptophan degrdn. that has been linked directly to the pathophysiol. of Huntington disease in humans by a mechanism that may involve reactive oxygen species.  This finding is suggestive of a conserved mechanism of polyglutamine toxicity from yeast to humans and identifies new candidate therapeutic targets for the treatment of Huntington disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0BkWdAqP-TLVg90H21EOLACvtfcHk0liHCh9b-l92bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsF2ksrs%253D&md5=9a56f8aa79eb9a0d9ec2eaea849182dd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fng1542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1542%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgini%26aufirst%3DF.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DQ.%26aulast%3DBennett%26aufirst%3DS.%2BC.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26atitle%3DA%2520genomic%2520screen%2520in%2520yeast%2520implicates%2520kynurenine%25203-monooxygenase%2520as%2520a%2520therapeutic%2520target%2520for%2520Huntington%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2005%26volume%3D37%26issue%3D5%26spage%3D526%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Campesan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyasaikumar, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyriacou, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span> </span><span class="NLM_article-title">The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington’s disease</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.cub.2011.04.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=21636279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=961-966&issue=11&author=S.+Campesanauthor=E.+W.+Greenauthor=C.+Bredaauthor=K.+V.+Sathyasaikumarauthor=P.+J.+Muchowskiauthor=R.+Schwarczauthor=C.+P.+Kyriacouauthor=F.+Giorgini&title=The+kynurenine+pathway+modulates+neurodegeneration+in+a+Drosophila+model+of+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease</span></div><div class="casAuthors">Campesan, Susanna; Green, Edward W.; Breda, Carlo; Sathyasaikumar, Korrapati V.; Muchowski, Paul J.; Schwarcz, Robert; Kyriacou, Charalambos P.; Giorgini, Flaviano</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">961-966</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degrdn. have been implicated in the pathophysiol. of neurodegenerative disorders, including Huntington's disease (HD) [].  A central hallmark of HD is neurodegeneration caused by a polyglutamine expansion in the huntingtin (htt) protein [].  Here we exploit a transgenic Drosophila melanogaster model of HD to interrogate the therapeutic potential of KP manipulation.  We observe that genetic and pharmacol. inhibition of kynurenine 3-monooxygenase (KMO) increases levels of the neuroprotective metabolite kynurenic acid (KYNA) relative to the neurotoxic metabolite 3-hydroxykynurenine (3-HK) and ameliorates neurodegeneration.  We also find that genetic inhibition of tryptophan 2,3-dioxygenase (TDO), the first and rate-limiting step in the pathway, leads to a similar neuroprotective shift toward KYNA synthesis.  Importantly, we demonstrate that the feeding of KYNA and 3-HK to HD model flies directly modulates neurodegeneration, underscoring the causative nature of these metabolites.  This study provides the first genetic evidence that inhibition of KMO and TDO activity protects against neurodegenerative disease in an animal model, indicating that strategies targeted at two key points within the KP may have therapeutic relevance in HD, and possibly other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVd3ZDuYatabVg90H21EOLACvtfcHk0liHCh9b-l92bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKmtr8%253D&md5=15ae2d2478db87ec6748d74af31ea322</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2011.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2011.04.028%26sid%3Dliteratum%253Aachs%26aulast%3DCampesan%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DE.%2BW.%26aulast%3DBreda%26aufirst%3DC.%26aulast%3DSathyasaikumar%26aufirst%3DK.%2BV.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DKyriacou%26aufirst%3DC.%2BP.%26aulast%3DGiorgini%26aufirst%3DF.%26atitle%3DThe%2520kynurenine%2520pathway%2520modulates%2520neurodegeneration%2520in%2520a%2520Drosophila%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Biol.%26date%3D2011%26volume%3D21%26issue%3D11%26spage%3D961%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattoli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speciale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span> </span><span class="NLM_article-title">Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=2003&pages=621-628&author=R.+Pellicciariauthor=L.+Amoriauthor=G.+Costantinoauthor=A.+Giordaniauthor=A.+Macchiaruloauthor=L.+Mattoliauthor=P.+Pevarelloauthor=C.+Specialeauthor=M.+Varasi&title=Modulation+of+the+kynurine+pathway+of+tryptophan+metabolism+in+search+for+neuroprotective+agents.+Focus+on+kynurenine-3-hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DAmori%26aufirst%3DL.%26aulast%3DCostantino%26aufirst%3DG.%26aulast%3DGiordani%26aufirst%3DA.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DMattoli%26aufirst%3DL.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DSpeciale%26aufirst%3DC.%26aulast%3DVarasi%26aufirst%3DM.%26atitle%3DModulation%2520of%2520the%2520kynurine%2520pathway%2520of%2520tryptophan%2520metabolism%2520in%2520search%2520for%2520neuroprotective%2520agents.%2520Focus%2520on%2520kynurenine-3-hydroxylase%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2003%26volume%3D527%26spage%3D621%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Amori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1111%2Fj.1471-4159.2009.05893.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=19226371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=316-325&issue=2&author=L.+Amoriauthor=P.+Guidettiauthor=R.+Pellicciariauthor=Y.+Kajiiauthor=R.+Schwarcz&title=On+the+relationship+between+the+two+branches+of+the+kynurenine+pathway+in+the+rat+brain+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo</span></div><div class="casAuthors">Amori, Laura; Guidetti, Paolo; Pellicciari, Roberto; Kajii, Yasushi; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-325</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In the mammalian brain, kynurenine aminotransferase II (KAT II) and kynurenine 3-monooxygenase (KMO), key enzymes of the kynurenine pathway (KP) of tryptophan degrdn., form the neuroactive metabolites kynurenic acid (KYNA) and 3-hydroxykynurenine (3-HK), resp.  Although phys. segregated, both enzymes use the pivotal KP metabolite L-kynurenine as a substrate.  We studied the functional consequences of this cellular compartmentalization in vivo using two specific tools, the KAT II inhibitor BFF 122 and the KMO inhibitor UPF 648.  The acute effects of selective KAT II or KMO inhibition were studied using a radiotracing method in which the de novo synthesis of KYNA, and of 3-HK and its downstream metabolite quinolinic acid (QUIN), is monitored following an intrastriatal injection of 3H-kynurenine.  In naive rats, intrastriatal BFF 122 decreased newly formed KYNA by 66%, without influencing 3-HK or QUIN prodn.  Conversely, UPF 648 reduced 3-HK synthesis (by 64%) without affecting KYNA formation.  Similar, selective effects of KAT II and KMO inhibition were obsd. when the inhibitors were applied acutely together with the excitotoxin QUIN, which impairs local KP metab.  Somewhat different effects of KMO (but not KAT II) inhibition were obtained in rats that had received an intrastriatal QUIN injection 7 days earlier.  In these neuron-depleted striata, UPF 648 not only decreased both 3-HK and QUIN prodn. (by 77% and 66%, resp.) but also moderately raised KYNA synthesis (by 27%).  These results indicate a remarkable functional segregation of the two pathway branches in the brain, boding well for the development of selective KAT II or KMO inhibitors for cognitive enhancement and neuroprotection, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd9pXuKi1ZgrVg90H21EOLACvtfcHk0lhkXTn_h8le7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKgtbg%253D&md5=8cf09ef8d475d1d2771ab6e1326c336d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.05893.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.05893.x%26sid%3Dliteratum%253Aachs%26aulast%3DAmori%26aufirst%3DL.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DKajii%26aufirst%3DY.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DOn%2520the%2520relationship%2520between%2520the%2520two%2520branches%2520of%2520the%2520kynurenine%2520pathway%2520in%2520the%2520rat%2520brain%2520in%2520vivo%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D109%26issue%3D2%26spage%3D316%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Heyes, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span> </span><span class="NLM_article-title">Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1997&pages=351-356&issue=2&author=M.+P.+Heyesauthor=C.+Y.+Chenauthor=E.+O.+Majorauthor=K.+Saito&title=Different+kynurenine+pathway+enzymes+limit+quinolinic+acid+formation+by+various+human+cell+types"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeyes%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DMajor%26aufirst%3DE.%2BO.%26aulast%3DSaito%26aufirst%3DK.%26atitle%3DDifferent%2520kynurenine%2520pathway%2520enzymes%2520limit%2520quinolinic%2520acid%2520formation%2520by%2520various%2520human%2520cell%2520types%26jtitle%3DBiochem.%2520J.%26date%3D1997%26volume%3D326%26issue%3D2%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Guillemin, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smythe, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armati, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brew, B. J.</span><span> </span><span class="NLM_article-title">Expression of the kynurenine pathway enzymes in human microglia and macrophages</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">527</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=527&publication_year=2003&pages=105-112&author=G.+J.+Guilleminauthor=D.+G.+Smithauthor=G.+A.+Smytheauthor=P.+J.+Armatiauthor=B.+J.+Brew&title=Expression+of+the+kynurenine+pathway+enzymes+in+human+microglia+and+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DSmythe%26aufirst%3DG.%2BA.%26aulast%3DArmati%26aufirst%3DP.%2BJ.%26aulast%3DBrew%26aufirst%3DB.%2BJ.%26atitle%3DExpression%2520of%2520the%2520kynurenine%2520pathway%2520enzymes%2520in%2520human%2520microglia%2520and%2520macrophages%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2003%26volume%3D527%26spage%3D105%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rzeski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dybel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wejksza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zdzisińska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandefer-Szerszeń, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turski, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J.</span><span> </span><span class="NLM_article-title">Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1002%2Fjnr.20505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15880762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFagtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2005&pages=677-682&issue=5&author=W.+Rzeskiauthor=T.+Kockiauthor=A.+Dybelauthor=K.+Wejkszaauthor=B.+Zdzisi%C5%84skaauthor=M.+Kandefer-Szersze%C5%84author=W.+A.+Turskiauthor=E.+Okunoauthor=J.+Albrecht&title=Demonstration+of+kynurenine+aminotransferases+I+and+II+and+characterization+of+kynurenic+acid+synthesis+in+cultured+cerebral+cortical+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons</span></div><div class="casAuthors">Rzeski, Wojciech; Kocki, Tomasz; Dybel, Anna; Wejksza, Katarzyna; Zdzisinska, Barbara; Kandefer-Szerszen, Martyna; Turski, Waldemar A.; Okuno, Etsuo; Albrecht, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">677-682</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The present study characterizes the synthesis of kynurenic acid (KYNA) from exogenously added kynurenine and its regulation by extrinsic factors, in cultured cerebral cortical neurons and, for comparison, in astrocytes incubated under identical conditions.  The neuronal culture showed pos. immunostaining for both kynurenic acid aminotransferase (KAT) isoforms I and II.  Neurons synthesized KYNA at a rate about 2.3 times higher than astrocytes.  Neuronal, but not astrocytic, KYNA synthesis was lowered ∼30% by ionotropic glutamate receptor agonists [(R,S)-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA; 100 μM) and N-methyl-D-aspartic acid (NMDA; 100 μM)] and depolarizing agents [KCl (50 mM) and 4-aminopyridine (4-AP; 10 μM)].  Neuronal and astrocytic synthesis alike were vulnerable to inhibition exerted by the aminotransferase inhibitor aminooxyacetic acid (AOAA), glutamate (IC50: 31 and 85 μM, resp.), substrates of the L-amino transport system [leucine (Leu); IC50: 19 and 42 μM, resp.] and 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid (BCH; IC50: 19 and 28 μM, resp.).  Glutamine (Gln), which is a metabolic precursor of glutamate in astrocytes and L-system substrate in both cell types, inhibited KYNA synthesis both in neurons and in astrocytes (IC50: 268 and 318 μM, resp.).  α-Ketoisocaproic acid (KIC), a Leu transamination product that is produced mainly in astrocytes and shuttled to neurons to modulate intraneuronal concn. of glutamate, stimulated KYNA synthesis in neurons but did not affect the synthesis in astrocytes.  In conclusion, this study is the first to demonstrate active, regulation-prone KYNA synthesis in neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCYn81xHIdcLVg90H21EOLACvtfcHk0lhkXTn_h8le7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFagtbg%253D&md5=d4388e49de0c0046d9a9d112ad636d02</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20505%26sid%3Dliteratum%253Aachs%26aulast%3DRzeski%26aufirst%3DW.%26aulast%3DKocki%26aufirst%3DT.%26aulast%3DDybel%26aufirst%3DA.%26aulast%3DWejksza%26aufirst%3DK.%26aulast%3DZdzisi%25C5%2584ska%26aufirst%3DB.%26aulast%3DKandefer-Szersze%25C5%2584%26aufirst%3DM.%26aulast%3DTurski%26aufirst%3DW.%2BA.%26aulast%3DOkuno%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DJ.%26atitle%3DDemonstration%2520of%2520kynurenine%2520aminotransferases%2520I%2520and%2520II%2520and%2520characterization%2520of%2520kynurenic%2520acid%2520synthesis%2520in%2520cultured%2520cerebral%2520cortical%2520neurons%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2005%26volume%3D80%26issue%3D5%26spage%3D677%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span> </span><span class="NLM_article-title">Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1124%2Fjpet.102.034439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=12235226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1-10&author=R.+Schwarczauthor=R.+Pellicciari&title=Manipulation+of+brain+kynurenines%3A+glial+targets%2C+neuronal+effects%2C+and+clinical+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities</span></div><div class="casAuthors">Schwarcz, Robert; Pellicciari, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Degrdn. of the essential amino acid tryptophan along the kynurenine pathway (KP) yields several neuroactive intermediates, including the free radical generator 3-hydroxykynurenine, the excitotoxic N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid, and the NMDA and α7 nicotinic acetylcholine receptor antagonist kynurenic acid.  The ambient levels of these compds. are detd. by several KP enzymes, which in the brain are preferentially localized in astrocytes and microglial cells.  Normal fluctuations in the brain levels of neuroactive KP intermediates might modulate several neurotransmitter systems.  Impairment of KP metab. is functionally significant and occurs in a variety of diseases that affect the brain.  Pharmacol. agents targeting specific KP enzymes are now available to manipulate the concn. of neuroactive KP intermediates in the brain.  These compds. can be used to normalize KP defects, show remarkable efficacy in animal models of central nervous system disorders, and offer novel therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVe45AXh3TXrVg90H21EOLACvtfcHk0lhkXTn_h8le7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2ru7k%253D&md5=3b1c0ecc1601b35d1b335f386c18ecd5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.034439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.034439%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DPellicciari%26aufirst%3DR.%26atitle%3DManipulation%2520of%2520brain%2520kynurenines%253A%2520glial%2520targets%252C%2520neuronal%2520effects%252C%2520and%2520clinical%2520opportunities%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Guillemin, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smythe, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brew, B. J.</span><span> </span><span class="NLM_article-title">Characterization of the kynurenine pathway in human neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">12884</span><span class="NLM_x">–</span> <span class="NLM_lpage">12892</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1523%2FJNEUROSCI.4101-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=18032661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=12884-12892&author=G.+J.+Guilleminauthor=K.+M.+Cullenauthor=C.+K.+Limauthor=G.+A.+Smytheauthor=B.+Garnerauthor=V.+Kapoorauthor=O.+Takikawaauthor=B.+J.+Brew&title=Characterization+of+the+kynurenine+pathway+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Kynurenine pathway in human neurons</span></div><div class="casAuthors">Guillemin, Gilles J.; Cullen, Karen M.; Lim, Chai K.; Smythe, George A.; Garner, Brett; Kapoor, Vimal; Takikawa, Osamu; Brew, Bruce J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">12884-12892</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The kynurenine pathway is a major route of L-tryptophan catabolism producing neuroactive metabolites implicated in neurodegeneration and immune tolerance.  We characterized the kynurenine pathway in human neurons and the human SK-N-SH neuroblastoma cell line and found that the kynurenine pathway enzymes were variably expressed.  Picolinic carboxylase was expressed only in primary and some adult neurons but not in SK-N-SH cells.  Because of this difference, SK-N-SH cells were able to produce the excitotoxin quinolinic acid, whereas human neurons produced the neuroprotectant picolinic acid.  The net result of kynurenine pathway induction in human neurons is therefore predicted to result in neuroprotection, immune regulation, and tumor inhibition, whereas in SK-N-SH cells, it may result in neurotoxicity, immune tolerance, and tumor promotion.  This study represents the first comprehensive characterization of the kynurenine pathway in neurons and the first description of the involvement of the kynurenine pathway as a mechanism for controlling both tumor cell neurotoxicity and persistence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodgz7ShgU7irVg90H21EOLACvtfcHk0lhdykfldNL_Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWrsr3F&md5=55e63fe7ac90b71e50cc1bb3c49a9141</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4101-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4101-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26aulast%3DCullen%26aufirst%3DK.%2BM.%26aulast%3DLim%26aufirst%3DC.%2BK.%26aulast%3DSmythe%26aufirst%3DG.%2BA.%26aulast%3DGarner%26aufirst%3DB.%26aulast%3DKapoor%26aufirst%3DV.%26aulast%3DTakikawa%26aufirst%3DO.%26aulast%3DBrew%26aufirst%3DB.%2BJ.%26atitle%3DCharacterization%2520of%2520the%2520kynurenine%2520pathway%2520in%2520human%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D12884%26epage%3D12892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span> </span><span class="NLM_article-title">Kynurenines in the mammalian brain: When physiology meets pathology</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fnrn3257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22678511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=465-477&author=R.+Schwarczauthor=J.+P.+Brunoauthor=P.+J.+Muchowskiauthor=H.+Q.+Wu&title=Kynurenines+in+the+mammalian+brain%3A+When+physiology+meets+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines in the mammalian brain: when physiology meets pathology</span></div><div class="casAuthors">Schwarcz, Robert; Bruno, John P.; Muchowski, Paul J.; Wu, Hui-Qiu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-477</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compds., including kynurenic acid, 3-hydroxykynurenine and quinolinic acid.  The synthesis of these metabolites is regulated by an enzymic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system.  Dysregulation of this pathway, resulting in hyper- or hypofunction of active metabolites, is assocd. with neurodegenerative and other neurol. disorders, as well as with psychiatric diseases such as depression and schizophrenia.  With recently developed pharmacol. agents, it is now possible to restore metabolic equil. and envisage novel therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7vLdWHblurVg90H21EOLACvtfcHk0lhdykfldNL_Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1CmsL4%253D&md5=b30a985543d32947138d98e6de82b9ea</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrn3257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3257%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26atitle%3DKynurenines%2520in%2520the%2520mammalian%2520brain%253A%2520When%2520physiology%2520meets%2520pathology%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D465%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fukui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapoport, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Blood-Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2017</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1111%2Fj.1471-4159.1991.tb03460.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=1827495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK3MXktVGltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=2007-2017&issue=6&author=S.+Fukuiauthor=R.+Schwarczauthor=S.+I.+Rapoportauthor=Y.+Takadaauthor=Q.+R.+Smith&title=Blood-Brain+Barrier+Transport+of+Kynurenines%3A+Implications+for+Brain+Synthesis+and+Metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier transport of kynurenines:  implications for brain synthesis and metabolism</span></div><div class="casAuthors">Fukui, Shinsuke; Schwarcz, Robert; Rapoport, Stanley I.; Takada, Yoshiaki; Smith, Quentin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2007-17</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To evaluate the potential contribution of circulating kynurenines to brain kynurenine pools, the rates of cerebral uptake and mechanisms of blood-brain barrier transport were detd. for several kynurenine metabolites of tryptophan, including L-kynurenine (L-KYN), 3-hydroxykynurenine (3-HKYN), 3-hydroxyanthranilic acid (3-HANA), anthranilic acid (ANA), kynurenic acid (KYNA), and quinolinic acid (QUIN), in pentobarbital-anesthetized rats using an in situ brain perfusion technique.  L-KYN was taken up into brain at a significant rate [permeability-surface area product (PA) = 2-3 × 10-3 mL/s/g] by the large neutral amino acid carrier (L-system) of the blood-brain barrier.  Best-fit ests. of the Vmax and Km of saturable L-KYN transfer equaled 4.5 × 10-4 μmol/s/g and 0.16 μmol/mL, resp.  The same carrier may also mediate the brain uptake of 3-HKYN as D,L-3-HKYN competitively inhibited the brain transfer of the large neutral amino acid L-leucine.  For the other metabolites, uptake appeared mediated by passive diffusion.  This occurred at a significant rate for ANA (PA, 0.7-1.6 × 10-3 mL/s/g), and at far lower rates (PA, 2-7 × 10-5 mL/s/g) for 3-HANA, KYNA, and QUIN.  Transfer for KYNA, 3-HANA, and ANA also appeared to be limited by plasma protein binding.  The results demonstrate the saturable transfer of L-KYN across the blood-brain barrier and suggest that circulating L-KYN, 3-HKYN, and ANA may each contribute significantly to resp. cerebral pools.  In contrast, QUIN, KYNA, and 3-HANA cross the blood-brain barrier poorly, and therefore are not expected to contribute significantly to brain pools under normal conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrAlsvOTFGLVg90H21EOLACvtfcHk0lhdykfldNL_Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVGltLY%253D&md5=b97956c6ef4e07edad4d30a809286536</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1991.tb03460.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1991.tb03460.x%26sid%3Dliteratum%253Aachs%26aulast%3DFukui%26aufirst%3DS.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DRapoport%26aufirst%3DS.%2BI.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DBlood-Brain%2520Barrier%2520Transport%2520of%2520Kynurenines%253A%2520Implications%2520for%2520Brain%2520Synthesis%2520and%2520Metabolism%26jtitle%3DJ.%2520Neurochem.%26date%3D1991%26volume%3D56%26issue%3D6%26spage%3D2007%26epage%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zwilling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathyasaikumar, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews-Zwilling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adame, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassoulpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchowski, P. J.</span><span> </span><span class="NLM_article-title">Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration</span> <span class="citation_source-journal">Cell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=863-874&issue=6&author=D.+Zwillingauthor=S.+Y.+Huangauthor=K.+V.+Sathyasaikumarauthor=F.+M.+Notarangeloauthor=P.+Guidettiauthor=H.+Q.+Wuauthor=J.+Leeauthor=J.+Truongauthor=Y.+Andrews-Zwillingauthor=E.+W.+Hsiehauthor=J.+Y.+Louieauthor=T.+Wuauthor=K.+Scearce-Levieauthor=C.+Patrickauthor=A.+Adameauthor=F.+Giorginiauthor=S.+Moussaouiauthor=G.+Laueauthor=A.+Rassoulpourauthor=G.+Flikauthor=Y.+Huangauthor=J.+M.+Muchowskiauthor=E.+Masliahauthor=R.+Schwarczauthor=P.+J.+Muchowski&title=Kynurenine+3-monooxygenase+inhibition+in+blood+ameliorates+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZwilling%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DS.%2BY.%26aulast%3DSathyasaikumar%26aufirst%3DK.%2BV.%26aulast%3DNotarangelo%26aufirst%3DF.%2BM.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTruong%26aufirst%3DJ.%26aulast%3DAndrews-Zwilling%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DE.%2BW.%26aulast%3DLouie%26aufirst%3DJ.%2BY.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DPatrick%26aufirst%3DC.%26aulast%3DAdame%26aufirst%3DA.%26aulast%3DGiorgini%26aufirst%3DF.%26aulast%3DMoussaoui%26aufirst%3DS.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DRassoulpour%26aufirst%3DA.%26aulast%3DFlik%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMuchowski%26aufirst%3DJ.%2BM.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DMuchowski%26aufirst%3DP.%2BJ.%26atitle%3DKynurenine%25203-monooxygenase%2520inhibition%2520in%2520blood%2520ameliorates%2520neurodegeneration%26jtitle%3DCell.%26date%3D2011%26volume%3D145%26issue%3D6%26spage%3D863%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chiarugi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Kynurenine Disposition in Blood and Brain of Mice: Effects of Selective Inhibitors of Kynurenine Hydroxylase and of Kynureninase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=8764597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=692-698&issue=2&author=A.+Chiarugiauthor=R.+Carpenedoauthor=F.+Moroni&title=Kynurenine+Disposition+in+Blood+and+Brain+of+Mice%3A+Effects+of+Selective+Inhibitors+of+Kynurenine+Hydroxylase+and+of+Kynureninase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase</span></div><div class="casAuthors">Chiarugi A; Carpenedo R; Moroni F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">692-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To study the regulation of the synthesis of quinolinic and kynurenic acids in vivo, we evaluated (a) the metabolism of administered kynurenine by measuring the content of its main metabolites 3-hydroxykynurenine, anthranilic acid, and 3-hydroxyanthranilic acid in blood and brain of mice; (b) the effects of (m-nitrobenzoyl)alanine, a selective inhibitor of kynurenine hydroxylase and of (o-methoxybenzoyl) alanine, a selective inhibitor of kynureninase, on this metabolism; and (c) the effects of (o-methoxybenzoyl)alanine on liver kynureninase and 3-hydroxykynureninase activity.  The conclusions drawn from these experiments are (a) the disposition of administered kynurenine preferentially occurs through hydroxylation in brain and through hydrolysis in peripheral tissues; (b) (m-nitrobenzoyl)alanine, the inhibitor of kynurenine hydroxylase, causes the expected changes in brain kynurenine metabolism, such as a decrease of 3-hydroxykynurenine, and an increase of kynurenic acid; and (c) (o-methoxybenzoyl)alanine, the kynureninase inhibitor, increases brain concentration of the cytotoxic compound 3-hydroxykynurenine, and unexpectedly does not reduce brain concentration of 3-hydroxyanthranilic acid, the direct precursor of quinolinic acid.  Taken together, the experiments suggest that the systemic administration of a kynurenine hydroxylase inhibitor is a rational approach to increase the brain content of kynurenate and to decrease that of cytotoxic kynurenine metabolites, such as 3-hydroxykynurenine and quinolinic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-MKFVxCBo-Ny3lHz94U-GfW6udTcc2ea-ipyDyyYngrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D&md5=b9843554a48282aa2660283eab76c8df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiarugi%26aufirst%3DA.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DKynurenine%2520Disposition%2520in%2520Blood%2520and%2520Brain%2520of%2520Mice%253A%2520Effects%2520of%2520Selective%2520Inhibitors%2520of%2520Kynurenine%2520Hydroxylase%2520and%2520of%2520Kynureninase%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26issue%3D2%26spage%3D692%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markey, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, M. P.</span><span> </span><span class="NLM_article-title">Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1992&pages=25-39&author=K.+Saitoauthor=S.+P.+Markeyauthor=M.+P.+Heyes&title=Effects+of+immune+activation+on+quinolinic+acid+and+neuroactive+kynurenines+in+the+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DMarkey%26aufirst%3DS.%2BP.%26aulast%3DHeyes%26aufirst%3DM.%2BP.%26atitle%3DEffects%2520of%2520immune%2520activation%2520on%2520quinolinic%2520acid%2520and%2520neuroactive%2520kynurenines%2520in%2520the%2520mouse%26jtitle%3DNeuroscience%26date%3D1992%26volume%3D51%26spage%3D25%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patte-Mensah, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taleb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourguignon, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bihel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maitre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah-Nyagan, A. G.</span><span> </span><span class="NLM_article-title">The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=254-260&author=C.+Kleinauthor=C.+Patte-Mensahauthor=O.+Talebauthor=J.-J.+Bourguignonauthor=M.+Schmittauthor=F.+Bihelauthor=M.+Maitreauthor=A.+G.+Mensah-Nyagan&title=The+neuroprotector+kynurenic+acid+increases+neuronal+cell+survival+through+neprilysin+induction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DPatte-Mensah%26aufirst%3DC.%26aulast%3DTaleb%26aufirst%3DO.%26aulast%3DBourguignon%26aufirst%3DJ.-J.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DBihel%26aufirst%3DF.%26aulast%3DMaitre%26aufirst%3DM.%26aulast%3DMensah-Nyagan%26aufirst%3DA.%2BG.%26atitle%3DThe%2520neuroprotector%2520kynurenic%2520acid%2520increases%2520neuronal%2520cell%2520survival%2520through%2520neprilysin%2520induction%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D70%26spage%3D254%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Stone, T. W.</span><span> </span><span class="NLM_article-title">Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=149-154&issue=4&author=T.+W.+Stone&title=Development+and+therapeutic+potential+of+kynurenic+acid+and+kynurenine+derivatives+for+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BW.%26atitle%3DDevelopment%2520and%2520therapeutic%2520potential%2520of%2520kynurenic%2520acid%2520and%2520kynurenine%2520derivatives%2520for%2520neuroprotection%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2000%26volume%3D21%26issue%3D4%26spage%3D149%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Stone, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, L. G.</span><span> </span><span class="NLM_article-title">Endogenous kynurenines as targets for drug discovery and development</span> <span class="citation_source-journal">Nat. Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1038%2Fnrd870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=12402501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslGqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=609-620&issue=8&author=T.+W.+Stoneauthor=L.+G.+Darlington&title=Endogenous+kynurenines+as+targets+for+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous kynurenines as targets for drug discovery and development</span></div><div class="casAuthors">Stone, Trevor W.; Darlington, L. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">609-620</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The kynurenine pathway is the main pathway for tryptophan metab.  It generates compds. that can modulate activity at glutamate receptors and possibly nicotinic receptors, in addn. to some as-yet-unidentified sites.  The pathway is in a unique position to regulate other aspects of the metab. of tryptophan to neuroactive compds., and also seems to be a key factor in the communication between the nervous and immune systems.  It also has potentially important roles in the regulation of cell proliferation and tissue function in the periphery.  As a result, the pathway presents a multitude of potential sites for drug discovery in neuroscience, oncol. and visceral pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Wxl-a-7RF7Vg90H21EOLACvtfcHk0liYIfMOATxKNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslGqtr4%253D&md5=079072419577259ddc6df3c7ff151dcd</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd870%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BW.%26aulast%3DDarlington%26aufirst%3DL.%2BG.%26atitle%3DEndogenous%2520kynurenines%2520as%2520targets%2520for%2520drug%2520discovery%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discovery%26date%3D2002%26volume%3D1%26issue%3D8%26spage%3D609%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Storey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipolloni, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Movement disorder following excitotoxin lesions in primates</span> <span class="citation_source-journal">Neuroreport.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=1259-1261&issue=10&author=E.+Storeyauthor=P.+B.+Cipolloniauthor=R.+J.+Ferranteauthor=N.+W.+Kowallauthor=M.+F.+Beal&title=Movement+disorder+following+excitotoxin+lesions+in+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStorey%26aufirst%3DE.%26aulast%3DCipolloni%26aufirst%3DP.%2BB.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMovement%2520disorder%2520following%2520excitotoxin%2520lesions%2520in%2520primates%26jtitle%3DNeuroreport.%26date%3D1994%26volume%3D5%26issue%3D10%26spage%3D1259%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whetsell, W. O.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, R. M.</span><span> </span><span class="NLM_article-title">Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x"> (</span><span class="NLM_issue">4582</span><span class="NLM_x">) </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1983&pages=316-318&issue=4582&author=R.+Schwarczauthor=W.+O.+Whetsellauthor=R.+M.+Mangano&title=Quinolinic+acid%3A+An+endogenous+metabolite+that+produces+axon-sparing+lesions+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DWhetsell%26aufirst%3DW.%2BO.%26aulast%3DMangano%26aufirst%3DR.%2BM.%26atitle%3DQuinolinic%2520acid%253A%2520An%2520endogenous%2520metabolite%2520that%2520produces%2520axon-sparing%2520lesions%2520in%2520rat%2520brain%26jtitle%3DScience%26date%3D1983%26volume%3D219%26issue%3D4582%26spage%3D316%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span> </span><span class="NLM_article-title">Chronic quinolinic acid lesions in rats closely resemble Huntington’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=1710657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=1649-1659&issue=6&author=M.+F.+Bealauthor=R.+J.+Ferranteauthor=K.+J.+Swartzauthor=N.+W.+Kowall&title=Chronic+quinolinic+acid+lesions+in+rats+closely+resemble+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic quinolinic acid lesions in rats closely resemble Huntington's disease</span></div><div class="casAuthors">Beal, M. Flint; Ferrante, Robert J.; Swartz, Kenton J.; Kowall, Neil W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1649-59</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">The authors previously found a relative sparing of somatostatin and neuropeptide Y neurons 1 wk after producing striatal lesions with NMDA receptor agonists.  These results are similar to postmortem findings in Huntington's disease (HD), though in this illness there are two- to threefold increases in striatal somatostatin and neuropeptide Y concns., which may be due to striatal atrophy.  The present study examd. the effects of striatal excitotoxin lesions at 6 mo and 1 yr, because these lesions exhibit striatal shrinkage and atrophy similar to that occurring in HD striatum.  At 6 mo and 1 yr, lesions with the NMDA receptor agonist quinolinic acid (QA) resulted in increases (up to twofold) in concns. of somatostatin and neuropeptide Y immunoreactivity, while concns. of GABA, substance P immunoreactivity, and ChAT activity were reduced.  In contrast, somatostatin and neuropeptide Y concns. did not increase 6 mo after kainic acid (KA) or α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) lesions.  At both 6 mo and 1 yr, QA lesions showed striking sparing of NADPH-diaphorase neurons as compared with both AMPA and KA lesions, neither of which showed preferential sparing of these neurons.  Long-term QA lesions also resulted in increases in concns. of both 5-HT and 5-hydroxyindoleacetic acid (HIAA), similar to findings in HD.  Chronic QA lesions therefore closely resemble the neurochem. features of HD, because they result in increases in somatostatin and neuropeptide Y and in 5-HT and HIAA.  These findings strengthen the possibility that an NMDA receptor-mediated excitotoxic process could play a role in the pathogenesis of HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4R2paUdLIwbVg90H21EOLACvtfcHk0liYIfMOATxKNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFKgtLo%253D&md5=6d7ded31592dd7548de2f0fc5a1f724c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DFerrante%26aufirst%3DR.%2BJ.%26aulast%3DSwartz%26aufirst%3DK.%2BJ.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26atitle%3DChronic%2520quinolinic%2520acid%2520lesions%2520in%2520rats%2520closely%2520resemble%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D1991%26volume%3D11%26issue%3D6%26spage%3D1649%26epage%3D1659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Okuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, H.</span><span> </span><span class="NLM_article-title">Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">12553</span><span class="NLM_x">–</span> <span class="NLM_lpage">12558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=12553-12558&author=S.+Okudaauthor=N.+Nishiyamaauthor=H.+Saitoauthor=H.+Katsuki&title=Hydrogen+peroxide-mediated+neuronal+cell+death+induced+by+an+endogenous+neurotoxin%2C+3-hydroxykynurenine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DNishiyama%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DKatsuki%26aufirst%3DH.%26atitle%3DHydrogen%2520peroxide-mediated%2520neuronal%2520cell%2520death%2520induced%2520by%2520an%2520endogenous%2520neurotoxin%252C%25203-hydroxykynurenine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D12553%26epage%3D12558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Stone, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catherine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, L. G.</span><span> </span><span class="NLM_article-title">Tryptophan Metabolites and Brain Disorders</span> <span class="citation_source-journal">Clin. Chem. Lab. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1515%2FCCLM.2003.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=12940508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtlymu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2003&pages=852-859&issue=7&author=T.+W.+Stoneauthor=G.+M.+Mackayauthor=C.+M.+Forrestauthor=J.+Catherineauthor=C.+J.+Clarkauthor=L.+G.+Darlington&title=Tryptophan+Metabolites+and+Brain+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Tryptophan metabolites and brain disorders</span></div><div class="casAuthors">Stone, Trevor W.; Mackay, Gillian M.; Forrest, Caroline M.; Clark, Catherine J.; Darlington, L. Gail</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry and Laboratory Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">852-859</span>CODEN:
                <span class="NLM_cas:coden">CCLMFW</span>;
        ISSN:<span class="NLM_cas:issn">1434-6621</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Tryptophan is metabolized primarily along the kynurenine pathway, of which two components are now known to have marked effects on neurons in the central nervous system.  Quinolinic acid is an agonist at the population of glutamate receptors which are sensitive to N-methyl-D-aspartate (NMDA), and kynurenic acid is an antagonist at several glutamate receptors.  Consequently quinolinic acid can act as a neurotoxin while kynurenic acid is neuroprotectant.  A third kynurenine, 3-hydroxykynurenine, can generate free radicals and contribute to, or exacerbate, neuronal damage.  Changes in the abs. or relative concns. of these kynurenines have been implicated in a variety of central nervous system disorders such as the AIDS-dementia complex and Huntington's disease, raising the possibility that interference with their actions or synthesis could lead to new forms of pharmacotherapy for these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP8J5HeG3vGbVg90H21EOLACvtfcHk0liYIfMOATxKNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtlymu74%253D&md5=2ee1eeb87c079f6dff75979e7a1e65d5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1515%2FCCLM.2003.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FCCLM.2003.129%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DT.%2BW.%26aulast%3DMackay%26aufirst%3DG.%2BM.%26aulast%3DForrest%26aufirst%3DC.%2BM.%26aulast%3DCatherine%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DC.%2BJ.%26aulast%3DDarlington%26aufirst%3DL.%2BG.%26atitle%3DTryptophan%2520Metabolites%2520and%2520Brain%2520Disorders%26jtitle%3DClin.%2520Chem.%2520Lab.%2520Med.%26date%3D2003%26volume%3D41%26issue%3D7%26spage%3D852%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Majláth, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vécsei, L.</span><span> </span><span class="NLM_article-title">Kynurenines and other novel therapeutic strategies in the treatment of dementia</span> <span class="citation_source-journal">Ther. Adv. Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1177%2F1756285613494989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OktrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=386-397&issue=6&author=Z.+Majl%C3%A1thauthor=J.+Tajtiauthor=L.+V%C3%A9csei&title=Kynurenines+and+other+novel+therapeutic+strategies+in+the+treatment+of+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenines and other novel therapeutic strategies in the treatment of dementia</span></div><div class="casAuthors">Majlath, Zsofia; Tajti, Janos; Vecsei, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Neurological Disorders</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">386-397, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">TANDCF</span>;
        ISSN:<span class="NLM_cas:issn">1756-2856</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Dementia is a common neuropsychol. disorder with an increasing incidence.  The most prevalent type of dementia is Alzheimer's disease.  The underlying pathophysiol. features of the cognitive decline are neurodegenerative processes, a cerebrovascular dysfunction and immunol. alterations.  The therapeutic approaches are still limited, although intensive research is being conducted with the aim of finding neuroprotective strategies.  The widely accepted cholinesterase inhibitors and glutamate antagonists did not meet expectations of preventing disease progression, and research is therefore currently focusing on novel targets.  Nonsteroidal anti-inflammatory drugs, secretase inhibitors and statins are promising drug candidates for the prevention and management of different forms of dementia.  The kynurenine pathway has been assocd. with various neurodegenerative disorders and cerebrovascular diseases.  This pathway is also closely related to neuroinflammatory processes and it has been implicated in the pathomechanisms of certain kinds of dementia.  Targeting the kynurenine system may be of therapeutic value in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFMJvLjV_RG7Vg90H21EOLACvtfcHk0ljnlpPI2PDiPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OktrbN&md5=25d0ce73219bd6b1f0ca675ae98b7f47</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1177%2F1756285613494989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1756285613494989%26sid%3Dliteratum%253Aachs%26aulast%3DMajl%25C3%25A1th%26aufirst%3DZ.%26aulast%3DTajti%26aufirst%3DJ.%26aulast%3DV%25C3%25A9csei%26aufirst%3DL.%26atitle%3DKynurenines%2520and%2520other%2520novel%2520therapeutic%2520strategies%2520in%2520the%2520treatment%2520of%2520dementia%26jtitle%3DTher.%2520Adv.%2520Neurol.%2520Disord.%26date%3D2013%26volume%3D6%26issue%3D6%26spage%3D386%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Parsons, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danysz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollenburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przegalinski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzascik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chizh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headley, P. M.</span><span> </span><span class="NLM_article-title">Novel systemically active antagonists of the glycine site of the N-methyl-d-aspartate receptor: Electrophysiological, biochemical and behavioral characterization</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=9400002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK1cXis1Gitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1264-1275&author=C.+G.+Parsonsauthor=W.+Danyszauthor=G.+Quackauthor=S.+Hartmannauthor=B.+Lorenzauthor=C.+Wollenburgauthor=L.+Baranauthor=E.+Przegalinskiauthor=W.+Kostowskiauthor=P.+Krzascikauthor=B.+Chizhauthor=P.+M.+Headley&title=Novel+systemically+active+antagonists+of+the+glycine+site+of+the+N-methyl-d-aspartate+receptor%3A+Electrophysiological%2C+biochemical+and+behavioral+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization</span></div><div class="casAuthors">Parsons, Chris G.; Danysz, Wojciech; Quack, Gunter; Hartmann, Sabine; Lorenz, Bianke; Wollenburg, Christine; Baran, Leokadia; Przegalinski, Edmund; Kostowski, Wojciech; Krzascik, Pawel; Chizh, Boris; Headley, P. Max.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1264-1275</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A series of novel tricyclic pyrido-phthalazine-dione derivs. was tested for antagonistic effects at the strychnine-insensitive modulatory site of the N-methyl-D-aspartate (NMDA) receptor (glycineB).  All compds. displaced [3H]MDL-105,519 binding to rat cortical membranes with IC50 values of between 90 nM and 3.6 μM.  In patch-clamp expts., steady-state inward current responses of cultured hippocampal neurons to NMDA (200 μM, glycine 1 μM) were antagonized by these same compds. with IC50 values of 0.14 to 13.8 μM.  The antagonism obsd. was typical for glycineB antagonists, i.e., they induced desensitization and their effects were not use or voltage dependent.  Moreover, increasing concns. of glycine were able to decrease their apparent potency.  Much higher concns. (>100 μM) were required to antagonize α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced currents.  They were potent, systemically active NMDA receptor antagonists in vivo against responses of single neurons in the rat spinal cord to microelectrophoretic application of NMDA with ID50 values in the low milligram per kg i.v. range.  They also inhibited pentylenetetrazol-, NMDA- and maximal electroshock-induced convulsions in mice with ED50 values ranging from 8 to 100 mg/kg i.p.  The duration of anticonvulsive action was rather short but was prolonged by the org. acid transport inhibitor probenecid (200 mg/kg).  The agents tested represent a novel class of systemically active glycineB antagonists with greatly improved bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1EQUFAPvrZbVg90H21EOLACvtfcHk0ljnlpPI2PDiPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1Gitg%253D%253D&md5=d0d894db997e1d9a2b33c619185a1ce0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DC.%2BG.%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DQuack%26aufirst%3DG.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DLorenz%26aufirst%3DB.%26aulast%3DWollenburg%26aufirst%3DC.%26aulast%3DBaran%26aufirst%3DL.%26aulast%3DPrzegalinski%26aufirst%3DE.%26aulast%3DKostowski%26aufirst%3DW.%26aulast%3DKrzascik%26aufirst%3DP.%26aulast%3DChizh%26aufirst%3DB.%26aulast%3DHeadley%26aufirst%3DP.%2BM.%26atitle%3DNovel%2520systemically%2520active%2520antagonists%2520of%2520the%2520glycine%2520site%2520of%2520the%2520N-methyl-d-aspartate%2520receptor%253A%2520Electrophysiological%252C%2520biochemical%2520and%2520behavioral%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1264%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sapko, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagle, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington’s disease</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.expneurol.2005.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=16099455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2006&pages=31-40&issue=1&author=M.+T.+Sapkoauthor=P.+Guidettiauthor=P.+Yuauthor=D.+A.+Tagleauthor=R.+Pellicciariauthor=R.+Schwarcz&title=Endogenous+kynurenate+controls+the+vulnerability+of+striatal+neurons+to+quinolinate%3A+Implications+for+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease</span></div><div class="casAuthors">Sapko, Michael T.; Guidetti, Paolo; Yu, Ping; Tagle, Danilo A.; Pellicciari, Roberto; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Excessive activation of NMDA receptors results in excitotoxic nerve cell loss, which is believed to play a crit. role in the pathophysiol. of Huntington's disease (HD) and several other catastrophic neurodegenerative diseases.  Kynurenic acid (KYNA), a neuroinhibitory tryptophan metabolite, has neuroprotective properties and may serve as an endogenous anti-excitotoxic agent.  This hypothesis was tested in the striatum, using mice with a targeted deletion of kynurenine aminotransferase II (KAT II), a major biosynthetic enzyme of KYNA in the mammalian brain.  On post-natal day (PND) 14, the striatum of mkat-2-/- mice showed a redn. in KYNA levels but contained normal concns. of the metabolically related neurotoxins 3-hydroxykynurenine and quinolinic acid (QUIN).  Intrastriatal injections of QUIN, a NMDA receptor agonist, caused significantly larger lesions in these immature mutant mice than in age-matched wild-type animals.  This lesion enlargement was not obsd. when mkat-2-/- mice were acutely pre-treated with the kynurenine 3-hydroxylase inhibitor UPF 648, which counteracted the striatal KYNA deficit.  Moreover, no increased vulnerability to QUIN was obsd. in 2-mo-old mkat-2-/- mice, which present with normal brain KYNA levels.  Intrastriatal injections of the non-NMDA receptor agonist kainate caused similar lesion sizes in both genotypes regardless of age.  These results indicate that endogenous KYNA preferentially controls the vulnerability of striatal neurons to QUIN.  Our data suggest that timely pharmacol. interventions resulting in an up-regulation of brain KYNA levels may benefit patients suffering from HD or other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5WclI6mnY7Vg90H21EOLACvtfcHk0ljnlpPI2PDiPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL&md5=76a890b6b0bfa21fac83fdf9235d1bf5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2005.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2005.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSapko%26aufirst%3DM.%2BT.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DTagle%26aufirst%3DD.%2BA.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DEndogenous%2520kynurenate%2520controls%2520the%2520vulnerability%2520of%2520striatal%2520neurons%2520to%2520quinolinate%253A%2520Implications%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Neurol.%26date%3D2006%26volume%3D197%26issue%3D1%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Poeggeler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassoulpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=188-197&issue=1&author=B.+Poeggelerauthor=A.+Rassoulpourauthor=H.+Q.+Wuauthor=P.+Guidettiauthor=R.+C.+Robertsauthor=R.+Schwarcz&title=Dopamine+receptor+activation+reveals+a+novel%2C+kynurenate-sensitive+component+of+striatal+N-methyl-D-aspartate+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoeggeler%26aufirst%3DB.%26aulast%3DRassoulpour%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DR.%2BC.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DDopamine%2520receptor%2520activation%2520reveals%2520a%2520novel%252C%2520kynurenate-sensitive%2520component%2520of%2520striatal%2520N-methyl-D-aspartate%2520neurotoxicity%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D148%26issue%3D1%26spage%3D188%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Chiarugi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Kynurenine disposition in blood and brain of mice: Effects of selective inhibitors of kynurenine hydroxylase and of kynureninase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=8764597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1996&pages=692-698&issue=2&author=A.+Chiarugiauthor=R.+Carpenedoauthor=F.+Moroni&title=Kynurenine+disposition+in+blood+and+brain+of+mice%3A+Effects+of+selective+inhibitors+of+kynurenine+hydroxylase+and+of+kynureninase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase</span></div><div class="casAuthors">Chiarugi A; Carpenedo R; Moroni F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">692-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">To study the regulation of the synthesis of quinolinic and kynurenic acids in vivo, we evaluated (a) the metabolism of administered kynurenine by measuring the content of its main metabolites 3-hydroxykynurenine, anthranilic acid, and 3-hydroxyanthranilic acid in blood and brain of mice; (b) the effects of (m-nitrobenzoyl)alanine, a selective inhibitor of kynurenine hydroxylase and of (o-methoxybenzoyl) alanine, a selective inhibitor of kynureninase, on this metabolism; and (c) the effects of (o-methoxybenzoyl)alanine on liver kynureninase and 3-hydroxykynureninase activity.  The conclusions drawn from these experiments are (a) the disposition of administered kynurenine preferentially occurs through hydroxylation in brain and through hydrolysis in peripheral tissues; (b) (m-nitrobenzoyl)alanine, the inhibitor of kynurenine hydroxylase, causes the expected changes in brain kynurenine metabolism, such as a decrease of 3-hydroxykynurenine, and an increase of kynurenic acid; and (c) (o-methoxybenzoyl)alanine, the kynureninase inhibitor, increases brain concentration of the cytotoxic compound 3-hydroxykynurenine, and unexpectedly does not reduce brain concentration of 3-hydroxyanthranilic acid, the direct precursor of quinolinic acid.  Taken together, the experiments suggest that the systemic administration of a kynurenine hydroxylase inhibitor is a rational approach to increase the brain content of kynurenate and to decrease that of cytotoxic kynurenine metabolites, such as 3-hydroxykynurenine and quinolinic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-MKFVxCBo-Ny3lHz94U-GfW6udTcc2eYRatzFVm_hObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zktVWmsw%253D%253D&md5=b9843554a48282aa2660283eab76c8df</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiarugi%26aufirst%3DA.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DKynurenine%2520disposition%2520in%2520blood%2520and%2520brain%2520of%2520mice%253A%2520Effects%2520of%2520selective%2520inhibitors%2520of%2520kynurenine%2520hydroxylase%2520and%2520of%2520kynureninase%26jtitle%3DJ.%2520Neurochem.%26date%3D1996%26volume%3D67%26issue%3D2%26spage%3D692%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Speciale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2FS0014-2999%2896%2900613-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=8982663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK28XntFajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=1996&pages=263-267&issue=3&author=C.+Specialeauthor=H.+Q.+Wuauthor=M.+Ciniauthor=M.+Marconiauthor=M.+Varasiauthor=R.+Schwarcz&title=%28R%2CS%29-3%2C4-dichlorobenzoylalanine+%28FCE+28833A%29+causes+a+large+and+persistent+increase+in+brain+kynurenic+acid+levels+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats</span></div><div class="casAuthors">Speciale, Carmela; Wu, Hui-Qiu; Cini, Massimo; Marconi, Marina; Varasi, Mario; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-267</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Kynurenic acid is an endogenous excitatory amino-acid receptor antagonist with neuroprotective and anticonvulsant properties.  We demonstrate here that systemic administration of the new and potent kynurenine 3-hydroxylase inhibitor (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a dose-dependent elevation in endogenous kynurenine and kynurenic acid levels in rat brain tissue.  In hippocampal microdialyzates, peak increases of 10- and 80-fold above basal kynurenic acid concns., resp., were obtained after a single oral or i.p. administration of 400 mg/kg FCE 28833A.  After i.p. treatment with FCE 28833A, extracellular brain kynurenic acid levels remained significantly elevated for at least 22 h, rendering this compd. a far more effective enhancer of kynurenic acid levels than the previously described kynurenine 3-hydroxylase blocker m-nitrobenzoylalanine.  FCE 28833A and similar mols. may have therapeutic value in diseases which are linked to a hyperfunction of excitatory amino-acid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA8SDjJSJ-WrVg90H21EOLACvtfcHk0licxVw3KKRzPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFajs7g%253D&md5=57728270fcd997712d2c8f597837a6ae</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900613-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900613-9%26sid%3Dliteratum%253Aachs%26aulast%3DSpeciale%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DCini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DM.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3D%2528R%252CS%2529-3%252C4-dichlorobenzoylalanine%2520%2528FCE%252028833A%2529%2520causes%2520a%2520large%2520and%2520persistent%2520increase%2520in%2520brain%2520kynurenic%2520acid%2520levels%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D315%26issue%3D3%26spage%3D263%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Sapko, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagle, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington’s disease</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.expneurol.2005.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=16099455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2006&pages=31-40&author=M.+T.+Sapkoauthor=P.+Guidettiauthor=P.+Yuauthor=D.+A.+Tagleauthor=R.+Pellicciariauthor=R.+Schwarcz&title=Endogenous+kynurenate+controls+the+vulnerability+of+striatal+neurons+to+quinolinate%3A+Implications+for+Huntington%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease</span></div><div class="casAuthors">Sapko, Michael T.; Guidetti, Paolo; Yu, Ping; Tagle, Danilo A.; Pellicciari, Roberto; Schwarcz, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Excessive activation of NMDA receptors results in excitotoxic nerve cell loss, which is believed to play a crit. role in the pathophysiol. of Huntington's disease (HD) and several other catastrophic neurodegenerative diseases.  Kynurenic acid (KYNA), a neuroinhibitory tryptophan metabolite, has neuroprotective properties and may serve as an endogenous anti-excitotoxic agent.  This hypothesis was tested in the striatum, using mice with a targeted deletion of kynurenine aminotransferase II (KAT II), a major biosynthetic enzyme of KYNA in the mammalian brain.  On post-natal day (PND) 14, the striatum of mkat-2-/- mice showed a redn. in KYNA levels but contained normal concns. of the metabolically related neurotoxins 3-hydroxykynurenine and quinolinic acid (QUIN).  Intrastriatal injections of QUIN, a NMDA receptor agonist, caused significantly larger lesions in these immature mutant mice than in age-matched wild-type animals.  This lesion enlargement was not obsd. when mkat-2-/- mice were acutely pre-treated with the kynurenine 3-hydroxylase inhibitor UPF 648, which counteracted the striatal KYNA deficit.  Moreover, no increased vulnerability to QUIN was obsd. in 2-mo-old mkat-2-/- mice, which present with normal brain KYNA levels.  Intrastriatal injections of the non-NMDA receptor agonist kainate caused similar lesion sizes in both genotypes regardless of age.  These results indicate that endogenous KYNA preferentially controls the vulnerability of striatal neurons to QUIN.  Our data suggest that timely pharmacol. interventions resulting in an up-regulation of brain KYNA levels may benefit patients suffering from HD or other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5WclI6mnY7Vg90H21EOLACvtfcHk0licxVw3KKRzPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGitrzL&md5=76a890b6b0bfa21fac83fdf9235d1bf5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2005.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2005.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSapko%26aufirst%3DM.%2BT.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DTagle%26aufirst%3DD.%2BA.%26aulast%3DPellicciari%26aufirst%3DR.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DEndogenous%2520kynurenate%2520controls%2520the%2520vulnerability%2520of%2520striatal%2520neurons%2520to%2520quinolinate%253A%2520Implications%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DExp.%2520Neurol.%26date%3D2006%26volume%3D197%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Röver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huguenin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szente, A.</span><span> </span><span class="NLM_article-title">Synthesis and Biochemical Evaluation of <i>N</i>-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4378</span><span class="NLM_x">–</span> <span class="NLM_lpage">4385</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970467t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4378-4385&author=S.+R%C3%B6verauthor=A.+M.+Cesuraauthor=P.+Hugueninauthor=R.+Kettlerauthor=A.+Szente&title=Synthesis+and+Biochemical+Evaluation+of+N-%284-Phenylthiazol-2-yl%29benzenesulfonamides+as+High-Affinity+Inhibitors+of+Kynurenine+3-Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm970467t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970467t%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6ver%26aufirst%3DS.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DHuguenin%26aufirst%3DP.%26aulast%3DKettler%26aufirst%3DR.%26aulast%3DSzente%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Biochemical%2520Evaluation%2520of%2520N-%25284-Phenylthiazol-2-yl%2529benzenesulfonamides%2520as%2520High-Affinity%2520Inhibitors%2520of%2520Kynurenine%25203-Hydroxylase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4378%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Moroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruginelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini-Giampietro, D. E.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">467</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=467&publication_year=1999&pages=199-206&author=F.+Moroniauthor=A.+Cozziauthor=F.+Peruginelliauthor=R.+Carpenedoauthor=D.+E.+Pellegrini-Giampietro&title=Neuroprotective+effects+of+kynurenine-3-hydroxylase+inhibitors+in+models+of+brain+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoroni%26aufirst%3DF.%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DPeruginelli%26aufirst%3DF.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DPellegrini-Giampietro%26aufirst%3DD.%2BE.%26atitle%3DNeuroprotective%2520effects%2520of%2520kynurenine-3-hydroxylase%2520inhibitors%2520in%2520models%2520of%2520brain%2520ischemia%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1999%26volume%3D467%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Cozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenedo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroni, F.</span><span> </span><span class="NLM_article-title">Kynurenine hydroxylase inhibitors reduce ischemic brain damage: Studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1097%2F00004647-199907000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=10413032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVCqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=771-777&issue=7&author=A.+Cozziauthor=R.+Carpenedoauthor=F.+Moroni&title=Kynurenine+hydroxylase+inhibitors+reduce+ischemic+brain+damage%3A+Studies+with+%28m-nitrobenzoyl%29-alanine+%28mNBA%29+and+3%2C4-dimethoxy-%5BN-4-%28nitrophenyl%29thiazol-2yl%5D-benzenesulfonamide+%28Ro+61-8048%29+in+models+of+focal+or+global+brain+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2YL]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia</span></div><div class="casAuthors">Cozzi, A.; Carpenedo, R.; Moroni, F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Two kynurenine hydroxylase inhibitors, (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048), have been tested as neuroprotective agents on brain lesions induced by bilateral carotid occlusion in gerbils or by middle cerebral artery occlusion in rats.  The percentage of lesioned pyramidal neurons found in the hippocampal CA 1 region of gerbils subjected to bilateral carotid occlusion for 5 min decreased from 92±10% in vehicle-treated animals to 7±6% after mNBA (400 mg/kg i.p., three times at 1, 30, and 180 min after occlusion) or to 10±11% after Ro 61-8048 (40 mg/kg i.p., three times).  A significant redn. in infarct vols. also was found when the kynurenine hydroxylase inhibitors were given to rats after permanent middle cerebral artery occlusion (from 207±111 mm3 in vehicle-treated rats to 82±18 and to 62±57 mm3 in rats treated with mNBA, 400 mg/kg i.p., or with Ro 61-8048, 40 mg/kg i.p., resp.).  The administration of mNBA (400 mg/kg i.p.) or Ro 61-8048 (40 mg/kg i.p.) to gerbils with a dialysis probe in their dorsal hippocampus or to rats with a dialysis probe in their parietal cortex significantly increased kynurenic acid concn. in the dialyzates.  The data suggest that inhibition of kynurenine hydroxylase could be a new avenue to reduce neuronal loss in brain ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvjv2QFdoiC7Vg90H21EOLACvtfcHk0ljiP8n8qGyO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVCqsbk%253D&md5=ff003fd2c888b9c7e97afd193fe6fbd0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1097%2F00004647-199907000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-199907000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DCozzi%26aufirst%3DA.%26aulast%3DCarpenedo%26aufirst%3DR.%26aulast%3DMoroni%26aufirst%3DF.%26atitle%3DKynurenine%2520hydroxylase%2520inhibitors%2520reduce%2520ischemic%2520brain%2520damage%253A%2520Studies%2520with%2520%2528m-nitrobenzoyl%2529-alanine%2520%2528mNBA%2529%2520and%25203%252C4-dimethoxy-%255BN-4-%2528nitrophenyl%2529thiazol-2yl%255D-benzenesulfonamide%2520%2528Ro%252061-8048%2529%2520in%2520models%2520of%2520focal%2520or%2520global%2520brain%2520ischemia%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1999%26volume%3D19%26issue%3D7%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Samadi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grégoire, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassoulpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bédard, P. J.</span><span> </span><span class="NLM_article-title">Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=792-802&issue=7&author=P.+Samadiauthor=L.+Gr%C3%A9goireauthor=A.+Rassoulpourauthor=P.+Guidettiauthor=E.+Izzoauthor=R.+Schwarczauthor=P.+J.+B%C3%A9dard&title=Effect+of+kynurenine+3-hydroxylase+inhibition+on+the+dyskinetic+and+antiparkinsonian+responses+to+levodopa+in+Parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamadi%26aufirst%3DP.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DL.%26aulast%3DRassoulpour%26aufirst%3DA.%26aulast%3DGuidetti%26aufirst%3DP.%26aulast%3DIzzo%26aufirst%3DE.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DB%25C3%25A9dard%26aufirst%3DP.%2BJ.%26atitle%3DEffect%2520of%2520kynurenine%25203-hydroxylase%2520inhibition%2520on%2520the%2520dyskinetic%2520and%2520antiparkinsonian%2520responses%2520to%2520levodopa%2520in%2520Parkinsonian%2520monkeys%26jtitle%3DMov.%2520Disord.%26date%3D2005%26volume%3D20%26issue%3D7%26spage%3D792%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Beconi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael Prime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo-Sherman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Sanjuan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2297-2306&issue=12&author=M.+G.+Beconiauthor=D.+Yatesauthor=K.+Lyonsauthor=K.+Matthewsauthor=S.+Cliftonauthor=T.+Meadauthor=M.+Michael+Primeauthor=D.+Winklerauthor=C.+O%E2%80%99Connellauthor=D.+Walterauthor=L.+M.+Toledo-Shermanauthor=I.+Munoz-Sanjuanauthor=C.+Dominguez&title=Metabolism+and+Pharmacokinetics+of+JM6+in+Mice%3A+JM6+Is+Not+a+Prodrug+for+Ro-61-8048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeconi%26aufirst%3DM.%2BG.%26aulast%3DYates%26aufirst%3DD.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DK.%26aulast%3DClifton%26aufirst%3DS.%26aulast%3DMead%26aufirst%3DT.%26aulast%3DMichael%2BPrime%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DC.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DToledo-Sherman%26aufirst%3DL.%2BM.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMetabolism%2520and%2520Pharmacokinetics%2520of%2520JM6%2520in%2520Mice%253A%2520JM6%2520Is%2520Not%2520a%2520Prodrug%2520for%2520Ro-61-8048%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26issue%3D12%26spage%3D2297%26epage%3D2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Courtney, S. M.; Prime, M.; Mitchell, W.; Brown, C. J.; De Aguiar Pena, P. C.; Johnson, P.; Dominguez, C.; Toledo-Sherman, L. M.; Munoz, I.</span><span> </span><span class="NLM_article-title">Kynurenine-3-Monooxygenase Inhibitors, Pharmaceutical Compositions and Methods of use Thereof</span>. International Patent WO2013/033085, Mar 7,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+M.+Courtney&author=M.+Prime&author=W.+Mitchell&author=C.+J.+Brown&author=P.+C.+De+Aguiar+Pena&author=P.+Johnson&author=C.+Dominguez&author=L.+M.+Toledo-Sherman&author=I.+Munoz&title=Kynurenine-3-Monooxygenase+Inhibitors%2C+Pharmaceutical+Compositions+and+Methods+of+use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DS.%2BM.%26atitle%3DKynurenine-3-Monooxygenase%2520Inhibitors%252C%2520Pharmaceutical%2520Compositions%2520and%2520Methods%2520of%2520use%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Dominguez, C.; Toledo-Sherman, L. M.; Courtney, S. M.; Prime, M.; Mitchell, W.; Brown, C. J.; De Aguiar Pena, P. C.; Johnson, P.</span><span> </span><span class="NLM_article-title">Certain Kynurenine-3-Monooxygenase Inhibitors, Pharmaceutical Compositions and Methods of use Thereof</span>. International Patent WO2013/016488, Jan 31,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Dominguez&author=L.+M.+Toledo-Sherman&author=S.+M.+Courtney&author=M.+Prime&author=W.+Mitchell&author=C.+J.+Brown&author=P.+C.+De+Aguiar+Pena&author=P.+Johnson&title=Certain+Kynurenine-3-Monooxygenase+Inhibitors%2C+Pharmaceutical+Compositions+and+Methods+of+use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DCertain%2520Kynurenine-3-Monooxygenase%2520Inhibitors%252C%2520Pharmaceutical%2520Compositions%2520and%2520Methods%2520of%2520use%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&issue=7&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0liHXI5LVGEJ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26issue%3D7%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Albaneze-Walker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazaral, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormer, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, J. A.</span><span> </span><span class="NLM_article-title">Improved Carbonylation of Heterocyclic Chlorides and Electronically Challenging Aryl Bromides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">2097</span><span class="NLM_x">–</span> <span class="NLM_lpage">2100</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0498287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=2097-2100&issue=13&author=J.+Albaneze-Walkerauthor=C.+Bazaralauthor=T.+Leaveyauthor=P.+G.+Dormerauthor=J.+A.+Murry&title=Improved+Carbonylation+of+Heterocyclic+Chlorides+and+Electronically+Challenging+Aryl+Bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol0498287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0498287%26sid%3Dliteratum%253Aachs%26aulast%3DAlbaneze-Walker%26aufirst%3DJ.%26aulast%3DBazaral%26aufirst%3DC.%26aulast%3DLeavey%26aufirst%3DT.%26aulast%3DDormer%26aufirst%3DP.%2BG.%26aulast%3DMurry%26aufirst%3DJ.%2BA.%26atitle%3DImproved%2520Carbonylation%2520of%2520Heterocyclic%2520Chlorides%2520and%2520Electronically%2520Challenging%2520Aryl%2520Bromides%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26issue%3D13%26spage%3D2097%26epage%3D2100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">van der Westhuyzen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, C. J.</span><span> </span><span class="NLM_article-title">Effect of Substituent Structure on Pyrimidine Electrophilic Substitution</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">5394</span><span class="NLM_x">–</span> <span class="NLM_lpage">5405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=5394-5405&issue=25&author=C.+W.+van+der+Westhuyzenauthor=A.+L.+Rousseauauthor=C.+J.+Parkinson&title=Effect+of+Substituent+Structure+on+Pyrimidine+Electrophilic+Substitution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuyzen%26aufirst%3DC.%2BW.%26aulast%3DRousseau%26aufirst%3DA.%2BL.%26aulast%3DParkinson%26aufirst%3DC.%2BJ.%26atitle%3DEffect%2520of%2520Substituent%2520Structure%2520on%2520Pyrimidine%2520Electrophilic%2520Substitution%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26issue%3D25%26spage%3D5394%26epage%3D5405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, T.</span><span> </span><span class="NLM_article-title">Dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II): An effective catalyst for cross-coupling of secondary and primary alkyl Grignard and alkylzinc reagents with organic halides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00313a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1984&pages=158-163&issue=1&author=T.+Hayashiauthor=M.+Konishiauthor=Y.+Koboriauthor=M.+Kumadaauthor=T.+Higuchi&title=Dichloro%5B1%2C1%E2%80%B2-bis%28diphenylphosphino%29ferrocene%5Dpalladium%28II%29%3A+An+effective+catalyst+for+cross-coupling+of+secondary+and+primary+alkyl+Grignard+and+alkylzinc+reagents+with+organic+halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja00313a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00313a032%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DKobori%26aufirst%3DY.%26aulast%3DKumada%26aufirst%3DM.%26aulast%3DHiguchi%26aufirst%3DT.%26atitle%3DDichloro%255B1%252C1%25E2%2580%25B2-bis%2528diphenylphosphino%2529ferrocene%255Dpalladium%2528II%2529%253A%2520An%2520effective%2520catalyst%2520for%2520cross-coupling%2520of%2520secondary%2520and%2520primary%2520alkyl%2520Grignard%2520and%2520alkylzinc%2520reagents%2520with%2520organic%2520halides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1984%26volume%3D106%26issue%3D1%26spage%3D158%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Pearson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">The Mechanism of Benzylic Bromination with <i>N</i>-Bromosuccinimide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00886a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=354-355&issue=3&author=R.+E.+Pearsonauthor=J.+C.+Martin&title=The+Mechanism+of+Benzylic+Bromination+with+N-Bromosuccinimide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja00886a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00886a029%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DR.%2BE.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Mechanism%2520of%2520Benzylic%2520Bromination%2520with%2520N-Bromosuccinimide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26issue%3D3%26spage%3D354%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Bernard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiani, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piras, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivoldini, A.</span><span> </span><span class="NLM_article-title">Dealkylation of Activated Alkyl Aryl Ethers Using Lithium Chloride in Dimethylformamide</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1055%2Fs-1989-27225" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1989&pages=287-289&author=A.+M.+Bernardauthor=M.+R.+Ghianiauthor=P.+P.+Pirasauthor=A.+Rivoldini&title=Dealkylation+of+Activated+Alkyl+Aryl+Ethers+Using+Lithium+Chloride+in+Dimethylformamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1055%2Fs-1989-27225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1989-27225%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DA.%2BM.%26aulast%3DGhiani%26aufirst%3DM.%2BR.%26aulast%3DPiras%26aufirst%3DP.%2BP.%26aulast%3DRivoldini%26aufirst%3DA.%26atitle%3DDealkylation%2520of%2520Activated%2520Alkyl%2520Aryl%2520Ethers%2520Using%2520Lithium%2520Chloride%2520in%2520Dimethylformamide%26jtitle%3DSynthesis%26date%3D1989%26volume%3D4%26spage%3D287%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Doláková, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masojídková, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holy, A.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of Pyrimidinecarbonitriles and Their Derivatives</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1107-1115&issue=5&author=P.+Dol%C3%A1kov%C3%A1author=M.+Masoj%C3%ADdkov%C3%A1author=A.+Holy&title=Efficient+Synthesis+of+Pyrimidinecarbonitriles+and+Their+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDol%25C3%25A1kov%25C3%25A1%26aufirst%3DP.%26aulast%3DMasoj%25C3%25ADdkov%25C3%25A1%26aufirst%3DM.%26aulast%3DHoly%26aufirst%3DA.%26atitle%3DEfficient%2520Synthesis%2520of%2520Pyrimidinecarbonitriles%2520and%2520Their%2520Derivatives%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D71%26issue%3D5%26spage%3D1107%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Finnegan, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofquist, R.</span><span> </span><span class="NLM_article-title">An Improved Synthesis of 5-Substituted Tetrazoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">3908</span><span class="NLM_x">–</span> <span class="NLM_lpage">3911</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01548a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaG1MXhtFOqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1958&pages=3908-3911&author=W.+G.+Finneganauthor=R.+A.+Henryauthor=R.+Lofquist&title=An+Improved+Synthesis+of+5-Substituted+Tetrazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">An improved synthesis of 5-substituted tetrazoles</span></div><div class="casAuthors">Finnegan, William G.; Henry, Ronald A.; Lofquist, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3908-11</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">5-Substituted tetrazoles (I) are readily obtained from alkyl-or arylnitriles and inorg. azides in HCONMe2 (II) or Et2SO.  C7F15CN, b705 100-2°, was prepd. in 52% yield from the acid by the method of Gilman and Jones (C.A. 37, 56961).  The appropriate nitrile (0.2 mole), 14.3 g. NaN3, LiCl, the appropriate ammonium chloride or catalyst in the desired molar ratio, and 100 cc. solvent heated with stirring, the solvent evapd. in vacuo on the steam bath, and the residue (if H2O-insol.) dissolved in 100 cc. H2O, acidified with concd. HCl to pH 2, cooled to 5°, and filtered gave the corresponding I (method A).  The crude residue (if sol. or partially sol. in H2O) dissolved in 100 cc. H2O, basified with 50% aq. NaOH, and evapd. to dryness in vacuo on the steam bath, the residue dissolved in 100 cc. H2O, acidified to pH 2 with concd. HCl, and evapd. to dryness on the steam bath, and the residue extd. with EtOH or MeOH yielded the corresponding I (method B).  The finally acidified soln. in method B concd., cooled to room temp., adjusted to pH 5 with base, treated with 0.1 mole aq. Cu(OAc)2, and filtered, the residue washed with H2O, suspended in 100-200 cc. H2O, heated with stirring to 50°, bubbled with H2S, and filtered, and the filtrate evapd. to dryness in vacuo gave the corresponding I (method C).  In this manner were prepd. the following I (5-substituent, m.p., % yield, azide used, reaction temp., reaction time in hrs., reaction medium used, and method used given): H, 147-51° (decompn.) (EtOAc), 69.2, Me3NHN3, 105-10°, 22, II, B;  Pr, 63-4° (iso-Pr2O), 73.5, NH4N3 (III), 120-5°, 24, II, C; HOCH2CH2, 83-4° (EtCOMe), 93.3°, III, 120-5°, 24, II, B;  MeO(CH2)2, 66-7° (EtOAc), 100, III, 120°, 18, II, B;  EtO2CCH2, 128-30° (iso-PrOH), 81, III, 95°, 8, II, A;  NaOSO2(CH2)2, 208-9° (decompn.) (95% EtOH), -, III, 120-5°, 7, II, B;  PhCH2, 123-5° [(CH2Cl)2], 84.1, III, 120-5°, 7, II, A; MeS, 150-1° (decompn.) (H2O), 91.5, III, 95°, 6, II, A; PhCH2S, 137.5-8.5° (30% EtOH), 22, III, 95°, 5, II, A; C7F15, -, 100, III, 95°, 4, II, A; Ph (IV), 213-15° (decompn.) (H2O), 100, III, 125°, 7, II, A; IV, -, 90.6, Me3NHN3, 100°, 3, II, A; IV, -, 90, III, 100°, 96°, Ethyl Cellosolve, A; IV,  -, 51.3, NaN3, reflux, 20.5, II, A; IV, -, 43.9, NaN3, 120-5°, 24, Me2SO, A (the Na salt was pptd. with CH2Cl2 and treated in H2O with concd. HCl to yield IV); IV, -, 19.4, NaN3, 126°, 24, Methyl Cellosolve, A; p-H2NC6H4, 268-70° (aq. II), -, -, -, -, -, -; p-NCC6H4, above 300° (decompn.) (H2O), -, -, -, -, -, -; bis(5-tetrazolyl)methane, 215-19° (decompn.) (MeCN), 100, III, 95°, 16, II, A; 1,4-bis(5-tetrazolyl)butane, 204-5° (decompn.) (95% EtOH), 26, III, 100°, 96, Ethyl Cellosolve, A; 1,4-bis(5-tetrazolyl)- benzene (V), above 300° (decompn.) (95% EtOH), 100, III, 125°, 7, II, A.  A series of runs was performed for the prepn. of IV by treating 0.2 mole PhCN, 100 cc. HCONMe2, and 0.22 mole NaN3 during 7 hrs. at 123-7° in the presence of various added salts or catalyst (added material, mole-%, and % yield of IV given): none, -, 24.9; NH4Cl, 10, 59.6 (54.1); Bu2NH.HCl, 5, 51.6; PhNH2.HCl, 5.8, 57.2; PhNH2.HCl, 10, 73.8; EtSO4H, 4, 51.3; EtSO3H (in 100 cc. MeOCH2CH2OH), 8, 16.3; Et2O-BF3, 10, 55.6; Me4NCl, 100, 40.4; LiCl, 100, 48.6; H2O, - (5 cc.), 5.8.  The appropriate substituted benzonitrile (0.2 mole), 0.22 mole III, and 100 cc. HCONMe2 yielded during 3 hrs. at 100° varying yields of I depending on the substituent (5- substituent of I and % yield given): p-NH2, 10.4, p-MeO 43.2, p-Me 63.8, H, 75.6, p-NO2 96.9, m-NO2 99.5, p-CN 90.5 (and a small amt. of V).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5x4qHLA-D-rVg90H21EOLACvtfcHk0lhwVbGXXeE5lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXhtFOqtg%253D%253D&md5=c02810dd38cce62bfdfe9c398136201d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja01548a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01548a028%26sid%3Dliteratum%253Aachs%26aulast%3DFinnegan%26aufirst%3DW.%2BG.%26aulast%3DHenry%26aufirst%3DR.%2BA.%26aulast%3DLofquist%26aufirst%3DR.%26atitle%3DAn%2520Improved%2520Synthesis%2520of%25205-Substituted%2520Tetrazoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1958%26volume%3D80%26spage%3D3908%26epage%3D3911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennuyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tailleux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staels, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span> </span><span class="NLM_article-title">Novel non-carboxylic acid retinoids: 1,2,4-Oxadiazol-5-one derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=489-492&issue=2&author=J.+Chartonauthor=R.+Deprez-Poulainauthor=N.+Hennuyerauthor=A.+Tailleuxauthor=B.+Staelsauthor=B.+Deprez&title=Novel+non-carboxylic+acid+retinoids%3A+1%2C2%2C4-Oxadiazol-5-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26aulast%3DHennuyer%26aufirst%3DN.%26aulast%3DTailleux%26aufirst%3DA.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DNovel%2520non-carboxylic%2520acid%2520retinoids%253A%25201%252C2%252C4-Oxadiazol-5-one%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D2%26spage%3D489%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Santilli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. L.</span><span> </span><span class="NLM_article-title">Synthesis of 3-Arylsulfonylmethyl-1,2-4-oxadiazole-5-carboxylic Acid Derivatives</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1979&pages=1197-1200&issue=6&author=A.+Santilliauthor=R.+L.+Morris&title=Synthesis+of+3-Arylsulfonylmethyl-1%2C2-4-oxadiazole-5-carboxylic+Acid+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantilli%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DR.%2BL.%26atitle%3DSynthesis%2520of%25203-Arylsulfonylmethyl-1%252C2-4-oxadiazole-5-carboxylic%2520Acid%2520Derivatives%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1979%26volume%3D16%26issue%3D6%26spage%3D1197%26epage%3D1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Manley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balitza, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodman, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1673-1677&issue=10&author=P.+J.+Manleyauthor=A.+E.+Balitzaauthor=M.+T.+Bilodeauauthor=K.+E.+Collauthor=R.+C.+Hartmanauthor=K.+W.+McFallauthor=L.+D.+Rodmanauthor=K.+A.+Thomas&title=2%2C4-Disubstituted+pyrimidines%3A+A+novel+class+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DBalitza%26aufirst%3DA.%2BE.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DHartman%26aufirst%3DR.%2BC.%26aulast%3DMcFall%26aufirst%3DK.%2BW.%26aulast%3DRodman%26aufirst%3DL.%2BD.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3D2%252C4-Disubstituted%2520pyrimidines%253A%2520A%2520novel%2520class%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D10%26spage%3D1673%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Winkler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo-Sherman, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebneth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Sanjuan, I.</span><span> </span><span class="NLM_article-title">Development of LC/MS/MS, High-Throughput Enzymatic and Cellular Assays for the Characterization of Compounds That Inhibit Kynurenine Monooxygenase (KMO)</span> <span class="citation_source-journal">J. Biol. Screening.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1177%2F1087057113489731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=23690293" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=879-889&issue=8&author=D.+Winklerauthor=M.+Beconiauthor=L.+M.+Toledo-Shermanauthor=M.+Primeauthor=A.+Ebnethauthor=C.+Dominguezauthor=I.+Mu%C3%B1oz-Sanjuan&title=Development+of+LC%2FMS%2FMS%2C+High-Throughput+Enzymatic+and+Cellular+Assays+for+the+Characterization+of+Compounds+That+Inhibit+Kynurenine+Monooxygenase+%28KMO%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1177%2F1087057113489731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113489731%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DD.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DToledo-Sherman%26aufirst%3DL.%2BM.%26aulast%3DPrime%26aufirst%3DM.%26aulast%3DEbneth%26aufirst%3DA.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DMu%25C3%25B1oz-Sanjuan%26aufirst%3DI.%26atitle%3DDevelopment%2520of%2520LC%252FMS%252FMS%252C%2520High-Throughput%2520Enzymatic%2520and%2520Cellular%2520Assays%2520for%2520the%2520Characterization%2520of%2520Compounds%2520That%2520Inhibit%2520Kynurenine%2520Monooxygenase%2520%2528KMO%2529%26jtitle%3DJ.%2520Biol.%2520Screening.%26date%3D2013%26volume%3D18%26issue%3D8%26spage%3D879%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Krueger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. E.</span><span> </span><span class="NLM_article-title">Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2Fj.pharmthera.2005.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=15922018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1SltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=357-387&author=S.+K.+Kruegerauthor=D.+E.+Williams&title=Mammalian+flavin-containing+monooxygenases%3A+structure%2Ffunction%2C+genetic+polymorphisms+and+role+in+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism</span></div><div class="casAuthors">Krueger, Sharon K.; Williams, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">357-387</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Flavin-contg. monooxygenase (FMO) oxygenates drugs and xenobiotics contg. a "soft nucleophile", usually N or S.  FMO, like cytochrome P 450 (CYP), is a monooxygenase, utilizing the reducing equiv. of NADPH to reduce 1 atom of O2 to H2O, while the other atom is used to oxidize the substrate.  FMO and CYP also exhibit similar tissue and cellular location, mol. wt., substrate specificity, and exist as multiple enzymes under developmental control.  The human FMO functional gene family is much smaller (5 families each with a single member) than CYP.  FMO does not require a reductase to transfer electrons from NADPH and the catalytic cycle of the 2 monooxygenases is strikingly different.  Another distinction is the lack of induction of FMOs by xenobiotics.  In general, CYP is the major contributor to oxidative xenobiotic metab.  However, FMO activity may be of significance in a no. of cases and should not be overlooked.  FMO and CYP have overlapping substrate specificities, but often yield distinct metabolites with potentially significant toxicol./pharmacol. consequences.  The physiol. function(s) of FMOs are poorly understood.  Three of the 5 expressed human FMO genes, FMO1, FMO2, and FMO3, exhibit genetic polymorphisms.  The most studied of these is FMO3 (adult human liver) in which mutant alleles contribute to the disease known as trimethylaminuria.  The consequences of these FMO genetic polymorphisms in drug metab. and human health are areas of research requiring further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfwDBzxhgaYbVg90H21EOLACvtfcHk0lgHyWNFVQpRjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1SltLc%253D&md5=2f0b76495aa8a53069bacc9b4ae8de43</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2005.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2005.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DKrueger%26aufirst%3DS.%2BK.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26atitle%3DMammalian%2520flavin-containing%2520monooxygenases%253A%2520structure%252Ffunction%252C%2520genetic%2520polymorphisms%2520and%2520role%2520in%2520drug%2520metabolism%26jtitle%3DPharmacol.%2520Ther.%26date%3D2005%26volume%3D106%26spage%3D357%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Melo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floriano, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, J. A. N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leao, J. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalhães, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maigret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nascimento, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, N.</span><span> </span><span class="NLM_article-title">Theoretical study of arginine–carboxylate interactions</span> <span class="citation_source-journal">J. Mol. Struct.: THEOCHEM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1016%2FS0166-1280%2898%2900396-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADyaK1MXit12itLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=1999&pages=81-90&issue=1&author=A.+Meloauthor=M.+J.+Ramosauthor=W.+B.+Florianoauthor=J.+A.+N.+F.+Gomesauthor=J.+F.+R.+Leaoauthor=A.+L.+Magalh%C3%A3esauthor=B.+Maigretauthor=M.+C.+Nascimentoauthor=N.+Reuter&title=Theoretical+study+of+arginine%E2%80%93carboxylate+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical study of arginine-carboxylate interactions</span></div><div class="casAuthors">Melo, A.; Ramos, M. J.; Floriano, W. B.; Gomes, J. A. N. F.; Leao, J. F. R.; Magalhaes, A. L.; Maigret, B.; Nascimento, M. C.; Reuter, N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure: THEOCHEM</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">81-90</span>CODEN:
                <span class="NLM_cas:coden">THEODJ</span>;
        ISSN:<span class="NLM_cas:issn">0166-1280</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The importance of the guanidinium-carboxylate interactions has sprung from the obsd. salt bridges often present in biol. systems involving the arginine-glutamate or arginine-aspartate side chains.  The strength of these interactions has been explained on the basis of a great coulombic energy gain, due to the closeness of two charges of opposite sign and the occurrence of H-bond interactions.  However, in some environments proton transfer, from guanidinium to carboxylate, can occur with the consequent annihilation of charge.  In this work, both ab-initio (6-31G** and MP2/6-31G**) and semi-empirical (AM1) calcns. were performed in vacuo on appropriate models, methylguanidinium-acetate and methylguanidine-acetic acid to simulate the zwitterionic and the neutral forms, resp.  The results obtained indicate that, in solvent-free hydrophobic environments, the neutral form should be more stable than the zwitterionic one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVeW2ZpN-T-7Vg90H21EOLACvtfcHk0lgHyWNFVQpRjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXit12itLY%253D&md5=36b8a16151fe18fcc1709759e671b3b6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0166-1280%2898%2900396-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-1280%252898%252900396-0%26sid%3Dliteratum%253Aachs%26aulast%3DMelo%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26aulast%3DFloriano%26aufirst%3DW.%2BB.%26aulast%3DGomes%26aufirst%3DJ.%2BA.%2BN.%2BF.%26aulast%3DLeao%26aufirst%3DJ.%2BF.%2BR.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DA.%2BL.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DNascimento%26aufirst%3DM.%2BC.%26aulast%3DReuter%26aufirst%3DN.%26atitle%3DTheoretical%2520study%2520of%2520arginine%25E2%2580%2593carboxylate%2520interactions%26jtitle%3DJ.%2520Mol.%2520Struct.%253A%2520THEOCHEM%26date%3D1999%26volume%3D463%26issue%3D1%26spage%3D81%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Amaral, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafite, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Outeiro, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrutton, N. S.</span><span> </span><span class="NLM_article-title">Structural basis of kynurenine 3-monooxygenase inhibition</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">496</span><span class="NLM_x"> (</span><span class="NLM_issue">7445</span><span class="NLM_x">) </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2013&pages=382-385&issue=7445&author=M.+Amaralauthor=C.+Levyauthor=D.+J.+Heyesauthor=P.+Lafiteauthor=T.+F.+Outeiroauthor=F.+Giorginiauthor=D.+Leysauthor=N.+S.+Scrutton&title=Structural+basis+of+kynurenine+3-monooxygenase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmaral%26aufirst%3DM.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DHeyes%26aufirst%3DD.%2BJ.%26aulast%3DLafite%26aufirst%3DP.%26aulast%3DOuteiro%26aufirst%3DT.%2BF.%26aulast%3DGiorgini%26aufirst%3DF.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DScrutton%26aufirst%3DN.%2BS.%26atitle%3DStructural%2520basis%2520of%2520kynurenine%25203-monooxygenase%2520inhibition%26jtitle%3DNature%26date%3D2013%26volume%3D496%26issue%3D7445%26spage%3D382%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Krajcsi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tóth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beéry, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sziráki, I.</span><span> </span><span class="NLM_article-title">Efflux transporters in the blood-brain interfaces-in vitro and in vivo methods and correlations</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm501350y&amp;key=10.1517%2F17425255.2012.668184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm501350y&amp;key=22394316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm501350y&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=419-431&issue=4&author=P.+Krajcsiauthor=M.+Janiauthor=B.+T%C3%B3thauthor=F.+Erdoauthor=E.+Kisauthor=E.+Be%C3%A9ryauthor=I.+Szir%C3%A1ki&title=Efflux+transporters+in+the+blood-brain+interfaces-in+vitro+and+in+vivo+methods+and+correlations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Efflux transporters in the blood-brain interfaces - in vitro and in vivo methods and correlations</span></div><div class="casAuthors">Krajcsi, Peter; Jani, Marton; Toth, Beata; Erdoo, Franciska; Kis, Emese; Beery, Erzsebet; Sziraki, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Sufficient brain exposure is crucial to the success of CNS drugs.  The twofold greater attrition rate in clin. development of CNS drugs over the resp. attrition rate of non-CNS drugs is due to lack of efficacy.  It is generally thought that poor brain exposure is at least partly responsible for this, as the concn.-time profile at the brain target site is crit. for efficacy.  Efflux transporters in the blood-brain interfaces play a crucial role in modulation of permeability of drugs across these interfaces.  Validation of preclin. tools to correctly predict brain exposure in humans is essential.Areas covered: This review summarizes in vitro and in vivo tools to detect and characterize interactions of drugs with efflux transporters relevant to blood-brain interfaces.  Furthermore, the article discusses the strengths and weaknesses of these methods and the limitations of their application, in addn. to covering in vitro - in vivo correlations.Expert opinion: A more detailed validation of in vitro efflux transporter assays employing primary brain endothelial cultures is needed.  This should go along with mapping uptake transporters expressed in the blood-brain interfaces.  With the availability of specific inhibitors, utilization of in vivo methods such as brain microdialysis is increasing.  Once transporter-humanized mice are available, we may witness a further increase in applications of in vivo methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-t2mdNe-CKbVg90H21EOLACvtfcHk0lgHyWNFVQpRjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOrsL0%253D&md5=deca903466a82d5d026bf8ca08bbecbf</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.668184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.668184%26sid%3Dliteratum%253Aachs%26aulast%3DKrajcsi%26aufirst%3DP.%26aulast%3DJani%26aufirst%3DM.%26aulast%3DT%25C3%25B3th%26aufirst%3DB.%26aulast%3DErdo%26aufirst%3DF.%26aulast%3DKis%26aufirst%3DE.%26aulast%3DBe%25C3%25A9ry%26aufirst%3DE.%26aulast%3DSzir%25C3%25A1ki%26aufirst%3DI.%26atitle%3DEfflux%2520transporters%2520in%2520the%2520blood-brain%2520interfaces-in%2520vitro%2520and%2520in%2520vivo%2520methods%2520and%2520correlations%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D8%26issue%3D4%26spage%3D419%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Jauch, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethy, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weick, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span> </span><span class="NLM_article-title">Intravenous administration of L-kynurenine to rhesus monkeys: Effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1993&pages=467-472&issue=5&author=D.+A.+Jauchauthor=V.+H.+Sethyauthor=B.+G.+Weickauthor=T.+N.+Chaseauthor=R.+Schwarcz&title=Intravenous+administration+of+L-kynurenine+to+rhesus+monkeys%3A+Effect+on+quinolinate+and+kynurenate+levels+in+serum+and+cerebrospinal+fluid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJauch%26aufirst%3DD.%2BA.%26aulast%3DSethy%26aufirst%3DV.%2BH.%26aulast%3DWeick%26aufirst%3DB.%2BG.%26aulast%3DChase%26aufirst%3DT.%2BN.%26aulast%3DSchwarcz%26aufirst%3DR.%26atitle%3DIntravenous%2520administration%2520of%2520L-kynurenine%2520to%2520rhesus%2520monkeys%253A%2520Effect%2520on%2520quinolinate%2520and%2520kynurenate%2520levels%2520in%2520serum%2520and%2520cerebrospinal%2520fluid%26jtitle%3DNeuropharmacology%26date%3D1993%26volume%3D32%26issue%3D5%26spage%3D467%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Alexander, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarcz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. P.</span><span> </span><span class="NLM_article-title">Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2012&pages=627-637&issue=3&author=K.+S.+Alexanderauthor=H.+Q.+Wuauthor=R.+Schwarczauthor=J.+P.+Bruno&title=Acute+elevations+of+brain+kynurenic+acid+impair+cognitive+flexibility%3A+normalization+by+the+alpha7+positive+modulator+galantamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DSchwarcz%26aufirst%3DR.%26aulast%3DBruno%26aufirst%3DJ.%2BP.%26atitle%3DAcute%2520elevations%2520of%2520brain%2520kynurenic%2520acid%2520impair%2520cognitive%2520flexibility%253A%2520normalization%2520by%2520the%2520alpha7%2520positive%2520modulator%2520galantamine%26jtitle%3DPsychopharmacology%26date%3D2012%26volume%3D220%26issue%3D3%26spage%3D627%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Westerink, B. H. C.; Cremers, T. I. F. H.</span>, Eds.  <span class="citation_source-book">Handbook of Microdialyis – Methods, Applications and Clinical Aspects</span>; <span class="NLM_publisher-name">Academic Press, Elsevier</span>: <span class="NLM_publisher-loc">London, UK</span>.<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+H.+C.+Westerink&author=T.+I.+F.+H.+Cremers&title=Handbook+of+Microdialyis+%E2%80%93+Methods%2C+Applications+and+Clinical+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWesterink%26aufirst%3DB.%2BH.%2BC.%26btitle%3DHandbook%2520of%2520Microdialyis%2520%25E2%2580%2593%2520Methods%252C%2520Applications%2520and%2520Clinical%2520Aspects%26pub%3DAcademic%2520Press%252C%2520Elsevier%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4j36" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4j36','PDB','4j36'); return false;">PDB: 4j36</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i94"><a href="/doi/suppl/10.1021/jm501350y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78625"></div></div></div></div></div><hr /></hr><p class="last">Methods for permeability and efflux studies; methods for in vivo studies in efflux transporter knock out mouse model; methods for sample preparation and LC-MS/MS analysis conditions; methods for plasma extraction; methods for tissue homogenate preparation; methods for LC-MS/MS methodology; methods for pharmacokinetic analysis; methods for pharmacodynamic in vivo studies; methods for terminal PK/PD studies; methods for tissue distribution study; methods for analysis of KYN, KYNA, 3-HK, and AA; methods for analysis of QA; methods for microdialysis studies; methods for quantification of KP metabolites in plasma and microdialysate samples; methods for quantification of compound <b>75</b> in plasma and microdialysate samples. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501350y/suppl_file/jm501350y_si_001.pdf">jm501350y_si_001.pdf (191.71 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501350y&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501350y%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-3" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501350y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799591e296522f0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
